##ANALYSISTYPE=SOMATIC_PAIR
##DESCRIPTION=tumor_af=Mutant allele frequency in tumor (Sample I17R018Ra01_01).
##DESCRIPTION=tumor_dp=Tumor Depth (Sample I17R018Ra01_01).
##DESCRIPTION=normal_af=Mutant allele frequency in normal (Sample I17R018Rb01_01).
##DESCRIPTION=normal_dp=Normal depth (Sample I17R018Rb01_01).
##DESCRIPTION=filter=Filter criteria from vcf file.
##DESCRIPTION=snp_q=Quality parameters - SNP quality (QUAL).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, NM number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=interpro=Interpro domains.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD database.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=Polyphen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=ihdb_hom=Homozygous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_het=Heterozyous variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_wt=Wildtype variant counts in NGSD for the same processing system.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Comments from the NGSD. Comments of other samples are listed in brackets!
##DESCRIPTION=gene_info=General gene information from the NGSD.
##DESCRIPTION=som_ihdb_c=Somatic variant count within NGSD.
##DESCRIPTION=som_ihdb_p=Projects with somatic variant in NGSD.
##DESCRIPTION=dna_tum_freq=Variant frequency.
##DESCRIPTION=dna_tum_depth=Sequencing depth at the variant position.
##DESCRIPTION=dna_ref_freq=Variant frequency.
##DESCRIPTION=dna_ref_depth=Sequencing depth at the variant position.
##FILTER=s.special_chromosome=Special chromosome.
#chr	start	end	ref	obs	tumor_af	tumor_dp	normal_af	normal_dp	filter	snp_q	gene	variant_type	coding_and_splicing	interpro	Pathway_KEGG_full	Function_description	Pathway_BioCarta_full	RepeatMasker	dbSNP	1000g	ExAC	gnomAD	COSMIC	OMIM	ClinVar	HGMD	phyloP	MetaLR	Sift	PolyPhen2	FATHMM	CADD	ihdb_hom	ihdb_het	ihdb_wt	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info	som_ihdb_c	som_ihdb_p	dna_tum_freq	dna_tum_depth	dna_ref_freq	dna_ref_depth
chr1	1660917	1660917	T	C	0.4000	25	0.0811	38		47	RP1-283E3.8,RP1-283E3.4,SLC35E2	intron_variant	RP1-283E3.8:ENST00000598846:intron_variant:MODIFIER:exon2/19:n.2631+5212A>G:,RP1-283E3.4:ENST00000417099:intron_variant:MODIFIER:exon1/1:n.150-768T>C:,RP1-283E3.4:ENST00000577672:intron_variant:MODIFIER:exon1/1:n.252+4715T>C:,SLC35E2:ENST00000355439:intron_variant:MODIFIER:exon6/6:c.733-4056A>G:,SLC35E2:ENST00000400924:intron_variant:MODIFIER:exon5/5:c.733-4056A>G:			Putative transporter (By similarity)				0.0000	0.0000	0.0000																					0		0.3929	28	0.0732	41
chr1	1662734	1662734	T	C	0.2000	20	0.0000	23		63	RP1-283E3.8,RP1-283E3.4,SLC35E2	intron_variant,non_coding_transcript_exon_variant	RP1-283E3.8:ENST00000598846:intron_variant:MODIFIER:exon2/19:n.2631+3395A>G:,RP1-283E3.4:ENST00000577672:intron_variant:MODIFIER:exon1/1:n.253-4522T>C:,SLC35E2:ENST00000355439:intron_variant:MODIFIER:exon6/6:c.732+3395A>G:,SLC35E2:ENST00000400924:intron_variant:MODIFIER:exon5/5:c.732+3395A>G:,RP1-283E3.4:ENST00000417099:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1199T>C:			Putative transporter (By similarity)				0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	23
chr1	8464353	8464353	T	C	0.2000	20	0.0000	25		64	RERE	intron_variant	RERE:ENST00000337907:intron_variant:MODIFIER:exon13/23:c.1284+18434A>G:,RERE:ENST00000377464:intron_variant:MODIFIER:exon6/16:c.480+18434A>G:,RERE:ENST00000400907:intron_variant:MODIFIER:exon11/14:c.1284+18434A>G:,RERE:ENST00000476556:intron_variant:MODIFIER:exon2/12:c.-379+18434A>G:,RERE:ENST00000400908:intron_variant:MODIFIER:exon12/22:c.1284+18434A>G:,RERE:ENST00000488215:intron_variant:MODIFIER:exon2/4:c.-379+18434A>G:,RERE:ENST00000460659:intron_variant:MODIFIER:exon2/2:n.334+18434A>G:,RERE:ENST00000492766:intron_variant:MODIFIER:exon3/3:n.268+18434A>G:,RERE:ENST00000465125:intron_variant:MODIFIER:exon2/2:n.301+18434A>G:		Dentatorubropallidoluysian atrophy (DRPLA)	Plays a role as a transcriptional repressor during development. May play a role in the control of cell survival. Overexpression of RERE recruits BAX to the nucleus particularly to POD and triggers caspase-3 activation, leading to cell death				0.0000	0.0000	0.0000		605226 [RERE (provisional) Neurodevelopmental disorder with or without anomalies of the brain,eye,or heart,616975];																			0		0.2000	20	0.0000	25
chr1	9302960	9302960	G	A	0.0800	75	0.0000	68		70	H6PD	intron_variant	H6PD:ENST00000602477:intron_variant:MODIFIER:exon1/4:c.24-2024G>A:,H6PD:ENST00000377403:intron_variant:MODIFIER:exon1/4:c.-10-2024G>A:		Pentose phosphate pathway	Oxidizes glucose-6-phosphate and glucose, as well as other hexose-6-phosphates				0.0000	0.0000	0.0000		138090 [H6PD (confirmed) Cortisone reductase deficiency 1,604931];																			0		0.0750	80	0.0000	75
chr1	9369779	9369779	A	G	0.1389	36	0.0000	72		78	SPSB1	intron_variant	SPSB1:ENST00000328089:intron_variant:MODIFIER:exon1/2:c.-150+16649A>G:,SPSB1:ENST00000450402:intron_variant:MODIFIER:exon1/1:c.-150+15126A>G:			Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins				0.0000	0.0000	0.0000																					0		0.1389	36	0.0000	72
chr1	15501816	15501816	A	G	0.1481	27	0.0000	29		55	TMEM51	intron_variant	TMEM51:ENST00000376008:intron_variant:MODIFIER:exon1/3:c.-267+21366A>G:,TMEM51:ENST00000428417:intron_variant:MODIFIER:exon1/2:c.-194+22536A>G:,TMEM51:ENST00000376014:intron_variant:MODIFIER:exon1/3:c.-267+22536A>G:,TMEM51:ENST00000451326:intron_variant:MODIFIER:exon1/2:c.-194+22536A>G:,TMEM51:ENST00000400796:intron_variant:MODIFIER:exon1/2:c.-194+21366A>G:,TMEM51:ENST00000434578:intron_variant:MODIFIER:exon1/3:c.-267+21366A>G:							0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	29
chr1	16890289	16890289	C	T	0.3636	11	0.0000	17		36	NBPF1	3_prime_UTR_variant	NBPF1:ENST00000430580:3_prime_UTR_variant:MODIFIER:exon29/29:c.*149G>A:						rs774641957	0.0000	0.0000	0.0000																					0		0.2778	18	0.0500	20
chr1	16929443	16929443	C	T	0.1786	28	0.0000	17		57	NBPF1	intron_variant,non_coding_transcript_exon_variant	NBPF1:ENST00000430580:intron_variant:MODIFIER:exon2/28:c.-467+5560G>A:,NBPF1:ENST00000392963:intron_variant:MODIFIER:exon2/18:c.-191+1293G>A:,NBPF1:ENST00000420513:intron_variant:MODIFIER:exon1/3:n.143+5560G>A:,NBPF1:ENST00000599069:intron_variant:MODIFIER:exon2/2:n.498-1105G>A:,NBPF1:ENST00000599908:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.102G>A:						rs150744407	0.0000	0.0000	0.0000																					0		0.1724	29	0.0000	17
chr1	16973996	16973996	A	G	0.2778	18	0.0488	41		61	MST1P2	non_coding_transcript_exon_variant	MST1P2:ENST00000334429:non_coding_transcript_exon_variant:MODIFIER:exon8/20:n.773A>G:,MST1P2:ENST00000418421:non_coding_transcript_exon_variant:MODIFIER:exon6/7:n.619A>G:,MST1P2:ENST00000457982:non_coding_transcript_exon_variant:MODIFIER:exon7/18:n.729A>G:						rs200256873	0.0000	0.0000	0.0000																					0		0.3600	25	0.1064	47
chr1	19543899	19543899	T	C	0.3125	16	0.0000	16		36	EMC1,RP1-43E13.2	3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	EMC1:ENST00000477853:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1898A>G:,EMC1:ENST00000375199:3_prime_UTR_variant:MODIFIER:exon23/23:c.*1898A>G:,RP1-43E13.2:ENST00000437898:intron_variant:MODIFIER:exon1/1:n.59+6846T>C:,EMC1:ENST00000480380:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.3361A>G:							0.0000	0.0000	0.0000		616846 [EMC1 (provisional) Cerebellar atrophy,visual impairment,and psychomotor retardation,616875];																			0		0.3125	16	0.0000	16
chr1	20978564	20978564	T	C	0.1087	46	0.0000	46		63	DDOST,PINK1-AS	3_prime_UTR_variant,non_coding_transcript_exon_variant	DDOST:ENST00000375048:3_prime_UTR_variant:MODIFIER:exon11/11:c.*308A>G:,DDOST:ENST00000602624:3_prime_UTR_variant:MODIFIER:exon11/11:c.*308A>G:,DDOST:ENST00000415136:3_prime_UTR_variant:MODIFIER:exon10/10:c.*308A>G:,PINK1-AS:ENST00000451424:non_coding_transcript_exon_variant:MODIFIER:exon1/3:n.123A>G:		N-Glycan biosynthesis;Glycan structures - biosynthesis 1	Essential subunit of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains			rs1131967	0.0000	0.0000	0.0000		602202 [DDOST (provisional) Congenital disorder of glycosylation,type Ir,614507];																			0		0.1087	46	0.0000	46
chr1	21109960	21109960	T	C	0.1739	23	0.0000	26		64	HP1BP3	intron_variant	HP1BP3:ENST00000312239:intron_variant:MODIFIER:exon1/12:c.-100-2927A>G:,HP1BP3:ENST00000438032:intron_variant:MODIFIER:exon1/8:c.-100-2927A>G:,HP1BP3:ENST00000424732:intron_variant:MODIFIER:exon1/7:c.-18-3556A>G:,HP1BP3:ENST00000417710:intron_variant:MODIFIER:exon1/4:c.-101+2719A>G:,HP1BP3:ENST00000375000:intron_variant:MODIFIER:exon1/4:c.-100-2927A>G:,HP1BP3:ENST00000437575:intron_variant:MODIFIER:exon1/3:c.-209-2927A>G:,HP1BP3:ENST00000419490:intron_variant:MODIFIER:exon1/2:c.-19+2786A>G:,HP1BP3:ENST00000414993:intron_variant:MODIFIER:exon1/3:c.-101+2786A>G:,HP1BP3:ENST00000443615:intron_variant:MODIFIER:exon1/1:c.-19+2719A>G:			Component of heterochromatin, may be involved in chromatin structure and function (By similarity)				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	26
chr1	21499854	21499854	T	C	0.3889	19	0.0000	20		44	EIF4G3	intron_variant	EIF4G3:ENST00000400422:intron_variant:MODIFIER:exon2/33:c.-272+2814A>G:,EIF4G3:ENST00000602326:intron_variant:MODIFIER:exon2/34:c.-272+2814A>G:,EIF4G3:ENST00000356916:intron_variant:MODIFIER:exon1/14:c.-470+1349A>G:,EIF4G3:ENST00000438975:intron_variant:MODIFIER:exon2/9:c.-272+2814A>G:,EIF4G3:ENST00000411888:intron_variant:MODIFIER:exon2/8:c.-143+2814A>G:			Probable component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome. Thought to be a functional homolog of EIF4G1	Eukaryotic protein translation;Internal Ribosome Entry Pathway;mTOR Signaling Pathway;Regulation of eIF4e and p70 S6 Kinase			0.0000	0.0000	0.0000																					0		0.4211	19	0.0000	20
chr1	21500081	21500081	T	C	0.1143	35	0.0000	25		53	EIF4G3	intron_variant	EIF4G3:ENST00000400422:intron_variant:MODIFIER:exon2/33:c.-272+2587A>G:,EIF4G3:ENST00000602326:intron_variant:MODIFIER:exon2/34:c.-272+2587A>G:,EIF4G3:ENST00000356916:intron_variant:MODIFIER:exon1/14:c.-470+1122A>G:,EIF4G3:ENST00000438975:intron_variant:MODIFIER:exon2/9:c.-272+2587A>G:,EIF4G3:ENST00000411888:intron_variant:MODIFIER:exon2/8:c.-143+2587A>G:			Probable component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome. Thought to be a functional homolog of EIF4G1	Eukaryotic protein translation;Internal Ribosome Entry Pathway;mTOR Signaling Pathway;Regulation of eIF4e and p70 S6 Kinase			0.0000	0.0000	0.0000																					0		0.1143	35	0.0000	25
chr1	23626863	23626863	T	C	0.1852	27	0.0238	42		52	RP5-1057J7.6-HNRNPR	intergenic_region	RP5-1057J7.6-HNRNPR:ENSG00000261326-ENSG00000125944:intergenic_region:MODIFIER::n.23626863T>C:							0.0000	0.0000	0.0000																					0		0.1852	27	0.0238	42
chr1	27794550	27794550	T	C	0.2353	17	0.0000	23		61	WASF2	intron_variant	WASF2:ENST00000430629:intron_variant:MODIFIER:exon1/8:c.-44+21947A>G:,WASF2:ENST00000536657:intron_variant:MODIFIER:exon1/7:c.-44+21947A>G:		Adherens junction;Regulation of actin cytoskeleton	Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex	Y branching of actin filaments			0.0000	0.0000	0.0000																					0		0.2353	17	0.0000	23
chr1	28835937	28835937	A	G	0.2642	53	0.0714	57		55	RCC1,SNHG3	intron_variant,non_coding_transcript_exon_variant	RCC1:ENST00000398958:intron_variant:MODIFIER:exon3/11:c.-10+520A>G:,RCC1:ENST00000427469:intron_variant:MODIFIER:exon3/8:c.-10+520A>G:,RCC1:ENST00000434290:intron_variant:MODIFIER:exon3/10:c.-115+520A>G:,RCC1:ENST00000373833:intron_variant:MODIFIER:exon3/12:c.-153+524A>G:,SNHG3:ENST00000437681:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2406A>G:,SNHG3:ENST00000413987:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.734A>G:			Guanine-nucleotide releasing factor that promotes the exchange of Ran-bound GDP by GTP. Involved in the regulation of onset of chromosome condensation in the S phase. Binds both to the nucleosomes and double-stranded DNA. RCC1-Ran complex (together with other proteins) acts as a component of a signal transmission pathway that detects unreplicated DNA. Plays a key role in nucleo- cytoplasmic transport, mitosis and nuclear-envelope assembly	Cycling of Ran in nucleocytoplasmic transport;Role of Ran in mitotic spindle regulation			0.0000	0.0000	0.0000																					0		0.2642	53	0.0877	57
chr1	29499764	29499764	T	C	0.3846	13	0.0000	23		50	SRSF4	intron_variant	SRSF4:ENST00000373795:intron_variant:MODIFIER:exon1/5:c.107+8394A>G:,SRSF4:ENST00000546138:intron_variant:MODIFIER:exon1/3:c.107+8394A>G:,SRSF4:ENST00000466448:intron_variant:MODIFIER:exon1/4:n.237+8394A>G:,SRSF4:ENST00000605204:intron_variant:MODIFIER:exon1/7:c.108-4614A>G:			Plays a role in alternative splice site selection during pre-mRNA splicing. Represses the splicing of MAPT/Tau exon 10				0.0000	0.0000	0.0000																					0		0.3846	13	0.0000	23
chr1	31454249	31454249	A	G	0.1290	32	0.0000	38		55	PUM1	missense_variant,3_prime_UTR_variant,non_coding_transcript_exon_variant	PUM1:ENST00000373741:missense_variant:MODERATE:exon8/22:c.1270T>C:p.Phe424Leu,PUM1:ENST00000424085:missense_variant:MODERATE:exon4/18:c.436T>C:p.Phe146Leu,PUM1:ENST00000257075:missense_variant:MODERATE:exon8/22:c.1162T>C:p.Phe388Leu,PUM1:ENST00000373747:missense_variant:MODERATE:exon8/22:c.1162T>C:p.Phe388Leu,PUM1:ENST00000525843:missense_variant:MODERATE:exon8/21:c.1210T>C:p.Phe404Leu,PUM1:ENST00000426105:missense_variant:MODERATE:exon8/22:c.1162T>C:p.Phe388Leu,PUM1:ENST00000498419:missense_variant:MODERATE:exon3/17:c.280T>C:p.Phe94Leu,PUM1:ENST00000440538:missense_variant:MODERATE:exon8/22:c.1162T>C:p.Phe388Leu,PUM1:ENST00000423018:missense_variant:MODERATE:exon6/19:c.874T>C:p.Phe292Leu,PUM1:ENST00000373742:missense_variant:MODERATE:exon6/20:c.982T>C:p.Phe328Leu,PUM1:ENST00000532678:missense_variant:MODERATE:exon3/6:c.325T>C:p.Phe109Leu,PUM1:ENST00000526215:3_prime_UTR_variant:MODIFIER:exon5/5:c.*165T>C:,PUM1:ENST00000526128:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.233T>C:			Sequence-specific RNA-binding protein that regulates translation and mRNA stability by binding the 3'-UTR of mRNA targets. May be required to support proliferation and self-renewal of stem cells (By similarity)				0.0000	0.0000	0.0000					8.448000,8.448000	T,T	D,D,D,D,D,D,D,D,D,D,,,	B,P,P,D,B,P,B,P,	T,T,T,T,T,T,T,T,	24.70											0		0.1250	32	0.0000	39
chr1	31454251	31454251	A	T	0.1290	32	0.0000	38		59	PUM1	missense_variant&splice_region_variant,splice_region_variant&non_coding_transcript_exon_variant,splice_region_variant,3_prime_UTR_variant	PUM1:ENST00000373741:missense_variant&splice_region_variant:MODERATE:exon8/22:c.1268T>A:p.Leu423Gln,PUM1:ENST00000424085:missense_variant&splice_region_variant:MODERATE:exon4/18:c.434T>A:p.Leu145Gln,PUM1:ENST00000257075:missense_variant&splice_region_variant:MODERATE:exon8/22:c.1160T>A:p.Leu387Gln,PUM1:ENST00000373747:missense_variant&splice_region_variant:MODERATE:exon8/22:c.1160T>A:p.Leu387Gln,PUM1:ENST00000525843:missense_variant&splice_region_variant:MODERATE:exon8/21:c.1208T>A:p.Leu403Gln,PUM1:ENST00000426105:missense_variant&splice_region_variant:MODERATE:exon8/22:c.1160T>A:p.Leu387Gln,PUM1:ENST00000498419:missense_variant&splice_region_variant:MODERATE:exon3/17:c.278T>A:p.Leu93Gln,PUM1:ENST00000440538:missense_variant&splice_region_variant:MODERATE:exon8/22:c.1160T>A:p.Leu387Gln,PUM1:ENST00000423018:missense_variant&splice_region_variant:MODERATE:exon6/19:c.872T>A:p.Leu291Gln,PUM1:ENST00000373742:missense_variant&splice_region_variant:MODERATE:exon6/20:c.980T>A:p.Leu327Gln,PUM1:ENST00000532678:missense_variant&splice_region_variant:MODERATE:exon3/6:c.323T>A:p.Leu108Gln,PUM1:ENST00000526128:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon2/4:n.231T>A:,PUM1:ENST00000526215:splice_region_variant:LOW:exon5/5:c.*163T>A:,PUM1:ENST00000526215:3_prime_UTR_variant:MODIFIER:exon5/5:c.*163T>A:			Sequence-specific RNA-binding protein that regulates translation and mRNA stability by binding the 3'-UTR of mRNA targets. May be required to support proliferation and self-renewal of stem cells (By similarity)				0.0000	0.0000	0.0000					8.448000	T	T,D,D,D,D,D,D,D,T,D	P,D,P,D,P,P,P,D	T,T,T,T,T,T,T,T	27.20											0		0.1250	32	0.0000	39
chr1	32485502	32485502	A	G	0.2000	20	0.0000	31		61	KHDRBS1	intron_variant	KHDRBS1:ENST00000327300:intron_variant:MODIFIER:exon1/8:c.382+5524A>G:,KHDRBS1:ENST00000307714:intron_variant:MODIFIER:exon1/8:n.452+5524A>G:,KHDRBS1:ENST00000492989:intron_variant:MODIFIER:exon1/7:c.382+5524A>G:,KHDRBS1:ENST00000484270:intron_variant:MODIFIER:exon1/10:n.196+5524A>G:			Recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, functions as an adapter protein in signal transduction cascades by binding to SH2 and SH3 domain- containing proteins. Role in G2-M progression in the cell cycle. Represses CBP-dependent transcriptional activation apparently by competing with other nuclear factors for binding to CBP. Also acts as a putative regulator of mRNA stability and/or translation rates and mediates mRNA nuclear export. Positively regulates the association of constitutive transport element (CTE)-containing mRNA with large polyribosomes and translation initiation. According to some authors, is not involved in the nucleocytoplasmic export of unspliced (CTE)-containing RNA species according to (PubMed:22253824)				0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	31
chr1	33149338	33149338	A	G	0.3158	21	0.0000	27		68	RBBP4,SYNC	3_prime_UTR_variant,intron_variant	RBBP4:ENST00000373493:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4032A>G:,SYNC:ENST00000409190:intron_variant:MODIFIER:exon4/4:c.1438+273T>C:,SYNC:ENST00000373484:intron_variant:MODIFIER:exon3/3:c.1358+521T>C:			Core histone-binding subunit that may target chromatin assembly factors, chromatin remodeling factors and histone deacetylases to their histone substrates in a manner that is regulated by nucleosomal DNA. Component of several complexes which regulate chromatin metabolism. These include the chromatin assembly factor 1 (CAF-1) complex, which is required for chromatin assembly following DNA replication and DNA repair; the core histone deacetylase (HDAC) complex, which promotes histone deacetylation and consequent transcriptional repression; the nucleosome remodeling and histone deacetylase complex (the NuRD complex), which promotes transcriptional repression by histone deacetylation and nucleosome remodeling; the PRC2/EED-EZH2 complex, which promotes repression of homeotic genes during development; and the NURF (nucleosome remodeling factor) complex				0.0000	0.0000	0.0000																					0		0.2857	21	0.0000	27
chr1	33308295	33308295	A	G	0.3077	13	0.0286	35		64	S100PBP	intron_variant	S100PBP:ENST00000373475:intron_variant:MODIFIER:exon5/6:c.1025-10385A>G:,S100PBP:ENST00000373476:intron_variant:MODIFIER:exon5/6:c.1025-10385A>G:,S100PBP:ENST00000531123:intron_variant:MODIFIER:exon6/6:n.1284-89A>G:							0.0000	0.0000	0.0000																					0		0.3077	13	0.0286	35
chr1	33490073	33490073	-	T	0.0833	86	0.0000	99		46	AK2,RP1-117O3.2	frameshift_variant,3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	AK2:ENST00000354858:frameshift_variant:HIGH:exon2/6:c.188dupA:p.Leu64fs,AK2:ENST00000373449:frameshift_variant:HIGH:exon2/7:c.188dupA:p.Leu64fs,AK2:ENST00000467905:frameshift_variant:HIGH:exon2/8:c.188dupA:p.Leu64fs,AK2:ENST00000480134:frameshift_variant:HIGH:exon2/5:c.188dupA:p.Leu64fs,AK2:ENST00000487289:frameshift_variant:HIGH:exon2/5:c.188dupA:p.Leu64fs,AK2:ENST00000550338:3_prime_UTR_variant:MODIFIER:exon3/7:c.*177dupA:,RP1-117O3.2:ENST00000427524:intron_variant:MODIFIER:exon1/1:n.246-6557dupT:,AK2:ENST00000548033:intron_variant:MODIFIER:exon1/5:c.94-2770dupA:,AK2:ENST00000548559:non_coding_transcript_exon_variant:MODIFIER:exon4/5:n.402dupA:,AK2:ENST00000551979:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.228dupA:		Purine metabolism	Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. Adenylate kinase activity is critical for regulation of the phosphate utilization and the AMP de novo biosynthesis pathways. Plays a key role in hematopoiesis				0.0000	0.0000	0.0000		103020 [AK2 (confirmed) Reticular dysgenesis,267500];																			0		0.0531	113	0.0000	146
chr1	33794096	33794096	T	C	0.2500	20	0.0000	27		71	PHC2	intron_variant	PHC2:ENST00000419414:intron_variant:MODIFIER:exon14/14:c.2425+375A>G:,PHC2:ENST00000431992:intron_variant:MODIFIER:exon12/12:c.2335+375A>G:,PHC2:ENST00000485928:intron_variant:MODIFIER:exon6/7:n.987+375A>G:,PHC2:ENST00000373418:intron_variant:MODIFIER:exon6/6:c.817+375A>G:,PHC2:ENST00000373422:intron_variant:MODIFIER:exon7/7:c.1240+375A>G:,PHC2:ENST00000257118:intron_variant:MODIFIER:exon13/13:c.2422+375A>G:,PHC2:ENST00000467894:intron_variant:MODIFIER:exon7/7:n.1135+375A>G:,PHC2:ENST00000373416:intron_variant:MODIFIER:exon13/13:c.817+375A>G:			Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility				0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	31
chr1	36068281	36068281	T	C	0.1905	21	0.0392	52		53	PSMB2	3_prime_UTR_variant	PSMB2:ENST00000373237:3_prime_UTR_variant:MODIFIER:exon6/6:c.*587A>G:		Proteasome	The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit has a trypsin-like activity				0.0000	0.0000	0.0000																					0		0.1905	21	0.0385	52
chr1	38468950	38468950	T	C	0.3750	8	0.0000	16		33	FHL3	intron_variant	FHL3:ENST00000373016:intron_variant:MODIFIER:exon1/5:c.-21+2079A>G:,FHL3:ENST00000485803:intron_variant:MODIFIER:exon1/4:n.146+2079A>G:,FHL3:ENST00000475084:intron_variant:MODIFIER:exon1/3:n.146+2079A>G:,FHL3:ENST00000477194:intron_variant:MODIFIER:exon1/5:n.168+2161A>G:							0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	16
chr1	39606385	39606385	A	G	0.1471	39	0.0200	52		61	MACF1	intron_variant	MACF1:ENST00000567887:intron_variant:MODIFIER:exon1/100:c.220+56275A>G:,MACF1:ENST00000545844:intron_variant:MODIFIER:exon2/93:c.220+56275A>G:,MACF1:ENST00000372915:intron_variant:MODIFIER:exon1/96:c.220+56275A>G:,MACF1:ENST00000361689:intron_variant:MODIFIER:exon1/92:c.220+56275A>G:,MACF1:ENST00000317713:intron_variant:MODIFIER:exon1/92:c.220+56275A>G:,MACF1:ENST00000539005:intron_variant:MODIFIER:exon1/90:c.220+56275A>G:,MACF1:ENST00000524432:intron_variant:MODIFIER:exon1/31:c.94+34996A>G:,MACF1:ENST00000467673:intron_variant:MODIFIER:exon1/3:n.289+34996A>G:			Isoform 2 is a F-actin-binding protein which may play a role in cross-linking actin to other cytoskeletal proteins and also binds to microtubules. Plays an important role in ERBB2- dependent stabilization of microtubules at the cell cortex. Acts as a positive regulator of Wnt receptor signaling pathway and is involved in the translocation of AXIN1 and its associated complex (composed of APC, CTNNB1 and GSK3B) from the cytoplasm to the cell membrane. Has actin-regulated ATPase activity and is essential for controlling focal adhesions (FAs) assembly and dynamics. May play role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with GOLGA4. Plays a key role in wound healing and epidermal cell migration. Required for efficient upward migration of bulge cells in response to wounding and this function is primarily rooted in its ability to coordinate MT dynamics and polarize hair follicle stem cells (By similarity)				0.0000	0.0000	0.0000																					0		0.1538	39	0.0192	52
chr1	41180386	41180386	A	G	0.2500	20	0.0000	22		58	NFYC	intron_variant	NFYC:ENST00000467203:intron_variant:MODIFIER:exon1/5:n.220+22847A>G:,NFYC:ENST00000424419:intron_variant:MODIFIER:exon1/4:n.182+22847A>G:,NFYC:ENST00000427410:intron_variant:MODIFIER:exon1/8:c.-9+22847A>G:,NFYC:ENST00000447388:intron_variant:MODIFIER:exon1/9:c.-9+22847A>G:,NFYC:ENST00000425457:intron_variant:MODIFIER:exon1/10:c.-9+22847A>G:,NFYC:ENST00000453631:intron_variant:MODIFIER:exon1/5:c.-112-8975A>G:,NFYC:ENST00000456393:intron_variant:MODIFIER:exon1/9:c.-9+22847A>G:,NFYC:ENST00000372654:intron_variant:MODIFIER:exon2/10:c.-9+1893A>G:,NFYC:ENST00000534399:intron_variant:MODIFIER:exon1/4:c.-225-8494A>G:,NFYC:ENST00000372653:intron_variant:MODIFIER:exon3/14:c.-279+2245A>G:,NFYC:ENST00000372669:intron_variant:MODIFIER:exon1/8:c.-9+22367A>G:,NFYC:ENST00000372652:intron_variant:MODIFIER:exon1/9:c.-9+5098A>G:,NFYC:ENST00000372651:intron_variant:MODIFIER:exon1/9:c.-9+5098A>G:		Antigen processing and presentation	Stimulates the transcription of various genes by recognizing and binding to a CCAAT motif in promoters, for example in type 1 collagen, albumin and beta-actin genes	Overview of telomerase RNA component gene hTerc Transcriptional Regulation			0.0000	0.0000	0.0000																					0		0.2500	20	0.0000	22
chr1	46163466	46163466	T	C	0.2000	20	0.0000	24		63	IPP	intron_variant	IPP:ENST00000359942:intron_variant:MODIFIER:exon9/9:c.1651+2276A>G:,IPP:ENST00000461718:intron_variant:MODIFIER:exon1/1:n.125+137A>G:,IPP:ENST00000495072:intron_variant:MODIFIER:exon2/2:n.454-462A>G:			May play a role in organizing the actin cytoskeleton				0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	25
chr1	52535739	52535739	A	G	0.3077	13	0.0000	26		59	BTF3L4	intron_variant	BTF3L4:ENST00000313334:intron_variant:MODIFIER:exon3/5:c.168+5129A>G:,BTF3L4:ENST00000477828:intron_variant:MODIFIER:exon4/6:c.*235+5129A>G:,BTF3L4:ENST00000489308:intron_variant:MODIFIER:exon3/4:c.168+5129A>G:,BTF3L4:ENST00000526132:intron_variant:MODIFIER:exon3/4:n.344+4659A>G:,BTF3L4:ENST00000472944:intron_variant:MODIFIER:exon2/4:c.-7+5129A>G:,BTF3L4:ENST00000484036:intron_variant:MODIFIER:exon3/4:c.168+5129A>G:,BTF3L4:ENST00000533836:intron_variant:MODIFIER:exon3/4:n.230-1083A>G:							0.0000	0.0000	0.0000																					0		0.3077	13	0.0000	26
chr1	78196394	78196394	-	A	0.1875	38	0.0000	63		52	USP33	frameshift_variant	USP33:ENST00000357428:frameshift_variant:HIGH:exon8/24:c.639dupT:p.Leu214fs,USP33:ENST00000370794:frameshift_variant:HIGH:exon8/24:c.546dupT:p.Leu183fs,USP33:ENST00000370793:frameshift_variant:HIGH:exon9/25:c.639dupT:p.Leu214fs,USP33:ENST00000370792:frameshift_variant:HIGH:exon9/22:c.639dupT:p.Leu214fs			Deubiquitinating enzyme involved in various processes such as centrosome duplication, cellular migration and beta-2 adrenergic receptor/ADRB2 recycling. Involved in regulation of centrosome duplication by mediating deubiquitination of CCP110 in S and G2/M phase, leading to stabilize CCP110 during the period which centrioles duplicate and elongate. Involved in cell migration via its interaction with intracellular domain of ROBO1, leading to regulate the Slit signaling. Plays a role in commissural axon guidance cross the ventral midline of the neural tube in a Slit-dependent manner, possibly by mediating the deubiquitination of ROBO1. Acts as a regulator of G-protein coupled receptor (GPCR) signaling by mediating the deubiquitination of beta-arrestins (ARRB1 and ARRB2) and beta-2 adrenergic receptor (ADRB2). Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2. Upon dissociation, it is probably transferred to the translocated beta- arrestins, leading to beta-arrestins deubiquitination and disengagement from ADRB2. This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins. Deubiquitinates DIO2, thereby regulating thyroid hormone regulation. Mediates deubiquitination of both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains				0.0000	0.0000	0.0000																					0		0.1429	42	0.0000	54
chr1	78958916	78958916	C	A	0.1096	73	0.0000	51		71	PTGFR	missense_variant	PTGFR:ENST00000370757:missense_variant:MODERATE:exon2/3:c.488C>A:p.Ala163Asp,PTGFR:ENST00000370758:missense_variant:MODERATE:exon3/4:c.488C>A:p.Ala163Asp,PTGFR:ENST00000497923:missense_variant:MODERATE:exon2/5:c.488C>A:p.Ala163Asp,PTGFR:ENST00000370756:missense_variant:MODERATE:exon2/4:c.488C>A:p.Ala163Asp	GPCR__rhodopsin-like_superfamily__1_	Calcium signaling pathway;Neuroactive ligand-receptor interaction	Receptor for prostaglandin F2-alpha (PGF2-alpha). The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. Initiates luteolysis in the corpus luteum (By similarity)			rs781334182	0.0000	0.00002	0.00003					5.697000	T	D,D,D	D,D	T,T,T	29.20											0		0.1096	73	0.0000	51
chr1	81945466	81945466	A	G	0.1087	49	0.0000	42		62	LPHN2	intron_variant	LPHN2:ENST00000473719:intron_variant:MODIFIER:exon2/4:n.419+34692A>G:,LPHN2:ENST00000370721:intron_variant:MODIFIER:exon2/24:c.-248+34692A>G:,LPHN2:ENST00000370723:intron_variant:MODIFIER:exon2/24:c.-248+34692A>G:,LPHN2:ENST00000370725:intron_variant:MODIFIER:exon2/25:c.-248+34692A>G:,LPHN2:ENST00000370727:intron_variant:MODIFIER:exon2/24:c.-248+34692A>G:,LPHN2:ENST00000370728:intron_variant:MODIFIER:exon2/24:c.-248+34692A>G:,LPHN2:ENST00000370730:intron_variant:MODIFIER:exon2/23:c.-248+34692A>G:,LPHN2:ENST00000469377:intron_variant:MODIFIER:exon2/8:n.380+34692A>G:			Calcium-independent receptor of low affinity for alpha- latrotoxin, an excitatory neurotoxin present in black widow spider venom which triggers massive exocytosis from neurons and neuroendocrine cells. Receptor propably implicated in the regulation of exocytosis (By similarity)				0.0000	0.0000	0.0000																					0		0.1373	51	0.0000	42
chr1	81947051	81947051	A	G	0.2000	25	0.0270	37		60	LPHN2	intron_variant	LPHN2:ENST00000473719:intron_variant:MODIFIER:exon2/4:n.419+36277A>G:,LPHN2:ENST00000370721:intron_variant:MODIFIER:exon2/24:c.-248+36277A>G:,LPHN2:ENST00000370723:intron_variant:MODIFIER:exon2/24:c.-248+36277A>G:,LPHN2:ENST00000370725:intron_variant:MODIFIER:exon2/25:c.-248+36277A>G:,LPHN2:ENST00000370727:intron_variant:MODIFIER:exon2/24:c.-248+36277A>G:,LPHN2:ENST00000370728:intron_variant:MODIFIER:exon2/24:c.-248+36277A>G:,LPHN2:ENST00000370730:intron_variant:MODIFIER:exon2/23:c.-248+36277A>G:,LPHN2:ENST00000469377:intron_variant:MODIFIER:exon2/8:n.380+36277A>G:			Calcium-independent receptor of low affinity for alpha- latrotoxin, an excitatory neurotoxin present in black widow spider venom which triggers massive exocytosis from neurons and neuroendocrine cells. Receptor propably implicated in the regulation of exocytosis (By similarity)				0.0000	0.0000	0.0000																					0		0.2308	26	0.0270	37
chr1	94936952	94936952	A	G	0.5833	12	0.0000	16		33	ABCD3	intron_variant	ABCD3:ENST00000454898:intron_variant:MODIFIER:exon5/23:c.408-2370A>G:,ABCD3:ENST00000394233:intron_variant:MODIFIER:exon4/18:c.336-2370A>G:,ABCD3:ENST00000536817:intron_variant:MODIFIER:exon3/21:c.117-2370A>G:,ABCD3:ENST00000370214:intron_variant:MODIFIER:exon4/22:c.336-2370A>G:,ABCD3:ENST00000315713:intron_variant:MODIFIER:exon4/8:c.336-2370A>G:,ABCD3:ENST00000468860:intron_variant:MODIFIER:exon5/7:n.413-2370A>G:		ABC transporters	Probable transporter. The nucleotide-binding fold acts as an ATP-binding subunit with ATPase activity				0.0000	0.0000	0.0000		170995 [ABCD3 (provisional) Bile acid synthesis defect,congenital,5,616278];																			0		0.5833	12	0.0000	16
chr1	95388771	95388771	-	T	0.1765	35	0.0000	26		42	CNN3	intron_variant	CNN3:ENST00000370206:intron_variant:MODIFIER:exon1/6:c.57+3622dupA:,CNN3:ENST00000538964:intron_variant:MODIFIER:exon2/7:c.57+3622dupA:,CNN3:ENST00000394202:intron_variant:MODIFIER:exon1/5:c.57+3622dupA:,CNN3:ENST00000545882:intron_variant:MODIFIER:exon1/6:c.-67+2417dupA:,CNN3:ENST00000415017:intron_variant:MODIFIER:exon1/6:c.-67+2417dupA:,CNN3:ENST00000474409:intron_variant:MODIFIER:exon1/3:n.274+958dupA:			Thin filament-associated protein that is implicated in the regulation and modulation of smooth muscle contraction. It is capable of binding to actin, calmodulin, troponin C and tropomyosin. The interaction of calponin with actin inhibits the actomyosin Mg-ATPase activity				0.0000	0.0000	0.0000																					0		0.0296	135	0.0000	24
chr1	110910031	110910031	A	G	0.5714	8	0.0000	23		53	SLC16A4	intron_variant	SLC16A4:ENST00000369779:intron_variant:MODIFIER:exon8/8:c.1337-3516T>C:,SLC16A4:ENST00000472422:intron_variant:MODIFIER:exon7/7:c.1193-3516T>C:,SLC16A4:ENST00000369781:intron_variant:MODIFIER:exon7/7:c.833-3516T>C:,SLC16A4:ENST00000461647:intron_variant:MODIFIER:exon6/6:c.*526-3516T>C:,SLC16A4:ENST00000437429:intron_variant:MODIFIER:exon6/6:c.1007-3496T>C:,SLC16A4:ENST00000528649:intron_variant:MODIFIER:exon6/6:c.*931-3496T>C:,SLC16A4:ENST00000492412:intron_variant:MODIFIER:exon7/7:c.*1030-3516T>C:,SLC16A4:ENST00000541986:intron_variant:MODIFIER:exon7/7:c.1151-3516T>C:			Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate (By similarity)				0.0000	0.0000	0.0000																					0		0.5000	8	0.0000	23
chr1	142786432	142786432	T	C	0.2174	23	0.0488	41		54	RP11-417J8.3-RP11-423O2.3	intergenic_region	RP11-417J8.3-RP11-423O2.3:ENSG00000230880-ENSG00000230446:intergenic_region:MODIFIER::n.142786432T>C:							0.0000	0.0000	0.0000																					0		0.2174	23	0.0435	46
chr1	143177233	143177233	T	C	0.3333	12	0.0000	36		51	RP11-782C8.2,RP11-782C8.1	intron_variant	RP11-782C8.2:ENST00000412204:intron_variant:MODIFIER:exon6/8:n.2503+12201A>G:,RP11-782C8.1:ENST00000438000:intron_variant:MODIFIER:exon1/3:n.60-43401T>C:,RP11-782C8.2:ENST00000422129:intron_variant:MODIFIER:exon2/2:n.253+16889A>G:,RP11-782C8.1:ENST00000447407:intron_variant:MODIFIER:exon1/3:n.60-43401T>C:,RP11-782C8.1:ENST00000428930:intron_variant:MODIFIER:exon1/2:n.60-54046T>C:							0.0000	0.0000	0.0000																					0		0.2500	20	0.0278	36
chr1	144603930	144603930	C	T	0.3889	18	0.0000	23		53	RP11-640M9.2	intron_variant	RP11-640M9.2:ENST00000419820:intron_variant:MODIFIER:exon3/3:n.2607-1512C>T:,RP11-640M9.2:ENST00000429694:intron_variant:MODIFIER:exon2/10:n.873-480C>T:,RP11-640M9.2:ENST00000421407:intron_variant:MODIFIER:exon4/11:n.742-2439C>T:,RP11-640M9.2:ENST00000447534:intron_variant:MODIFIER:exon3/3:n.2385-1512C>T:,RP11-640M9.2:ENST00000449960:intron_variant:MODIFIER:exon2/6:n.299+5150C>T:,RP11-640M9.2:ENST00000423405:intron_variant:MODIFIER:exon1/10:n.270-548C>T:,RP11-640M9.2:ENST00000448227:intron_variant:MODIFIER:exon1/2:n.168-480C>T:,RP11-640M9.2:ENST00000437451:intron_variant:MODIFIER:exon1/2:n.131-2439C>T:,RP11-640M9.2:ENST00000437133:intron_variant:MODIFIER:exon1/8:n.127-548C>T:						rs1699848	0.0000	0.0000	0.0000																					0		0.4211	19	0.0000	23
chr1	144814763	144814763	G	T	0.1111	45	0.0000	27		55	NBPF9	missense_variant,5_prime_UTR_variant,non_coding_transcript_exon_variant	NBPF9:ENST00000375552:missense_variant:MODERATE:exon3/15:c.395G>T:p.Arg132Leu,NBPF9:ENST00000338347:missense_variant:MODERATE:exon3/14:c.401G>T:p.Arg134Leu,NBPF9:ENST00000440491:missense_variant:MODERATE:exon3/16:c.401G>T:p.Arg134Leu,NBPF9:ENST00000281815:5_prime_UTR_variant:MODIFIER:exon3/13:c.-545G>T:,NBPF9:ENST00000483630:non_coding_transcript_exon_variant:MODIFIER:exon3/4:n.397G>T:,NBPF9:ENST00000468645:non_coding_transcript_exon_variant:MODIFIER:exon3/15:n.397G>T:,NBPF9:ENST00000491652:non_coding_transcript_exon_variant:MODIFIER:exon3/13:n.397G>T:,NBPF9:ENST00000496755:non_coding_transcript_exon_variant:MODIFIER:exon3/15:n.397G>T:,NBPF9:ENST00000465793:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.204G>T:,NBPF9:ENST00000471873:non_coding_transcript_exon_variant:MODIFIER:exon1/3:n.81G>T:							0.0000	0.00002	0.00001					-2.059000,-2.059000	T,T	,T,T	,B,B,P,D,B	,T,T	0.00											0		0.1519	79	0.1176	68
chr1	148571157	148571157	-	A	0.2222	22	0.0000	23		42	NBPF15	intron_variant	NBPF15:ENST00000369187:intron_variant:MODIFIER:exon3/18:c.-191+2286dupA:,NBPF15:ENST00000464336:intron_variant:MODIFIER:exon6/22:n.973+2286dupA:,NBPF15:ENST00000488031:intron_variant:MODIFIER:exon4/5:n.707+2286dupA:,NBPF15:ENST00000442702:intron_variant:MODIFIER:exon3/20:c.-622+2286dupA:							0.0000	0.0000	0.0000																					0		0.0714	56	0.0000	24
chr1	150542381	150542381	T	C	0.2500	16	0.0000	26		66	RN7SL600P-MCL1	intergenic_region	RN7SL600P-MCL1:ENSG00000264584-ENSG00000143384:intergenic_region:MODIFIER::n.150542381T>C:							0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	26
chr1	150543816	150543816	T	C	0.1538	42	0.0000	73		82	RN7SL600P-MCL1	intergenic_region	RN7SL600P-MCL1:ENSG00000264584-ENSG00000143384:intergenic_region:MODIFIER::n.150543816T>C:							0.0000	0.0000	0.0000																					0		0.1667	42	0.0000	73
chr1	151419682	151419682	T	C	0.4375	16	0.0000	17		35	POGZ	intron_variant	POGZ:ENST00000271715:intron_variant:MODIFIER:exon1/18:c.-1-5001A>G:,POGZ:ENST00000358476:intron_variant:MODIFIER:exon1/16:n.28-5001A>G:,POGZ:ENST00000361398:intron_variant:MODIFIER:exon1/17:c.-1-5001A>G:,POGZ:ENST00000368863:intron_variant:MODIFIER:exon1/16:c.-1-5001A>G:,POGZ:ENST00000409503:intron_variant:MODIFIER:exon1/18:c.-1-5001A>G:,POGZ:ENST00000531094:intron_variant:MODIFIER:exon1/17:c.-1-5001A>G:,POGZ:ENST00000540984:intron_variant:MODIFIER:exon1/12:c.-692-5001A>G:,POGZ:ENST00000491586:intron_variant:MODIFIER:exon1/17:c.-1-5001A>G:,POGZ:ENST00000485040:intron_variant:MODIFIER:exon1/6:n.29-5001A>G:,POGZ:ENST00000467287:intron_variant:MODIFIER:exon1/3:n.37-5001A>G:,POGZ:ENST00000533461:intron_variant:MODIFIER:exon1/3:c.-1-5001A>G:,POGZ:ENST00000533351:intron_variant:MODIFIER:exon2/4:c.-2+3704A>G:,POGZ:ENST00000450842:intron_variant:MODIFIER:exon1/2:c.-1-5001A>G:,POGZ:ENST00000476128:intron_variant:MODIFIER:exon1/2:n.29-5001A>G:			Plays a role in mitotic cell cycle progression and is involved in kinetochore assembly and mitotic sister chromatid cohesion. Probably through its association with CBX5 plays a role in mitotic chromosome segregation by regulating aurora kinase B/AURKB activation and AURKB and CBX5 dissociation from chromosome arms				0.0000	0.0000	0.0000		614787 [POGZ (provisional) White-Sutton syndrome,616364];																			0		0.4375	16	0.0000	18
chr1	155528828	155528828	T	C	0.3750	8	0.0357	28		50	ASH1L	intron_variant	ASH1L:ENST00000368346:intron_variant:MODIFIER:exon1/27:c.-100+3116A>G:,ASH1L:ENST00000392403:intron_variant:MODIFIER:exon1/27:c.-100+3116A>G:,ASH1L:ENST00000548830:intron_variant:MODIFIER:exon2/4:c.-100+3116A>G:		Tight junction	Histone methyltransferase specifically methylating 'Lys- 36' of histone H3 (H3K36me)				0.0000	0.0000	0.0000																					0		0.3750	8	0.0357	28
chr1	164538076	164538076	G	A	0.0952	42	0.0000	26		53	PBX1	intron_variant	PBX1:ENST00000420696:intron_variant:MODIFIER:exon2/8:c.265+5528G>A:,PBX1:ENST00000340699:intron_variant:MODIFIER:exon3/3:c.265+5528G>A:,PBX1:ENST00000498497:intron_variant:MODIFIER:exon2/2:n.265+5528G>A:,PBX1:ENST00000401534:intron_variant:MODIFIER:exon2/6:c.265+5528G>A:,PBX1:ENST00000559240:intron_variant:MODIFIER:exon2/6:c.265+5528G>A:,PBX1:ENST00000367897:intron_variant:MODIFIER:exon2/7:c.265+5528G>A:,PBX1:ENST00000540236:intron_variant:MODIFIER:exon2/8:c.265+5528G>A:,PBX1:ENST00000559578:intron_variant:MODIFIER:exon2/3:c.49+5528G>A:			Binds the sequence 5'-ATCAATCAA-3'. Acts as a transcriptional activator of PF4 in complex with MEIS1. Converted into a potent transcriptional activator by the (1;19) translocation. May have a role in steroidogenesis and, subsequently, sexual development and differentiation. Isoform PBX1b as part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Probably in complex with MEIS2, is involved in transcriptional regulation by KLF4. Acts as a transcriptional activator of NKX2-5 and a transcriptional repressor of CDKN2B. Together with NKX2-5, it is required for spleen development through a mechanism that involves CDKN2B repression (By similarity)				0.0000	0.0000	0.0000		176310 [PBX1 (confirmed) Leukemia,acute pre-B-cell];																			0		0.0952	42	0.0000	26
chr1	164590306	164590306	A	G	0.2353	17	0.0000	20		52	PBX1	intron_variant	PBX1:ENST00000420696:intron_variant:MODIFIER:exon2/8:c.265+57758A>G:,PBX1:ENST00000340699:intron_variant:MODIFIER:exon3/3:c.265+57758A>G:,PBX1:ENST00000498497:intron_variant:MODIFIER:exon2/2:n.265+57758A>G:,PBX1:ENST00000401534:intron_variant:MODIFIER:exon2/6:c.265+57758A>G:,PBX1:ENST00000559240:intron_variant:MODIFIER:exon2/6:c.265+57758A>G:,PBX1:ENST00000367897:intron_variant:MODIFIER:exon2/7:c.265+57758A>G:,PBX1:ENST00000540236:intron_variant:MODIFIER:exon2/8:c.265+57758A>G:,PBX1:ENST00000559578:intron_variant:MODIFIER:exon2/3:c.49+57758A>G:,PBX1:ENST00000560469:intron_variant:MODIFIER:exon1/7:n.221+44065A>G:,PBX1:ENST00000496120:intron_variant:MODIFIER:exon1/7:n.85+30635A>G:,PBX1:ENST00000468104:intron_variant:MODIFIER:exon1/8:n.228-4860A>G:			Binds the sequence 5'-ATCAATCAA-3'. Acts as a transcriptional activator of PF4 in complex with MEIS1. Converted into a potent transcriptional activator by the (1;19) translocation. May have a role in steroidogenesis and, subsequently, sexual development and differentiation. Isoform PBX1b as part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Probably in complex with MEIS2, is involved in transcriptional regulation by KLF4. Acts as a transcriptional activator of NKX2-5 and a transcriptional repressor of CDKN2B. Together with NKX2-5, it is required for spleen development through a mechanism that involves CDKN2B repression (By similarity)				0.0000	0.0000	0.0000		176310 [PBX1 (confirmed) Leukemia,acute pre-B-cell];																			0		0.2353	17	0.0000	20
chr1	164653195	164653195	A	G	0.1250	36	0.0000	25		51	PBX1	intron_variant,non_coding_transcript_exon_variant	PBX1:ENST00000420696:intron_variant:MODIFIER:exon2/8:c.266-108536A>G:,PBX1:ENST00000340699:intron_variant:MODIFIER:exon3/3:c.266-108536A>G:,PBX1:ENST00000401534:intron_variant:MODIFIER:exon2/6:c.266-108536A>G:,PBX1:ENST00000559240:intron_variant:MODIFIER:exon2/6:c.266-108536A>G:,PBX1:ENST00000367897:intron_variant:MODIFIER:exon2/7:c.266-108536A>G:,PBX1:ENST00000540236:intron_variant:MODIFIER:exon2/8:c.266-108536A>G:,PBX1:ENST00000559578:intron_variant:MODIFIER:exon2/3:c.50-108536A>G:,PBX1:ENST00000560469:intron_variant:MODIFIER:exon1/7:n.221+106954A>G:,PBX1:ENST00000496120:intron_variant:MODIFIER:exon1/7:n.85+93524A>G:,PBX1:ENST00000468104:intron_variant:MODIFIER:exon2/8:n.395+57862A>G:,PBX1:ENST00000560641:intron_variant:MODIFIER:exon2/8:c.-51+26586A>G:,PBX1:ENST00000482110:intron_variant:MODIFIER:exon1/2:c.-51+52842A>G:,PBX1:ENST00000558796:intron_variant:MODIFIER:exon1/2:n.244+31819A>G:,PBX1:ENST00000498497:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.2094A>G:			Binds the sequence 5'-ATCAATCAA-3'. Acts as a transcriptional activator of PF4 in complex with MEIS1. Converted into a potent transcriptional activator by the (1;19) translocation. May have a role in steroidogenesis and, subsequently, sexual development and differentiation. Isoform PBX1b as part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Probably in complex with MEIS2, is involved in transcriptional regulation by KLF4. Acts as a transcriptional activator of NKX2-5 and a transcriptional repressor of CDKN2B. Together with NKX2-5, it is required for spleen development through a mechanism that involves CDKN2B repression (By similarity)				0.0000	0.0000	0.0000		176310 [PBX1 (confirmed) Leukemia,acute pre-B-cell];																			0		0.1944	36	0.0000	25
chr1	164819099	164819099	-	A	0.2632	23	0.0000	30		48	PBX1	3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	PBX1:ENST00000420696:3_prime_UTR_variant:MODIFIER:exon9/9:c.*3192dupA:,PBX1:ENST00000558796:intron_variant:MODIFIER:exon2/2:n.257+18385dupA:,PBX1:ENST00000540246:intron_variant:MODIFIER:exon6/6:c.885+28242dupA:,PBX1:ENST00000465089:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.10832dupA:			Binds the sequence 5'-ATCAATCAA-3'. Acts as a transcriptional activator of PF4 in complex with MEIS1. Converted into a potent transcriptional activator by the (1;19) translocation. May have a role in steroidogenesis and, subsequently, sexual development and differentiation. Isoform PBX1b as part of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells is involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element. Probably in complex with MEIS2, is involved in transcriptional regulation by KLF4. Acts as a transcriptional activator of NKX2-5 and a transcriptional repressor of CDKN2B. Together with NKX2-5, it is required for spleen development through a mechanism that involves CDKN2B repression (By similarity)				0.0000	0.0000	0.0000		176310 [PBX1 (confirmed) Leukemia,acute pre-B-cell];																			0		0.2632	19	0.0000	25
chr1	171456862	171456862	A	G	0.2000	21	0.0000	22		56	PRRC2C	intron_variant	PRRC2C:ENST00000392078:intron_variant:MODIFIER:exon1/34:c.-58+1988A>G:,PRRC2C:ENST00000426496:intron_variant:MODIFIER:exon1/31:c.-58+1988A>G:,PRRC2C:ENST00000476522:intron_variant:MODIFIER:exon1/11:n.185+1988A>G:,PRRC2C:ENST00000367742:intron_variant:MODIFIER:exon1/33:c.-58+1988A>G:,PRRC2C:ENST00000338920:intron_variant:MODIFIER:exon1/33:c.-58+1988A>G:,PRRC2C:ENST00000467601:intron_variant:MODIFIER:exon1/4:n.140+1988A>G:							0.0000	0.0000	0.0000																					0		0.2381	21	0.0000	22
chr1	186839910	186839910	G	A	0.2105	19	0.0000	19		52	PLA2G4A	intron_variant	PLA2G4A:ENST00000367466:intron_variant:MODIFIER:exon3/17:c.115+262G>A:,PLA2G4A:ENST00000442353:intron_variant:MODIFIER:exon3/15:c.115+262G>A:,PLA2G4A:ENST00000466600:intron_variant:MODIFIER:exon2/6:n.184+262G>A:		Glycerophospholipid metabolism;Ether lipid metabolism;Arachidonic acid metabolism;Linoleic acid metabolism;alpha-Linolenic acid metabolism;MAPK signaling pathway;VEGF signaling pathway;Fc epsilon RI signaling pathway;Long-term depression;GnRH signaling pathway	Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. Together with its lysophospholipid activity, it is implicated in the initiation of the inflammatory response	Aspirin Blocks Signaling Pathway Involved in Platelet Activation;Eicosanoid Metabolism;Fc Epsilon Receptor I Signaling in Mast Cells;p38 MAPK Signaling Pathway 		rs139418625	0.00359425	0.00890	0.00699		600522 [PLA2G4A (provisional) Phospholipase A2,group IV A,deficiency of];																			0		0.2105	19	0.0000	19
chr1	197111525	197111525	-	T	0.3158	22	0.0000	25		46	ASPM	frameshift_variant	ASPM:ENST00000367409:frameshift_variant:HIGH:exon3/28:c.1856dupA:p.Asn619fs,ASPM:ENST00000294732:frameshift_variant:HIGH:exon3/27:c.1856dupA:p.Asn619fs			Probable role in mitotic spindle regulation and coordination of mitotic processes. May have a preferential role in regulating neurogenesis				0.0000	0.0000	0.0000		605481 [ASPM (confirmed) Microcephaly 5,primary,autosomal recessive,608716];																			0		0.2000	20	0.0000	23
chr1	200323847	200323847	T	C	0.3500	20	0.0000	20		46	LINC00862	intron_variant	LINC00862:ENST00000367355:intron_variant:MODIFIER:exon4/4:n.551-11309A>G:,LINC00862:ENST00000367356:intron_variant:MODIFIER:exon2/3:n.418-11309A>G:							0.0000	0.0000	0.0000																					0		0.3500	20	0.0000	20
chr1	211452637	211452637	-	A	0.2121	42	0.0000	58		56	RCOR3	frameshift_variant	RCOR3:ENST00000419091:frameshift_variant:HIGH:exon7/12:c.705dupA:p.Glu236fs,RCOR3:ENST00000367006:frameshift_variant:HIGH:exon7/11:c.705dupA:p.Glu236fs,RCOR3:ENST00000452621:frameshift_variant:HIGH:exon7/11:c.705dupA:p.Glu236fs,RCOR3:ENST00000528926:frameshift_variant:HIGH:exon8/13:c.801dupA:p.Glu268fs,RCOR3:ENST00000367005:frameshift_variant:HIGH:exon6/11:c.531dupA:p.Glu178fs,RCOR3:ENST00000534460:frameshift_variant:HIGH:exon1/4:c.63dupA:p.Glu22fs			May act as a component of a corepressor complex that represses transcription (Potential)				0.0000	0.0000	0.0000																					0		0.1220	41	0.0000	55
chr1	211979519	211979519	T	C	0.2857	14	0.0000	24		60	LPGAT1	intron_variant	LPGAT1:ENST00000366996:intron_variant:MODIFIER:exon2/7:c.239-12987A>G:,LPGAT1:ENST00000366997:intron_variant:MODIFIER:exon2/7:c.239-12987A>G:			Lysophoshatidylglycerol (LPG) specific acyltransferase that recognizes various acyl-CoAs and LPGs as substrates but demonstrates a clear preference for long chain saturated fatty acyl-CoAs and oleoyl-CoA as acyl donors. Prefers oleoyl-LPG over palmitoyl-LPG as an acyl receptor and oleoyl-CoA over lauroyl-CoA as an acyl donor				0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	24
chr1	224192688	224192688	A	G	0.3095	42	0.0600	50		71	RP11-504P24.4	intron_variant	RP11-504P24.4:ENST00000449219:intron_variant:MODIFIER:exon3/3:n.374+1332A>G:							0.0000	0.0000	0.0000																					0		0.3095	42	0.0600	50
chr1	231470864	231470864	T	C	0.4167	13	0.0000	17		35	EXOC8	3_prime_UTR_variant	EXOC8:ENST00000360394:3_prime_UTR_variant:MODIFIER:exon1/1:c.*450A>G:,EXOC8:ENST00000366645:3_prime_UTR_variant:MODIFIER:exon1/1:c.*450A>G:			Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane				0.0000	0.0000	0.0000																					0		0.4615	13	0.0000	17
chr1	241787465	241787465	C	T	0.2857	15	0.0000	29		49	OPN3	intron_variant	OPN3:ENST00000366554:intron_variant:MODIFIER:exon1/3:c.373+15719G>A:,OPN3:ENST00000331838:intron_variant:MODIFIER:exon1/3:c.374-8227G>A:,OPN3:ENST00000469376:intron_variant:MODIFIER:exon1/3:n.459+15719G>A:,OPN3:ENST00000490673:intron_variant:MODIFIER:exon1/2:n.474+15719G>A:,OPN3:ENST00000463155:intron_variant:MODIFIER:exon1/2:n.75-26166G>A:,OPN3:ENST00000478849:intron_variant:MODIFIER:exon1/4:n.330-8227G>A:			May play a role in encephalic photoreception			rs28396501	0.0000	0.0000	0.0000																					0		0.1818	22	0.0312	32
chr1	243323270	243323270	T	C	0.3929	30	0.0667	47		61	CEP170	intron_variant	CEP170:ENST00000366542:intron_variant:MODIFIER:exon13/19:c.3677-3513A>G:,CEP170:ENST00000366543:intron_variant:MODIFIER:exon12/18:c.3383-3621A>G:,CEP170:ENST00000366544:intron_variant:MODIFIER:exon12/18:c.3383-3513A>G:,CEP170:ENST00000336415:intron_variant:MODIFIER:exon8/14:c.3566-3513A>G:,CEP170:ENST00000490813:intron_variant:MODIFIER:exon1/7:c.-39+3305A>G:,CEP170:ENST00000413359:intron_variant:MODIFIER:exon1/5:c.212-3621A>G:,CEP170:ENST00000464936:intron_variant:MODIFIER:exon1/5:c.-147+3305A>G:,CEP170:ENST00000492145:intron_variant:MODIFIER:exon1/3:c.-147+3190A>G:			Plays a role in microtubule organization				0.0000	0.0000	0.0000																					0		0.4333	30	0.0851	47
chr1	243481440	243481440	A	G	0.4286	8	0.0000	21		44	SDCCAG8	intron_variant	SDCCAG8:ENST00000366541:intron_variant:MODIFIER:exon9/17:c.1068+1245A>G:,SDCCAG8:ENST00000355875:intron_variant:MODIFIER:exon8/16:c.939+1245A>G:,SDCCAG8:ENST00000343783:intron_variant:MODIFIER:exon6/14:c.633+1245A>G:,SDCCAG8:ENST00000435549:intron_variant:MODIFIER:exon4/10:c.408+1245A>G:			Plays a role in the establishment of cell polarity and epithelial lumen formation (By similarity). May play a role in ciliogenesis				0.0000	0.0000	0.0000		613524 [SDCCAG8 (provisional) Senior-Loken syndrome 7,613615|Bardet-Biedl syndrome 16,615993];																			0		0.5000	8	0.0000	21
chr1	247368325	247368325	T	C	0.1333	30	0.0000	19		58	MIR3916	intron_variant	MIR3916:ENST00000421406:intron_variant:MODIFIER:exon1/3:n.78+4393A>G:,MIR3916:ENST00000606173:intron_variant:MODIFIER:exon1/3:n.167-2928A>G:,MIR3916:ENST00000606212:intron_variant:MODIFIER:exon1/1:n.125-2943A>G:,MIR3916:ENST00000606454:intron_variant:MODIFIER:exon1/1:n.133-2928A>G:							0.0000	0.0000	0.0000																					0		0.1333	30	0.0000	19
chr2	3452219	3452219	C	A	0.0741	27	0.0000	16		56	TRAPPC12	intron_variant	TRAPPC12:ENST00000324266:intron_variant:MODIFIER:exon6/11:c.1530+4557C>A:,TRAPPC12:ENST00000382110:intron_variant:MODIFIER:exon6/11:c.1530+4557C>A:,TRAPPC12:ENST00000441983:intron_variant:MODIFIER:exon5/6:c.567+4557C>A:,TRAPPC12:ENST00000417243:intron_variant:MODIFIER:exon3/7:c.363+4557C>A:,TRAPPC12:ENST00000469147:intron_variant:MODIFIER:exon2/5:n.179+4557C>A:,TRAPPC12:ENST00000441099:intron_variant:MODIFIER:exon2/4:c.156+4557C>A:,TRAPPC12:ENST00000433382:intron_variant:MODIFIER:exon1/5:n.166+4557C>A:,TRAPPC12:ENST00000462983:intron_variant:MODIFIER:exon1/3:n.100+4557C>A:,TRAPPC12:ENST00000479897:intron_variant:MODIFIER:exon1/3:n.96+4557C>A:,TRAPPC12:ENST00000415624:intron_variant:MODIFIER:exon1/6:c.24+4557C>A:			May be involved in endoplasmic reticulum to Golgi apparatus trafficking at a very early stage				0.0000	0.0000	0.0000																					0		0.0714	28	0.0000	17
chr2	20546682	20546682	C	T	0.1379	31	0.0000	24		65	PUM2	intron_variant	PUM2:ENST00000536417:intron_variant:MODIFIER:exon1/19:c.-78+3676G>A:,PUM2:ENST00000403432:intron_variant:MODIFIER:exon1/20:c.-19+3676G>A:,PUM2:ENST00000442400:intron_variant:MODIFIER:exon1/6:c.-19+5245G>A:,PUM2:ENST00000420234:intron_variant:MODIFIER:exon1/4:n.25+3889G>A:,PUM2:ENST00000429419:intron_variant:MODIFIER:exon1/4:c.-19+3676G>A:,PUM2:ENST00000432105:intron_variant:MODIFIER:exon1/5:c.-19+5245G>A:,PUM2:ENST00000446940:intron_variant:MODIFIER:exon1/4:c.-19+3284G>A:,PUM2:ENST00000424110:intron_variant:MODIFIER:exon1/4:c.-337+3676G>A:			Sequence-specific RNA-binding protein that regulates translation and mRNA stability by binding the 3'-UTR of mRNA targets. Its interactions and tissue specificity suggest that it may be required to support proliferation and self-renewal of stem cells by regulating the translation of key transcripts				0.0000	0.0000	0.0000																					0		0.1290	31	0.0000	24
chr2	26010757	26010757	T	C	0.2105	20	0.0000	23		60	ASXL2	intron_variant	ASXL2:ENST00000435504:intron_variant:MODIFIER:exon5/12:c.403+11497A>G:,ASXL2:ENST00000336112:intron_variant:MODIFIER:exon4/11:c.319+11497A>G:,ASXL2:ENST00000272341:intron_variant:MODIFIER:exon4/12:c.-378+11497A>G:,ASXL2:ENST00000497092:intron_variant:MODIFIER:exon3/4:n.341+11497A>G:			Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. PcG proteins are not required to initiate repression, but to maintain it during later stages of development. They probably act via methylation of histones, rendering chromatin heritably changed in its expressibility (By similarity). Involved in transcriptional regulation mediated by ligand-bound nuclear hormone receptors, such as peroxisome proliferator-activated receptor gamma (PPARG). Acts as coactivator for PPARG and enhances its adipocyte differentiation-inducing activity; the function seems to involve differential recruitment of acetylated and methylated histone H3				0.0000	0.0000	0.0000		612991 [ASXL2 (provisional) Shashi-Pena syndrome,617190];																			0		0.2000	20	0.0000	23
chr2	26011933	26011933	T	C	0.1212	34	0.0000	18		53	ASXL2	intron_variant	ASXL2:ENST00000435504:intron_variant:MODIFIER:exon5/12:c.403+10321A>G:,ASXL2:ENST00000336112:intron_variant:MODIFIER:exon4/11:c.319+10321A>G:,ASXL2:ENST00000272341:intron_variant:MODIFIER:exon4/12:c.-378+10321A>G:,ASXL2:ENST00000497092:intron_variant:MODIFIER:exon3/4:n.341+10321A>G:			Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development. PcG proteins are not required to initiate repression, but to maintain it during later stages of development. They probably act via methylation of histones, rendering chromatin heritably changed in its expressibility (By similarity). Involved in transcriptional regulation mediated by ligand-bound nuclear hormone receptors, such as peroxisome proliferator-activated receptor gamma (PPARG). Acts as coactivator for PPARG and enhances its adipocyte differentiation-inducing activity; the function seems to involve differential recruitment of acetylated and methylated histone H3				0.0000	0.0000	0.0000		612991 [ASXL2 (provisional) Shashi-Pena syndrome,617190];																			0		0.1176	34	0.0000	18
chr2	27727324	27727324	A	G	0.1224	50	0.0270	37		59	GCKR	intron_variant	GCKR:ENST00000264717:intron_variant:MODIFIER:exon9/18:c.750+838A>G:,GCKR:ENST00000424318:intron_variant:MODIFIER:exon8/17:c.180+838A>G:,GCKR:ENST00000472290:intron_variant:MODIFIER:exon9/10:n.772+838A>G:			Inhibits glucokinase by forming an inactive complex with this enzyme				0.0000	0.0000	0.0000		600842 [GCKR (confirmed) Fasting plasma glucose level QTL 5,613463];																			0		0.1400	50	0.0256	39
chr2	32224627	32224627	T	C	0.2174	24	0.0000	18		51	MEMO1,DPY30	sequence_feature,intron_variant	MEMO1:ENST00000404530:sequence_feature:LOW::c.61+10629A>G:,MEMO1:ENST00000426310:sequence_feature:LOW::c.61+10629A>G:,MEMO1:ENST00000295065:intron_variant:MODIFIER:exon1/8:c.61+10629A>G:,DPY30:ENST00000446765:intron_variant:MODIFIER:exon2/9:n.134+23864A>G:,MEMO1:ENST00000404530:intron_variant:MODIFIER:exon2/9:c.61+10629A>G:,MEMO1:ENST00000490459:intron_variant:MODIFIER:exon1/6:n.95+11384A>G:,MEMO1:ENST00000426310:intron_variant:MODIFIER:exon1/7:c.61+10629A>G:,MEMO1:ENST00000413686:intron_variant:MODIFIER:exon1/6:n.231+10629A>G:,MEMO1:ENST00000407893:intron_variant:MODIFIER:exon1/3:c.61+10629A>G:			May control cell migration by relaying extracellular chemotactic signals to the microtubule cytoskeleton. Mediator of ERBB2 signaling. The MEMO1-RHOA-DIAPH1 signaling pathway plays an important role in ERBB2-dependent stabilization of microtubules at the cell cortex. It controls the localization of APC and CLASP2 to the cell membrane, via the regulation of GSK3B activity. In turn, membrane-bound APC allows the localization of the MACF1 to the cell membrane, which is required for microtubule capture and stabilization. Is required for breast carcinoma cell migration.,As part of the MLL1/MLL complex, involved in the methylation of histone H3 at 'Lys-4', particularly trimethylation. Histone H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. May play some role in histone H3 acetylation. In a teratocarcinoma cell, plays a crucial role in retinoic acid-induced differentiation along the neural lineage, regulating gene induction and H3 'Lys-4' methylation at key developmental loci. May also play an indirect or direct role in endosomal transport				0.0000	0.0000	0.0000																					0		0.2083	24	0.0000	18
chr2	32506397	32506397	A	G	0.1739	23	0.0000	18		52	YIPF4	intron_variant	YIPF4:ENST00000238831:intron_variant:MODIFIER:exon1/5:c.79+3094A>G:,YIPF4:ENST00000495355:intron_variant:MODIFIER:exon1/1:n.106+3094A>G:,YIPF4:ENST00000437765:intron_variant:MODIFIER:exon1/4:c.4+3094A>G:			Involved in the maintenance of the Golgi structure				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	18
chr2	32733950	32733950	A	G	0.2500	16	0.0000	25		64	BIRC6	intron_variant	BIRC6:ENST00000421745:intron_variant:MODIFIER:exon51/73:c.9980+624A>G:		Ubiquitin mediated proteolysis	Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification				0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	25
chr2	32745810	32745810	A	G	0.2000	31	0.0263	39		54	BIRC6	intron_variant	BIRC6:ENST00000421745:intron_variant:MODIFIER:exon57/73:c.11623+1797A>G:		Ubiquitin mediated proteolysis	Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification				0.0000	0.0000	0.0000																					0		0.2258	31	0.0488	41
chr2	32746570	32746570	A	G	0.2500	24	0.0000	20		54	BIRC6	intron_variant	BIRC6:ENST00000421745:intron_variant:MODIFIER:exon57/73:c.11623+2557A>G:		Ubiquitin mediated proteolysis	Anti-apoptotic protein which can regulate cell death by controlling caspases and by acting as an E3 ubiquitin-protein ligase. Has an unusual ubiquitin conjugation system in that it could combine in a single polypeptide, ubiquitin conjugating (E2) with ubiquitin ligase (E3) activity, forming a chimeric E2/E3 ubiquitin ligase. Its tragets include CASP9 and DIABLO/SMAC. Acts as an inhibitor of CASP3, CASP7 and CASP9. Important regulator for the final stages of cytokinesis. Crucial for normal vesicle targeting to the site of abscission, but also for the integrity of the midbody and the midbody ring, and its striking ubiquitin modification				0.0000	0.0000	0.0000																					0		0.2500	24	0.0000	22
chr2	37329235	37329235	T	C	0.2750	42	0.0789	38		55	EIF2AK2	3_prime_UTR_variant	EIF2AK2:ENST00000233057:3_prime_UTR_variant:MODIFIER:exon17/17:c.*5181A>G:			IFN-induced dsRNA-dependent serine/threonine-protein kinase which plays a key role in the innate immune response to viral infection and is also involved in the regulation of signal transduction, apoptosis, cell proliferation and differentiation. Exerts its antiviral activity on a wide range of DNA and RNA viruses including hepatitis C virus (HCV), hepatitis B virus (HBV), measles virus (MV) and herpes simplex virus 1 (HHV-1). Inhibits viral replication via phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (EIF2S1), this phosphorylation impairs the recycling of EIF2S1 between successive rounds of initiation leading to inhibition of translation which eventually results in shutdown of cellular and viral protein synthesis. Also phosphorylates other substrates including p53/TP53, PPP2R5A, DHX9, ILF3, IRS1 and the HHV-1 viral protein US11. In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity and phosphorylates CDK1 at 'Tyr-4' upon DNA damage, facilitating its ubiquitination and proteosomal degradation. Either as an adapter protein and/or via its kinase activity, can regulate various signaling pathways (p38 MAP kinase, NF-kappa-B and insulin signaling pathways) and transcription factors (JUN, STAT1, STAT3, IRF1, ATF3) involved in the expression of genes encoding proinflammatory cytokines and IFNs. Activates the NF-kappa-B pathway via interaction with IKBKB and TRAF family of proteins and activates the p38 MAP kinase pathway via interaction with MAP2K6. Can act as both a positive and negative regulator of the insulin signaling pathway (ISP). Negatively regulates ISP by inducing the inhibitory phosphorylation of insulin receptor substrate 1 (IRS1) at 'Ser- 312' and positively regulates ISP via phosphorylation of PPP2R5A which activates FOXO1, which in turn up-regulates the expression of insulin receptor substrate 2 (IRS2). Can regulate NLRP3 inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 and NLRC4 inflammasomes. Can trigger apoptosis via FADD-mediated activation of CASP8. Plays a role in the regulation of the cytoskeleton by binding to gelsolin (GSN), sequestering the protein in an inactive conformation away from actin	Bone Remodelling;Double Stranded RNA Induced Gene Expression;Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages;Regulation of eIF2;Toll-Like Receptor Pathway			0.0000	0.0000	0.0000																					0		0.2857	42	0.0789	38
chr2	39704196	39704196	A	G	0.1290	33	0.0000	44		55	AC007246.3	intron_variant	AC007246.3:ENST00000449569:intron_variant:MODIFIER:exon3/5:n.282+22690A>G:,AC007246.3:ENST00000426083:intron_variant:MODIFIER:exon3/8:n.214+22690A>G:,AC007246.3:ENST00000443038:intron_variant:MODIFIER:exon1/1:n.168-39359A>G:,AC007246.3:ENST00000422128:intron_variant:MODIFIER:exon3/5:n.296+22690A>G:,AC007246.3:ENST00000446698:intron_variant:MODIFIER:exon2/4:n.79+22690A>G:							0.0000	0.0000	0.0000																					0		0.1212	33	0.0000	44
chr2	42404575	42404575	A	G	0.2083	24	0.0000	39		76	EML4	intron_variant	EML4:ENST00000401738:intron_variant:MODIFIER:exon1/23:c.25+7799A>G:,EML4:ENST00000318522:intron_variant:MODIFIER:exon1/22:c.25+7799A>G:,EML4:ENST00000402711:intron_variant:MODIFIER:exon1/21:c.25+7799A>G:,EML4:ENST00000409040:intron_variant:MODIFIER:exon1/3:n.256+7799A>G:,EML4:ENST00000482660:intron_variant:MODIFIER:exon1/2:n.246+7799A>G:			May modify the assembly dynamics of microtubules, such that microtubules are slightly longer, but more dynamic (By similarity)				0.0000	0.0000	0.0000																					0		0.2083	24	0.0000	39
chr2	48107240	48107240	T	C	0.1176	34	0.0000	30		54	FBXO11	intron_variant	FBXO11:ENST00000403359:intron_variant:MODIFIER:exon1/22:c.232+25388A>G:,FBXO11:ENST00000402508:intron_variant:MODIFIER:exon1/22:c.-21+8525A>G:,FBXO11:ENST00000316377:intron_variant:MODIFIER:exon1/22:c.-21+25388A>G:,FBXO11:ENST00000492225:intron_variant:MODIFIER:exon1/15:n.80+25388A>G:,FBXO11:ENST00000424163:intron_variant:MODIFIER:exon1/4:c.-21+24992A>G:,FBXO11:ENST00000480038:intron_variant:MODIFIER:exon1/5:n.94+8525A>G:,FBXO11:ENST00000378314:intron_variant:MODIFIER:exon1/4:c.-123+25388A>G:			Substrate recognition component of the a (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins. Binds to and neddylates phosphorylated p53/TP53, inhibiting its transcriptional activity. SCF(FBXO11) does not seem to direct ubiquitination of TP53				0.0000	0.0000	0.0000																					0		0.1176	34	0.0000	30
chr2	54210555	54210555	A	G	0.2083	24	0.0000	19		56	ACYP2	intron_variant	ACYP2:ENST00000607452:intron_variant:MODIFIER:exon2/6:c.62+9608A>G:,ACYP2:ENST00000458030:intron_variant:MODIFIER:exon2/4:n.582+9608A>G:,ACYP2:ENST00000422521:intron_variant:MODIFIER:exon2/4:c.62+9608A>G:		Glycolysis / Gluconeogenesis;Pyruvate metabolism;Benzoate degradation via CoA ligation	Its physiological role is not yet clear				0.0000	0.0000	0.0000																					0		0.2083	24	0.0000	19
chr2	55784471	55784471	T	C	0.5000	8	0.0000	16		33	SMEK2	intron_variant	SMEK2:ENST00000345102:intron_variant:MODIFIER:exon16/16:c.2454+1440A>G:,SMEK2:ENST00000272313:intron_variant:MODIFIER:exon14/14:c.2199+1440A>G:,SMEK2:ENST00000407823:intron_variant:MODIFIER:exon15/15:c.2358+1440A>G:			Regulatory subunit of serine/threonine-protein phosphatase 4 (PP4). May regulate the activity of PPP4C at centrosomal microtubule organizing centers				0.0000	0.0000	0.0000																					0		0.5000	8	0.0000	16
chr2	61520946	61520946	T	C	0.0870	47	0.0000	44		51	USP34	intron_variant	USP34:ENST00000398571:intron_variant:MODIFIER:exon32/79:c.4462-261A>G:,USP34:ENST00000472706:intron_variant:MODIFIER:exon2/4:n.208+2989A>G:			Ubiquitin hydrolase that can remove conjugated ubiquitin from AXIN1 and AXIN2, thereby acting as a regulator of Wnt signaling pathway. Acts as an activator of the Wnt signaling pathway downstream of the beta-catenin destruction complex by deubiquitinating and stabilizing AXIN1 and AXIN2, leading to promote nuclear accumulation of AXIN1 and AXIN2 and positively regulate beta-catenin (CTNBB1)-mediated transcription. Recognizes and hydrolyzes the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins				0.0000	0.0000	0.0000																					0		0.0851	47	0.0000	44
chr2	63139472	63139472	A	G	0.2857	28	0.1000	52		54	EHBP1	intron_variant	EHBP1:ENST00000263991:intron_variant:MODIFIER:exon11/24:c.1291-30381A>G:,EHBP1:ENST00000405015:intron_variant:MODIFIER:exon10/22:c.1186-30381A>G:,EHBP1:ENST00000431489:intron_variant:MODIFIER:exon10/22:c.1186-30381A>G:,EHBP1:ENST00000354487:intron_variant:MODIFIER:exon10/23:c.1186-30381A>G:,EHBP1:ENST00000405289:intron_variant:MODIFIER:exon9/22:c.1186-30381A>G:			May play a role in actin reorganization. Links clathrin- mediated endocytosis to the actin cytoskeleton				0.0000	0.0000	0.0000		609922 [EHBP1 (provisional) Prostate cancer,hereditary,12,611868];																			0		0.2857	28	0.0962	52
chr2	64244408	64244408	T	C	0.2500	20	0.0000	26		66	VPS54	intron_variant	VPS54:ENST00000272322:intron_variant:MODIFIER:exon1/22:c.-21+1664A>G:,VPS54:ENST00000409558:intron_variant:MODIFIER:exon1/22:c.-21+1664A>G:			May be involved in retrograde transport from early and late endosomes to the late Golgi. The GARP complex is required for the maintenance of the cycling of mannose 6-phosphate receptors between the TGN and endosomes, this cycling is necessary for proper lysosomal sorting of acid hydrolases such as CTSD				0.0000	0.0000	0.0000																					0		0.2500	20	0.0000	26
chr2	65321502	65321502	T	C	0.3571	14	0.0303	33		61	RAB1A	intron_variant	RAB1A:ENST00000409784:intron_variant:MODIFIER:exon3/5:c.193-3290A>G:,RAB1A:ENST00000494188:intron_variant:MODIFIER:exon2/2:n.267+10366A>G:,RAB1A:ENST00000409892:intron_variant:MODIFIER:exon2/3:c.97-5298A>G:,RAB1A:ENST00000398529:intron_variant:MODIFIER:exon3/3:c.192+3603A>G:,RAB1A:ENST00000409751:intron_variant:MODIFIER:exon2/4:c.97-3290A>G:,RAB1A:ENST00000260638:intron_variant:MODIFIER:exon4/4:c.192+3603A>G:,RAB1A:ENST00000356214:intron_variant:MODIFIER:exon3/4:c.192+3603A>G:			Probably required for transit of protein from the ER through Golgi compartment. Binds GTP and GDP and possesses intrinsic GTPase activity	Rab GTPases Mark Targets In The Endocytotic Machinery			0.0000	0.0000	0.0000																					0		0.3571	14	0.0303	33
chr2	65345885	65345885	T	C	0.2609	23	0.0488	41		61	RAB1A	intron_variant	RAB1A:ENST00000409784:intron_variant:MODIFIER:exon1/5:c.23+11142A>G:,RAB1A:ENST00000494188:intron_variant:MODIFIER:exon1/2:n.194+11142A>G:,RAB1A:ENST00000409892:intron_variant:MODIFIER:exon1/3:c.23+11142A>G:,RAB1A:ENST00000398529:intron_variant:MODIFIER:exon1/3:c.23+11142A>G:,RAB1A:ENST00000409751:intron_variant:MODIFIER:exon1/4:c.23+11142A>G:,RAB1A:ENST00000356214:intron_variant:MODIFIER:exon1/4:c.23+11142A>G:			Probably required for transit of protein from the ER through Golgi compartment. Binds GTP and GDP and possesses intrinsic GTPase activity	Rab GTPases Mark Targets In The Endocytotic Machinery			0.0000	0.0000	0.0000																					0		0.2609	23	0.0488	41
chr2	65350727	65350727	T	C	0.1818	22	0.0000	43		64	RAB1A	intron_variant	RAB1A:ENST00000409784:intron_variant:MODIFIER:exon1/5:c.23+6300A>G:,RAB1A:ENST00000494188:intron_variant:MODIFIER:exon1/2:n.194+6300A>G:,RAB1A:ENST00000409892:intron_variant:MODIFIER:exon1/3:c.23+6300A>G:,RAB1A:ENST00000398529:intron_variant:MODIFIER:exon1/3:c.23+6300A>G:,RAB1A:ENST00000409751:intron_variant:MODIFIER:exon1/4:c.23+6300A>G:,RAB1A:ENST00000356214:intron_variant:MODIFIER:exon1/4:c.23+6300A>G:			Probably required for transit of protein from the ER through Golgi compartment. Binds GTP and GDP and possesses intrinsic GTPase activity	Rab GTPases Mark Targets In The Endocytotic Machinery			0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	43
chr2	69970411	69970411	A	G	0.1379	29	0.0000	32		52	ANXA4	intron_variant	ANXA4:ENST00000394295:intron_variant:MODIFIER:exon1/12:c.-47+1104A>G:,ANXA4:ENST00000418066:intron_variant:MODIFIER:exon3/3:n.864+22408A>G:,ANXA4:ENST00000477632:intron_variant:MODIFIER:exon1/11:n.81+22408A>G:,ANXA4:ENST00000409920:intron_variant:MODIFIER:exon1/12:c.-47+1104A>G:,ANXA4:ENST00000460439:intron_variant:MODIFIER:exon1/5:n.74+1104A>G:,ANXA4:ENST00000536030:intron_variant:MODIFIER:exon1/12:c.-334+1104A>G:,ANXA4:ENST00000460942:intron_variant:MODIFIER:exon1/6:n.71+1104A>G:,ANXA4:ENST00000487351:intron_variant:MODIFIER:exon1/6:n.43+1104A>G:			Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis (By similarity)				0.0000	0.0000	0.0000																					0		0.1379	29	0.0000	32
chr2	69977686	69977686	A	G	0.1143	71	0.0000	45		70	ANXA4	intron_variant	ANXA4:ENST00000394295:intron_variant:MODIFIER:exon1/12:c.-47+8379A>G:,ANXA4:ENST00000418066:intron_variant:MODIFIER:exon3/3:n.864+29683A>G:,ANXA4:ENST00000477632:intron_variant:MODIFIER:exon1/11:n.81+29683A>G:,ANXA4:ENST00000409920:intron_variant:MODIFIER:exon1/12:c.-47+8379A>G:,ANXA4:ENST00000460439:intron_variant:MODIFIER:exon1/5:n.74+8379A>G:,ANXA4:ENST00000536030:intron_variant:MODIFIER:exon1/12:c.-334+8379A>G:,ANXA4:ENST00000460942:intron_variant:MODIFIER:exon1/6:n.71+8379A>G:,ANXA4:ENST00000487351:intron_variant:MODIFIER:exon1/6:n.43+8379A>G:			Calcium/phospholipid-binding protein which promotes membrane fusion and is involved in exocytosis (By similarity)				0.0000	0.0000	0.0000																					0		0.1268	71	0.0000	45
chr2	85550526	85550526	T	C	0.1579	58	0.0141	72		57	TGOLN2	intron_variant	TGOLN2:ENST00000409015:intron_variant:MODIFIER:exon3/3:c.1309-604A>G:,TGOLN2:ENST00000282120:intron_variant:MODIFIER:exon5/5:c.841-662A>G:,TGOLN2:ENST00000377386:intron_variant:MODIFIER:exon3/3:c.1309-662A>G:,TGOLN2:ENST00000398263:intron_variant:MODIFIER:exon4/4:c.1135-662A>G:,TGOLN2:ENST00000409232:intron_variant:MODIFIER:exon3/3:c.1309-645A>G:			May be involved in regulating membrane traffic to and from trans-Golgi network				0.0000	0.0000	0.0000																					0		0.1552	58	0.0139	72
chr2	85551507	85551507	T	C	0.1351	38	0.0333	31		55	TGOLN2	intron_variant	TGOLN2:ENST00000409015:intron_variant:MODIFIER:exon3/3:c.1308+531A>G:,TGOLN2:ENST00000282120:intron_variant:MODIFIER:exon5/5:c.840+531A>G:,TGOLN2:ENST00000377386:intron_variant:MODIFIER:exon3/3:c.1308+531A>G:,TGOLN2:ENST00000398263:intron_variant:MODIFIER:exon4/4:c.1134+531A>G:,TGOLN2:ENST00000409232:intron_variant:MODIFIER:exon3/3:c.1308+531A>G:			May be involved in regulating membrane traffic to and from trans-Golgi network				0.0000	0.0000	0.0000																					0		0.1316	38	0.0270	37
chr2	85614038	85614038	A	G	0.3684	19	0.0000	20		45	ELMOD3	intron_variant	ELMOD3:ENST00000315658:intron_variant:MODIFIER:exon9/10:c.739-2836A>G:,ELMOD3:ENST00000409013:intron_variant:MODIFIER:exon11/13:c.739-2836A>G:,ELMOD3:ENST00000409890:intron_variant:MODIFIER:exon11/13:c.739-2836A>G:,ELMOD3:ENST00000490508:intron_variant:MODIFIER:exon9/11:n.951-2836A>G:,ELMOD3:ENST00000446464:intron_variant:MODIFIER:exon9/11:c.739-183A>G:,ELMOD3:ENST00000423095:intron_variant:MODIFIER:exon8/11:c.485-183A>G:,ELMOD3:ENST00000409344:intron_variant:MODIFIER:exon12/14:c.739-2836A>G:,ELMOD3:ENST00000428955:intron_variant:MODIFIER:exon10/10:c.739-183A>G:,ELMOD3:ENST00000393852:intron_variant:MODIFIER:exon10/12:c.739-2836A>G:,ELMOD3:ENST00000429764:intron_variant:MODIFIER:exon6/6:c.*130-183A>G:,ELMOD3:ENST00000414593:intron_variant:MODIFIER:exon7/9:c.*130-2836A>G:,ELMOD3:ENST00000410106:intron_variant:MODIFIER:exon7/9:c.*411-2836A>G:,ELMOD3:ENST00000444108:intron_variant:MODIFIER:exon8/11:c.739-183A>G:,ELMOD3:ENST00000496957:intron_variant:MODIFIER:exon2/4:n.167-2836A>G:			Lacks GTPase-activating protein (GAP) toward guanine nucleotide exchange factor ARL2				0.0000	0.0000	0.0000		615427 [ELMOD3 (provisional) Deafness,autosomal recessive 88,615429];																			0		0.3684	19	0.0000	20
chr2	87777104	87777104	T	C	0.0806	62	0.0000	72		69	LINC00152,RP11-1399P15.1	intron_variant,non_coding_transcript_exon_variant	LINC00152:ENST00000409054:intron_variant:MODIFIER:exon1/1:n.278+21940T>C:,LINC00152:ENST00000331944:intron_variant:MODIFIER:exon1/1:n.217+21940T>C:,LINC00152:ENST00000409139:intron_variant:MODIFIER:exon1/2:n.217+21940T>C:,LINC00152:ENST00000409898:intron_variant:MODIFIER:exon1/3:n.170+21940T>C:,LINC00152:ENST00000419680:intron_variant:MODIFIER:exon3/3:n.468+4700T>C:,LINC00152:ENST00000414584:intron_variant:MODIFIER:exon1/3:n.151-537T>C:,LINC00152:ENST00000455131:intron_variant:MODIFIER:exon1/2:n.142-2638T>C:,LINC00152:ENST00000423846:intron_variant:MODIFIER:exon2/2:n.250+4700T>C:,LINC00152:ENST00000414030:intron_variant:MODIFIER:exon2/2:n.249-2638T>C:,LINC00152:ENST00000437561:intron_variant:MODIFIER:exon2/2:n.248+7281T>C:,RP11-1399P15.1:ENST00000608142:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.450A>G:							0.0000	0.0000	0.0000																					0		0.0794	63	0.0000	74
chr2	88349974	88349974	T	C	0.1290	31	0.0000	22		58	KRCC1	intron_variant	KRCC1:ENST00000347055:intron_variant:MODIFIER:exon1/3:c.-291+5171A>G:							0.0000	0.0000	0.0000																					0		0.1290	31	0.0000	22
chr2	89160405	89160405	C	A	0.1250	16	0.0000	199		68	IGKJ4,AC096579.13,AC096579.7	missense_variant,intron_variant	IGKJ4:ENST00000390239:missense_variant:MODERATE:exon1/1:c.30G>T:p.Glu10Asp,AC096579.13:ENST00000452230:intron_variant:MODIFIER:exon1/2:n.39+632G>T:,AC096579.7:ENST00000430694:intron_variant:MODIFIER:exon2/2:n.721+993G>T:,AC096579.7:ENST00000418209:intron_variant:MODIFIER:exon1/1:n.38+993G>T:							0.0000	0.0000	0.00000																					0		0.0870	23	0.0042	237
chr2	96497426	96497426	T	C	0.1250	32	0.0000	50		55	LINC00342-ANKRD36C	intergenic_region	LINC00342-ANKRD36C:ENSG00000232931-ENSG00000174501:intergenic_region:MODIFIER::n.96497426T>C:							0.0000	0.0000	0.0000																					0		0.1250	32	0.0000	50
chr2	97290865	97290865	T	C	0.1667	30	0.0000	22		65	KANSL3	intron_variant	KANSL3:ENST00000431828:intron_variant:MODIFIER:exon3/20:c.387-5366A>G:,KANSL3:ENST00000354204:intron_variant:MODIFIER:exon3/20:c.*229-5366A>G:,KANSL3:ENST00000447759:intron_variant:MODIFIER:exon4/21:c.*46+2794A>G:,KANSL3:ENST00000487070:intron_variant:MODIFIER:exon3/19:n.509-5584A>G:,KANSL3:ENST00000420155:intron_variant:MODIFIER:exon3/20:c.387-5366A>G:,KANSL3:ENST00000599854:intron_variant:MODIFIER:exon3/20:c.126-5366A>G:,KANSL3:ENST00000441706:intron_variant:MODIFIER:exon3/16:c.126-5366A>G:,KANSL3:ENST00000440133:intron_variant:MODIFIER:exon3/20:c.-141-5584A>G:,KANSL3:ENST00000597150:intron_variant:MODIFIER:exon3/20:c.387-5584A>G:,KANSL3:ENST00000444759:intron_variant:MODIFIER:exon3/19:c.387-5584A>G:,KANSL3:ENST00000425656:intron_variant:MODIFIER:exon2/10:c.*229-5366A>G:,KANSL3:ENST00000452268:intron_variant:MODIFIER:exon4/11:c.*186-5366A>G:,KANSL3:ENST00000448075:intron_variant:MODIFIER:exon1/5:c.-141-5584A>G:,KANSL3:ENST00000451819:intron_variant:MODIFIER:exon2/3:c.386+6184A>G:,KANSL3:ENST00000416138:intron_variant:MODIFIER:exon2/3:c.216-11509A>G:,KANSL3:ENST00000418735:intron_variant:MODIFIER:exon2/4:c.126-5584A>G:,KANSL3:ENST00000435669:intron_variant:MODIFIER:exon3/5:c.126-5366A>G:			As part of the NSL complex it is involved in acetylation of nucleosomal histone H4 on several lysine residues and therefore may be involved in the regulation of transcription				0.0000	0.0000	0.0000																					0		0.1667	30	0.0000	22
chr2	99812857	99812857	A	G	0.2909	55	0.0943	53		58	MRPL30,C2orf15	3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	MRPL30:ENST00000338148:3_prime_UTR_variant:MODIFIER:exon6/6:c.*689A>G:,C2orf15:ENST00000512183:3_prime_UTR_variant:MODIFIER:exon6/6:c.*689A>G:,C2orf15:ENST00000424491:intron_variant:MODIFIER:exon9/13:c.*51+638A>G:,MRPL30:ENST00000409841:intron_variant:MODIFIER:exon5/5:c.*119-165A>G:,MRPL30:ENST00000465432:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.747A>G:							0.0000	0.0000	0.0000																					0		0.2909	55	0.0943	53
chr2	101901480	101901480	T	C	0.1111	45	0.0000	38		57	RNF149	intron_variant	RNF149:ENST00000295317:intron_variant:MODIFIER:exon5/6:c.960+1063A>G:,RNF149:ENST00000424632:intron_variant:MODIFIER:exon5/7:c.960+1063A>G:,RNF149:ENST00000490553:intron_variant:MODIFIER:exon1/1:n.27+1063A>G:,RNF149:ENST00000463726:intron_variant:MODIFIER:exon1/1:n.423+1063A>G:			E3 ubiquitin-protein ligase. Ubiquitinates BRAF, inducing its proteasomal degradation				0.0000	0.0000	0.0000																					0		0.1111	45	0.0000	38
chr2	101920747	101920747	T	C	0.1148	61	0.0000	68		62	RNF149	intron_variant	RNF149:ENST00000295317:intron_variant:MODIFIER:exon1/6:c.460+3844A>G:,RNF149:ENST00000424632:intron_variant:MODIFIER:exon1/7:c.460+3844A>G:			E3 ubiquitin-protein ligase. Ubiquitinates BRAF, inducing its proteasomal degradation				0.0000	0.0000	0.0000																					0		0.1148	61	0.0147	68
chr2	101921467	101921467	T	C	0.1739	23	0.0303	33		65	RNF149	intron_variant	RNF149:ENST00000295317:intron_variant:MODIFIER:exon1/6:c.460+3124A>G:,RNF149:ENST00000424632:intron_variant:MODIFIER:exon1/7:c.460+3124A>G:			E3 ubiquitin-protein ligase. Ubiquitinates BRAF, inducing its proteasomal degradation				0.0000	0.0000	0.0000																					0		0.1739	23	0.0303	33
chr2	102348026	102348026	A	G	0.1739	23	0.0000	31		62	MAP4K4	intron_variant	MAP4K4:ENST00000324219:intron_variant:MODIFIER:exon2/30:c.123+33026A>G:,MAP4K4:ENST00000427603:intron_variant:MODIFIER:exon3/4:c.123+33026A>G:,MAP4K4:ENST00000425019:intron_variant:MODIFIER:exon2/30:c.123+33026A>G:,MAP4K4:ENST00000302217:intron_variant:MODIFIER:exon2/24:c.123+33026A>G:,MAP4K4:ENST00000350198:intron_variant:MODIFIER:exon2/28:c.123+33026A>G:,MAP4K4:ENST00000413150:intron_variant:MODIFIER:exon2/28:c.123+33026A>G:,MAP4K4:ENST00000347699:intron_variant:MODIFIER:exon2/29:c.123+33026A>G:,MAP4K4:ENST00000456652:intron_variant:MODIFIER:exon2/24:c.123+33026A>G:,MAP4K4:ENST00000417294:intron_variant:MODIFIER:exon1/28:c.9+33026A>G:		MAPK signaling pathway	Serine/threonine kinase that may play a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway. Phosphorylates SMAD1 on Thr-322	MAPKinase Signaling Pathway			0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	31
chr2	112197416	112197416	-	T	0.2632	20	0.0000	23		43	MIR4435-1HG	intron_variant	MIR4435-1HG:ENST00000439362:intron_variant:MODIFIER:exon1/5:n.164+55045dupA:,MIR4435-1HG:ENST00000431385:intron_variant:MODIFIER:exon1/3:n.136+55045dupA:,MIR4435-1HG:ENST00000443467:intron_variant:MODIFIER:exon1/5:n.164+55045dupA:,MIR4435-1HG:ENST00000432818:intron_variant:MODIFIER:exon1/3:n.216+55045dupA:,MIR4435-1HG:ENST00000444301:intron_variant:MODIFIER:exon1/3:n.149+55045dupA:,MIR4435-1HG:ENST00000453478:intron_variant:MODIFIER:exon1/3:n.170+55045dupA:,MIR4435-1HG:ENST00000409569:intron_variant:MODIFIER:exon1/1:n.203-10220dupA:,MIR4435-1HG:ENST00000419736:intron_variant:MODIFIER:exon3/3:n.469-10220dupA:,MIR4435-1HG:ENST00000308604:intron_variant:MODIFIER:exon2/2:n.251-10220dupA:,MIR4435-1HG:ENST00000603310:intron_variant:MODIFIER:exon1/1:n.114+1668dupA:,MIR4435-1HG:ENST00000604981:intron_variant:MODIFIER:exon3/3:n.461-10220dupA:,MIR4435-1HG:ENST00000442293:intron_variant:MODIFIER:exon2/2:n.249-10220dupA:,MIR4435-1HG:ENST00000441075:intron_variant:MODIFIER:exon2/2:n.527-10220dupA:							0.0000	0.0000	0.0000																					0		0.0494	81	0.0000	55
chr2	113919654	113919654	A	G	0.1600	25	0.0000	18		57	PSD4	intron_variant	PSD4:ENST00000465917:intron_variant:MODIFIER:exon1/1:n.211+4542A>G:			Guanine nucleotide exchange factor for ARF6 and ARL14/ARF7. Through ARL14 activation, controls the movement of MHC class II-containing vesicles along the actin cytoskeleton in dendritic cells. Involved in membrane recycling. Interacts with several phosphatidylinositol phosphate species, including phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,5- bisphosphate and phosphatidylinositol 4,5-bisphosphate				0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	18
chr2	114470032	114470032	T	C	0.2424	33	0.0500	40		58	SLC35F5	intron_variant	SLC35F5:ENST00000469702:intron_variant:MODIFIER:exon2/2:n.246+6699A>G:			Putative solute transporter (Potential)				0.0000	0.0000	0.0000																					0		0.2424	33	0.0500	40
chr2	128469808	128469808	T	C	0.3333	22	0.0000	24		59	WDR33	intron_variant	WDR33:ENST00000322313:intron_variant:MODIFIER:exon18/21:c.3308+1349A>G:			Essential for both cleavage and polyadenylation of pre- mRNA 3' ends				0.0000	0.0000	0.0000																					0		0.3182	22	0.0000	24
chr2	130909822	130909822	-	A	0.1563	38	0.0000	27		41	SMPD4	3_prime_UTR_variant,non_coding_transcript_exon_variant	SMPD4:ENST00000409031:3_prime_UTR_variant:MODIFIER:exon20/20:c.*305dupT:,SMPD4:ENST00000454468:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2493dupT:,SMPD4:ENST00000412570:3_prime_UTR_variant:MODIFIER:exon19/19:c.*2476dupT:,SMPD4:ENST00000433118:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2207dupT:,SMPD4:ENST00000351288:3_prime_UTR_variant:MODIFIER:exon19/19:c.*305dupT:,SMPD4:ENST00000439886:3_prime_UTR_variant:MODIFIER:exon15/15:c.*305dupT:,SMPD4:ENST00000453750:3_prime_UTR_variant:MODIFIER:exon13/13:c.*305dupT:,SMPD4:ENST00000431183:3_prime_UTR_variant:MODIFIER:exon17/17:c.*305dupT:,SMPD4:ENST00000443958:3_prime_UTR_variant:MODIFIER:exon13/13:c.*305dupT:,SMPD4:ENST00000491128:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1729dupT:,SMPD4:ENST00000482171:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.3457dupT:		Sphingolipid metabolism	Catalyzes the hydrolysis of membrane sphingomyelin to form phosphorylcholine and ceramide				0.0000	0.0000	0.0000																					0		0.1111	36	0.0000	31
chr2	132459280	132459280	A	G	0.1333	31	0.0000	36		60	LINC01087-C2orf27A	intergenic_region	LINC01087-C2orf27A:ENSG00000224559-ENSG00000197927:intergenic_region:MODIFIER::n.132459280A>G:							0.0000	0.0000	0.0000																					0		0.1613	31	0.0000	36
chr2	132459869	132459869	A	G	0.2174	23	0.0000	23		64	LINC01087-C2orf27A	intergenic_region	LINC01087-C2orf27A:ENSG00000224559-ENSG00000197927:intergenic_region:MODIFIER::n.132459869A>G:							0.0000	0.0000	0.0000																					0		0.2174	23	0.0000	24
chr2	136532215	136532215	A	G	0.1429	28	0.0000	18		53	UBXN4	intron_variant	UBXN4:ENST00000272638:intron_variant:MODIFIER:exon9/12:c.951-1604A>G:,UBXN4:ENST00000490163:intron_variant:MODIFIER:exon5/8:n.650-1604A>G:,UBXN4:ENST00000471246:intron_variant:MODIFIER:exon1/3:n.102-1604A>G:			Involved in endoplasmic reticulum-associated protein degradation (ERAD)				0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	18
chr2	143662978	143662978	-	T	0.1667	39	0.0000	27		40	KYNU	intron_variant	KYNU:ENST00000264170:intron_variant:MODIFIER:exon2/13:c.170-13193dupT:,KYNU:ENST00000375773:intron_variant:MODIFIER:exon2/11:c.170-13193dupT:,KYNU:ENST00000409512:intron_variant:MODIFIER:exon3/14:c.170-13193dupT:,KYNU:ENST00000410015:intron_variant:MODIFIER:exon2/4:c.170-13193dupT:,KYNU:ENST00000424385:intron_variant:MODIFIER:exon3/5:c.169+19880dupT:		Tryptophan metabolism	Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3- hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3- hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity				0.0000	0.0000	0.0000		605197 [KYNU (provisional) Hydroxykynureninuria,236800];																			0		0.0065	617	0.0000	487
chr2	143724660	143724660	-	A	0.0842	111	0.0000	87		48	KYNU	intron_variant	KYNU:ENST00000264170:intron_variant:MODIFIER:exon8/13:c.729+6327dupA:,KYNU:ENST00000375773:intron_variant:MODIFIER:exon8/11:c.729+6327dupA:,KYNU:ENST00000409512:intron_variant:MODIFIER:exon9/14:c.729+6327dupA:		Tryptophan metabolism	Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3- hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3- hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity				0.0000	0.0000	0.0000		605197 [KYNU (provisional) Hydroxykynureninuria,236800];																			0		0.0160	500	0.0000	378
chr2	143792773	143792773	-	T	0.1458	50	0.0000	26		40	KYNU	intron_variant	KYNU:ENST00000264170:intron_variant:MODIFIER:exon12/13:c.1041+1889dupT:,KYNU:ENST00000409512:intron_variant:MODIFIER:exon13/14:c.1041+1889dupT:		Tryptophan metabolism	Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3- hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3- hydroxyanthranilic acid (3-OHAA), respectively. Has a preference for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase activity				0.0000	0.0000	0.0000		605197 [KYNU (provisional) Hydroxykynureninuria,236800];																			0		0.0278	216	0.0000	164
chr2	145666886	145666886	A	G	0.1714	35	0.0000	27		68	TEX41	intron_variant	TEX41:ENST00000445791:intron_variant:MODIFIER:exon2/3:n.307+141039A>G:,TEX41:ENST00000597655:intron_variant:MODIFIER:exon5/5:n.756+5516A>G:,TEX41:ENST00000598659:intron_variant:MODIFIER:exon5/5:n.756+5516A>G:,TEX41:ENST00000600679:intron_variant:MODIFIER:exon4/6:n.613+5516A>G:,TEX41:ENST00000601277:intron_variant:MODIFIER:exon4/4:n.529+45321A>G:,TEX41:ENST00000451027:intron_variant:MODIFIER:exon3/3:n.469-135047A>G:,TEX41:ENST00000596540:intron_variant:MODIFIER:exon5/6:n.654+45321A>G:,TEX41:ENST00000596230:intron_variant:MODIFIER:exon3/5:n.468+141039A>G:,TEX41:ENST00000594471:intron_variant:MODIFIER:exon2/5:n.308-31539A>G:,TEX41:ENST00000597469:intron_variant:MODIFIER:exon2/6:n.307+141039A>G:,TEX41:ENST00000598248:intron_variant:MODIFIER:exon5/5:n.594+45321A>G:,TEX41:ENST00000595686:intron_variant:MODIFIER:exon2/5:n.174-26038A>G:,TEX41:ENST00000597670:intron_variant:MODIFIER:exon4/7:n.513+141039A>G:,TEX41:ENST00000600064:intron_variant:MODIFIER:exon5/6:n.623+141039A>G:,TEX41:ENST00000599187:intron_variant:MODIFIER:exon4/7:n.487+45321A>G:,TEX41:ENST00000451774:intron_variant:MODIFIER:exon3/4:n.404+5516A>G:,TEX41:ENST00000599072:intron_variant:MODIFIER:exon3/4:n.396+141039A>G:,TEX41:ENST00000596589:intron_variant:MODIFIER:exon4/5:n.325+43859A>G:,TEX41:ENST00000597893:intron_variant:MODIFIER:exon4/6:n.325+43859A>G:,TEX41:ENST00000594626:intron_variant:MODIFIER:exon2/3:n.353+141039A>G:							0.0000	0.0000	0.0000																					0		0.1714	35	0.0000	27
chr2	145666924	145666924	A	G	0.1111	46	0.0000	36		64	TEX41	intron_variant	TEX41:ENST00000445791:intron_variant:MODIFIER:exon2/3:n.307+141077A>G:,TEX41:ENST00000597655:intron_variant:MODIFIER:exon5/5:n.756+5554A>G:,TEX41:ENST00000598659:intron_variant:MODIFIER:exon5/5:n.756+5554A>G:,TEX41:ENST00000600679:intron_variant:MODIFIER:exon4/6:n.613+5554A>G:,TEX41:ENST00000601277:intron_variant:MODIFIER:exon4/4:n.529+45359A>G:,TEX41:ENST00000451027:intron_variant:MODIFIER:exon3/3:n.469-135009A>G:,TEX41:ENST00000596540:intron_variant:MODIFIER:exon5/6:n.654+45359A>G:,TEX41:ENST00000596230:intron_variant:MODIFIER:exon3/5:n.468+141077A>G:,TEX41:ENST00000594471:intron_variant:MODIFIER:exon2/5:n.308-31501A>G:,TEX41:ENST00000597469:intron_variant:MODIFIER:exon2/6:n.307+141077A>G:,TEX41:ENST00000598248:intron_variant:MODIFIER:exon5/5:n.594+45359A>G:,TEX41:ENST00000595686:intron_variant:MODIFIER:exon2/5:n.174-26000A>G:,TEX41:ENST00000597670:intron_variant:MODIFIER:exon4/7:n.513+141077A>G:,TEX41:ENST00000600064:intron_variant:MODIFIER:exon5/6:n.623+141077A>G:,TEX41:ENST00000599187:intron_variant:MODIFIER:exon4/7:n.487+45359A>G:,TEX41:ENST00000451774:intron_variant:MODIFIER:exon3/4:n.404+5554A>G:,TEX41:ENST00000599072:intron_variant:MODIFIER:exon3/4:n.396+141077A>G:,TEX41:ENST00000596589:intron_variant:MODIFIER:exon4/5:n.325+43897A>G:,TEX41:ENST00000597893:intron_variant:MODIFIER:exon4/6:n.325+43897A>G:,TEX41:ENST00000594626:intron_variant:MODIFIER:exon2/3:n.353+141077A>G:							0.0000	0.0000	0.0000																					0		0.1304	46	0.0000	36
chr2	145669821	145669821	A	G	0.1364	45	0.0000	40		70	TEX41	intron_variant	TEX41:ENST00000445791:intron_variant:MODIFIER:exon2/3:n.307+143974A>G:,TEX41:ENST00000597655:intron_variant:MODIFIER:exon5/5:n.756+8451A>G:,TEX41:ENST00000598659:intron_variant:MODIFIER:exon5/5:n.756+8451A>G:,TEX41:ENST00000600679:intron_variant:MODIFIER:exon4/6:n.613+8451A>G:,TEX41:ENST00000601277:intron_variant:MODIFIER:exon4/4:n.529+48256A>G:,TEX41:ENST00000451027:intron_variant:MODIFIER:exon3/3:n.469-132112A>G:,TEX41:ENST00000596540:intron_variant:MODIFIER:exon5/6:n.654+48256A>G:,TEX41:ENST00000596230:intron_variant:MODIFIER:exon3/5:n.468+143974A>G:,TEX41:ENST00000594471:intron_variant:MODIFIER:exon2/5:n.308-28604A>G:,TEX41:ENST00000597469:intron_variant:MODIFIER:exon2/6:n.307+143974A>G:,TEX41:ENST00000598248:intron_variant:MODIFIER:exon5/5:n.594+48256A>G:,TEX41:ENST00000595686:intron_variant:MODIFIER:exon2/5:n.174-23103A>G:,TEX41:ENST00000597670:intron_variant:MODIFIER:exon4/7:n.513+143974A>G:,TEX41:ENST00000600064:intron_variant:MODIFIER:exon5/6:n.623+143974A>G:,TEX41:ENST00000599187:intron_variant:MODIFIER:exon4/7:n.487+48256A>G:,TEX41:ENST00000451774:intron_variant:MODIFIER:exon3/4:n.404+8451A>G:,TEX41:ENST00000599072:intron_variant:MODIFIER:exon3/4:n.396+143974A>G:,TEX41:ENST00000596589:intron_variant:MODIFIER:exon4/5:n.325+46794A>G:,TEX41:ENST00000597893:intron_variant:MODIFIER:exon4/6:n.325+46794A>G:,TEX41:ENST00000594626:intron_variant:MODIFIER:exon2/3:n.353+143974A>G:							0.0000	0.0000	0.0000																					0		0.1556	45	0.0000	40
chr2	153196513	153196513	A	G	0.2727	22	0.0294	35		62	FMNL2	intron_variant	FMNL2:ENST00000288670:intron_variant:MODIFIER:exon1/25:c.117+4279A>G:			Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the cortical actin filament dynamics				0.0000	0.0000	0.0000																					0		0.2727	22	0.0286	35
chr2	153223694	153223694	A	G	0.1633	51	0.0175	57		52	FMNL2	intron_variant	FMNL2:ENST00000288670:intron_variant:MODIFIER:exon1/25:c.117+31460A>G:			Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the cortical actin filament dynamics				0.0000	0.0000	0.0000																					0		0.1765	51	0.0175	57
chr2	159880093	159880093	A	G	0.3158	21	0.0000	26		60	TANC1	intron_variant	TANC1:ENST00000263635:intron_variant:MODIFIER:exon2/26:c.-16+22392A>G:,TANC1:ENST00000454300:intron_variant:MODIFIER:exon2/24:c.-16+22392A>G:			May be a scaffold component in the postsynaptic density (By similarity)				0.0000	0.0000	0.0000																					0		0.3333	21	0.0000	26
chr2	160288031	160288031	C	T	0.3333	9	0.0000	18		39	BAZ2B	intron_variant	BAZ2B:ENST00000392783:intron_variant:MODIFIER:exon9/36:c.1901-364G>A:,BAZ2B:ENST00000343439:intron_variant:MODIFIER:exon9/35:c.1894+1237G>A:,BAZ2B:ENST00000355831:intron_variant:MODIFIER:exon9/35:c.1901-364G>A:,BAZ2B:ENST00000392782:intron_variant:MODIFIER:exon9/35:c.1895-364G>A:,BAZ2B:ENST00000472953:intron_variant:MODIFIER:exon1/7:n.2798-364G>A:,BAZ2B:ENST00000441143:intron_variant:MODIFIER:exon1/4:c.193+1237G>A:			May play a role in transcriptional regulation interacting with ISWI				0.0000	0.0000	0.0000																					0		0.3333	9	0.0000	18
chr2	160405242	160405242	T	C	0.2353	17	0.0000	21		55	BAZ2B	intron_variant	BAZ2B:ENST00000392783:intron_variant:MODIFIER:exon2/36:c.-3+7092A>G:,BAZ2B:ENST00000343439:intron_variant:MODIFIER:exon2/35:c.-3+7092A>G:,BAZ2B:ENST00000355831:intron_variant:MODIFIER:exon2/35:c.-3+7092A>G:,BAZ2B:ENST00000392782:intron_variant:MODIFIER:exon2/35:c.-3+7092A>G:,BAZ2B:ENST00000467184:intron_variant:MODIFIER:exon1/4:n.42+7092A>G:,BAZ2B:ENST00000541068:intron_variant:MODIFIER:exon2/3:c.-3+7092A>G:,BAZ2B:ENST00000437839:intron_variant:MODIFIER:exon2/4:c.-3+7092A>G:,BAZ2B:ENST00000483316:intron_variant:MODIFIER:exon2/3:n.252+7092A>G:			May play a role in transcriptional regulation interacting with ISWI				0.0000	0.0000	0.0000																					0		0.2353	17	0.0000	21
chr2	160407880	160407880	T	C	0.4000	10	0.0000	20		42	BAZ2B	intron_variant	BAZ2B:ENST00000392783:intron_variant:MODIFIER:exon2/36:c.-3+4454A>G:,BAZ2B:ENST00000343439:intron_variant:MODIFIER:exon2/35:c.-3+4454A>G:,BAZ2B:ENST00000355831:intron_variant:MODIFIER:exon2/35:c.-3+4454A>G:,BAZ2B:ENST00000392782:intron_variant:MODIFIER:exon2/35:c.-3+4454A>G:,BAZ2B:ENST00000467184:intron_variant:MODIFIER:exon1/4:n.42+4454A>G:,BAZ2B:ENST00000541068:intron_variant:MODIFIER:exon2/3:c.-3+4454A>G:,BAZ2B:ENST00000437839:intron_variant:MODIFIER:exon2/4:c.-3+4454A>G:,BAZ2B:ENST00000483316:intron_variant:MODIFIER:exon2/3:n.252+4454A>G:			May play a role in transcriptional regulation interacting with ISWI				0.0000	0.0000	0.0000																					0		0.4000	10	0.0000	20
chr2	160462168	160462168	T	C	0.1905	21	0.0000	21		60	BAZ2B	intron_variant	BAZ2B:ENST00000392783:intron_variant:MODIFIER:exon1/36:c.-46+10585A>G:,BAZ2B:ENST00000343439:intron_variant:MODIFIER:exon1/35:c.-46+10585A>G:,BAZ2B:ENST00000355831:intron_variant:MODIFIER:exon1/35:c.-46+10585A>G:,BAZ2B:ENST00000392782:intron_variant:MODIFIER:exon1/35:c.-46+10585A>G:,BAZ2B:ENST00000541068:intron_variant:MODIFIER:exon1/3:c.-46+10585A>G:,BAZ2B:ENST00000437839:intron_variant:MODIFIER:exon1/4:c.-46+9737A>G:,BAZ2B:ENST00000483316:intron_variant:MODIFIER:exon1/3:n.209+10585A>G:,BAZ2B:ENST00000552327:intron_variant:MODIFIER:exon1/1:n.31+9737A>G:			May play a role in transcriptional regulation interacting with ISWI				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	23
chr2	162042007	162042007	C	T	0.1818	22	0.0000	25		53	TANK	intron_variant	TANK:ENST00000259075:intron_variant:MODIFIER:exon2/7:c.99+5735C>T:,TANK:ENST00000432002:intron_variant:MODIFIER:exon2/5:c.99+5735C>T:,TANK:ENST00000457476:intron_variant:MODIFIER:exon2/3:c.99+5735C>T:,TANK:ENST00000392749:intron_variant:MODIFIER:exon2/7:c.99+5735C>T:,TANK:ENST00000440506:intron_variant:MODIFIER:exon2/3:c.99+5735C>T:,TANK:ENST00000429217:intron_variant:MODIFIER:exon2/6:c.99+5735C>T:,TANK:ENST00000402568:intron_variant:MODIFIER:exon3/7:c.273+5735C>T:,TANK:ENST00000406287:intron_variant:MODIFIER:exon3/7:c.273+5735C>T:,TANK:ENST00000457887:intron_variant:MODIFIER:exon2/6:c.99+5735C>T:,TANK:ENST00000441987:intron_variant:MODIFIER:exon2/4:c.99+5735C>T:,TANK:ENST00000432692:intron_variant:MODIFIER:exon2/6:c.99+5735C>T:,TANK:ENST00000405852:intron_variant:MODIFIER:exon2/8:c.99+5735C>T:,TANK:ENST00000456358:intron_variant:MODIFIER:exon2/5:c.177+5735C>T:,TANK:ENST00000468831:intron_variant:MODIFIER:exon1/5:n.279+5735C>T:,TANK:ENST00000403609:intron_variant:MODIFIER:exon1/2:c.99+5735C>T:,TANK:ENST00000489393:intron_variant:MODIFIER:exon1/1:n.109+5735C>T:		MAPK signaling pathway;Apoptosis;Adipocytokine signaling pathway;Small cell lung cancer	Acts as a regulator of TRAF function by maintaining them in a latent state. Overexpression inhibits TRAF2-mediated NF- kappa-B activation signaled by CD40, TNFR1 and TNFR2. Blocks TRAF2 binding to LMP1 and inhibits LMP1-mediated NF-kappa-B activation. May be involved in I-kappa-B-kinase (IKK) regulation; may function as an adapter for kinases such as TBK1 or IKBKE that can modulate IKK activity	TNF/Stress Related Signaling;TNFR2 Signaling Pathway			0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	25
chr2	175084616	175084616	T	C	0.3846	13	0.0000	18		39	OLA1	intron_variant	OLA1:ENST00000409546:intron_variant:MODIFIER:exon4/10:c.433+3145A>G:,OLA1:ENST00000284719:intron_variant:MODIFIER:exon4/10:c.373+3145A>G:,OLA1:ENST00000344357:intron_variant:MODIFIER:exon3/9:c.-102+3145A>G:,OLA1:ENST00000428402:intron_variant:MODIFIER:exon4/7:c.373+3145A>G:			Hydrolyzes ATP, and can also hydrolyze GTP with lower efficiency. Has lower affinity for GTP				0.0000	0.0000	0.0000																					0		0.3846	13	0.0000	18
chr2	178107140	178107140	-	A	0.1282	40	0.0000	36		42	NFE2L2	intron_variant	NFE2L2:ENST00000397062:intron_variant:MODIFIER:exon1/4:c.46-8142dupT:,NFE2L2:ENST00000397063:intron_variant:MODIFIER:exon1/4:c.-3-8142dupT:,NFE2L2:ENST00000446151:intron_variant:MODIFIER:exon1/4:c.-3-8142dupT:,NFE2L2:ENST00000464747:intron_variant:MODIFIER:exon4/7:c.-3-8142dupT:,NFE2L2:ENST00000449627:intron_variant:MODIFIER:exon1/2:c.-3-8142dupT:,NFE2L2:ENST00000448782:intron_variant:MODIFIER:exon1/4:c.-3-8142dupT:,NFE2L2:ENST00000430047:intron_variant:MODIFIER:exon1/2:c.46-8142dupT:,NFE2L2:ENST00000586532:intron_variant:MODIFIER:exon2/5:c.43-8142dupT:,NFE2L2:ENST00000421929:intron_variant:MODIFIER:exon1/4:c.-3-8142dupT:,NFE2L2:ENST00000423513:intron_variant:MODIFIER:exon1/2:c.-3-8142dupT:,NFE2L2:ENST00000588123:intron_variant:MODIFIER:exon2/4:c.-3-8142dupT:,NFE2L2:ENST00000477534:intron_variant:MODIFIER:exon1/1:n.136-8142dupT:,NFE2L2:ENST00000462023:intron_variant:MODIFIER:exon1/1:n.129-8142dupT:		Prion disease	Transcription activator that binds to antioxidant response (ARE) elements in the promoter regions of target genes. Important for the coordinated up-regulation of genes in response to oxidative stress. May be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region				0.0000	0.0000	0.0000																					0		0.0400	100	0.0000	100
chr2	178107638	178107638	G	T	0.2143	28	0.0000	27		70	NFE2L2	intron_variant	NFE2L2:ENST00000397062:intron_variant:MODIFIER:exon1/4:c.46-8639C>A:,NFE2L2:ENST00000397063:intron_variant:MODIFIER:exon1/4:c.-3-8639C>A:,NFE2L2:ENST00000446151:intron_variant:MODIFIER:exon1/4:c.-3-8639C>A:,NFE2L2:ENST00000464747:intron_variant:MODIFIER:exon4/7:c.-3-8639C>A:,NFE2L2:ENST00000449627:intron_variant:MODIFIER:exon1/2:c.-3-8639C>A:,NFE2L2:ENST00000448782:intron_variant:MODIFIER:exon1/4:c.-3-8639C>A:,NFE2L2:ENST00000430047:intron_variant:MODIFIER:exon1/2:c.46-8639C>A:,NFE2L2:ENST00000586532:intron_variant:MODIFIER:exon2/5:c.43-8639C>A:,NFE2L2:ENST00000421929:intron_variant:MODIFIER:exon1/4:c.-3-8639C>A:,NFE2L2:ENST00000423513:intron_variant:MODIFIER:exon1/2:c.-3-8639C>A:,NFE2L2:ENST00000588123:intron_variant:MODIFIER:exon2/4:c.-3-8639C>A:,NFE2L2:ENST00000477534:intron_variant:MODIFIER:exon1/1:n.136-8639C>A:,NFE2L2:ENST00000462023:intron_variant:MODIFIER:exon1/1:n.129-8639C>A:		Prion disease	Transcription activator that binds to antioxidant response (ARE) elements in the promoter regions of target genes. Important for the coordinated up-regulation of genes in response to oxidative stress. May be involved in the transcriptional activation of genes of the beta-globin cluster by mediating enhancer activity of hypersensitive site 2 of the beta-globin locus control region			rs367780071	0.0000	0.0000	0.0000																					0		0.2143	28	0.0000	28
chr2	190647429	190647429	C	T	0.1136	45	0.0000	45		68	ORMDL1	5_prime_UTR_variant,intron_variant	ORMDL1:ENST00000325795:5_prime_UTR_variant:MODIFIER:exon1/3:c.-108G>A:,ORMDL1:ENST00000458355:5_prime_UTR_variant:MODIFIER:exon2/3:c.-108G>A:,ORMDL1:ENST00000392350:intron_variant:MODIFIER:exon1/3:c.-7-101G>A:,ORMDL1:ENST00000392349:intron_variant:MODIFIER:exon2/4:c.-7-101G>A:,ORMDL1:ENST00000409519:intron_variant:MODIFIER:exon1/2:c.-7-101G>A:,ORMDL1:ENST00000442547:intron_variant:MODIFIER:exon1/2:c.-7-101G>A:			Negative regulator of sphingolipid synthesis				0.0000	0.0000	0.0000																					0		0.1111	45	0.0000	45
chr2	191851798	191851798	-	A	0.2500	27	0.0000	39		49	STAT1	splice_region_variant&intron_variant	STAT1:ENST00000361099:splice_region_variant&intron_variant:LOW:exon12/24:c.1098-5dupT:,STAT1:ENST00000409465:splice_region_variant&intron_variant:LOW:exon11/23:c.1098-5dupT:,STAT1:ENST00000540176:splice_region_variant&intron_variant:LOW:exon10/22:c.*424-5dupT:,STAT1:ENST00000392322:splice_region_variant&intron_variant:LOW:exon12/22:c.1098-5dupT:,STAT1:ENST00000452281:splice_region_variant&intron_variant:LOW:exon11/21:c.*424-5dupT:,STAT1:ENST00000392323:splice_region_variant&intron_variant:LOW:exon13/23:c.1104-5dupT:		Toll-like receptor signaling pathway;Jak-STAT signaling pathway;Pancreatic cancer	Signal transducer and transcription activator that mediates cellular responses to interferons (IFNs), cytokine KITLG/SCF and other cytokines and growth factors. Following type I IFN (IFN-alpha and IFN-beta) binding to cell surface receptors, signaling via protein kinases leads to activation of Jak kinases (TYK2 and JAK1) and to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with ISGF3G/IRF-9 to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state. In response to type II IFN (IFN-gamma), STAT1 is tyrosine- and serine-phosphorylated. It then forms a homodimer termed IFN- gamma-activated factor (GAF), migrates into the nucleus and binds to the IFN gamma activated sequence (GAS) to drive the expression of the target genes, inducing a cellular antiviral state. Becomes activated in response to KITLG/SCF and KIT signaling. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4	Apoptotic Signaling in Response to DNA Damage;Bioactive Peptide Induced Signaling Pathway;EGF Signaling Pathway;IFN alpha signaling pathway;IFN gamma signaling pathway ;IL-10 Anti-inflammatory Signaling Pathway;IL22 Soluble Receptor Signaling Pathway ;Inhibition of Cellular Proliferation by Gleevec;MAPKinase Signaling Pathway;p38 MAPK Signaling Pathway ;PDGF Signaling Pathway;TPO Signaling Pathway		rs568537379	0.00159744	0.00050	0.00033		600555 [STAT1 (provisional) Immunodeficiency 31A,mycobacteriosis,autosomal dominant,614892|Immunodeficiency 31B,mycobacterial and viral infections,autosomal recessive,613796|Immunodeficiency 31C,autosomal dominant,614162];																			0		0.0135	296	0.0000	368
chr2	202007423	202007423	A	G	0.2000	20	0.0000	18		51	CFLAR,CFLAR-AS1	missense_variant,intron_variant	CFLAR:ENST00000439154:missense_variant:MODERATE:exon6/10:c.662A>G:p.Lys221Arg,CFLAR:ENST00000309955:intron_variant:MODIFIER:exon5/9:c.606+2261A>G:,CFLAR-AS1:ENST00000415011:intron_variant:MODIFIER:exon6/6:n.916-2255T>C:,CFLAR:ENST00000443227:intron_variant:MODIFIER:exon4/8:c.318+2261A>G:,CFLAR:ENST00000340870:intron_variant:MODIFIER:exon5/9:c.606+2261A>G:,CFLAR:ENST00000355558:intron_variant:MODIFIER:exon5/8:c.606+2261A>G:,CFLAR:ENST00000341582:intron_variant:MODIFIER:exon5/7:c.606+2261A>G:,CFLAR:ENST00000342795:intron_variant:MODIFIER:exon5/8:c.606+2261A>G:,CFLAR:ENST00000423241:intron_variant:MODIFIER:exon5/9:c.606+2261A>G:,CFLAR:ENST00000457277:intron_variant:MODIFIER:exon4/8:c.606+2261A>G:,CFLAR:ENST00000462763:intron_variant:MODIFIER:exon3/5:c.318+2261A>G:,CFLAR:ENST00000479953:intron_variant:MODIFIER:exon3/7:c.318+2261A>G:,CFLAR:ENST00000474842:intron_variant:MODIFIER:exon1/5:n.254+2261A>G:,CFLAR-AS1:ENST00000474886:intron_variant:MODIFIER:exon1/1:n.61+1436T>C:		Apoptosis	Apoptosis regulator protein which may function as a crucial link between cell survival and cell death pathways in mammalian cells. Acts as an inhibitor of TNFRSF6 mediated apoptosis. A proteolytic fragment (p43) is likely retained in the death-inducing signaling complex (DISC) thereby blocking further recruitment and processing of caspase-8 at the complex. Full length and shorter isoforms have been shown either to induce apoptosis or to reduce TNFRSF-triggered apoptosis. Lacks enzymatic (caspase) activity	FAS signaling pathway ( CD95 );HIV-I Nef: negative effector of Fas and TNF;IL-2 Receptor Beta Chain in T cell Activation;Induction of apoptosis through DR3 and DR4/5 Death Receptors 			0.0000	0.0000	0.0000																					0		0.1905	21	0.0000	21
chr2	203322594	203322594	A	G	0.3333	9	0.0000	24		50	BMPR2	intron_variant	BMPR2:ENST00000374580:intron_variant:MODIFIER:exon1/12:c.77-6938A>G:,BMPR2:ENST00000374574:intron_variant:MODIFIER:exon1/11:c.77-6938A>G:		Cytokine-cytokine receptor interaction;TGF-beta signaling pathway	On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Binds to BMP-7, BMP-2 and, less efficiently, BMP-4. Binding is weak but enhanced by the presence of type I receptors for BMPs	ALK in cardiac myocytes			0.0000	0.0000	0.0000		600799 [BMPR2 (confirmed) Pulmonary hypertension,familial primary,1,with or without HHT,178600|Pulmonary hypertension,primary,fenfluramine or dexfenfluramine-associated,178600|Pulmonary venoocclusive disease 1,265450];																			0		0.3333	9	0.0000	24
chr2	204165357	204165357	A	G	0.1905	21	0.0000	21		54	CYP20A1-MRPL50P2	intergenic_region	CYP20A1-MRPL50P2:ENSG00000119004-ENSG00000238285:intergenic_region:MODIFIER::n.204165357A>G:							0.0000	0.0000	0.0000																					0		0.1905	21	0.0000	21
chr2	204165491	204165491	A	G	0.2273	22	0.0000	27		71	CYP20A1-MRPL50P2	intergenic_region	CYP20A1-MRPL50P2:ENSG00000119004-ENSG00000238285:intergenic_region:MODIFIER::n.204165491A>G:							0.0000	0.0000	0.0000																					0		0.2273	22	0.0000	27
chr2	204168787	204168787	A	G	0.2903	42	0.0652	58		52	CYP20A1-MRPL50P2	intergenic_region	CYP20A1-MRPL50P2:ENSG00000119004-ENSG00000238285:intergenic_region:MODIFIER::n.204168787A>G:							0.0000	0.0000	0.0000																					0		0.4762	42	0.1207	58
chr2	204168985	204168985	A	G	0.1379	29	0.0000	34		56	CYP20A1-MRPL50P2	intergenic_region	CYP20A1-MRPL50P2:ENSG00000119004-ENSG00000238285:intergenic_region:MODIFIER::n.204168985A>G:							0.0000	0.0000	0.0000																					0		0.1290	31	0.0000	36
chr2	206987204	206987204	T	C	0.0952	45	0.0000	36		53	NDUFS1	3_prime_UTR_variant	NDUFS1:ENST00000233190:3_prime_UTR_variant:MODIFIER:exon19/19:c.*1705A>G:		Oxidative phosphorylation	Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (By similarity). This is the largest subunit of complex I and it is a component of the iron-sulfur (IP) fragment of the enzyme. It may form part of the active site crevice where NADH is oxidized				0.0000	0.0000	0.0000																					0		0.1333	45	0.0000	36
chr2	211652627	211652627	A	G	0.5000	2	0.0833	36		45	CPS1-RP11-212J19.1	intergenic_region	CPS1-RP11-212J19.1:ENSG00000021826-ENSG00000271074:intergenic_region:MODIFIER::n.211652627A>G:							0.0000	0.0000	0.0000																					0		0.5000	2	0.0833	36
chr2	216276304	216276304	-	A	0.1786	34	0.0000	28		42	FN1	intron_variant	FN1:ENST00000354785:intron_variant:MODIFIER:exon13/45:c.1942-1468dupT:,FN1:ENST00000421182:intron_variant:MODIFIER:exon13/44:c.1942-1468dupT:,FN1:ENST00000323926:intron_variant:MODIFIER:exon13/46:c.1942-1468dupT:,FN1:ENST00000336916:intron_variant:MODIFIER:exon13/45:c.1942-1468dupT:,FN1:ENST00000357867:intron_variant:MODIFIER:exon13/43:c.1942-1468dupT:,FN1:ENST00000345488:intron_variant:MODIFIER:exon13/42:c.1942-1468dupT:,FN1:ENST00000346544:intron_variant:MODIFIER:exon13/43:c.1942-1468dupT:,FN1:ENST00000357009:intron_variant:MODIFIER:exon13/43:c.1942-1468dupT:,FN1:ENST00000359671:intron_variant:MODIFIER:exon13/44:c.1942-1468dupT:,FN1:ENST00000446046:intron_variant:MODIFIER:exon13/45:c.1942-1468dupT:,FN1:ENST00000443816:intron_variant:MODIFIER:exon13/44:c.1942-1468dupT:,FN1:ENST00000432072:intron_variant:MODIFIER:exon13/44:c.1942-1468dupT:,FN1:ENST00000356005:intron_variant:MODIFIER:exon13/43:c.1942-1468dupT:		Cell Communication;Focal adhesion;ECM-receptor interaction;Regulation of actin cytoskeleton;Small cell lung cancer	Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization. Participates in the regulation of type I collagen deposition by osteoblasts				0.0000	0.0000	0.0000		135600 [FN1 (confirmed) Glomerulopathy with fibronectin deposits 2,601894|Plasma fibronectin deficiency,614101];																			0		0.0043	928	0.0000	939
chr2	217538446	217538446	A	G	0.0448	136	0.0000	134		56	IGFBP5	3_prime_UTR_variant	IGFBP5:ENST00000233813:3_prime_UTR_variant:MODIFIER:exon4/4:c.*3028T>C:			IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors				0.0000	0.0000	0.0000																					0		0.0441	136	0.0000	134
chr2	223808503	223808503	-	A	0.3077	40	0.0250	41		47	ACSL3	3_prime_UTR_variant	ACSL3:ENST00000357430:3_prime_UTR_variant:MODIFIER:exon17/17:c.*2137dupA:		Fatty acid metabolism;PPAR signaling pathway;Adipocytokine signaling pathway	Acyl-CoA synthetases (ACSL) activates long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL3 mediates hepatic lipogenesis (By similarity). Preferentially uses myristate, laurate, arachidonate and eicosapentaenoate as substrates (By similarity). Has mainly an anabolic role in energy metabolism. Required for the incorporation of fatty acids into phosphatidylcholine, the major phospholipid located on the surface of VLDL (very low density lipoproteins)				0.0000	0.0000	0.0000																					0		0.1714	35	0.0000	39
chr2	234624338	234624338	A	G	0.1714	35	0.0000	26		68	UGT1A10,UGT1A9,UGT1A7,UGT1A6,UGT1A5,UGT1A8	intron_variant	UGT1A10:ENST00000344644:intron_variant:MODIFIER:exon1/4:c.856-51342A>G:,UGT1A9:ENST00000354728:intron_variant:MODIFIER:exon1/4:c.855+42903A>G:,UGT1A7:ENST00000373426:intron_variant:MODIFIER:exon1/4:c.855+32900A>G:,UGT1A6:ENST00000305139:intron_variant:MODIFIER:exon1/4:c.861+21827A>G:,UGT1A5:ENST00000373414:intron_variant:MODIFIER:exon1/4:c.867+1834A>G:,UGT1A8:ENST00000608381:intron_variant:MODIFIER:exon1/4:c.867+1834A>G:,UGT1A8:ENST00000373450:intron_variant:MODIFIER:exon1/4:c.856-51342A>G:,UGT1A10:ENST00000373445:intron_variant:MODIFIER:exon1/4:c.856-51342A>G:,UGT1A8:ENST00000609637:intron_variant:MODIFIER:exon1/4:c.855+42903A>G:,UGT1A6:ENST00000373424:intron_variant:MODIFIER:exon2/5:c.60+21827A>G:,UGT1A6:ENST00000480628:intron_variant:MODIFIER:exon2/2:n.186+21827A>G:,UGT1A6:ENST00000446481:intron_variant:MODIFIER:exon2/6:c.60+21827A>G:,UGT1A6:ENST00000484784:intron_variant:MODIFIER:exon1/2:c.202-2101A>G:,UGT1A6:ENST00000478062:intron_variant:MODIFIER:exon1/1:n.182-13812A>G:,UGT1A6:ENST00000406651:intron_variant:MODIFIER:exon1/4:c.60+21827A>G:		Pentose and glucuronate interconversions;Androgen and estrogen metabolism;Starch and sucrose metabolism;Retinol metabolism;Porphyrin and chlorophyll metabolism;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450;Drug metabolism - other enzymes	UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds.,UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This isoform has specificity for phenols				0.0000	0.0000	0.0000																					0		0.1714	35	0.0000	26
chr2	236510198	236510198	A	G	0.3333	21	0.0000	25		62	AGAP1	intron_variant	AGAP1:ENST00000409457:intron_variant:MODIFIER:exon1/9:c.163+106705A>G:,AGAP1:ENST00000336665:intron_variant:MODIFIER:exon1/16:c.163+106705A>G:,AGAP1:ENST00000304032:intron_variant:MODIFIER:exon1/17:c.163+106705A>G:,AGAP1:ENST00000402604:intron_variant:MODIFIER:exon1/4:c.4+77015A>G:			GTPase-activating protein for ARF1 and, to a lesser extent, ARF5. Directly and specifically regulates the adapter protein 3 (AP-3)-dependent trafficking of proteins in the endosomal-lysosomal system				0.0000	0.0000	0.0000																					0		0.3333	21	0.0000	25
chr2	238290950	238290950	T	C	0.2000	25	0.0000	28		70	COL6A3	intron_variant	COL6A3:ENST00000295550:intron_variant:MODIFIER:exon4/43:c.1313-808A>G:,COL6A3:ENST00000347401:intron_variant:MODIFIER:exon3/42:c.710-808A>G:,COL6A3:ENST00000353578:intron_variant:MODIFIER:exon3/42:c.695-808A>G:,COL6A3:ENST00000472056:intron_variant:MODIFIER:exon2/40:c.92-808A>G:,COL6A3:ENST00000409809:intron_variant:MODIFIER:exon2/41:c.695-808A>G:,COL6A3:ENST00000346358:intron_variant:MODIFIER:exon4/42:c.1313-808A>G:,COL6A3:ENST00000392004:intron_variant:MODIFIER:exon3/7:c.695-808A>G:,COL6A3:ENST00000392003:intron_variant:MODIFIER:exon2/6:c.92-808A>G:,COL6A3:ENST00000433762:intron_variant:MODIFIER:exon4/5:c.1313-808A>G:		Cell Communication;Focal adhesion;ECM-receptor interaction	Collagen VI acts as a cell-binding protein				0.0000	0.0000	0.0000		120250 [COL6A3 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090|Dystonia 27,616411];																			0		0.2000	25	0.0000	28
chr2	238802777	238802777	A	G	0.3846	13	0.0000	18		39	RAMP1	intron_variant	RAMP1:ENST00000254661:intron_variant:MODIFIER:exon2/2:c.191+16773A>G:,RAMP1:ENST00000404910:intron_variant:MODIFIER:exon2/2:c.125+16773A>G:,RAMP1:ENST00000409726:intron_variant:MODIFIER:exon3/3:c.125+16773A>G:,RAMP1:ENST00000403885:intron_variant:MODIFIER:exon2/2:c.125+16773A>G:			Transports the calcitonin gene-related peptide type 1 receptor (CALCRL) to the plasma membrane. Acts as a receptor for calcitonin-gene-related peptide (CGRP) together with CALCRL				0.0000	0.0000	0.0000																					0		0.3846	13	0.0000	18
chr3	9743114	9743114	A	G	0.5000	4	0.0345	30		40	MTMR14	intron_variant,non_coding_transcript_exon_variant	MTMR14:ENST00000296003:intron_variant:MODIFIER:exon18/18:c.1770-360A>G:,MTMR14:ENST00000353332:intron_variant:MODIFIER:exon17/17:c.1614-360A>G:,MTMR14:ENST00000420925:intron_variant:MODIFIER:exon8/8:c.696-360A>G:,MTMR14:ENST00000447144:intron_variant:MODIFIER:exon11/11:c.*563-360A>G:,MTMR14:ENST00000351233:intron_variant:MODIFIER:exon16/16:c.1434-360A>G:,MTMR14:ENST00000414996:intron_variant:MODIFIER:exon14/14:c.*947-360A>G:,MTMR14:ENST00000606184:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.2004A>G:			Lipid phosphatase which efficiently dephosphorylates phosphatidylinositol 3-phosphate (PtdIns3P) and PtdIns(3,5)P2; inactive toward PtdIns4P, PtdIns(3,4)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3				0.0000	0.0000	0.0000		611089 [MTMR14 (provisional) Centronuclear myopathy,autosomal,modifier of,160150];																			0		0.5000	4	0.0333	30
chr3	10349404	10349404	A	G	0.2500	16	0.0000	24		62	SEC13	intron_variant	SEC13:ENST00000383801:intron_variant:MODIFIER:exon6/9:c.589-2028T>C:,SEC13:ENST00000397109:intron_variant:MODIFIER:exon5/8:c.409-2028T>C:,SEC13:ENST00000337354:intron_variant:MODIFIER:exon6/9:c.460-2028T>C:,SEC13:ENST00000350697:intron_variant:MODIFIER:exon5/8:c.451-2028T>C:,SEC13:ENST00000479868:intron_variant:MODIFIER:exon2/5:n.1528-2028T>C:,SEC13:ENST00000397117:intron_variant:MODIFIER:exon5/8:c.409-2028T>C:,SEC13:ENST00000477547:intron_variant:MODIFIER:exon4/6:n.434-2028T>C:			Functions as a component of the nuclear pore complex (NPC) and the COPII coat. At the endoplasmic reticulum, SEC13 is involved in the biogenesis of COPII-coated vesicles				0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	24
chr3	11484953	11484953	A	G	0.0952	43	0.0000	31		53	ATG7	intron_variant	ATG7:ENST00000354449:intron_variant:MODIFIER:exon18/18:c.2079+16553A>G:,ATG7:ENST00000446450:intron_variant:MODIFIER:exon16/16:c.1839+63427A>G:,ATG7:ENST00000354956:intron_variant:MODIFIER:exon17/17:c.1998+16553A>G:,ATG7:ENST00000414717:intron_variant:MODIFIER:exon3/3:c.283-3030A>G:,ATG7:ENST00000427759:intron_variant:MODIFIER:exon3/3:c.279+16553A>G:,ATG7:ENST00000446110:intron_variant:MODIFIER:exon3/3:c.279+16553A>G:		Regulation of autophagy	E1-like activating enzyme involved in the 2 ubiquitin- like systems required for cytoplasm to vacuole transport (Cvt) and autophagy. Activates ATG12 for its conjugation with ATG5 as well as the ATG8 family proteins for their conjugation with phosphatidylethanolamine. Both systems are needed for the ATG8 association to Cvt vesicles and autophagosomes membranes. Required for autophagic death induced by caspase-8 inhibition. Required for mitophagy which contributes to regulate mitochondrial quantity and quality by eliminating the mitochondria to a basal level to fulfill cellular energy requirements and preventing excess ROS production. Modulates p53/TP53 activity to regulate cell cycle and survival during metabolic stress. Plays also a key role in the maintenance of axonal homeostasis, the prevention of axonal degeneration, the maintenance of hematopoietic stem cells, the formation of Paneth cell granules, as well as in adipose differentiation				0.0000	0.0000	0.0000																					0		0.1163	43	0.0000	31
chr3	25639678	25639678	-	A	0.1111	53	0.0000	58		45	TOP2B	3_prime_UTR_variant	TOP2B:ENST00000264331:3_prime_UTR_variant:MODIFIER:exon36/36:c.*119dupT:,TOP2B:ENST00000413971:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1632dupT:,TOP2B:ENST00000542520:3_prime_UTR_variant:MODIFIER:exon13/13:c.*119dupT:,TOP2B:ENST00000435706:3_prime_UTR_variant:MODIFIER:exon36/36:c.*119dupT:,TOP2B:ENST00000540199:3_prime_UTR_variant:MODIFIER:exon12/12:c.*119dupT:			Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks. Indirectly involved in vitamin D- coupled transcription regulation via its association with the WINAC complex, a chromatin-remodeling complex recruited by vitamin D receptor (VDR), which is required for the ligand-bound VDR- mediated transrepression of the CYP27B1 gene	Apoptotic DNA fragmentation and tissue homeostasis			0.0000	0.0000	0.0000																					0		0.1042	48	0.0000	52
chr3	28376504	28376504	T	C	0.2308	26	0.0250	41		56	AZI2	intron_variant	AZI2:ENST00000479665:intron_variant:MODIFIER:exon5/7:c.588+1724A>G:,AZI2:ENST00000295748:intron_variant:MODIFIER:exon6/8:n.847+1724A>G:,AZI2:ENST00000492044:intron_variant:MODIFIER:exon1/3:n.217+1724A>G:,AZI2:ENST00000463512:intron_variant:MODIFIER:exon5/6:n.965+1724A>G:,AZI2:ENST00000334100:intron_variant:MODIFIER:exon5/6:c.588+1724A>G:,AZI2:ENST00000488978:intron_variant:MODIFIER:exon1/2:n.386+1724A>G:,AZI2:ENST00000420543:intron_variant:MODIFIER:exon5/6:c.588+1724A>G:,AZI2:ENST00000457172:intron_variant:MODIFIER:exon6/7:c.588+1724A>G:,AZI2:ENST00000414162:intron_variant:MODIFIER:exon6/6:c.588+1724A>G:			Activates serine/threonine-protein kinase TBK1 and facilitates its oligomerization. Enhances the phosphorylation of NF-kappa-B p65 subunit RELA by TBK1. Promotes TBK1-induced as well as TNF-alpha or PMA-induced activation of NF-kappa-B. Participates in IFN-beta promoter activation via TICAM1				0.0000	0.0000	0.0000																					0		0.2308	26	0.0488	41
chr3	30649438	30649438	-	T	0.3043	27	0.0000	22		42	TGFBR2	intron_variant	TGFBR2:ENST00000359013:intron_variant:MODIFIER:exon1/7:c.94+981dupT:,TGFBR2:ENST00000295754:intron_variant:MODIFIER:exon1/6:c.94+981dupT:		MAPK signaling pathway;Cytokine-cytokine receptor interaction;TGF-beta signaling pathway;Adherens junction;Colorectal cancer;Pancreatic cancer;Chronic myeloid leukemia	Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non- canonical, SMAD-independent TGF-beta signaling pathways	ALK in cardiac myocytes;CTCF: First Multivalent Nuclear Factor;NFkB activation by Nontypeable Hemophilus influenzae;Role of Tob in T-cell activation;TGF beta signaling pathway		rs371844015	0.0000	0.0000	0.0000		190182 [TGFBR2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 6,614331|Esophageal cancer,somatic,133239|Loeys-Dietz syndrome 2,610168];																			0		0.0288	139	0.0000	63
chr3	30691870	30691870	G	A	0.0182	288	0.0000	256		60	TGFBR2	synonymous_variant,sequence_feature	TGFBR2:ENST00000359013:synonymous_variant:LOW:exon4/8:c.447G>A:p.Lys149Lys,TGFBR2:ENST00000295754:synonymous_variant:LOW:exon3/7:c.372G>A:p.Lys124Lys,TGFBR2:ENST00000359013:sequence_feature:LOW:exon4/8:c.447G>A:,TGFBR2:ENST00000295754:sequence_feature:LOW:exon3/7:c.372G>A:		MAPK signaling pathway;Cytokine-cytokine receptor interaction;TGF-beta signaling pathway;Adherens junction;Colorectal cancer;Pancreatic cancer;Chronic myeloid leukemia	Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non- canonical, SMAD-independent TGF-beta signaling pathways	ALK in cardiac myocytes;CTCF: First Multivalent Nuclear Factor;NFkB activation by Nontypeable Hemophilus influenzae;Role of Tob in T-cell activation;TGF beta signaling pathway			0.0000	0.0000	0.00000		190182 [TGFBR2 (confirmed) Colorectal cancer,hereditary nonpolyposis,type 6,614331|Esophageal cancer,somatic,133239|Loeys-Dietz syndrome 2,610168];																			0		0.0175	286	0.0040	251
chr3	44791512	44791512	T	C	0.2353	17	0.0000	23		61	KIAA1143	3_prime_UTR_variant,intron_variant	KIAA1143:ENST00000296121:3_prime_UTR_variant:MODIFIER:exon3/3:c.*3321A>G:,KIAA1143:ENST00000484437:intron_variant:MODIFIER:exon3/3:n.370+3325A>G:							0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	26
chr3	45125716	45125716	-	G	0.1186	65	0.0000	48		46	CDCP1	3_prime_UTR_variant	CDCP1:ENST00000296129:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1413dupC:			May be involved in cell adhesion and cell matrix association. May play a role in the regulation of anchorage versus migration or proliferation versus differentiation via its phosphorylation. May be a novel marker for leukemia diagnosis and for immature hematopoietic stem cell subsets. Belongs to the tetraspanin web involved in tumor progression and metastasis			rs772096639	0.0000	0.0000	0.0000																					0		0.0597	67	0.0000	48
chr3	48466959	48466959	G	A	0.2051	39	0.0000	49		82	PLXNB1	intron_variant	PLXNB1:ENST00000296440:intron_variant:MODIFIER:exon1/37:c.-59-217C>T:,PLXNB1:ENST00000358459:intron_variant:MODIFIER:exon1/38:c.-59-217C>T:,PLXNB1:ENST00000358536:intron_variant:MODIFIER:exon1/37:c.-59-217C>T:,PLXNB1:ENST00000448774:intron_variant:MODIFIER:exon1/19:c.-62-217C>T:,PLXNB1:ENST00000466353:intron_variant:MODIFIER:exon1/3:n.229+3703C>T:		Axon guidance	Receptor for SEMA4D. Plays a role in RHOA activation and subsequent changes of the actin cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration				0.0000	0.0000	0.0000																					0		0.2000	40	0.0000	49
chr3	50023513	50023513	A	G	0.4545	11	0.0400	26		39	RBM6	intron_variant	RBM6:ENST00000266022:intron_variant:MODIFIER:exon5/20:c.1483+10688A>G:,RBM6:ENST00000442092:intron_variant:MODIFIER:exon2/16:c.-10+23395A>G:,RBM6:ENST00000443081:intron_variant:MODIFIER:exon5/20:c.1087+10688A>G:,RBM6:ENST00000419610:intron_variant:MODIFIER:exon2/15:c.44+23395A>G:,RBM6:ENST00000539992:intron_variant:MODIFIER:exon2/15:c.-343+23395A>G:,RBM6:ENST00000441115:intron_variant:MODIFIER:exon4/16:n.422+10688A>G:,RBM6:ENST00000422955:intron_variant:MODIFIER:exon4/18:c.-10+10688A>G:,RBM6:ENST00000454079:intron_variant:MODIFIER:exon5/19:c.1087+10688A>G:,RBM6:ENST00000425608:intron_variant:MODIFIER:exon5/7:c.1483+10688A>G:,RBM6:ENST00000434592:intron_variant:MODIFIER:exon4/20:c.-10+10688A>G:,RBM6:ENST00000464013:intron_variant:MODIFIER:exon1/4:n.108+4412A>G:			Specifically binds poly(G) RNA homopolymers in vitro				0.0000	0.0000	0.0000																					0		0.4545	11	0.0385	26
chr3	50026227	50026227	A	G	0.1481	27	0.0000	36		62	RBM6	intron_variant	RBM6:ENST00000266022:intron_variant:MODIFIER:exon5/20:c.1484-10646A>G:,RBM6:ENST00000442092:intron_variant:MODIFIER:exon2/16:c.-10+26109A>G:,RBM6:ENST00000443081:intron_variant:MODIFIER:exon5/20:c.1088-10646A>G:,RBM6:ENST00000419610:intron_variant:MODIFIER:exon2/15:c.44+26109A>G:,RBM6:ENST00000539992:intron_variant:MODIFIER:exon2/15:c.-343+26109A>G:,RBM6:ENST00000441115:intron_variant:MODIFIER:exon4/16:n.423-10646A>G:,RBM6:ENST00000422955:intron_variant:MODIFIER:exon4/18:c.-10+13402A>G:,RBM6:ENST00000454079:intron_variant:MODIFIER:exon5/19:c.1088-10646A>G:,RBM6:ENST00000425608:intron_variant:MODIFIER:exon5/7:c.1483+13402A>G:,RBM6:ENST00000434592:intron_variant:MODIFIER:exon4/20:c.-10+13402A>G:,RBM6:ENST00000464013:intron_variant:MODIFIER:exon1/4:n.108+7126A>G:			Specifically binds poly(G) RNA homopolymers in vitro				0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	36
chr3	50026351	50026351	A	G	0.2222	27	0.0571	35		52	RBM6	intron_variant	RBM6:ENST00000266022:intron_variant:MODIFIER:exon5/20:c.1484-10522A>G:,RBM6:ENST00000442092:intron_variant:MODIFIER:exon2/16:c.-10+26233A>G:,RBM6:ENST00000443081:intron_variant:MODIFIER:exon5/20:c.1088-10522A>G:,RBM6:ENST00000419610:intron_variant:MODIFIER:exon2/15:c.44+26233A>G:,RBM6:ENST00000539992:intron_variant:MODIFIER:exon2/15:c.-343+26233A>G:,RBM6:ENST00000441115:intron_variant:MODIFIER:exon4/16:n.423-10522A>G:,RBM6:ENST00000422955:intron_variant:MODIFIER:exon4/18:c.-10+13526A>G:,RBM6:ENST00000454079:intron_variant:MODIFIER:exon5/19:c.1088-10522A>G:,RBM6:ENST00000425608:intron_variant:MODIFIER:exon5/7:c.1483+13526A>G:,RBM6:ENST00000434592:intron_variant:MODIFIER:exon4/20:c.-10+13526A>G:,RBM6:ENST00000464013:intron_variant:MODIFIER:exon1/4:n.108+7250A>G:			Specifically binds poly(G) RNA homopolymers in vitro				0.0000	0.0000	0.0000																					0		0.2500	28	0.0571	35
chr3	50369973	50369973	T	C	0.1923	27	0.0189	53		56	RASSF1	intron_variant	RASSF1:ENST00000357043:intron_variant:MODIFIER:exon2/5:c.370-388A>G:,RASSF1:ENST00000327761:intron_variant:MODIFIER:exon1/4:c.148-388A>G:,RASSF1:ENST00000395126:intron_variant:MODIFIER:exon2/5:c.-96-388A>G:,RASSF1:ENST00000395117:intron_variant:MODIFIER:exon1/4:c.251-388A>G:,RASSF1:ENST00000359365:intron_variant:MODIFIER:exon2/5:c.358-388A>G:,RASSF1:ENST00000482447:intron_variant:MODIFIER:exon1/3:c.251-686A>G:		Bladder cancer;Non-small cell lung cancer	Potential tumor suppressor. Required for death receptor- dependent apoptosis. Mediates activation of STK3/MST2 and STK4/MST1 during Fas-induced apoptosis by preventing their dephosphorylation. When associated with MOAP1, promotes BAX conformational change and translocation to mitochondrial membranes in response to TNF and TNFSF10 stimulation. Isoform A interacts with CDC20, an activator of the anaphase-promoting complex, APC, resulting in the inhibition of APC activity and mitotic progression. Inhibits proliferation by negatively regulating cell cycle progression at the level of G1/S-phase transition by regulating accumulation of cyclin D1 protein. Isoform C has been shown not to perform these roles, no function has been identified for this isoform. Isoform A disrupts interactions among MDM2, DAXX and USP7, thus contributing to the efficient activation of TP53 by promoting MDM2 self-ubiquitination in cell-cycle checkpoint control in response to DNA damage				0.0000	0.0000	0.0000		605082 [RASSF1 (confirmed) Lung cancer,211980];																			0		0.1852	27	0.0182	55
chr3	61641841	61641841	A	G	0.2222	18	0.0000	20		51	PTPRG	intron_variant	PTPRG:ENST00000474889:intron_variant:MODIFIER:exon1/29:c.86-92711A>G:,PTPRG:ENST00000495879:intron_variant:MODIFIER:exon1/2:n.805-92711A>G:,PTPRG:ENST00000475527:intron_variant:MODIFIER:exon1/1:n.523-92711A>G:,PTPRG:ENST00000295874:intron_variant:MODIFIER:exon1/28:c.86-92711A>G:			Possesses tyrosine phosphatase activity				0.0000	0.0000	0.0000																					0		0.2222	18	0.0000	20
chr3	61783583	61783583	-	AT	0.3333	22	0.0000	23		47	PTPRG	sequence_feature,intron_variant	PTPRG:ENST00000474889:sequence_feature:LOW::c.190+48927_190+48928insAT:,PTPRG:ENST00000295874:sequence_feature:LOW::c.190+48927_190+48928insAT:,PTPRG:ENST00000474889:intron_variant:MODIFIER:exon2/29:c.190+48927_190+48928insAT:,PTPRG:ENST00000295874:intron_variant:MODIFIER:exon2/28:c.190+48927_190+48928insAT:			Possesses tyrosine phosphatase activity				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	79
chr3	61783585	61783585	G	A	0.3182	22	0.0000	22		54	PTPRG	sequence_feature,intron_variant	PTPRG:ENST00000474889:sequence_feature:LOW::c.190+48929G>A:,PTPRG:ENST00000295874:sequence_feature:LOW::c.190+48929G>A:,PTPRG:ENST00000474889:intron_variant:MODIFIER:exon2/29:c.190+48929G>A:,PTPRG:ENST00000295874:intron_variant:MODIFIER:exon2/28:c.190+48929G>A:			Possesses tyrosine phosphatase activity				0.0000	0.0000	0.0000																					0		0.2727	22	0.0455	22
chr3	61787069	61787069	A	G	0.1481	27	0.0000	23		60	PTPRG	sequence_feature,intron_variant	PTPRG:ENST00000474889:sequence_feature:LOW::c.190+52413A>G:,PTPRG:ENST00000295874:sequence_feature:LOW::c.190+52413A>G:,PTPRG:ENST00000474889:intron_variant:MODIFIER:exon2/29:c.190+52413A>G:,PTPRG:ENST00000295874:intron_variant:MODIFIER:exon2/28:c.190+52413A>G:			Possesses tyrosine phosphatase activity				0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	23
chr3	61801004	61801004	A	G	0.2000	30	0.0000	30		72	PTPRG	sequence_feature,intron_variant	PTPRG:ENST00000474889:sequence_feature:LOW::c.190+66348A>G:,PTPRG:ENST00000295874:sequence_feature:LOW::c.190+66348A>G:,PTPRG:ENST00000474889:intron_variant:MODIFIER:exon2/29:c.190+66348A>G:,PTPRG:ENST00000295874:intron_variant:MODIFIER:exon2/28:c.190+66348A>G:			Possesses tyrosine phosphatase activity				0.0000	0.0000	0.0000																					0		0.2000	30	0.0000	30
chr3	65933496	65933496	T	C	0.4444	9	0.0000	20		44	MAGI1,MAGI1-IT1	intron_variant	MAGI1:ENST00000402939:intron_variant:MODIFIER:exon1/22:c.313+90175A>G:,MAGI1-IT1:ENST00000460754:intron_variant:MODIFIER:exon1/2:n.119+6619A>G:,MAGI1:ENST00000330909:intron_variant:MODIFIER:exon1/24:c.313+90175A>G:,MAGI1:ENST00000483466:intron_variant:MODIFIER:exon1/22:c.313+90175A>G:,MAGI1:ENST00000497477:intron_variant:MODIFIER:exon1/20:c.313+90175A>G:,MAGI1:ENST00000464060:intron_variant:MODIFIER:exon1/5:n.839+90175A>G:		Tight junction;Dentatorubropallidoluysian atrophy (DRPLA)	May play a role as scaffolding protein at cell-cell junctions. May regulate acid-induced ASIC3 currents by modulating its expression at the cell surface (By similarity)				0.0000	0.0000	0.0000																					0		0.4444	9	0.0000	21
chr3	65945197	65945197	T	C	0.2941	17	0.0278	37		64	MAGI1	intron_variant	MAGI1:ENST00000402939:intron_variant:MODIFIER:exon1/22:c.313+78474A>G:,MAGI1:ENST00000330909:intron_variant:MODIFIER:exon1/24:c.313+78474A>G:,MAGI1:ENST00000483466:intron_variant:MODIFIER:exon1/22:c.313+78474A>G:,MAGI1:ENST00000497477:intron_variant:MODIFIER:exon1/20:c.313+78474A>G:,MAGI1:ENST00000464060:intron_variant:MODIFIER:exon1/5:n.839+78474A>G:		Tight junction;Dentatorubropallidoluysian atrophy (DRPLA)	May play a role as scaffolding protein at cell-cell junctions. May regulate acid-induced ASIC3 currents by modulating its expression at the cell surface (By similarity)				0.0000	0.0000	0.0000																					0		0.2941	17	0.0270	37
chr3	65979866	65979866	T	C	0.3333	12	0.0000	25		60	MAGI1	intron_variant	MAGI1:ENST00000402939:intron_variant:MODIFIER:exon1/22:c.313+43805A>G:,MAGI1:ENST00000330909:intron_variant:MODIFIER:exon1/24:c.313+43805A>G:,MAGI1:ENST00000483466:intron_variant:MODIFIER:exon1/22:c.313+43805A>G:,MAGI1:ENST00000497477:intron_variant:MODIFIER:exon1/20:c.313+43805A>G:,MAGI1:ENST00000464060:intron_variant:MODIFIER:exon1/5:n.839+43805A>G:		Tight junction;Dentatorubropallidoluysian atrophy (DRPLA)	May play a role as scaffolding protein at cell-cell junctions. May regulate acid-induced ASIC3 currents by modulating its expression at the cell surface (By similarity)				0.0000	0.0000	0.0000																					0		0.3077	13	0.0000	27
chr3	65995036	65995036	T	C	0.3750	8	0.0000	18		39	MAGI1	intron_variant	MAGI1:ENST00000402939:intron_variant:MODIFIER:exon1/22:c.313+28635A>G:,MAGI1:ENST00000330909:intron_variant:MODIFIER:exon1/24:c.313+28635A>G:,MAGI1:ENST00000483466:intron_variant:MODIFIER:exon1/22:c.313+28635A>G:,MAGI1:ENST00000497477:intron_variant:MODIFIER:exon1/20:c.313+28635A>G:,MAGI1:ENST00000464060:intron_variant:MODIFIER:exon1/5:n.839+28635A>G:		Tight junction;Dentatorubropallidoluysian atrophy (DRPLA)	May play a role as scaffolding protein at cell-cell junctions. May regulate acid-induced ASIC3 currents by modulating its expression at the cell surface (By similarity)				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	18
chr3	67656457	67656457	T	C	0.3636	22	0.0000	19		43	SUCLG2	intron_variant	SUCLG2:ENST00000493112:intron_variant:MODIFIER:exon2/10:c.226+3422A>G:,SUCLG2:ENST00000307227:intron_variant:MODIFIER:exon2/10:c.226+3422A>G:,SUCLG2:ENST00000492795:intron_variant:MODIFIER:exon2/9:c.226+3422A>G:		Citrate cycle (TCA cycle);Propanoate metabolism	Catalyzes the GTP-dependent ligation of succinate and CoA to form succinyl-CoA (By similarity)				0.0000	0.0000	0.0000																					0		0.3636	22	0.0000	19
chr3	100261205	100261205	A	G	0.0909	46	0.0000	21		58	TMEM45A	intron_variant	TMEM45A:ENST00000403410:intron_variant:MODIFIER:exon3/7:c.46-12848A>G:,TMEM45A:ENST00000323523:intron_variant:MODIFIER:exon1/5:c.-3-12848A>G:,TMEM45A:ENST00000449609:intron_variant:MODIFIER:exon2/4:c.46-12848A>G:,TMEM45A:ENST00000462884:intron_variant:MODIFIER:exon2/3:n.155-12848A>G:							0.0000	0.0000	0.0000																					0		0.1087	46	0.0000	21
chr3	104132445	104132445	T	C	0.2778	36	0.0571	37		53	RP11-40M23.1-RP11-281P11.1	intergenic_region	RP11-40M23.1-RP11-281P11.1:ENSG00000214405-ENSG00000243635:intergenic_region:MODIFIER::n.104132445T>C:							0.0000	0.0000	0.0000																					0		0.2778	36	0.0811	37
chr3	107305698	107305698	A	G	0.1429	28	0.0000	45		62	BBX	intron_variant	BBX:ENST00000325805:intron_variant:MODIFIER:exon2/17:c.-83-58985A>G:,BBX:ENST00000415149:intron_variant:MODIFIER:exon2/16:c.-83-58985A>G:,BBX:ENST00000402543:intron_variant:MODIFIER:exon2/16:c.-200-58985A>G:,BBX:ENST00000485939:intron_variant:MODIFIER:exon2/6:n.190-58985A>G:,BBX:ENST00000427402:intron_variant:MODIFIER:exon2/7:c.-201-51651A>G:,BBX:ENST00000416476:intron_variant:MODIFIER:exon2/16:c.-83-58985A>G:,BBX:ENST00000454540:intron_variant:MODIFIER:exon2/3:c.-83-58985A>G:,BBX:ENST00000431630:intron_variant:MODIFIER:exon2/5:c.-83-58985A>G:,BBX:ENST00000449335:intron_variant:MODIFIER:exon2/5:c.-83-58985A>G:,BBX:ENST00000456817:intron_variant:MODIFIER:exon2/4:c.-83-58985A>G:,BBX:ENST00000458458:intron_variant:MODIFIER:exon1/2:c.-10+62284A>G:,BBX:ENST00000456419:intron_variant:MODIFIER:exon2/6:c.-83-58985A>G:,BBX:ENST00000402163:intron_variant:MODIFIER:exon2/10:c.-83-58985A>G:			Transcription factor that is necessary for cell cycle progression from G1 to S phase				0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	45
chr3	129485600	129485600	T	C	0.1429	28	0.0000	33		58	TMCC1	intron_variant	TMCC1:ENST00000393238:intron_variant:MODIFIER:exon3/5:c.576+61046A>G:,TMCC1:ENST00000426664:intron_variant:MODIFIER:exon3/5:c.234+61046A>G:,TMCC1:ENST00000329333:intron_variant:MODIFIER:exon1/3:c.39+27567A>G:,TMCC1:ENST00000505616:intron_variant:MODIFIER:exon3/3:c.234+61046A>G:							0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	33
chr3	129518409	129518409	T	C	0.5000	4	0.0435	23		34	TMCC1	intron_variant	TMCC1:ENST00000393238:intron_variant:MODIFIER:exon3/5:c.576+28237A>G:,TMCC1:ENST00000426664:intron_variant:MODIFIER:exon3/5:c.234+28237A>G:,TMCC1:ENST00000505616:intron_variant:MODIFIER:exon3/3:c.234+28237A>G:							0.0000	0.0000	0.0000																					0		0.5000	4	0.0435	23
chr3	129820694	129820694	T	C	0.1667	24	0.0000	19		52	FAM86HP,ALG1L2	intron_variant	FAM86HP:ENST00000513466:intron_variant:MODIFIER:exon7/7:n.858+913A>G:,ALG1L2:ENST00000511726:intron_variant:MODIFIER:exon2/2:n.124+7384T>C:,FAM86HP:ENST00000511564:intron_variant:MODIFIER:exon2/2:n.254+913A>G:			Putative glycosyltransferase (By similarity)				0.0000	0.0000	0.0000																					0		0.1667	24	0.0000	19
chr3	136226429	136226429	T	C	0.2381	24	0.0323	32		52	STAG1	intron_variant	STAG1:ENST00000383202:intron_variant:MODIFIER:exon7/33:c.677-4808A>G:,STAG1:ENST00000236698:intron_variant:MODIFIER:exon7/32:c.677-4808A>G:,STAG1:ENST00000483235:intron_variant:MODIFIER:exon10/35:c.*769-4808A>G:,STAG1:ENST00000434713:intron_variant:MODIFIER:exon10/35:c.-2-4808A>G:,STAG1:ENST00000487065:intron_variant:MODIFIER:exon8/21:c.*316-4808A>G:,STAG1:ENST00000462818:intron_variant:MODIFIER:exon4/5:n.545-4808A>G:			Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis				0.0000	0.0000	0.0000																					0		0.2000	25	0.0312	32
chr3	136463793	136463793	T	C	0.2500	29	0.0323	31		58	STAG1	intron_variant	STAG1:ENST00000383202:intron_variant:MODIFIER:exon1/33:c.-84+7244A>G:,STAG1:ENST00000236698:intron_variant:MODIFIER:exon1/32:c.-84+7244A>G:,STAG1:ENST00000483235:intron_variant:MODIFIER:exon1/35:c.-84+7244A>G:,STAG1:ENST00000434713:intron_variant:MODIFIER:exon1/35:c.-1160+7244A>G:,STAG1:ENST00000487065:intron_variant:MODIFIER:exon1/21:c.-84+7244A>G:,STAG1:ENST00000480733:intron_variant:MODIFIER:exon1/7:c.-84+7244A>G:			Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis				0.0000	0.0000	0.0000																					0		0.2500	28	0.0323	31
chr3	137810311	137810311	T	C	0.3500	21	0.0000	16		34	DZIP1L	intron_variant	DZIP1L:ENST00000327532:intron_variant:MODIFIER:exon5/15:c.870+914A>G:,DZIP1L:ENST00000488595:intron_variant:MODIFIER:exon1/6:n.83+914A>G:,DZIP1L:ENST00000469243:intron_variant:MODIFIER:exon6/13:c.870+914A>G:							0.0000	0.0000	0.0000																					0		0.3333	21	0.0000	16
chr3	138273686	138273686	T	C	0.3750	10	0.0000	19		36	CEP70	intron_variant	CEP70:ENST00000264982:intron_variant:MODIFIER:exon6/17:c.465+15474A>G:,CEP70:ENST00000542237:intron_variant:MODIFIER:exon5/16:c.405+15474A>G:,CEP70:ENST00000489254:intron_variant:MODIFIER:exon2/13:c.10-17497A>G:,CEP70:ENST00000484888:intron_variant:MODIFIER:exon6/17:c.465+15474A>G:,CEP70:ENST00000474781:intron_variant:MODIFIER:exon6/17:c.411+15474A>G:,CEP70:ENST00000481834:intron_variant:MODIFIER:exon6/15:c.465+15474A>G:,CEP70:ENST00000468900:intron_variant:MODIFIER:exon5/8:c.402+15474A>G:,CEP70:ENST00000462419:intron_variant:MODIFIER:exon5/8:c.405+15474A>G:,CEP70:ENST00000478673:intron_variant:MODIFIER:exon6/8:n.630+15474A>G:,CEP70:ENST00000464035:intron_variant:MODIFIER:exon5/5:c.465+15474A>G:			Plays a role in the organization of both preexisting and nascent microtubules in interphase cells. During mitosis, required for the organization and orientation of the mitotic spindle				0.0000	0.0000	0.0000																					0		0.3000	10	0.0000	19
chr3	141155433	141155433	A	G	0.2121	33	0.0476	42		58	ZBTB38	intron_variant	ZBTB38:ENST00000321464:intron_variant:MODIFIER:exon1/1:c.4-5798A>G:,ZBTB38:ENST00000509842:intron_variant:MODIFIER:exon7/7:c.1-5798A>G:,ZBTB38:ENST00000507722:intron_variant:MODIFIER:exon3/3:c.1-5798A>G:,ZBTB38:ENST00000503809:intron_variant:MODIFIER:exon3/3:c.1-5798A>G:,ZBTB38:ENST00000513258:intron_variant:MODIFIER:exon2/3:c.-98-1677A>G:,ZBTB38:ENST00000509883:intron_variant:MODIFIER:exon2/2:c.1-5798A>G:,ZBTB38:ENST00000514251:intron_variant:MODIFIER:exon2/3:c.-98-1677A>G:,ZBTB38:ENST00000510338:intron_variant:MODIFIER:exon2/2:c.1-5798A>G:,ZBTB38:ENST00000504673:intron_variant:MODIFIER:exon2/3:c.-123-1652A>G:,ZBTB38:ENST00000513570:intron_variant:MODIFIER:exon2/2:c.1-5798A>G:,ZBTB38:ENST00000441582:intron_variant:MODIFIER:exon1/1:c.1-5798A>G:,ZBTB38:ENST00000510726:intron_variant:MODIFIER:exon2/2:c.1-5798A>G:,ZBTB38:ENST00000509813:intron_variant:MODIFIER:exon1/1:c.-1+4348A>G:			Acts as a transcriptional activator. May be involved in the differentiation and/or survival of late postmitotic neurons (By similarity)				0.0000	0.0000	0.0000																					0		0.2121	33	0.0476	42
chr3	142135774	142135774	T	C	0.6000	5	0.0000	18		40	XRN1	intron_variant	XRN1:ENST00000264951:intron_variant:MODIFIER:exon13/41:c.1436+208A>G:,XRN1:ENST00000392981:intron_variant:MODIFIER:exon13/40:c.1436+208A>G:,XRN1:ENST00000472697:intron_variant:MODIFIER:exon10/20:n.1027+208A>G:			Major 5'-3' exoribonuclease involved in mRNA decay. Required for the 5'-3'-processing of the G4 tetraplex-containing DNA and RNA substrates. The kinetic of hydrolysis is faster for G4 RNA tetraplex than for G4 DNA tetraplex and monomeric RNA tetraplex. Binds to RNA and DNA (By similarity). Plays a role in replication-dependent histone mRNA degradation. May act as a tumor suppressor protein in osteogenic sarcoma (OGS)				0.0000	0.0000	0.0000																					0		0.6000	5	0.0000	18
chr3	142209065	142209065	T	C	0.1220	42	0.0000	38		61	ATR	intron_variant	ATR:ENST00000350721:intron_variant:MODIFIER:exon35/46:c.6078+2909A>G:,ATR:ENST00000383101:intron_variant:MODIFIER:exon34/45:c.5886+2909A>G:		Cell cycle;p53 signaling pathway	Serine/threonine protein kinase which activates checkpoint signaling upon genotoxic stresses such as ionizing radiation (IR), ultraviolet light (UV), or DNA replication stalling, thereby acting as a DNA damage sensor. Recognizes the substrate consensus sequence [ST]-Q. Phosphorylates BRCA1, CHEK1, MCM2, RAD17, RPA2, SMC1 and p53/TP53, which collectively inhibit DNA replication and mitosis and promote DNA repair, recombination and apoptosis. Phosphorylates 'Ser-139' of histone variant H2AX/H2AFX at sites of DNA damage, thereby regulating DNA damage response mechanism. Required for FANCD2 ubiquitination. Critical for maintenance of fragile site stability and efficient regulation of centrosome duplication	Cell Cycle: G1/S Check Point ;Cell Cycle: G2/M Checkpoint;Regulation of cell cycle progression by Plk3;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility			0.0000	0.0000	0.0000		601215 [ATR (confirmed) Seckel syndrome 1,210600|Cutaneous telangiectasia and cancer syndrome,familial,614564];																			0		0.1163	43	0.0000	38
chr3	145766622	145766622	-	A	0.1818	24	0.0000	32		42	RP11-88H10.3-RP11-274H2.5	intergenic_region	RP11-88H10.3-RP11-274H2.5:ENSG00000240095-ENSG00000261051:intergenic_region:MODIFIER::n.145766622_145766623insA:							0.0000	0.0000	0.0000																					0		0.1739	23	0.0312	32
chr3	145821156	145821156	T	C	0.3704	27	0.0000	16		34	RP11-274H2.2,PLOD2	intron_variant	RP11-274H2.2:ENST00000480247:intron_variant:MODIFIER:exon3/3:n.338-1618T>C:,PLOD2:ENST00000282903:intron_variant:MODIFIER:exon6/19:c.680-517A>G:,PLOD2:ENST00000360060:intron_variant:MODIFIER:exon6/18:c.680-517A>G:,PLOD2:ENST00000494950:intron_variant:MODIFIER:exon6/19:c.515-517A>G:,PLOD2:ENST00000469350:intron_variant:MODIFIER:exon6/6:c.596-517A>G:		Lysine degradation	Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links			rs9836521	0.511581	0.0000	0.0000		601865 [PLOD2 (confirmed) Bruck syndrome 2,609220];																			0		0.3704	27	0.0000	16
chr3	148915711	148915711	C	T	0.0805	89	0.0000	71		70	CP	intron_variant	CP:ENST00000264613:intron_variant:MODIFIER:exon9/18:c.1713+443G>A:,CP:ENST00000481169:intron_variant:MODIFIER:exon9/17:c.1713+443G>A:,CP:ENST00000494544:intron_variant:MODIFIER:exon6/15:c.1062+443G>A:,CP:ENST00000490639:intron_variant:MODIFIER:exon9/16:n.1745+443G>A:,CP:ENST00000462336:intron_variant:MODIFIER:exon1/3:n.87+443G>A:,CP:ENST00000489736:intron_variant:MODIFIER:exon5/6:n.938+443G>A:,CP:ENST00000497797:intron_variant:MODIFIER:exon2/2:n.322+443G>A:,CP:ENST00000471356:intron_variant:MODIFIER:exon2/2:n.532+443G>A:		Porphyrin and chlorophyll metabolism	Ceruloplasmin is a blue, copper-binding (6-7 atoms per molecule) glycoprotein. It has ferroxidase activity oxidizing Fe(2+) to Fe(3+) without releasing radical oxygen species. It is involved in iron transport across the cell membrane. Provides Cu(2+) ions for the ascorbate-mediated deaminase degradation of the heparan sulfate chains of GPC1. May also play a role in fetal lung development or pulmonary antioxidant defense (By similarity)				0.0000	0.0000	0.0000		117700 [CP (confirmed) Hypoceruloplasminemia,hereditary,604290|Cerebellar ataxia,604290|Hemosiderosis,systemic,due to aceruloplasminemia,604290];																			0		0.0899	89	0.0000	71
chr3	149214444	149214444	A	G	0.1923	26	0.0238	42		53	TM4SF4	intron_variant	TM4SF4:ENST00000305354:intron_variant:MODIFIER:exon3/4:c.402-2065A>G:,TM4SF4:ENST00000463068:intron_variant:MODIFIER:exon2/2:n.267-2065A>G:			Regulates the adhesive and proliferative status of intestinal epithelial cells. Can mediate density-dependent cell proliferation				0.0000	0.0000	0.0000																					0		0.1852	27	0.0238	42
chr3	155568543	155568543	T	C	0.1818	23	0.0000	26		64	SLC33A1	intron_variant	SLC33A1:ENST00000359479:intron_variant:MODIFIER:exon1/6:c.775+2469A>G:,SLC33A1:ENST00000392845:intron_variant:MODIFIER:exon1/5:c.775+2469A>G:,SLC33A1:ENST00000475842:intron_variant:MODIFIER:exon1/4:c.120+2617A>G:,SLC33A1:ENST00000468581:intron_variant:MODIFIER:exon1/4:c.94+2469A>G:,SLC33A1:ENST00000460729:intron_variant:MODIFIER:exon1/1:n.140+2469A>G:		Glycosphingolipid biosynthesis - ganglioseries	Probable acetyl-CoA transporter necessary for O- acetylation of gangliosides				0.0000	0.0000	0.0000		603690 [SLC33A1 (confirmed) Spastic paraplegia 42,autosomal dominant,612539|Congenital cataracts,hearing loss,and neurodegeneration,614482];																			0		0.1739	23	0.0000	26
chr3	158471217	158471217	A	G	0.1622	38	0.0000	27		70	MFSD1,RP11-379F4.4	intron_variant	MFSD1:ENST00000486568:intron_variant:MODIFIER:exon1/4:c.115+20900A>G:,RP11-379F4.4:ENST00000465477:intron_variant:MODIFIER:exon4/4:n.482+11284A>G:,MFSD1:ENST00000491804:intron_variant:MODIFIER:exon2/2:c.202+19391A>G:,RP11-379F4.4:ENST00000468242:intron_variant:MODIFIER:exon4/5:n.431+11284A>G:,MFSD1:ENST00000465739:intron_variant:MODIFIER:exon1/2:c.-57+5379A>G:							0.0000	0.0000	0.0000																					0		0.1842	38	0.0000	27
chr3	160219067	160219067	-	A	0.1538	48	0.0000	41		41	KPNA4	3_prime_UTR_variant	KPNA4:ENST00000334256:3_prime_UTR_variant:MODIFIER:exon17/17:c.*824dupT:			Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. Binds specifically and directly to substrates containing either a simple or bipartite NLS motif. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran- dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non- classical NLS. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non-classical NLS			rs796307536	0.0000	0.0000	0.0000																					0		0.1163	43	0.0000	36
chr3	171776117	171776117	-	A	0.1852	32	0.0000	25		41	FNDC3B	intron_variant	FNDC3B:ENST00000336824:intron_variant:MODIFIER:exon1/25:c.-29+17710dupA:,FNDC3B:ENST00000392699:intron_variant:MODIFIER:exon1/4:c.-29+18563dupA:,FNDC3B:ENST00000421757:intron_variant:MODIFIER:exon1/3:c.-29+18563dupA:,FNDC3B:ENST00000415807:intron_variant:MODIFIER:exon1/25:c.-29+18563dupA:,FNDC3B:ENST00000469491:intron_variant:MODIFIER:exon1/15:n.113+18563dupA:,FNDC3B:ENST00000423424:intron_variant:MODIFIER:exon1/3:c.-29+17710dupA:,FNDC3B:ENST00000416957:intron_variant:MODIFIER:exon1/25:c.-29+11387dupA:			May be a positive regulator of adipogenesis				0.0000	0.0000	0.0000																					0		0.0205	195	0.0000	26
chr3	172495542	172495542	A	G	0.2632	19	0.0000	21		54	ECT2	intron_variant	ECT2:ENST00000427830:intron_variant:MODIFIER:exon13/23:c.1455+3730A>G:,ECT2:ENST00000232458:intron_variant:MODIFIER:exon13/23:c.1455+3730A>G:,ECT2:ENST00000392692:intron_variant:MODIFIER:exon14/24:c.1548+3730A>G:,ECT2:ENST00000417960:intron_variant:MODIFIER:exon14/24:c.1452+3730A>G:,ECT2:ENST00000441497:intron_variant:MODIFIER:exon12/22:c.1455+3730A>G:,ECT2:ENST00000540509:intron_variant:MODIFIER:exon13/23:c.1548+3730A>G:,ECT2:ENST00000444250:intron_variant:MODIFIER:exon5/6:c.474+3730A>G:			Guanine nucleotide exchange factor (GEF) that catalyzes the exchange of GDP for GTP. Promotes guanine nucleotide exchange on the Rho family members of small GTPases, like RHOA, RHOC, RAC1 and CDC42. Required for signal transduction pathways involved in the regulation of cytokinesis. Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Regulates the translocation of RHOA from the central spindle to the equatorial region. Plays a role in the control of mitotic spindle assembly; regulates the activation of CDC42 in metaphase for the process of spindle fibers attachment to kinetochores before chromosome congression. Involved in the regulation of epithelial cell polarity; participates in the formation of epithelial tight junctions in a polarity complex PARD3-PARD6-protein kinase PRKCQ-dependent manner. Plays a role in the regulation of neurite outgrowth. Inhibits phenobarbital (PB)- induced NR1I3 nuclear translocation. Stimulates the activity of RAC1 through its association with the oncogenic PARD6A-PRKCI complex in cancer cells, thereby acting to coordinately drive tumor cell proliferation and invasion. Also stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death				0.0000	0.0000	0.0000																					0		0.2632	19	0.0000	21
chr3	176749260	176749260	T	C	0.0781	65	0.0000	80		57	TBL1XR1	intron_variant	TBL1XR1:ENST00000430069:intron_variant:MODIFIER:exon14/15:c.1416+1499A>G:,TBL1XR1:ENST00000457928:intron_variant:MODIFIER:exon14/15:c.1416+1499A>G:		Wnt signaling pathway	F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation				0.0000	0.0000	0.0000		608628 [TBL1XR1 (provisional) Mental retardation,autosomal dominant 41,616944|Pierpont syndrome,602342];																			0		0.0769	65	0.0000	80
chr3	176817843	176817843	T	C	0.1667	24	0.0000	25		60	TBL1XR1	intron_variant	TBL1XR1:ENST00000430069:intron_variant:MODIFIER:exon1/15:c.-121-1514A>G:,TBL1XR1:ENST00000457928:intron_variant:MODIFIER:exon1/15:c.-121-1514A>G:,TBL1XR1:ENST00000428970:intron_variant:MODIFIER:exon1/3:c.-203-46137A>G:,TBL1XR1:ENST00000424913:intron_variant:MODIFIER:exon1/4:c.-279-1514A>G:,TBL1XR1:ENST00000437738:intron_variant:MODIFIER:exon1/3:c.-45-35033A>G:,TBL1XR1:ENST00000431421:intron_variant:MODIFIER:exon1/3:c.-279-1514A>G:,TBL1XR1:ENST00000352800:intron_variant:MODIFIER:exon1/3:c.-45-35033A>G:,TBL1XR1:ENST00000450267:intron_variant:MODIFIER:exon1/4:c.-164-20110A>G:,TBL1XR1:ENST00000431674:intron_variant:MODIFIER:exon1/5:c.-198-1514A>G:,TBL1XR1:ENST00000422066:intron_variant:MODIFIER:exon2/5:c.-121-1514A>G:,TBL1XR1:ENST00000443315:intron_variant:MODIFIER:exon1/5:c.-240-1514A>G:,TBL1XR1:ENST00000422442:intron_variant:MODIFIER:exon1/4:c.-240-1514A>G:,TBL1XR1:ENST00000427349:intron_variant:MODIFIER:exon2/5:c.-151-1514A>G:,TBL1XR1:ENST00000413084:intron_variant:MODIFIER:exon1/5:c.-387-1514A>G:		Wnt signaling pathway	F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation				0.0000	0.0000	0.0000		608628 [TBL1XR1 (provisional) Mental retardation,autosomal dominant 41,616944|Pierpont syndrome,602342];																			0		0.1667	24	0.0000	25
chr3	176866317	176866317	T	C	0.3125	16	0.0303	34		54	TBL1XR1	intron_variant	TBL1XR1:ENST00000430069:intron_variant:MODIFIER:exon1/15:c.-122+47811A>G:,TBL1XR1:ENST00000457928:intron_variant:MODIFIER:exon1/15:c.-122+48592A>G:,TBL1XR1:ENST00000428970:intron_variant:MODIFIER:exon1/3:c.-204+47811A>G:,TBL1XR1:ENST00000424913:intron_variant:MODIFIER:exon1/4:c.-280+47811A>G:,TBL1XR1:ENST00000437738:intron_variant:MODIFIER:exon1/3:c.-46+47811A>G:,TBL1XR1:ENST00000431421:intron_variant:MODIFIER:exon1/3:c.-280+48592A>G:,TBL1XR1:ENST00000352800:intron_variant:MODIFIER:exon1/3:c.-46+48592A>G:,TBL1XR1:ENST00000450267:intron_variant:MODIFIER:exon1/4:c.-165+48592A>G:,TBL1XR1:ENST00000431674:intron_variant:MODIFIER:exon1/5:c.-199+48592A>G:,TBL1XR1:ENST00000422066:intron_variant:MODIFIER:exon2/5:c.-122+12342A>G:,TBL1XR1:ENST00000443315:intron_variant:MODIFIER:exon1/5:c.-241+47811A>G:,TBL1XR1:ENST00000422442:intron_variant:MODIFIER:exon1/4:c.-241+48592A>G:,TBL1XR1:ENST00000427349:intron_variant:MODIFIER:exon1/5:c.-238-17080A>G:,TBL1XR1:ENST00000413084:intron_variant:MODIFIER:exon1/5:c.-388+48592A>G:		Wnt signaling pathway	F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation				0.0000	0.0000	0.0000		608628 [TBL1XR1 (provisional) Mental retardation,autosomal dominant 41,616944|Pierpont syndrome,602342];																			0		0.3125	16	0.0833	36
chr3	176897943	176897943	T	C	0.1667	24	0.0000	22		60	TBL1XR1	intron_variant	TBL1XR1:ENST00000430069:intron_variant:MODIFIER:exon1/15:c.-122+16185A>G:,TBL1XR1:ENST00000457928:intron_variant:MODIFIER:exon1/15:c.-122+16966A>G:,TBL1XR1:ENST00000428970:intron_variant:MODIFIER:exon1/3:c.-204+16185A>G:,TBL1XR1:ENST00000424913:intron_variant:MODIFIER:exon1/4:c.-280+16185A>G:,TBL1XR1:ENST00000437738:intron_variant:MODIFIER:exon1/3:c.-46+16185A>G:,TBL1XR1:ENST00000431421:intron_variant:MODIFIER:exon1/3:c.-280+16966A>G:,TBL1XR1:ENST00000352800:intron_variant:MODIFIER:exon1/3:c.-46+16966A>G:,TBL1XR1:ENST00000450267:intron_variant:MODIFIER:exon1/4:c.-165+16966A>G:,TBL1XR1:ENST00000431674:intron_variant:MODIFIER:exon1/5:c.-199+16966A>G:,TBL1XR1:ENST00000422066:intron_variant:MODIFIER:exon1/5:c.-240+16966A>G:,TBL1XR1:ENST00000443315:intron_variant:MODIFIER:exon1/5:c.-241+16185A>G:,TBL1XR1:ENST00000422442:intron_variant:MODIFIER:exon1/4:c.-241+16966A>G:,TBL1XR1:ENST00000427349:intron_variant:MODIFIER:exon1/5:c.-239+16966A>G:,TBL1XR1:ENST00000413084:intron_variant:MODIFIER:exon1/5:c.-388+16966A>G:		Wnt signaling pathway	F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation				0.0000	0.0000	0.0000		608628 [TBL1XR1 (provisional) Mental retardation,autosomal dominant 41,616944|Pierpont syndrome,602342];																			0		0.1667	24	0.0000	22
chr3	176899186	176899186	T	C	0.2941	70	0.1111	72		53	TBL1XR1	intron_variant	TBL1XR1:ENST00000430069:intron_variant:MODIFIER:exon1/15:c.-122+14942A>G:,TBL1XR1:ENST00000457928:intron_variant:MODIFIER:exon1/15:c.-122+15723A>G:,TBL1XR1:ENST00000428970:intron_variant:MODIFIER:exon1/3:c.-204+14942A>G:,TBL1XR1:ENST00000424913:intron_variant:MODIFIER:exon1/4:c.-280+14942A>G:,TBL1XR1:ENST00000437738:intron_variant:MODIFIER:exon1/3:c.-46+14942A>G:,TBL1XR1:ENST00000431421:intron_variant:MODIFIER:exon1/3:c.-280+15723A>G:,TBL1XR1:ENST00000352800:intron_variant:MODIFIER:exon1/3:c.-46+15723A>G:,TBL1XR1:ENST00000450267:intron_variant:MODIFIER:exon1/4:c.-165+15723A>G:,TBL1XR1:ENST00000431674:intron_variant:MODIFIER:exon1/5:c.-199+15723A>G:,TBL1XR1:ENST00000422066:intron_variant:MODIFIER:exon1/5:c.-240+15723A>G:,TBL1XR1:ENST00000443315:intron_variant:MODIFIER:exon1/5:c.-241+14942A>G:,TBL1XR1:ENST00000422442:intron_variant:MODIFIER:exon1/4:c.-241+15723A>G:,TBL1XR1:ENST00000427349:intron_variant:MODIFIER:exon1/5:c.-239+15723A>G:,TBL1XR1:ENST00000413084:intron_variant:MODIFIER:exon1/5:c.-388+15723A>G:		Wnt signaling pathway	F-box-like protein involved in the recruitment of the ubiquitin/19S proteasome complex to nuclear receptor-regulated transcription units. Plays an essential role in transcription activation mediated by nuclear receptors. Probably acts as integral component of the N-Cor corepressor complex that mediates the recruitment of the 19S proteasome complex, leading to the subsequent proteasomal degradation of N-Cor complex, thereby allowing cofactor exchange, and transcription activation				0.0000	0.0000	0.0000		608628 [TBL1XR1 (provisional) Mental retardation,autosomal dominant 41,616944|Pierpont syndrome,602342];																			0		0.2857	70	0.1111	72
chr3	183399775	183399775	-	A	0.1429	43	0.0000	35		43	KLHL24	3_prime_UTR_variant	KLHL24:ENST00000454652:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2707dupA:			Specifically reduces kainate receptor-mediated currents in hippocampal neurons, most probably by modulating channel properties (By similarity)				0.0000	0.0000	0.0000		611295 [KLHL24 (provisional) Epidermolysis bullosa simplex,generalized,with scarring and hair loss,617294];																			0		0.0976	41	0.0000	37
chr3	183401583	183401583	-	T	0.3810	26	0.0000	28		47	KLHL24	3_prime_UTR_variant	KLHL24:ENST00000454652:3_prime_UTR_variant:MODIFIER:exon9/9:c.*4517dupT:			Specifically reduces kainate receptor-mediated currents in hippocampal neurons, most probably by modulating channel properties (By similarity)				0.0000	0.0000	0.0000		611295 [KLHL24 (provisional) Epidermolysis bullosa simplex,generalized,with scarring and hair loss,617294];																			0		0.2632	19	0.0000	29
chr3	186721438	186721438	A	G	0.2400	26	0.0513	39		57	ST6GAL1	intron_variant	ST6GAL1:ENST00000169298:intron_variant:MODIFIER:exon2/7:c.-182-35092A>G:,ST6GAL1:ENST00000457772:intron_variant:MODIFIER:exon2/6:c.-218-35092A>G:,ST6GAL1:ENST00000455441:intron_variant:MODIFIER:exon2/3:c.-87+39724A>G:,ST6GAL1:ENST00000427315:intron_variant:MODIFIER:exon1/3:c.-86-47599A>G:,ST6GAL1:ENST00000458216:intron_variant:MODIFIER:exon2/4:c.-232-35092A>G:,ST6GAL1:ENST00000430309:intron_variant:MODIFIER:exon2/3:c.-182-35092A>G:,ST6GAL1:ENST00000417392:intron_variant:MODIFIER:exon2/3:c.-182-35092A>G:,ST6GAL1:ENST00000438590:intron_variant:MODIFIER:exon1/2:c.-183+28560A>G:,ST6GAL1:ENST00000448408:intron_variant:MODIFIER:exon2/3:c.-183+6977A>G:,ST6GAL1:ENST00000485105:intron_variant:MODIFIER:exon1/1:n.53-2492A>G:		N-Glycan biosynthesis;Glycan structures - biosynthesis 1	Transfers sialic acid from the donor of substrate CMP- sialic acid to galactose containing acceptor substrates				0.0000	0.0000	0.0000																					0		0.2692	26	0.0513	39
chr3	187885207	187885207	A	G	0.2174	23	0.0313	34		51	LPP	intron_variant	LPP:ENST00000448637:intron_variant:MODIFIER:exon1/6:c.-67+14056A>G:,LPP:ENST00000416784:intron_variant:MODIFIER:exon1/4:c.-10+13398A>G:,LPP:ENST00000430340:intron_variant:MODIFIER:exon1/3:c.-217+13398A>G:,LPP:ENST00000414139:intron_variant:MODIFIER:exon1/3:c.-133+13398A>G:,LPP:ENST00000454789:intron_variant:MODIFIER:exon1/3:c.-67+13398A>G:			May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus				0.0000	0.0000	0.0000		600700 [LPP (provisional) Lipoma|Leukemia,acute myeloid,601626];																			0		0.2174	23	0.0588	34
chr3	187918137	187918137	A	G	0.0952	42	0.0000	37		53	LPP	intron_variant	LPP:ENST00000448637:intron_variant:MODIFIER:exon1/6:c.-67+46986A>G:,LPP:ENST00000416784:intron_variant:MODIFIER:exon1/4:c.-10+46328A>G:,LPP:ENST00000430340:intron_variant:MODIFIER:exon1/3:c.-216-25056A>G:,LPP:ENST00000414139:intron_variant:MODIFIER:exon1/3:c.-132-25056A>G:,LPP:ENST00000454789:intron_variant:MODIFIER:exon1/3:c.-67+46328A>G:			May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus				0.0000	0.0000	0.0000		600700 [LPP (provisional) Lipoma|Leukemia,acute myeloid,601626];																			0		0.0952	42	0.0000	37
chr3	187932180	187932180	A	G	0.1081	37	0.0000	40		52	LPP	intron_variant	LPP:ENST00000312675:intron_variant:MODIFIER:exon1/10:c.-133+1346A>G:,LPP:ENST00000448637:intron_variant:MODIFIER:exon1/6:c.-67+61029A>G:,LPP:ENST00000416784:intron_variant:MODIFIER:exon1/4:c.-10+60371A>G:,LPP:ENST00000430340:intron_variant:MODIFIER:exon1/3:c.-216-11013A>G:,LPP:ENST00000414139:intron_variant:MODIFIER:exon1/3:c.-132-11013A>G:,LPP:ENST00000454789:intron_variant:MODIFIER:exon1/3:c.-67+60371A>G:,LPP:ENST00000426274:intron_variant:MODIFIER:exon1/3:c.-67+6074A>G:,LPP:ENST00000420410:intron_variant:MODIFIER:exon1/3:c.-10+1561A>G:,LPP:ENST00000443217:intron_variant:MODIFIER:exon1/2:c.-133+1561A>G:			May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus				0.0000	0.0000	0.0000		600700 [LPP (provisional) Lipoma|Leukemia,acute myeloid,601626];																			0		0.1081	37	0.0000	40
chr3	187978645	187978645	A	G	0.4286	35	0.0962	52		61	LPP	intron_variant	LPP:ENST00000312675:intron_variant:MODIFIER:exon2/10:c.-10+35330A>G:,LPP:ENST00000448637:intron_variant:MODIFIER:exon1/6:c.-66-80806A>G:,LPP:ENST00000416784:intron_variant:MODIFIER:exon1/4:c.-10+106836A>G:,LPP:ENST00000430340:intron_variant:MODIFIER:exon2/3:c.-94+35330A>G:,LPP:ENST00000414139:intron_variant:MODIFIER:exon2/3:c.-10+35330A>G:,LPP:ENST00000454789:intron_variant:MODIFIER:exon1/3:c.-66-80806A>G:,LPP:ENST00000426274:intron_variant:MODIFIER:exon1/3:c.-67+52539A>G:,LPP:ENST00000420410:intron_variant:MODIFIER:exon1/3:c.-10+48026A>G:,LPP:ENST00000443217:intron_variant:MODIFIER:exon2/2:c.-10+35330A>G:,LPP:ENST00000543006:intron_variant:MODIFIER:exon1/10:c.-67+35330A>G:,LPP:ENST00000457242:intron_variant:MODIFIER:exon1/1:c.-10+20695A>G:			May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus				0.0000	0.0000	0.0000		600700 [LPP (provisional) Lipoma|Leukemia,acute myeloid,601626];																			0		0.4286	35	0.0962	52
chr3	188501066	188501066	A	G	0.0714	42	0.0000	34		53	LPP	intron_variant	LPP:ENST00000312675:intron_variant:MODIFIER:exon8/10:c.1410+22996A>G:,LPP:ENST00000543006:intron_variant:MODIFIER:exon8/10:c.1410+22996A>G:,LPP:ENST00000459897:intron_variant:MODIFIER:exon3/3:n.438+22996A>G:			May play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. May be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. Also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus				0.0000	0.0000	0.0000		600700 [LPP (provisional) Lipoma|Leukemia,acute myeloid,601626];																			0		0.0714	42	0.0000	34
chr3	190022484	190022484	T	G	0.3077	26	0.0000	23		59	NMNAT1P3-CLDN1	intergenic_region	NMNAT1P3-CLDN1:ENSG00000238077-ENSG00000163347:intergenic_region:MODIFIER::n.190022484T>G:						rs9290926	0.17472	0.0000	0.0000																					0		0.3077	26	0.0000	23
chr3	190022516	190022516	A	T	0.3333	21	0.0000	23		56	NMNAT1P3-CLDN1	intergenic_region	NMNAT1P3-CLDN1:ENSG00000238077-ENSG00000163347:intergenic_region:MODIFIER::n.190022516A>T:						rs9290927	0.17492	0.0000	0.0000																					0		0.3333	21	0.0000	23
chr3	195139339	195139339	T	C	0.1818	22	0.0000	23		58	ACAP2	intron_variant	ACAP2:ENST00000326793:intron_variant:MODIFIER:exon1/22:c.53+24185A>G:,ACAP2:ENST00000480906:intron_variant:MODIFIER:exon1/6:n.249+24185A>G:,ACAP2:ENST00000481463:intron_variant:MODIFIER:exon1/6:n.127+23540A>G:,ACAP2:ENST00000439666:intron_variant:MODIFIER:exon1/2:c.-22+24185A>G:,ACAP2:ENST00000447662:intron_variant:MODIFIER:exon1/5:c.54-5694A>G:			GTPase-activating protein (GAP) for ADP ribosylation factor 6 (ARF6)				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	23
chr3	195426490	195426490	A	G	0.2273	44	0.0476	43		60	LINC00969	intron_variant	LINC00969:ENST00000451982:intron_variant:MODIFIER:exon5/5:n.675+412A>G:,LINC00969:ENST00000602127:intron_variant:MODIFIER:exon5/5:n.653-8515A>G:,LINC00969:ENST00000597034:intron_variant:MODIFIER:exon4/4:n.597-8515A>G:,LINC00969:ENST00000599448:intron_variant:MODIFIER:exon3/3:n.645+412A>G:,LINC00969:ENST00000597482:intron_variant:MODIFIER:exon5/5:n.1271+412A>G:,LINC00969:ENST00000420851:intron_variant:MODIFIER:exon2/4:n.515-8515A>G:,LINC00969:ENST00000594715:intron_variant:MODIFIER:exon2/2:n.394+412A>G:,LINC00969:ENST00000431767:intron_variant:MODIFIER:exon1/3:n.152-8515A>G:,LINC00969:ENST00000451228:intron_variant:MODIFIER:exon1/3:n.65-8515A>G:,LINC00969:ENST00000608737:intron_variant:MODIFIER:exon1/3:n.169+412A>G:,LINC00969:ENST00000438608:intron_variant:MODIFIER:exon1/3:n.60+412A>G:						rs3107775	0.0000	0.0000	0.0000																					0		0.2273	44	0.0465	43
chr3	197003917	197003917	T	C	0.4545	11	0.0370	27		44	DLG1	intron_variant	DLG1:ENST00000346964:intron_variant:MODIFIER:exon4/25:c.318+5633A>G:,DLG1:ENST00000314062:intron_variant:MODIFIER:exon4/23:c.318+5633A>G:,DLG1:ENST00000357674:intron_variant:MODIFIER:exon4/24:c.318+5633A>G:,DLG1:ENST00000419354:intron_variant:MODIFIER:exon4/25:c.318+5633A>G:,DLG1:ENST00000422288:intron_variant:MODIFIER:exon3/22:c.318+5633A>G:,DLG1:ENST00000448528:intron_variant:MODIFIER:exon4/25:c.318+5633A>G:,DLG1:ENST00000450955:intron_variant:MODIFIER:exon3/23:c.318+5633A>G:,DLG1:ENST00000392382:intron_variant:MODIFIER:exon4/24:c.318+5633A>G:,DLG1:ENST00000419227:intron_variant:MODIFIER:exon4/14:c.318+5633A>G:,DLG1:ENST00000392381:intron_variant:MODIFIER:exon4/18:c.318+5633A>G:,DLG1:ENST00000471733:intron_variant:MODIFIER:exon4/16:n.445+5633A>G:,DLG1:ENST00000456699:intron_variant:MODIFIER:exon4/5:c.318+5633A>G:,DLG1:ENST00000392380:intron_variant:MODIFIER:exon4/6:c.318+5633A>G:,DLG1:ENST00000485409:intron_variant:MODIFIER:exon3/3:n.403+5633A>G:,DLG1:ENST00000419553:intron_variant:MODIFIER:exon4/4:c.318+5633A>G:,DLG1:ENST00000436682:intron_variant:MODIFIER:exon4/4:c.318+5633A>G:			Essential multidomain scaffolding protein required for normal development (By similarity). Recruits channels, receptors and signaling molecules to discrete plasma membrane domains in polarized cells. May play a role in adherens junction assembly, signal transduction, cell proliferation, synaptogenesis and lymphocyte activation. Regulates the excitability of cardiac myocytes by modulating the functional expression of Kv4 channels. Functional regulator of Kv1.5 channel				0.0000	0.0000	0.0000																					0		0.4545	11	0.0370	27
chr4	53876	53876	C	G	0.3333	12	0.0000	17		37	ZNF595	intron_variant	ZNF595:ENST00000526473:intron_variant:MODIFIER:exon1/3:c.3+491C>G:,ZNF595:ENST00000339368:intron_variant:MODIFIER:exon1/3:n.207+491C>G:,ZNF595:ENST00000507368:intron_variant:MODIFIER:exon1/1:n.206+491C>G:,ZNF595:ENST00000512065:intron_variant:MODIFIER:exon1/2:n.197+491C>G:,ZNF595:ENST00000509152:intron_variant:MODIFIER:exon1/3:c.3+491C>G:,ZNF595:ENST00000502981:intron_variant:MODIFIER:exon1/2:n.163+491C>G:			May be involved in transcriptional regulation			rs11722397	0.0000	0.0000	0.0000																					0		0.3333	12	0.0000	17
chr4	65136	65136	T	G	0.2381	42	0.0889	45		53	ZNF595	intron_variant	ZNF595:ENST00000339368:intron_variant:MODIFIER:exon3/3:n.430+5090T>G:,ZNF595:ENST00000507368:intron_variant:MODIFIER:exon1/1:n.206+11751T>G:,ZNF595:ENST00000512065:intron_variant:MODIFIER:exon2/2:n.324+5687T>G:,ZNF595:ENST00000509152:intron_variant:MODIFIER:exon3/3:c.227-2596T>G:			May be involved in transcriptional regulation			rs3884777	0.0000	0.0000	0.0000																					0		0.2381	42	0.0889	45
chr4	769053	769053	T	C	0.0930	43	0.0000	49		53	RP11-440L14.1	intron_variant	RP11-440L14.1:ENST00000503571:intron_variant:MODIFIER:exon1/1:n.78+6507A>G:,RP11-440L14.1:ENST00000507446:intron_variant:MODIFIER:exon1/1:n.59+6507A>G:							0.0000	0.0000	0.0000																					0		0.0930	43	0.0000	49
chr4	770422	770422	T	C	0.1143	35	0.0000	33		57	RP11-440L14.1	intron_variant	RP11-440L14.1:ENST00000503571:intron_variant:MODIFIER:exon1/1:n.78+5138A>G:,RP11-440L14.1:ENST00000507446:intron_variant:MODIFIER:exon1/1:n.59+5138A>G:							0.0000	0.0000	0.0000																					0		0.1143	35	0.0000	33
chr4	772610	772610	T	C	0.4000	10	0.0000	16		33	RP11-440L14.1	intron_variant	RP11-440L14.1:ENST00000503571:intron_variant:MODIFIER:exon1/1:n.78+2950A>G:,RP11-440L14.1:ENST00000507446:intron_variant:MODIFIER:exon1/1:n.59+2950A>G:							0.0000	0.0000	0.0000																					0		0.4000	10	0.0000	16
chr4	2841359	2841359	A	G	0.1087	46	0.0000	52		69	SH3BP2	3_prime_UTR_variant	SH3BP2:ENST00000503393:3_prime_UTR_variant:MODIFIER:exon13/13:c.*5798A>G:,SH3BP2:ENST00000442312:3_prime_UTR_variant:MODIFIER:exon13/13:c.*5798A>G:,SH3BP2:ENST00000356331:3_prime_UTR_variant:MODIFIER:exon13/13:c.*5798A>G:		Natural killer cell mediated cytotoxicity	Binds differentially to the SH3 domains of certain proteins of signal transduction pathways. Binds to phosphatidylinositols; linking the hemopoietic tyrosine kinase fes to the cytoplasmic membrane in a phosphorylation dependent mechanism				0.0000	0.0000	0.0000		602104 [SH3BP2 (confirmed) Cherubism,118400];																			0		0.0889	45	0.0000	52
chr4	8019637	8019637	T	C	0.1852	27	0.0000	31		68	ABLIM2	intron_variant	ABLIM2:ENST00000447017:intron_variant:MODIFIER:exon14/20:c.1423+1708A>G:,ABLIM2:ENST00000512594:intron_variant:MODIFIER:exon2/6:n.678+1708A>G:,ABLIM2:ENST00000361737:intron_variant:MODIFIER:exon12/16:c.1202-8808A>G:,ABLIM2:ENST00000296372:intron_variant:MODIFIER:exon13/17:c.1324+1708A>G:,ABLIM2:ENST00000318888:intron_variant:MODIFIER:exon13/19:c.526+1708A>G:,ABLIM2:ENST00000545242:intron_variant:MODIFIER:exon13/16:c.1324+1708A>G:,ABLIM2:ENST00000546334:intron_variant:MODIFIER:exon12/16:c.1202-8808A>G:,ABLIM2:ENST00000514025:intron_variant:MODIFIER:exon8/14:c.526+1708A>G:,ABLIM2:ENST00000341937:intron_variant:MODIFIER:exon13/19:c.1324+1708A>G:,ABLIM2:ENST00000361581:intron_variant:MODIFIER:exon13/17:c.1324+1708A>G:,ABLIM2:ENST00000407564:intron_variant:MODIFIER:exon11/15:c.1169-8808A>G:,ABLIM2:ENST00000505872:intron_variant:MODIFIER:exon11/17:c.1169-8808A>G:,ABLIM2:ENST00000428004:intron_variant:MODIFIER:exon12/13:c.1202-8808A>G:,ABLIM2:ENST00000510277:intron_variant:MODIFIER:exon10/11:c.727+1708A>G:		Axon guidance	May act as scaffold protein. May stimulate ABRA activity and ABRA-dependent SRF transcriptional activity				0.0000	0.0000	0.0000																					0		0.1852	27	0.0000	31
chr4	39459817	39459817	-	T	0.6364	357	0.0653	449		87	RPL9	frameshift_variant,non_coding_transcript_exon_variant	RPL9:ENST00000295955:frameshift_variant:HIGH:exon3/8:c.158dupA:p.Arg54fs,RPL9:ENST00000449470:frameshift_variant:HIGH:exon2/7:c.158dupA:p.Arg54fs,RPL9:ENST00000508595:frameshift_variant:HIGH:exon2/7:c.146dupA:p.Arg50fs,RPL9:ENST00000503040:frameshift_variant:HIGH:exon3/7:c.158dupA:p.Arg54fs,RPL9:ENST00000504470:frameshift_variant:HIGH:exon3/7:c.158dupA:p.Arg54fs,RPL9:ENST00000503277:non_coding_transcript_exon_variant:MODIFIER:exon1/6:n.244dupA:,RPL9:ENST00000514842:non_coding_transcript_exon_variant:MODIFIER:exon2/6:n.620dupA:,RPL9:ENST00000511075:non_coding_transcript_exon_variant:MODIFIER:exon3/5:n.200dupA:,RPL9:ENST00000437992:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.268dupA:		Ribosome					0.0000	0.0000	0.0000																					0		0.0423	355	0.0460	457
chr4	39550649	39550649	T	C	0.1538	26	0.0000	20		58	SMIM14,UGDH-AS1	3_prime_UTR_variant,intron_variant	SMIM14:ENST00000295958:3_prime_UTR_variant:MODIFIER:exon5/5:c.*3097A>G:,UGDH-AS1:ENST00000504032:intron_variant:MODIFIER:exon2/4:n.482+16899T>C:							0.0000	0.0000	0.0000																					0		0.1538	26	0.0000	21
chr4	39627274	39627274	T	C	0.3750	8	0.0000	16		33	SMIM14	intron_variant	SMIM14:ENST00000295958:intron_variant:MODIFIER:exon1/4:c.-36+13085A>G:,SMIM14:ENST00000511809:intron_variant:MODIFIER:exon1/3:c.-36+13085A>G:,SMIM14:ENST00000510628:intron_variant:MODIFIER:exon1/3:n.68+12509A>G:,SMIM14:ENST00000507613:intron_variant:MODIFIER:exon1/3:c.-36+13085A>G:,SMIM14:ENST00000505729:intron_variant:MODIFIER:exon1/4:c.-181+13085A>G:							0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	16
chr4	39725869	39725869	A	G	0.2273	22	0.0238	42		60	UBE2K	intron_variant	UBE2K:ENST00000261427:intron_variant:MODIFIER:exon1/6:c.64-13171A>G:,UBE2K:ENST00000510934:intron_variant:MODIFIER:exon1/4:c.64-13171A>G:,UBE2K:ENST00000295963:intron_variant:MODIFIER:exon1/4:c.64-13171A>G:,UBE2K:ENST00000513231:intron_variant:MODIFIER:exon1/5:n.253-21503A>G:,UBE2K:ENST00000438068:intron_variant:MODIFIER:exon1/6:n.165-13171A>G:,UBE2K:ENST00000503368:intron_variant:MODIFIER:exon1/4:c.63+25859A>G:,UBE2K:ENST00000445950:intron_variant:MODIFIER:exon1/5:c.64-13171A>G:,UBE2K:ENST00000510719:intron_variant:MODIFIER:exon1/3:c.63+25859A>G:		Ubiquitin mediated proteolysis;Huntington's disease	Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro, in the presence or in the absence of BRCA1-BARD1 E3 ubiquitin-protein ligase complex, catalyzes the synthesis of 'Lys-48'-linked polyubiquitin chains. Does not transfer ubiquitin directly to but elongates monoubiquitinated substrate protein. Mediates the selective degradation of short-lived and abnormal proteins, such as the endoplasmic reticulum-associated degradation (ERAD) of misfolded lumenal proteins. Ubiquitinates huntingtin. May mediate foam cell formation by the suppression of apoptosis of lipid-bearing macrophages through ubiquitination and subsequence degradation of p53/TP53. Proposed to be involved in ubiquitination and proteolytic processing of NF-kappa-B; in vitro supports ubiquitination of NFKB1. In case of infection by cytomegaloviruses may be involved in the US11-dependent degradation of MHC class I heavy chains following their export from the ER to the cytosol. In case of viral infections may be involved in the HPV E7 protein- dependent degradation of RB1				0.0000	0.0000	0.0000																					0		0.2273	22	0.0238	42
chr4	40626006	40626006	T	C	0.3636	12	0.0000	16		33	RBM47	intron_variant	RBM47:ENST00000295971:intron_variant:MODIFIER:exon1/6:c.-240+5407A>G:,RBM47:ENST00000319592:intron_variant:MODIFIER:exon1/5:c.-240+5407A>G:,RBM47:ENST00000510871:intron_variant:MODIFIER:exon1/6:c.-240+5407A>G:,RBM47:ENST00000514014:intron_variant:MODIFIER:exon1/5:c.-99+6474A>G:,RBM47:ENST00000515053:intron_variant:MODIFIER:exon1/3:c.-240+6119A>G:,RBM47:ENST00000505414:intron_variant:MODIFIER:exon2/3:c.-155+6474A>G:,RBM47:ENST00000514782:intron_variant:MODIFIER:exon1/3:c.-240+5989A>G:,RBM47:ENST00000511598:intron_variant:MODIFIER:exon2/4:c.-240+6474A>G:,RBM47:ENST00000511902:intron_variant:MODIFIER:exon1/2:c.-155+6474A>G:,RBM47:ENST00000505220:intron_variant:MODIFIER:exon1/3:c.-240+6474A>G:,RBM47:ENST00000513044:intron_variant:MODIFIER:exon1/1:n.134+5407A>G:							0.0000	0.0000	0.0000																					0		0.3333	12	0.0000	16
chr4	56280382	56280382	A	G	0.2778	18	0.0286	35		63	TMEM165	intron_variant	TMEM165:ENST00000381334:intron_variant:MODIFIER:exon2/5:c.433+2376A>G:,TMEM165:ENST00000506198:intron_variant:MODIFIER:exon1/2:c.208-10323A>G:,TMEM165:ENST00000508404:intron_variant:MODIFIER:exon3/6:c.*305+2376A>G:,TMEM165:ENST00000542052:intron_variant:MODIFIER:exon3/6:c.244+2376A>G:,TMEM165:ENST00000511710:intron_variant:MODIFIER:exon2/2:n.557+2376A>G:			May function as a calcium/proton transporter involved in calcium and in lysosomal pH homeostasis. Therefore, it may play an indirect role in protein glycosylation				0.0000	0.0000	0.0000		614726 [TMEM165 (provisional) Congenital disorder of glycosylation,type IIk,614727];																			0		0.2778	18	0.0286	35
chr4	56280979	56280979	-	T	0.2727	23	0.0000	37		55	TMEM165	intron_variant	TMEM165:ENST00000381334:intron_variant:MODIFIER:exon2/5:c.434-2254dupT:,TMEM165:ENST00000506198:intron_variant:MODIFIER:exon1/2:c.208-9720dupT:,TMEM165:ENST00000508404:intron_variant:MODIFIER:exon3/6:c.*306-2254dupT:,TMEM165:ENST00000542052:intron_variant:MODIFIER:exon3/6:c.245-2254dupT:,TMEM165:ENST00000511710:intron_variant:MODIFIER:exon2/2:n.558-2254dupT:			May function as a calcium/proton transporter involved in calcium and in lysosomal pH homeostasis. Therefore, it may play an indirect role in protein glycosylation				0.0000	0.0000	0.0000		614726 [TMEM165 (provisional) Congenital disorder of glycosylation,type IIk,614727];																			0		0.0755	53	0.0000	33
chr4	57318110	57318110	-	A	0.0909	66	0.0000	52		41	PAICS	frameshift_variant	PAICS:ENST00000399688:frameshift_variant:HIGH:exon8/10:c.871dupA:p.Ile291fs,PAICS:ENST00000514888:frameshift_variant:HIGH:exon8/10:c.574dupA:p.Ile192fs,PAICS:ENST00000264221:frameshift_variant:HIGH:exon8/10:c.850dupA:p.Ile284fs,PAICS:ENST00000505164:frameshift_variant:HIGH:exon8/10:c.850dupA:p.Ile284fs,PAICS:ENST00000512576:frameshift_variant:HIGH:exon7/9:c.850dupA:p.Ile284fs		Purine metabolism					0.0000	0.0000	0.0000																					0		0.0735	68	0.0000	51
chr4	71663935	71663935	A	G	0.1923	26	0.0000	18		56	RUFY3	intron_variant	RUFY3:ENST00000381006:intron_variant:MODIFIER:exon14/17:c.1558-1923A>G:,RUFY3:ENST00000502653:intron_variant:MODIFIER:exon15/18:c.1399-1923A>G:,RUFY3:ENST00000504805:intron_variant:MODIFIER:exon5/5:c.*84-1923A>G:,RUFY3:ENST00000512103:intron_variant:MODIFIER:exon2/4:c.132-1923A>G:,RUFY3:ENST00000507333:intron_variant:MODIFIER:exon2/3:n.130-1923A>G:,RUFY3:ENST00000503025:intron_variant:MODIFIER:exon1/4:n.223-1923A>G:			Implicated in the formation of a single axon by developing neurons. May inhibit the formation of additional axons by inhibition of PI3K in minor neuronal processes (By similarity)				0.0000	0.0000	0.0000																					0		0.1923	26	0.0000	18
chr4	71976141	71976141	T	C	0.2143	28	0.0000	22		65	DCK-SLC4A4	intergenic_region	DCK-SLC4A4:ENSG00000156136-ENSG00000080493:intergenic_region:MODIFIER::n.71976141T>C:							0.0000	0.0000	0.0000																					0		0.2143	28	0.0000	23
chr4	71994487	71994487	T	C	0.1818	22	0.0000	17		52	DCK-SLC4A4	intergenic_region	DCK-SLC4A4:ENSG00000156136-ENSG00000080493:intergenic_region:MODIFIER::n.71994487T>C:							0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	17
chr4	72014215	72014215	T	C	0.1290	31	0.0000	14		53	DCK-SLC4A4	intergenic_region	DCK-SLC4A4:ENSG00000156136-ENSG00000080493:intergenic_region:MODIFIER::n.72014215T>C:							0.0000	0.0000	0.0000																					0		0.1290	31	0.0000	14
chr4	79788251	79788251	A	G	0.2105	19	0.0333	30		53	BMP2K	intron_variant	BMP2K:ENST00000335016:intron_variant:MODIFIER:exon10/15:c.1231+1377A>G:,BMP2K:ENST00000389010:intron_variant:MODIFIER:exon11/14:c.*207+1377A>G:,BMP2K:ENST00000502871:intron_variant:MODIFIER:exon10/13:c.1231+1377A>G:,BMP2K:ENST00000502613:intron_variant:MODIFIER:exon3/8:c.307+1377A>G:			May be involved in osteoblast differentiation				0.0000	0.0000	0.0000																					0		0.2105	19	0.0333	30
chr4	95445339	95445339	A	G	0.4000	11	0.0000	22		50	PDLIM5	intron_variant	PDLIM5:ENST00000514743:intron_variant:MODIFIER:exon2/15:c.248+313A>G:,PDLIM5:ENST00000450793:intron_variant:MODIFIER:exon3/8:c.248+313A>G:,PDLIM5:ENST00000538141:intron_variant:MODIFIER:exon3/8:c.248+313A>G:,PDLIM5:ENST00000318007:intron_variant:MODIFIER:exon3/9:c.248+313A>G:,PDLIM5:ENST00000380180:intron_variant:MODIFIER:exon3/8:c.248+313A>G:,PDLIM5:ENST00000437932:intron_variant:MODIFIER:exon3/12:c.248+313A>G:,PDLIM5:ENST00000317968:intron_variant:MODIFIER:exon3/12:c.248+313A>G:,PDLIM5:ENST00000514830:intron_variant:MODIFIER:exon3/5:n.378+313A>G:,PDLIM5:ENST00000509333:intron_variant:MODIFIER:exon3/3:n.358+313A>G:,PDLIM5:ENST00000503974:intron_variant:MODIFIER:exon3/14:c.248+313A>G:,PDLIM5:ENST00000542407:intron_variant:MODIFIER:exon2/11:c.-118-49163A>G:,PDLIM5:ENST00000508216:intron_variant:MODIFIER:exon2/7:c.248+313A>G:,PDLIM5:ENST00000511767:intron_variant:MODIFIER:exon2/2:n.270+313A>G:,PDLIM5:ENST00000510099:intron_variant:MODIFIER:exon2/3:n.188+313A>G:,PDLIM5:ENST00000509357:intron_variant:MODIFIER:exon1/4:c.152+313A>G:,PDLIM5:ENST00000513341:intron_variant:MODIFIER:exon1/5:c.149+313A>G:,PDLIM5:ENST00000508531:intron_variant:MODIFIER:exon1/4:n.45+313A>G:			May play an important role in the heart development by scaffolding PKC to the Z-disk region. May play a role in the regulation of cardiomyocyte expansion. Overexpression promotes the development of heart hypertrophy. Contributes to the regulation of dendritic spine morphogenesis in neurons. May restrain postsynaptic growth of excitatory synapses (By similarity)				0.0000	0.0000	0.0000																					0		0.3636	11	0.0000	22
chr4	125590576	125590576	-	T	0.2857	26	0.0000	28		51	ANKRD50	frameshift_variant	ANKRD50:ENST00000504087:frameshift_variant:HIGH:exon4/5:c.3855dupA:p.Ala1286fs,ANKRD50:ENST00000515641:frameshift_variant:HIGH:exon3/4:c.3318dupA:p.Ala1107fs						rs760525425	0.0000	0.00001	0.00000																					0		0.2400	25	0.0000	26
chr4	153426990	153426990	T	C	0.4545	11	0.0000	19		41	FBXW7	intron_variant	FBXW7:ENST00000281708:intron_variant:MODIFIER:exon1/11:c.-70+29103A>G:,FBXW7:ENST00000603548:intron_variant:MODIFIER:exon1/12:c.-120+29103A>G:,FBXW7:ENST00000604872:intron_variant:MODIFIER:exon2/3:c.-120+29103A>G:		Neurodegenerative Diseases;Ubiquitin mediated proteolysis	Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins. Involved in the degradation of cyclin-E, MYC, NOTCH1 released notch intracellular domain (NICD), and probably PSEN1	Cyclin E Destruction Pathway			0.0000	0.0000	0.0000																					0		0.4545	11	0.0000	19
chr4	155486381	155486381	C	T	0.1091	55	0.0000	39		66	FGB	3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	FGB:ENST00000425838:3_prime_UTR_variant:MODIFIER:exon2/5:c.*20C>T:,FGB:ENST00000302068:intron_variant:MODIFIER:exon1/7:c.115-579C>T:,FGB:ENST00000497097:intron_variant:MODIFIER:exon1/2:n.122-579C>T:,FGB:ENST00000509493:intron_variant:MODIFIER:exon1/5:c.-168+2097C>T:,FGB:ENST00000502545:intron_variant:MODIFIER:exon1/6:n.96-579C>T:,FGB:ENST00000498375:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.166C>T:		Complement and coagulation cascades	Fibrinogen has a double function: yielding monomers that polymerize into fibrin and acting as a cofactor in platelet aggregation	Acute Myocardial Infarction;Extrinsic Prothrombin Activation Pathway;Fibrinolysis Pathway;Intrinsic Prothrombin Activation Pathway		rs2227401	0.161342	0.18463	0.17431		134830 [FGB (confirmed) Dysfibrinogenemia,congenital,616004|Afibrinogenemia,congenital,202400|Hypofibrinogenemia,congenital,202400];																			0		0.1071	56	0.0000	39
chr5	236696	236696	G	A	0.0513	117	0.0000	165		84	SDHA	missense_variant,non_coding_transcript_exon_variant	SDHA:ENST00000264932:missense_variant:MODERATE:exon10/15:c.1414G>A:p.Glu472Lys,SDHA:ENST00000504309:missense_variant:MODERATE:exon10/13:c.1414G>A:p.Glu472Lys,SDHA:ENST00000510361:missense_variant:MODERATE:exon9/14:c.1270G>A:p.Glu424Lys,SDHA:ENST00000515815:missense_variant:MODERATE:exon1/4:c.67G>A:p.Glu23Lys,SDHA:ENST00000505555:non_coding_transcript_exon_variant:MODIFIER:exon10/13:n.1454G>A:,SDHA:ENST00000514027:non_coding_transcript_exon_variant:MODIFIER:exon5/10:n.1369G>A:,SDHA:ENST00000515752:non_coding_transcript_exon_variant:MODIFIER:exon3/8:n.1000G>A:,SDHA:ENST00000511810:non_coding_transcript_exon_variant:MODIFIER:exon1/6:n.2161G>A:		Citrate cycle (TCA cycle);Oxidative phosphorylation	Flavoprotein (FP) subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q). Can act as a tumor suppressor	Electron Transport Reaction in Mitochondria		rs143798161	0.000599042	0.00091	0.00006		600857 [SDHA (confirmed) Leigh syndrome,256000|Mitochondrial respiratory chain complex II deficiency,252011|Cardiomyopathy,dilated,1GG,613642|Paragangliomas 5,614165];	RCV000409873.1 [uncertain significance]; 		9.454000	T	T,T,T,T	B,B,B,B,B	T,T,T	23.00											0		0.0775	129	0.0057	174
chr5	14179937	14179937	A	G	0.2632	19	0.0000	21		54	TRIO	intron_variant	TRIO:ENST00000344204:intron_variant:MODIFIER:exon1/56:c.157+35946A>G:,TRIO:ENST00000505971:intron_variant:MODIFIER:exon1/3:n.181+35946A>G:,TRIO:ENST00000502816:intron_variant:MODIFIER:exon1/4:n.181+35946A>G:,TRIO:ENST00000537187:intron_variant:MODIFIER:exon1/57:c.157+35946A>G:,TRIO:ENST00000512070:intron_variant:MODIFIER:exon1/56:c.-21+35946A>G:			Promotes the exchange of GDP by GTP. Together with leukocyte antigen-related (LAR) protein, it could play a role in coordinating cell-matrix and cytoskeletal rearrangements necessary for cell migration and cell growth	Rac 1 cell motility signaling pathway			0.0000	0.0000	0.0000		601893 [TRIO (provisional) Mental retardation,autosomal dominant 44,617061];																			0		0.2632	19	0.0000	21
chr5	14424603	14424603	G	A	0.1379	29	0.0000	35		52	TRIO	intron_variant	TRIO:ENST00000344204:intron_variant:MODIFIER:exon34/56:c.5203+4473G>A:,TRIO:ENST00000537187:intron_variant:MODIFIER:exon34/57:c.5203+4473G>A:,TRIO:ENST00000512070:intron_variant:MODIFIER:exon34/56:c.5026+4473G>A:,TRIO:ENST00000513206:intron_variant:MODIFIER:exon30/50:c.4402+4473G>A:,TRIO:ENST00000515144:intron_variant:MODIFIER:exon29/42:n.4121+4473G>A:			Promotes the exchange of GDP by GTP. Together with leukocyte antigen-related (LAR) protein, it could play a role in coordinating cell-matrix and cytoskeletal rearrangements necessary for cell migration and cell growth	Rac 1 cell motility signaling pathway			0.0000	0.0000	0.0000		601893 [TRIO (provisional) Mental retardation,autosomal dominant 44,617061];																			0		0.1429	28	0.0000	35
chr5	32246491	32246491	T	C	0.3750	8	0.0000	17		36	MTMR12	intron_variant	MTMR12:ENST00000382142:intron_variant:MODIFIER:exon10/15:c.1021+1617A>G:,MTMR12:ENST00000280285:intron_variant:MODIFIER:exon10/14:c.1021+1617A>G:,MTMR12:ENST00000264934:intron_variant:MODIFIER:exon10/13:c.1021+1617A>G:,MTMR12:ENST00000504049:intron_variant:MODIFIER:exon3/3:n.477+1617A>G:			Catalytically inactive phosphatase that plays a role as an adapter for the phosphatase myotubularin to regulate myotubularin intracellular location				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	17
chr5	34769014	34769014	A	G	0.2308	26	0.0000	24		67	RAI14	intron_variant	RAI14:ENST00000515799:intron_variant:MODIFIER:exon5/19:c.176+11311A>G:,RAI14:ENST00000265109:intron_variant:MODIFIER:exon3/17:c.167+11311A>G:,RAI14:ENST00000514527:intron_variant:MODIFIER:exon4/7:c.167+11311A>G:,RAI14:ENST00000510319:intron_variant:MODIFIER:exon3/6:c.*12+11295A>G:,RAI14:ENST00000513974:intron_variant:MODIFIER:exon4/6:c.167+11311A>G:,RAI14:ENST00000512629:intron_variant:MODIFIER:exon3/16:c.167+11311A>G:,RAI14:ENST00000428746:intron_variant:MODIFIER:exon3/17:c.167+11311A>G:,RAI14:ENST00000514873:intron_variant:MODIFIER:exon3/5:c.167+11311A>G:,RAI14:ENST00000508777:intron_variant:MODIFIER:exon4/14:c.151+11327A>G:,RAI14:ENST00000503673:intron_variant:MODIFIER:exon4/18:c.167+11311A>G:,RAI14:ENST00000504052:intron_variant:MODIFIER:exon3/5:c.167+11311A>G:,RAI14:ENST00000512305:intron_variant:MODIFIER:exon3/4:c.167+11311A>G:,RAI14:ENST00000514036:intron_variant:MODIFIER:exon4/5:c.167+11311A>G:,RAI14:ENST00000508315:intron_variant:MODIFIER:exon3/6:c.167+11311A>G:,RAI14:ENST00000515448:intron_variant:MODIFIER:exon4/4:c.*271+11311A>G:,RAI14:ENST00000503222:intron_variant:MODIFIER:exon3/6:c.*12+11295A>G:,RAI14:ENST00000512625:intron_variant:MODIFIER:exon3/6:c.167+11311A>G:,RAI14:ENST00000506376:intron_variant:MODIFIER:exon2/16:c.143+11311A>G:,RAI14:ENST00000507502:intron_variant:MODIFIER:exon2/2:n.252+11311A>G:,RAI14:ENST00000502736:intron_variant:MODIFIER:exon3/5:n.357+11311A>G:,RAI14:ENST00000507276:intron_variant:MODIFIER:exon2/6:n.247+11311A>G:,RAI14:ENST00000509247:intron_variant:MODIFIER:exon2/6:n.234+11295A>G:,RAI14:ENST00000397449:intron_variant:MODIFIER:exon2/16:c.146+11311A>G:							0.0000	0.0000	0.0000																					0		0.2308	26	0.0000	24
chr5	34906224	34906224	T	C	0.1081	37	0.0000	31		51	RAD1	3_prime_UTR_variant	RAD1:ENST00000382038:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2646A>G:			Component of the 9-1-1 cell-cycle checkpoint response complex that plays a major role in DNA repair. The 9-1-1 complex is recruited to DNA lesion upon damage by the RAD17-replication factor C (RFC) clamp loader complex. Acts then as a sliding clamp platform on DNA for several proteins involved in long-patch base excision repair (LP-BER). The 9-1-1 complex stimulates DNA polymerase beta (POLB) activity by increasing its affinity for the 3'-OH end of the primer-template and stabilizes POLB to those sites where LP-BER proceeds; endonuclease FEN1 cleavage activity on substrates with double, nick, or gap flaps of distinct sequences and lengths; and DNA ligase I (LIG1) on long-patch base excision repair substrates. The 9-1-1 complex is necessary for the recruitment of RHNO1 to sites of double-stranded breaks (DSB) occurring during the S phase. Isoform 1 possesses 3'->5' double stranded DNA exonuclease activity	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility			0.0000	0.0000	0.0000																					0		0.1053	38	0.0000	31
chr5	52388186	52388186	G	A	0.1429	28	0.0000	35		61	ITGA2	3_prime_UTR_variant	ITGA2:ENST00000296585:3_prime_UTR_variant:MODIFIER:exon30/30:c.*1757G>A:		Focal adhesion;ECM-receptor interaction;Hematopoietic cell lineage;Regulation of actin cytoskeleton;Small cell lung cancer	Integrin alpha-2/beta-1 is a receptor for laminin, collagen, collagen C-propeptides, fibronectin and E-cadherin. It recognizes the proline-hydroxylated sequence G-F-P-G-E-R in collagen. It is responsible for adhesion of platelets and other cells to collagens, modulation of collagen and collagenase gene expression, force generation and organization of newly synthesized extracellular matrix				0.0000	0.0000	0.0000		192974 [ITGA2 (provisional) Glycoprotein Ia deficiency,614200];																			0		0.1429	28	0.0000	35
chr5	52397307	52397307	-	T	0.4211	25	0.0000	26		46	MOCS2	frameshift_variant,3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	MOCS2:ENST00000396954:frameshift_variant:HIGH:exon5/7:c.258dupA:p.Val87fs,MOCS2:ENST00000450852:3_prime_UTR_variant:MODIFIER:exon5/7:c.*178dupA:,MOCS2:ENST00000510818:3_prime_UTR_variant:MODIFIER:exon5/7:c.*178dupA:,MOCS2:ENST00000508922:3_prime_UTR_variant:MODIFIER:exon5/6:c.*178dupA:,MOCS2:ENST00000584946:3_prime_UTR_variant:MODIFIER:exon4/6:c.*50dupA:,MOCS2:ENST00000527216:3_prime_UTR_variant:MODIFIER:exon5/6:c.*178dupA:,MOCS2:ENST00000361377:intron_variant:MODIFIER:exon4/5:c.*146+619dupA:,MOCS2:ENST00000582677:intron_variant:MODIFIER:exon3/4:c.*19-944dupA:,MOCS2:ENST00000502402:non_coding_transcript_exon_variant:MODIFIER:exon3/4:n.1181dupA:,MOCS2:ENST00000514553:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.443dupA:			Catalytic subunit of the molybdopterin synthase complex, a complex that catalyzes the conversion of precursor Z into molybdopterin. Acts by mediating the incorporation of 2 sulfur atoms from thiocarboxylated MOCS2A into precursor Z to generate a dithiolene group				0.0000	0.0000	0.0000		603708 [MOCS2 (provisional) Molybdenum cofactor deficiency B,252160];																			0		0.2381	21	0.0000	25
chr5	58814943	58814943	C	T	0.4167	12	0.0417	24		36	PDE4D	intron_variant	PDE4D:ENST00000340635:intron_variant:MODIFIER:exon1/14:c.456-303149G>A:,PDE4D:ENST00000360047:intron_variant:MODIFIER:exon1/14:c.47+67212G>A:,PDE4D:ENST00000507116:intron_variant:MODIFIER:exon1/14:c.263+249130G>A:,PDE4D:ENST00000502484:intron_variant:MODIFIER:exon3/16:c.273-303149G>A:,PDE4D:ENST00000546160:intron_variant:MODIFIER:exon2/15:c.273-303149G>A:,PDE4D:ENST00000505453:intron_variant:MODIFIER:exon1/10:c.-99+67212G>A:,PDE4D:ENST00000309641:intron_variant:MODIFIER:exon1/15:c.263+249130G>A:,PDE4D:ENST00000405053:intron_variant:MODIFIER:exon1/5:n.119-303149G>A:,PDE4D:ENST00000502575:intron_variant:MODIFIER:exon1/5:c.263+249130G>A:,PDE4D:ENST00000514231:intron_variant:MODIFIER:exon2/2:n.218+277943G>A:		Purine metabolism	Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes				0.0000	0.0000	0.0000		600129 [PDE4D (confirmed) Stroke,susceptibility to,1,606799|Acrodysostosis 2,with or without hormone resistance,614613];																			0		0.4167	12	0.0417	24
chr5	58938299	58938299	T	C	0.0962	53	0.0000	48		60	PDE4D	intron_variant	PDE4D:ENST00000340635:intron_variant:MODIFIER:exon1/14:c.455+250696A>G:,PDE4D:ENST00000507116:intron_variant:MODIFIER:exon1/14:c.263+125774A>G:,PDE4D:ENST00000502484:intron_variant:MODIFIER:exon3/16:c.272+346016A>G:,PDE4D:ENST00000546160:intron_variant:MODIFIER:exon2/15:c.272+346016A>G:,PDE4D:ENST00000309641:intron_variant:MODIFIER:exon1/15:c.263+125774A>G:,PDE4D:ENST00000405053:intron_variant:MODIFIER:exon1/5:n.118+250696A>G:,PDE4D:ENST00000502575:intron_variant:MODIFIER:exon1/5:c.263+125774A>G:,PDE4D:ENST00000514231:intron_variant:MODIFIER:exon2/2:n.218+154587A>G:,PDE4D:ENST00000512069:intron_variant:MODIFIER:exon1/2:n.218-81559A>G:		Purine metabolism	Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes				0.0000	0.0000	0.0000		600129 [PDE4D (confirmed) Stroke,susceptibility to,1,606799|Acrodysostosis 2,with or without hormone resistance,614613];																			0		0.1132	53	0.0000	48
chr5	58938544	58938544	T	C	0.0641	78	0.0000	56		53	PDE4D	intron_variant	PDE4D:ENST00000340635:intron_variant:MODIFIER:exon1/14:c.455+250451A>G:,PDE4D:ENST00000507116:intron_variant:MODIFIER:exon1/14:c.263+125529A>G:,PDE4D:ENST00000502484:intron_variant:MODIFIER:exon3/16:c.272+345771A>G:,PDE4D:ENST00000546160:intron_variant:MODIFIER:exon2/15:c.272+345771A>G:,PDE4D:ENST00000309641:intron_variant:MODIFIER:exon1/15:c.263+125529A>G:,PDE4D:ENST00000405053:intron_variant:MODIFIER:exon1/5:n.118+250451A>G:,PDE4D:ENST00000502575:intron_variant:MODIFIER:exon1/5:c.263+125529A>G:,PDE4D:ENST00000514231:intron_variant:MODIFIER:exon2/2:n.218+154342A>G:,PDE4D:ENST00000512069:intron_variant:MODIFIER:exon1/2:n.218-81804A>G:		Purine metabolism	Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes				0.0000	0.0000	0.0000		600129 [PDE4D (confirmed) Stroke,susceptibility to,1,606799|Acrodysostosis 2,with or without hormone resistance,614613];																			0		0.0641	78	0.0000	56
chr5	58977607	58977607	T	C	0.1600	25	0.0000	18		58	PDE4D	intron_variant	PDE4D:ENST00000340635:intron_variant:MODIFIER:exon1/14:c.455+211388A>G:,PDE4D:ENST00000507116:intron_variant:MODIFIER:exon1/14:c.263+86466A>G:,PDE4D:ENST00000502484:intron_variant:MODIFIER:exon3/16:c.272+306708A>G:,PDE4D:ENST00000546160:intron_variant:MODIFIER:exon2/15:c.272+306708A>G:,PDE4D:ENST00000309641:intron_variant:MODIFIER:exon1/15:c.263+86466A>G:,PDE4D:ENST00000405053:intron_variant:MODIFIER:exon1/5:n.118+211388A>G:,PDE4D:ENST00000502575:intron_variant:MODIFIER:exon1/5:c.263+86466A>G:,PDE4D:ENST00000514231:intron_variant:MODIFIER:exon2/2:n.218+115279A>G:,PDE4D:ENST00000512069:intron_variant:MODIFIER:exon1/2:n.218-120867A>G:		Purine metabolism	Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes				0.0000	0.0000	0.0000		600129 [PDE4D (confirmed) Stroke,susceptibility to,1,606799|Acrodysostosis 2,with or without hormone resistance,614613];																			0		0.1600	25	0.0000	18
chr5	62450893	62450893	A	G	0.2000	30	0.0000	18		58	RP11-586E1.1-CTD-2049O17.1	intergenic_region	RP11-586E1.1-CTD-2049O17.1:ENSG00000249579-ENSG00000248185:intergenic_region:MODIFIER::n.62450893A>G:							0.0000	0.0000	0.0000																					0		0.2000	30	0.0000	18
chr5	66291987	66291987	A	G	0.4444	9	0.0000	17		35	MAST4	intron_variant	MAST4:ENST00000404260:intron_variant:MODIFIER:exon4/28:c.675-58245A>G:,MAST4:ENST00000403625:intron_variant:MODIFIER:exon4/28:c.675-58245A>G:,MAST4:ENST00000490016:intron_variant:MODIFIER:exon3/10:c.108-58245A>G:,MAST4:ENST00000403666:intron_variant:MODIFIER:exon3/27:c.108-58245A>G:,MAST4:ENST00000405643:intron_variant:MODIFIER:exon2/27:c.128+32372A>G:,MAST4:ENST00000432426:intron_variant:MODIFIER:exon1/2:c.47+36865A>G:							0.0000	0.0000	0.0000																					0		0.4444	9	0.0000	17
chr5	70841288	70841288	A	G	0.2500	24	0.0488	42		55	BDP1	intron_variant,non_coding_transcript_exon_variant	BDP1:ENST00000358731:intron_variant:MODIFIER:exon32/38:c.6744+242A>G:,BDP1:ENST00000380675:intron_variant:MODIFIER:exon32/37:c.1152+242A>G:,BDP1:ENST00000514903:intron_variant:MODIFIER:exon9/15:c.1509+242A>G:,BDP1:ENST00000525844:intron_variant:MODIFIER:exon6/13:c.810+242A>G:,BDP1:ENST00000508917:non_coding_transcript_exon_variant:MODIFIER:exon32/32:n.7178A>G:			General activator of RNA polymerase III transcription. Requires for transcription from all three types of polymerase III promoters. Requires for transcription of genes with internal promoter elements and with promoter elements upstream of the initiation site				0.0000	0.0000	0.0000																					0		0.2500	24	0.0714	42
chr5	71492761	71492761	T	A	0.2222	9	0.0000	18		39	MAP1B	missense_variant	MAP1B:ENST00000296755:missense_variant:MODERATE:exon5/7:c.3579T>A:p.Asp1193Glu			Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B may play a role in the cytoskeletal changes that accompany neurite extension. Possibly MAP1B Binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DAPK1-mediated autophagic vesicle formation and membrane blebbing				0.0000	0.0000	0.0000					-0.064000	T	T	B,B	T	0.64											0		0.2222	9	0.0000	18
chr5	78384840	78384840	-	T	0.2222	33	0.0000	34		49	BHMT2,DMGDH	3_prime_UTR_variant,intron_variant	BHMT2:ENST00000255192:3_prime_UTR_variant:MODIFIER:exon8/8:c.*450dupT:,BHMT2:ENST00000521567:3_prime_UTR_variant:MODIFIER:exon7/7:c.*450dupT:,DMGDH:ENST00000520388:intron_variant:MODIFIER:exon4/4:n.606+15146dupA:		Glycine, serine and threonine metabolism	Involved in the regulation of homocysteine metabolism. Converts homocysteine to methionine using S-methylmethionine (SMM) as a methyl donor				0.0000	0.0000	0.0000																					0		0.1613	31	0.0000	34
chr5	85679070	85679070	T	C	0.2222	18	0.0000	23		54	CTC-261N6.2-CTD-2299E8.1	intergenic_region	CTC-261N6.2-CTD-2299E8.1:ENSG00000250124-ENSG00000251585:intergenic_region:MODIFIER::n.85679070T>C:							0.0000	0.0000	0.0000																					0		0.2222	18	0.0000	23
chr5	85679193	85679193	T	C	0.1739	24	0.0000	16		51	CTC-261N6.2-CTD-2299E8.1	intergenic_region	CTC-261N6.2-CTD-2299E8.1:ENSG00000250124-ENSG00000251585:intergenic_region:MODIFIER::n.85679193T>C:							0.0000	0.0000	0.0000																					0		0.1667	24	0.0000	15
chr5	90605479	90605479	T	C	0.0625	81	0.0000	45		61	LUCAT1	intron_variant	LUCAT1:ENST00000513492:intron_variant:MODIFIER:exon1/2:n.201+2633A>G:,LUCAT1:ENST00000511918:intron_variant:MODIFIER:exon3/4:n.596+3416A>G:						rs780085809	0.0000	0.0000	0.0000																					0		0.0617	81	0.0000	45
chr5	90606108	90606108	T	C	0.1176	34	0.0000	15		55	LUCAT1	intron_variant	LUCAT1:ENST00000513492:intron_variant:MODIFIER:exon1/2:n.201+2004A>G:,LUCAT1:ENST00000511918:intron_variant:MODIFIER:exon3/4:n.596+2787A>G:							0.0000	0.0000	0.0000																					0		0.1176	34	0.0000	15
chr5	90609488	90609488	T	C	0.0658	76	0.0000	41		60	LUCAT1,RP11-213H15.4	non_coding_transcript_exon_variant	LUCAT1:ENST00000513626:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.430A>G:,RP11-213H15.4:ENST00000607854:non_coding_transcript_exon_variant:MODIFIER:exon3/4:n.343A>G:,LUCAT1:ENST00000511918:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.411A>G:							0.0000	0.0000	0.0000																					0		0.0641	78	0.0000	45
chr5	112342747	112342747	A	G	0.2500	28	0.0444	45		61	DCP2	intron_variant	DCP2:ENST00000389063:intron_variant:MODIFIER:exon8/10:c.943-888A>G:,DCP2:ENST00000515408:intron_variant:MODIFIER:exon8/9:c.942+2973A>G:,DCP2:ENST00000513585:intron_variant:MODIFIER:exon6/8:c.886-888A>G:,DCP2:ENST00000543319:intron_variant:MODIFIER:exon6/8:c.310-888A>G:,DCP2:ENST00000512751:intron_variant:MODIFIER:exon5/5:c.*170-888A>G:,DCP2:ENST00000508359:intron_variant:MODIFIER:exon4/4:n.469-888A>G:			Decapping metalloenzyme that catalyzes the cleavage of the cap structure on mRNAs. Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP. Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. Plays a role in replication-dependent histone mRNA degradation. Has higher activity towards mRNAs that lack a poly(A) tail. Has no activity towards a cap structure lacking a RNA moiety				0.0000	0.0000	0.0000																					0		0.2500	28	0.0444	45
chr5	121366448	121366448	-	T	0.2333	32	0.0000	34		50	SRFBP1	intron_variant	SRFBP1:ENST00000504881:intron_variant:MODIFIER:exon2/2:n.311+8353dupT:			May be involved in regulating transcriptional activation of cardiac genes during the aging process. May play a role in biosynthesis and/or processing of SLC2A4 in adipose cells (By similarity)				0.0000	0.0000	0.0000																					0		0.1471	34	0.0000	38
chr5	121698792	121698792	A	G	0.2500	40	0.0000	37		84	SNCAIP	intron_variant	SNCAIP:ENST00000261367:intron_variant:MODIFIER:exon1/13:c.-1350-25470A>G:,SNCAIP:ENST00000514467:intron_variant:MODIFIER:exon1/3:c.-46-27992A>G:,SNCAIP:ENST00000510658:intron_variant:MODIFIER:exon1/9:c.-46-27992A>G:,SNCAIP:ENST00000542191:intron_variant:MODIFIER:exon1/9:c.-375-27992A>G:,SNCAIP:ENST00000506272:intron_variant:MODIFIER:exon1/4:c.-46-27992A>G:,SNCAIP:ENST00000508681:intron_variant:MODIFIER:exon1/3:c.-46-27992A>G:,SNCAIP:ENST00000509154:intron_variant:MODIFIER:exon2/9:c.-47+26193A>G:,SNCAIP:ENST00000261368:intron_variant:MODIFIER:exon1/10:c.-46-27992A>G:,SNCAIP:ENST00000512385:intron_variant:MODIFIER:exon1/9:c.-46-27992A>G:,SNCAIP:ENST00000379533:intron_variant:MODIFIER:exon1/12:c.-46-27992A>G:,SNCAIP:ENST00000379536:intron_variant:MODIFIER:exon1/9:c.-46-27992A>G:,SNCAIP:ENST00000379538:intron_variant:MODIFIER:exon1/9:c.-92-27992A>G:,SNCAIP:ENST00000514497:intron_variant:MODIFIER:exon2/4:c.-47+26193A>G:,SNCAIP:ENST00000510003:intron_variant:MODIFIER:exon1/6:n.49-27992A>G:,SNCAIP:ENST00000414317:intron_variant:MODIFIER:exon1/7:c.-74-27992A>G:,SNCAIP:ENST00000509023:intron_variant:MODIFIER:exon1/7:c.-46-27992A>G:,SNCAIP:ENST00000508017:intron_variant:MODIFIER:exon1/8:c.-46-27992A>G:,SNCAIP:ENST00000509652:intron_variant:MODIFIER:exon2/2:c.-47+26193A>G:		Parkinson's disease	Isoform 2 inhibits the ubiquitin ligase activity of SIAH1 and inhibits proteasomal degradation of target proteins. Isoform 2 inhibits autoubiquitination and proteasomal degradation of SIAH1, and thereby increases cellular levels of SIAH. Isoform 2 modulates SNCA monoubiquitination by SIAH1	Role of Parkin in the Ubiquitin-Proteasomal Pathway			0.0000	0.0000	0.0000																					0		0.2500	40	0.0000	37
chr5	121705369	121705369	-	T	0.1333	107	0.0000	57		47	SNCAIP	intron_variant	SNCAIP:ENST00000261367:intron_variant:MODIFIER:exon1/13:c.-1350-18884dupT:,SNCAIP:ENST00000514467:intron_variant:MODIFIER:exon1/3:c.-46-21406dupT:,SNCAIP:ENST00000510658:intron_variant:MODIFIER:exon1/9:c.-46-21406dupT:,SNCAIP:ENST00000542191:intron_variant:MODIFIER:exon1/9:c.-375-21406dupT:,SNCAIP:ENST00000506272:intron_variant:MODIFIER:exon1/4:c.-46-21406dupT:,SNCAIP:ENST00000508681:intron_variant:MODIFIER:exon1/3:c.-46-21406dupT:,SNCAIP:ENST00000509154:intron_variant:MODIFIER:exon2/9:c.-46-21406dupT:,SNCAIP:ENST00000261368:intron_variant:MODIFIER:exon1/10:c.-46-21406dupT:,SNCAIP:ENST00000512385:intron_variant:MODIFIER:exon1/9:c.-46-21406dupT:,SNCAIP:ENST00000379533:intron_variant:MODIFIER:exon1/12:c.-46-21406dupT:,SNCAIP:ENST00000379536:intron_variant:MODIFIER:exon1/9:c.-46-21406dupT:,SNCAIP:ENST00000379538:intron_variant:MODIFIER:exon1/9:c.-92-21406dupT:,SNCAIP:ENST00000514497:intron_variant:MODIFIER:exon2/4:c.-46-21406dupT:,SNCAIP:ENST00000510003:intron_variant:MODIFIER:exon1/6:n.49-21406dupT:,SNCAIP:ENST00000414317:intron_variant:MODIFIER:exon1/7:c.-74-21406dupT:,SNCAIP:ENST00000509023:intron_variant:MODIFIER:exon1/7:c.-46-21406dupT:,SNCAIP:ENST00000508017:intron_variant:MODIFIER:exon1/8:c.-46-21406dupT:,SNCAIP:ENST00000509652:intron_variant:MODIFIER:exon2/2:c.-46-21406dupT:		Parkinson's disease	Isoform 2 inhibits the ubiquitin ligase activity of SIAH1 and inhibits proteasomal degradation of target proteins. Isoform 2 inhibits autoubiquitination and proteasomal degradation of SIAH1, and thereby increases cellular levels of SIAH. Isoform 2 modulates SNCA monoubiquitination by SIAH1	Role of Parkin in the Ubiquitin-Proteasomal Pathway			0.0000	0.0000	0.0000																					0		0.0889	90	0.0000	192
chr5	121719081	121719081	A	G	0.1154	52	0.0000	22		61	SNCAIP,CTD-2280E9.1	intron_variant	SNCAIP:ENST00000261367:intron_variant:MODIFIER:exon1/13:c.-1350-5181A>G:,CTD-2280E9.1:ENST00000507143:intron_variant:MODIFIER:exon1/3:n.99+84T>C:,SNCAIP:ENST00000514467:intron_variant:MODIFIER:exon1/3:c.-46-7703A>G:,SNCAIP:ENST00000510658:intron_variant:MODIFIER:exon1/9:c.-46-7703A>G:,SNCAIP:ENST00000542191:intron_variant:MODIFIER:exon1/9:c.-375-7703A>G:,SNCAIP:ENST00000506272:intron_variant:MODIFIER:exon1/4:c.-46-7703A>G:,SNCAIP:ENST00000508681:intron_variant:MODIFIER:exon1/3:c.-46-7703A>G:,SNCAIP:ENST00000509154:intron_variant:MODIFIER:exon2/9:c.-46-7703A>G:,SNCAIP:ENST00000261368:intron_variant:MODIFIER:exon1/10:c.-46-7703A>G:,SNCAIP:ENST00000512385:intron_variant:MODIFIER:exon1/9:c.-46-7703A>G:,SNCAIP:ENST00000379533:intron_variant:MODIFIER:exon1/12:c.-46-7703A>G:,SNCAIP:ENST00000379536:intron_variant:MODIFIER:exon1/9:c.-46-7703A>G:,SNCAIP:ENST00000379538:intron_variant:MODIFIER:exon1/9:c.-92-7703A>G:,SNCAIP:ENST00000514497:intron_variant:MODIFIER:exon2/4:c.-46-7703A>G:,SNCAIP:ENST00000510003:intron_variant:MODIFIER:exon1/6:n.49-7703A>G:,SNCAIP:ENST00000414317:intron_variant:MODIFIER:exon1/7:c.-74-7703A>G:,SNCAIP:ENST00000509023:intron_variant:MODIFIER:exon1/7:c.-46-7703A>G:,SNCAIP:ENST00000508017:intron_variant:MODIFIER:exon1/8:c.-46-7703A>G:,SNCAIP:ENST00000509652:intron_variant:MODIFIER:exon2/2:c.-46-7703A>G:		Parkinson's disease	Isoform 2 inhibits the ubiquitin ligase activity of SIAH1 and inhibits proteasomal degradation of target proteins. Isoform 2 inhibits autoubiquitination and proteasomal degradation of SIAH1, and thereby increases cellular levels of SIAH. Isoform 2 modulates SNCA monoubiquitination by SIAH1	Role of Parkin in the Ubiquitin-Proteasomal Pathway		rs112249848	0.17472	0.0000	0.0000																					0		0.1636	55	0.0000	22
chr5	131799947	131799947	A	G	0.1379	30	0.0000	13		53	C5orf56	intron_variant	C5orf56:ENST00000378953:intron_variant:MODIFIER:exon3/3:c.89-11412A>G:,C5orf56:ENST00000407797:intron_variant:MODIFIER:exon3/3:c.89-5785A>G:							0.0000	0.0000	0.0000		147575 [IRF1 (confirmed) Myelodysplastic syndrome,preleukemic|Myelogenous leukemia,acute|Gastric cancer,somatic,613659|Nonsmall cell lung cancer,somatic,211980];																			0		0.1333	30	0.0000	13
chr5	132296709	132296709	T	C	0.1905	21	0.0000	18		53	AFF4	intron_variant	AFF4:ENST00000265343:intron_variant:MODIFIER:exon1/20:c.-5+2242A>G:,AFF4:ENST00000378595:intron_variant:MODIFIER:exon1/12:c.-5+2242A>G:,AFF4:ENST00000491831:intron_variant:MODIFIER:exon1/6:n.256+2242A>G:,AFF4:ENST00000465484:intron_variant:MODIFIER:exon1/4:n.255+2242A>G:			Key component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. In the SEC complex, AFF4 acts as a central scaffold that recruits other factors through direct interactions with ELL proteins (ELL, ELL2 or ELL3) and the P-TEFb complex. In case of infection by HIV-1 virus, the SEC complex is recruited by the viral Tat protein to stimulate viral gene expression				0.0000	0.0000	0.0000		604417 [AFF4 (provisional) CHOPS syndrome,616368];																			0		0.1905	21	0.0000	18
chr5	134183854	134183854	A	G	0.1739	23	0.0000	17		53	C5orf24,DDX46	intron_variant	C5orf24:ENST00000338051:intron_variant:MODIFIER:exon1/1:c.-4+2427A>G:,DDX46:ENST00000507053:intron_variant:MODIFIER:exon4/4:c.*84-6734A>G:,C5orf24:ENST00000394976:intron_variant:MODIFIER:exon1/1:c.-4+1952A>G:,C5orf24:ENST00000504727:intron_variant:MODIFIER:exon1/2:c.-4+1952A>G:,C5orf24:ENST00000435259:intron_variant:MODIFIER:exon2/2:c.-4+1301A>G:,C5orf24:ENST00000508791:intron_variant:MODIFIER:exon1/1:c.-4+1301A>G:			Plays an essential role in splicing, either prior to, or during splicing A complex formation				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	17
chr5	138099213	138099213	A	G	0.1538	29	0.0000	40		55	CTNNA1	intron_variant	CTNNA1:ENST00000302763:intron_variant:MODIFIER:exon1/17:c.-3+10014A>G:,CTNNA1:ENST00000517980:intron_variant:MODIFIER:exon3/5:c.-2-18399A>G:,CTNNA1:ENST00000522227:intron_variant:MODIFIER:exon2/4:c.-2-18399A>G:,CTNNA1:ENST00000524127:intron_variant:MODIFIER:exon2/3:c.-2-18399A>G:,CTNNA1:ENST00000523912:intron_variant:MODIFIER:exon1/3:c.-3+10353A>G:,CTNNA1:ENST00000520339:intron_variant:MODIFIER:exon2/3:c.-3+8361A>G:,CTNNA1:ENST00000355078:intron_variant:MODIFIER:exon1/16:c.-116+10014A>G:,CTNNA1:ENST00000521724:intron_variant:MODIFIER:exon1/16:c.-3+10014A>G:,CTNNA1:ENST00000518910:intron_variant:MODIFIER:exon1/3:c.-9+10014A>G:,CTNNA1:ENST00000519309:intron_variant:MODIFIER:exon1/6:c.-3+10014A>G:,CTNNA1:ENST00000519113:intron_variant:MODIFIER:exon1/3:c.-3+9426A>G:,CTNNA1:ENST00000520158:intron_variant:MODIFIER:exon1/5:c.-3+9086A>G:		Adherens junction;Tight junction;Leukocyte transendothelial migration;Endometrial cancer	Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical actin was found to be much more dynamic than E-cadherin/catenin complexes and CTNNA1 was shown not to bind to F-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. The homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the Arp2/3 complex for binding to actin filaments. May play a crucial role in cell differentiation	Cell to Cell Adhesion Signaling			0.0000	0.0000	0.0000		116805 [CTNNA1 (confirmed) Macular dystrophy,patterned,2,608970];																			0		0.2414	29	0.0000	40
chr5	138099247	138099247	A	G	0.1176	34	0.0000	36		57	CTNNA1	intron_variant	CTNNA1:ENST00000302763:intron_variant:MODIFIER:exon1/17:c.-3+10048A>G:,CTNNA1:ENST00000517980:intron_variant:MODIFIER:exon3/5:c.-2-18365A>G:,CTNNA1:ENST00000522227:intron_variant:MODIFIER:exon2/4:c.-2-18365A>G:,CTNNA1:ENST00000524127:intron_variant:MODIFIER:exon2/3:c.-2-18365A>G:,CTNNA1:ENST00000523912:intron_variant:MODIFIER:exon1/3:c.-3+10387A>G:,CTNNA1:ENST00000520339:intron_variant:MODIFIER:exon2/3:c.-3+8395A>G:,CTNNA1:ENST00000355078:intron_variant:MODIFIER:exon1/16:c.-116+10048A>G:,CTNNA1:ENST00000521724:intron_variant:MODIFIER:exon1/16:c.-3+10048A>G:,CTNNA1:ENST00000518910:intron_variant:MODIFIER:exon1/3:c.-9+10048A>G:,CTNNA1:ENST00000519309:intron_variant:MODIFIER:exon1/6:c.-3+10048A>G:,CTNNA1:ENST00000519113:intron_variant:MODIFIER:exon1/3:c.-3+9460A>G:,CTNNA1:ENST00000520158:intron_variant:MODIFIER:exon1/5:c.-3+9120A>G:		Adherens junction;Tight junction;Leukocyte transendothelial migration;Endometrial cancer	Associates with the cytoplasmic domain of a variety of cadherins. The association of catenins to cadherins produces a complex which is linked to the actin filament network, and which seems to be of primary importance for cadherins cell-adhesion properties. Can associate with both E- and N-cadherins. Originally believed to be a stable component of E-cadherin/catenin adhesion complexes and to mediate the linkage of cadherins to the actin cytoskeleton at adherens junctions. In contrast, cortical actin was found to be much more dynamic than E-cadherin/catenin complexes and CTNNA1 was shown not to bind to F-actin when assembled in the complex suggesting a different linkage between actin and adherens junctions components. The homodimeric form may regulate actin filament assembly and inhibit actin branching by competing with the Arp2/3 complex for binding to actin filaments. May play a crucial role in cell differentiation	Cell to Cell Adhesion Signaling		rs146216693	0.000599042	0.0000	0.0000		116805 [CTNNA1 (confirmed) Macular dystrophy,patterned,2,608970];																			0		0.1176	34	0.0000	36
chr5	138981754	138981754	A	G	0.2857	23	0.0323	32		58	UBE2D2	intron_variant	UBE2D2:ENST00000398733:intron_variant:MODIFIER:exon2/6:c.88+1734A>G:,UBE2D2:ENST00000511725:intron_variant:MODIFIER:exon2/6:c.1+1734A>G:,UBE2D2:ENST00000253815:intron_variant:MODIFIER:exon3/7:c.1+1734A>G:,UBE2D2:ENST00000505007:intron_variant:MODIFIER:exon3/6:c.1+1734A>G:,UBE2D2:ENST00000510470:intron_variant:MODIFIER:exon2/2:n.156+1734A>G:,UBE2D2:ENST00000398734:intron_variant:MODIFIER:exon2/7:c.88+1734A>G:,UBE2D2:ENST00000505548:intron_variant:MODIFIER:exon2/6:c.1+1734A>G:,UBE2D2:ENST00000511691:intron_variant:MODIFIER:exon1/4:n.32+1734A>G:		Ubiquitin mediated proteolysis	Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys- 48'-linked polyubiquitination. Mediates the selective degradation of short-lived and abnormal proteins. Functions in the E6/E6-AP- induced ubiquitination of p53/TP53. Mediates ubiquitination of PEX5 and autoubiquitination of STUB1 and TRAF6. Involved in the signal-induced conjugation and subsequent degradation of NFKBIA, FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent degradation of p53/TP53 and the activation of MAVS in the mitochondria by DDX58/RIG-I in response to viral infection. Essential for viral activation of IRF3				0.0000	0.0000	0.0000																					0		0.3043	23	0.0312	32
chr5	140066302	140066302	T	C	0.3529	17	0.0000	24		58	HARS	intron_variant	HARS:ENST00000504156:intron_variant:MODIFIER:exon2/12:c.181-3498A>G:,HARS:ENST00000457527:intron_variant:MODIFIER:exon2/12:c.181-3498A>G:,HARS:ENST00000431330:intron_variant:MODIFIER:exon2/9:c.180+4138A>G:,HARS:ENST00000448240:intron_variant:MODIFIER:exon2/11:c.-306-3498A>G:,HARS:ENST00000307633:intron_variant:MODIFIER:exon2/11:c.180+4138A>G:,HARS:ENST00000438307:intron_variant:MODIFIER:exon2/11:c.180+4138A>G:,HARS:ENST00000415192:intron_variant:MODIFIER:exon2/10:c.181-3498A>G:,HARS:ENST00000506579:intron_variant:MODIFIER:exon2/6:n.217+4138A>G:,HARS:ENST00000507746:intron_variant:MODIFIER:exon2/6:c.181-3498A>G:,HARS:ENST00000512396:intron_variant:MODIFIER:exon2/5:c.181-3050A>G:,HARS:ENST00000518126:intron_variant:MODIFIER:exon2/3:n.216-3498A>G:,HARS:ENST00000502888:intron_variant:MODIFIER:exon2/2:n.173-3498A>G:		Histidine metabolism;Aminoacyl-tRNA biosynthesis				rs185440931	0.000798722	0.0000	0.0000		142810 [HARS (provisional) Usher syndrome type 3B,614504|Charcot-Marie-Tooth disease,axonal,type 2W,616625];																			0		0.3529	17	0.0000	24
chr5	142658896	142658896	-	T	0.0667	91	0.0000	80		42	NR3C1	3_prime_UTR_variant	NR3C1:ENST00000394464:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2557dupA:,NR3C1:ENST00000343796:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2557dupA:,NR3C1:ENST00000415690:3_prime_UTR_variant:MODIFIER:exon9/9:c.*32dupA:		Neuroactive ligand-receptor interaction	Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth. Involved in chromatin remodeling. Plays a significant role in transactivation	Corticosteroids and cardioprotection;NFkB activation by Nontypeable Hemophilus influenzae;Visceral Fat Deposits and the Metabolic Syndrome			0.0000	0.0000	0.0000		138040 [NR3C1 (confirmed) Glucocorticoid resistance,615962];																			0		0.0513	78	0.0000	69
chr5	142692037	142692037	T	C	0.2308	41	0.0500	40		55	NR3C1	intron_variant	NR3C1:ENST00000231509:intron_variant:MODIFIER:exon3/8:c.1354+1527A>G:,NR3C1:ENST00000394464:intron_variant:MODIFIER:exon3/8:c.1351+1530A>G:,NR3C1:ENST00000343796:intron_variant:MODIFIER:exon3/8:c.1351+1530A>G:,NR3C1:ENST00000415690:intron_variant:MODIFIER:exon3/8:c.1351+1530A>G:,NR3C1:ENST00000424646:intron_variant:MODIFIER:exon3/8:c.1273+1530A>G:,NR3C1:ENST00000504572:intron_variant:MODIFIER:exon4/9:c.1354+1527A>G:,NR3C1:ENST00000394466:intron_variant:MODIFIER:exon3/8:c.1354+1527A>G:,NR3C1:ENST00000416954:intron_variant:MODIFIER:exon2/7:c.160+1530A>G:,NR3C1:ENST00000503201:intron_variant:MODIFIER:exon3/8:c.1351+1530A>G:,NR3C1:ENST00000504336:intron_variant:MODIFIER:exon2/3:n.291+1530A>G:		Neuroactive ligand-receptor interaction	Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth. Involved in chromatin remodeling. Plays a significant role in transactivation	Corticosteroids and cardioprotection;NFkB activation by Nontypeable Hemophilus influenzae;Visceral Fat Deposits and the Metabolic Syndrome			0.0000	0.0000	0.0000		138040 [NR3C1 (confirmed) Glucocorticoid resistance,615962];																			0		0.2683	41	0.0500	40
chr5	142746379	142746379	-	A	0.1818	23	0.0000	32		43	NR3C1	intron_variant	NR3C1:ENST00000231509:intron_variant:MODIFIER:exon2/8:c.1184+32841dupT:,NR3C1:ENST00000394464:intron_variant:MODIFIER:exon2/8:c.1184+32841dupT:,NR3C1:ENST00000343796:intron_variant:MODIFIER:exon2/8:c.1184+32841dupT:,NR3C1:ENST00000415690:intron_variant:MODIFIER:exon2/8:c.1184+32841dupT:,NR3C1:ENST00000424646:intron_variant:MODIFIER:exon2/8:c.1106+32841dupT:,NR3C1:ENST00000504572:intron_variant:MODIFIER:exon3/9:c.1184+32841dupT:,NR3C1:ENST00000394466:intron_variant:MODIFIER:exon2/8:c.1184+32841dupT:,NR3C1:ENST00000416954:intron_variant:MODIFIER:exon1/7:c.-8+37561dupT:,NR3C1:ENST00000503201:intron_variant:MODIFIER:exon2/8:c.1184+32841dupT:,NR3C1:ENST00000504336:intron_variant:MODIFIER:exon1/3:n.124+23063dupT:		Neuroactive ligand-receptor interaction	Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth. Involved in chromatin remodeling. Plays a significant role in transactivation	Corticosteroids and cardioprotection;NFkB activation by Nontypeable Hemophilus influenzae;Visceral Fat Deposits and the Metabolic Syndrome			0.0000	0.0000	0.0000		138040 [NR3C1 (confirmed) Glucocorticoid resistance,615962];																			0		0.1818	22	0.0000	136
chr5	145526382	145526382	T	C	0.1852	27	0.0000	28		69	LARS	intron_variant	LARS:ENST00000394434:intron_variant:MODIFIER:exon15/31:c.1504-2110A>G:,LARS:ENST00000545646:intron_variant:MODIFIER:exon14/30:c.1366-2110A>G:,LARS:ENST00000274562:intron_variant:MODIFIER:exon14/30:c.1423-2110A>G:,LARS:ENST00000510191:intron_variant:MODIFIER:exon14/30:c.1342-2110A>G:,LARS:ENST00000508667:intron_variant:MODIFIER:exon2/5:n.166-2110A>G:,LARS:ENST00000507095:intron_variant:MODIFIER:exon2/5:n.125-2110A>G:		Valine, leucine and isoleucine biosynthesis;Aminoacyl-tRNA biosynthesis	Catalyzes the specific attachment of an amino acid to its cognate tRNA in a two step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. Exhibits a post-transfer editing activity to hydrolyze mischarged tRNAs				0.0000	0.0000	0.0000		151350 [LARS (confirmed) Infantile liver failure syndrome 1,615438];																			0		0.1852	27	0.0000	28
chr5	148789565	148789565	A	G	0.2162	37	0.0000	46		73	MIR143HG,AC131025.8	intron_variant	MIR143HG:ENST00000602964:intron_variant:MODIFIER:exon1/1:n.200+2924A>G:,AC131025.8:ENST00000518014:intron_variant:MODIFIER:exon1/1:n.1196-160A>G:,MIR143HG:ENST00000512096:intron_variant:MODIFIER:exon2/3:n.126+2924A>G:,MIR143HG:ENST00000523269:intron_variant:MODIFIER:exon1/2:n.201+2924A>G:,MIR143HG:ENST00000505254:intron_variant:MODIFIER:exon1/5:n.201+2924A>G:,MIR143HG:ENST00000519898:intron_variant:MODIFIER:exon1/3:n.163+2924A>G:,MIR143HG:ENST00000522358:intron_variant:MODIFIER:exon1/2:n.116+2924A>G:,MIR143HG:ENST00000505340:intron_variant:MODIFIER:exon1/1:n.115+2924A>G:,MIR143HG:ENST00000524265:intron_variant:MODIFIER:exon1/1:n.115+2924A>G:,MIR143HG:ENST00000509909:intron_variant:MODIFIER:exon1/3:n.115+2924A>G:							0.0000	0.0000	0.0000																					0		0.2162	37	0.0000	46
chr5	148927507	148927507	T	C	0.1600	25	0.0000	33		56	CSNK1A1	intron_variant	CSNK1A1:ENST00000515768:intron_variant:MODIFIER:exon2/10:c.230+2131A>G:,CSNK1A1:ENST00000261798:intron_variant:MODIFIER:exon2/9:c.230+2131A>G:,CSNK1A1:ENST00000377843:intron_variant:MODIFIER:exon2/9:c.230+2131A>G:,CSNK1A1:ENST00000504676:intron_variant:MODIFIER:exon1/8:c.-38+2131A>G:,CSNK1A1:ENST00000515435:intron_variant:MODIFIER:exon1/9:c.-38+2131A>G:,CSNK1A1:ENST00000523203:intron_variant:MODIFIER:exon2/3:c.230+2131A>G:		Wnt signaling pathway;Hedgehog signaling pathway	Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates CTNNB1 at 'Ser-45'. May play a role in segregating chromosomes during mitosis	Deregulation of CDK5 in Alzheimers Disease;Hypoxia and p53 in the Cardiovascular system;NFAT and Hypertrophy of the heart (Transcription in the broken heart);WNT Signaling Pathway			0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	33
chr5	153767564	153767564	A	G	0.1818	22	0.0000	23		59	GALNT10,SAP30L-AS1	3_prime_UTR_variant,intron_variant	GALNT10:ENST00000425427:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1529A>G:,GALNT10:ENST00000297107:intron_variant:MODIFIER:exon7/11:c.1056+1574A>G:,GALNT10:ENST00000520647:intron_variant:MODIFIER:exon8/13:c.*578+1574A>G:,GALNT10:ENST00000377661:intron_variant:MODIFIER:exon6/10:c.870+1574A>G:,SAP30L-AS1:ENST00000519727:intron_variant:MODIFIER:exon2/3:n.201+55358T>C:,GALNT10:ENST00000519544:intron_variant:MODIFIER:exon3/4:n.448+1574A>G:		O-Glycan biosynthesis;Glycan structures - biosynthesis 1	Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D- galactosamine residue to a serine or threonine residue on the protein receptor. Has activity toward Muc5Ac and EA2 peptide substrates				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	23
chr5	167923152	167923152	A	G	0.3000	10	0.0333	30		52	RARS	intron_variant	RARS:ENST00000231572:intron_variant:MODIFIER:exon6/14:c.701+711A>G:,RARS:ENST00000520013:intron_variant:MODIFIER:exon5/13:c.*202+711A>G:,RARS:ENST00000538719:intron_variant:MODIFIER:exon5/13:c.83+711A>G:		Arginine and proline metabolism;Aminoacyl-tRNA biosynthesis	Forms part of a macromolecular complex that catalyzes the attachment of specific amino acids to cognate tRNAs during protein synthesis. Modulates the secretion of AIMP1 and may be involved in generation of the inflammatory cytokine EMAP2 from AIMP1				0.0000	0.0000	0.0000		107820 [RARS (confirmed) Leukodystrophy,hypomyelinating,9,616140];																			0		0.3000	10	0.0333	30
chr5	175816651	175816651	-	T	0.0714	83	0.0000	70		41	HIGD2A,ARL10	3_prime_UTR_variant,intron_variant	HIGD2A:ENST00000274787:3_prime_UTR_variant:MODIFIER:exon2/2:c.*159dupT:,ARL10:ENST00000514533:intron_variant:MODIFIER:exon1/1:c.133-12085dupT:			Proposed subunit of cytochrome c oxidase (COX, complex IV), which is the terminal component of the mitochondrial respiratory chain that catalyzes the reduction of oxygen to water. May be involved in cytochrome c oxidase activity. May play a role in the assembly of respiratory supercomplexes				0.0000	0.0000	0.0000																					0		0.0513	78	0.0000	67
chr5	177644603	177644603	T	C	0.3077	14	0.0000	26		64	PHYKPL	intron_variant	PHYKPL:ENST00000308158:intron_variant:MODIFIER:exon8/12:c.928-2172A>G:,PHYKPL:ENST00000481436:intron_variant:MODIFIER:exon5/9:n.1152-2172A>G:,PHYKPL:ENST00000481811:intron_variant:MODIFIER:exon1/5:n.360-611A>G:,PHYKPL:ENST00000489262:intron_variant:MODIFIER:exon8/12:n.1992-2172A>G:,PHYKPL:ENST00000474052:intron_variant:MODIFIER:exon5/9:c.*316-2172A>G:,PHYKPL:ENST00000393488:intron_variant:MODIFIER:exon1/5:c.121-2172A>G:,PHYKPL:ENST00000493197:intron_variant:MODIFIER:exon10/13:c.*981-2172A>G:,PHYKPL:ENST00000494126:intron_variant:MODIFIER:exon7/9:n.1855-2717A>G:,PHYKPL:ENST00000510991:intron_variant:MODIFIER:exon1/3:n.382-2717A>G:,PHYKPL:ENST00000476487:intron_variant:MODIFIER:exon3/6:n.873-2172A>G:,PHYKPL:ENST00000506045:intron_variant:MODIFIER:exon2/5:c.*188-2172A>G:			Catalyzes the pyridoxal-phosphate-dependent breakdown of 5-phosphohydroxy-L-lysine, converting it to ammonia, inorganic phosphate and 2-aminoadipate semialdehyde				0.0000	0.0000	0.0000		614683 [AGXT2L2 (provisional) Phosphohydroxylysinuria,615011];																			0		0.2857	14	0.0000	26
chr6	3020788	3020788	T	C	0.1667	24	0.0000	27		57	RP1-90J20.12	non_coding_transcript_exon_variant	RP1-90J20.12:ENST00000603222:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.401T>C:							0.0000	0.0000	0.0000																					0		0.1667	24	0.0000	27
chr6	7120608	7120608	A	G	0.1000	40	0.0000	42		54	RREB1	intron_variant	RREB1:ENST00000379938:intron_variant:MODIFIER:exon1/12:c.-285+12315A>G:,RREB1:ENST00000379933:intron_variant:MODIFIER:exon1/11:c.-285+12607A>G:,RREB1:ENST00000491191:intron_variant:MODIFIER:exon1/5:c.-328+12315A>G:,RREB1:ENST00000471433:intron_variant:MODIFIER:exon1/6:c.-285+12311A>G:,RREB1:ENST00000467782:intron_variant:MODIFIER:exon1/3:c.-197+12315A>G:,RREB1:ENST00000334984:intron_variant:MODIFIER:exon1/11:c.-285+12315A>G:,RREB1:ENST00000349384:intron_variant:MODIFIER:exon1/11:c.-285+12315A>G:,RREB1:ENST00000475946:intron_variant:MODIFIER:exon1/6:n.71+11673A>G:			Transcription factor that binds specifically to the RAS- responsive elements (RRE) of gene promoters. May be involved in Ras/Raf-mediated cell differentiation by enhancing calcitonin expression. Represses the angiotensinogen gene. Negatively regulates the transcriptional activity of AR. Potentiates the transcriptional activity of NEUROD1				0.0000	0.0000	0.0000																					0		0.1000	40	0.0000	42
chr6	16391181	16391181	T	C	0.5000	6	0.0000	18		37	ATXN1	intron_variant	ATXN1:ENST00000244769:intron_variant:MODIFIER:exon7/8:c.-160-62480A>G:,ATXN1:ENST00000436367:intron_variant:MODIFIER:exon6/7:c.-160-62480A>G:			Chromatin-binding factor that repress Notch signaling in the absence of Notch intracellular domain by acting as a CBF1 corepressor. Binds to the HEY promoter and might assist, along with NCOR2, RBPJ-mediated repression. Binds RNA in vitro. May be involved in RNA metabolism. The expansion of the polyglutamine tract may alter this function				0.0000	0.0000	0.0000		601556 [ATXN1 (confirmed) Spinocerebellar ataxia 1,164400];																			0		0.5000	6	0.0000	18
chr6	28873936	28873936	T	C	0.1538	26	0.0000	21		54	TRIM27	intron_variant,non_coding_transcript_exon_variant	TRIM27:ENST00000377199:intron_variant:MODIFIER:exon7/7:c.946+1077A>G:,TRIM27:ENST00000414543:intron_variant:MODIFIER:exon4/4:c.148+1077A>G:,TRIM27:ENST00000377194:intron_variant:MODIFIER:exon7/8:c.946+1077A>G:,TRIM27:ENST00000467742:intron_variant:MODIFIER:exon1/1:n.349+1077A>G:,TRIM27:ENST00000481474:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.3849A>G:			Has a transcriptional repressor activity by cooperating with EPC1. Induces apoptosis by activating Jun N-terminal kinase and p38 kinase and also increases caspase-3-like activity independently of mitochondrial events. May function in male germ cell development. Has DNA-binding activity and preferentially bound to double-stranded DNA (By similarity). E3 ubiquitin-protein ligase that mediates ubiquitination of PIK3C2B and inhibits its activity; mediates the formation of 'Lys-48'-linked polyubiquitin chains; the function inhibits CD4 T-cell activation				0.0000	0.0000	0.0000																					0		0.1538	26	0.0000	21
chr6	30459125	30459125	G	A	0.0698	473	0.0064	627		78	HLA-E	synonymous_variant	HLA-E:ENST00000376630:synonymous_variant:LOW:exon4/8:c.822G>A:p.Glu274Glu		Cell adhesion molecules (CAMs);Antigen processing and presentation;Natural killer cell mediated cytotoxicity;Type I diabetes mellitus;Autoimmune thyroid disease;Allograft rejection;Graft-versus-host disease	Preferably binds to a peptide derived from the signal sequence of most HLA-A, -B, -C and -G molecules				0.0000	0.0000	0.0000																					0		0.1371	700	0.0177	792
chr6	31323254	31323254	G	C	0.2538	1694	0.0222	1713		720	HLA-B	synonymous_variant,non_coding_transcript_exon_variant	HLA-B:ENST00000412585:synonymous_variant:LOW:exon4/8:c.735C>G:p.Gly245Gly,HLA-B:ENST00000463574:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.326C>G:,HLA-B:ENST00000498007:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.1001C>G:		Cell adhesion molecules (CAMs);Antigen processing and presentation;Natural killer cell mediated cytotoxicity;Type I diabetes mellitus;Autoimmune thyroid disease;Allograft rejection;Graft-versus-host disease	Involved in the presentation of foreign antigens to the immune system			rs61759952	0.0617013	0.07650	0.00984	COSM3774226	142830 [HLA-B (confirmed) Spondyloarthropathy,susceptibility to,1,106300|Abacavir hypersensitivity,susceptibility to|Synovitis,chronic,susceptibility to|Drug-induced liver injury due to flucloxacillin|Toxic epidermal necrolysis,susceptibility to,608579|Stevens-Johnson syndrome,susceptibility to,608579];																			0		0.2447	1880	0.0280	1823
chr6	31323262	31323262	G	A	0.2380	1592	0.0233	1636		550	HLA-B	missense_variant,non_coding_transcript_exon_variant	HLA-B:ENST00000412585:missense_variant:MODERATE:exon4/8:c.727C>T:p.Arg243Trp,HLA-B:ENST00000463574:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.318C>T:,HLA-B:ENST00000498007:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.993C>T:	Immunoglobulin-like__1_,Immunoglobulin_C1-set__2_,Immunoglobulin-like_fold__1_	Cell adhesion molecules (CAMs);Antigen processing and presentation;Natural killer cell mediated cytotoxicity;Type I diabetes mellitus;Autoimmune thyroid disease;Allograft rejection;Graft-versus-host disease	Involved in the presentation of foreign antigens to the immune system			rs77665001	0.0000	0.07558	0.00572		142830 [HLA-B (confirmed) Spondyloarthropathy,susceptibility to,1,106300|Abacavir hypersensitivity,susceptibility to|Synovitis,chronic,susceptibility to|Drug-induced liver injury due to flucloxacillin|Toxic epidermal necrolysis,susceptibility to,608579|Stevens-Johnson syndrome,susceptibility to,608579];			0.052000	T	D,,	B	T	29.50											0		0.2289	1791	0.0285	1756
chr6	31903376	31903376	A	G	0.3333	21	0.0000	23		56	C2,CFB	intron_variant	C2:ENST00000299367:intron_variant:MODIFIER:exon6/17:c.850-324A>G:,CFB:ENST00000456570:intron_variant:MODIFIER:exon4/29:c.529+1634A>G:,CFB:ENST00000556679:intron_variant:MODIFIER:exon4/29:c.529+1634A>G:,C2:ENST00000469372:intron_variant:MODIFIER:exon2/13:c.112-324A>G:,C2:ENST00000497706:intron_variant:MODIFIER:exon3/12:c.211-324A>G:,C2:ENST00000452323:intron_variant:MODIFIER:exon3/13:c.346+1634A>G:,C2:ENST00000411571:intron_variant:MODIFIER:exon4/5:c.*90-324A>G:,C2:ENST00000484636:intron_variant:MODIFIER:exon4/4:c.*90-324A>G:,C2:ENST00000442278:intron_variant:MODIFIER:exon4/15:c.454-324A>G:,CFB:ENST00000477310:intron_variant:MODIFIER:exon3/27:c.443-1720A>G:,C2:ENST00000482060:intron_variant:MODIFIER:exon6/17:c.*563-324A>G:,C2:ENST00000383177:intron_variant:MODIFIER:exon3/13:c.307+1634A>G:,C2:ENST00000485690:intron_variant:MODIFIER:exon1/7:c.16-324A>G:		Complement and coagulation cascades;Systemic lupus erythematosus,Complement and coagulation cascades	Component C2 which is part of the classical pathway of the complement system is cleaved by activated factor C1 into two fragments: C2b and C2a. C2a, a serine protease, then combines with complement factor 4b to generate the C3 or C5 convertase.,Factor B which is part of the alternate pathway of the complement system is cleaved by factor D into 2 fragments: Ba and Bb. Bb, a serine protease, then combines with complement factor 3b to generate the C3 or C5 convertase. It has also been implicated in proliferation and differentiation of preactivated B- lymphocytes, rapid spreading of peripheral blood monocytes, stimulation of lymphocyte blastogenesis and lysis of erythrocytes. Ba inhibits the proliferation of preactivated B-lymphocytes	Classical Complement Pathway;Complement Pathway;Lectin Induced Complement Pathway,Alternative Complement Pathway;Complement Pathway			0.0000	0.0000	0.0000		613927 [C2 (confirmed) C2 deficiency,217000|Macular degeneration,age-related,14,reduced risk of,615489]:138470 [CFB (confirmed) Macular degeneration,age-related,14,reduced risk of,615489|Hemolytic uremic syndrome,atypical,susceptibility to,4,612924|Complement factor B deficiency,615561];																			0		0.3333	21	0.0000	23
chr6	32546251	32546251	T	G	0.1379	32	0.0000	28		57	HLA-DRB6-HLA-DRB1	intergenic_region	HLA-DRB6-HLA-DRB1:ENSG00000229391-ENSG00000196126:intergenic_region:MODIFIER::n.32546251T>G:						rs867086163	0.0000	0.0000	0.0000		142857 [HLA-DRB1 (confirmed) Pemphigoid,susceptibility to|Sarcoidosis,susceptibility to,1,181000|Multiple sclerosis,susceptibility to,1,126200|Rheumatoid arthritis,susceptibility to,180300];																			0		0.0882	34	0.0000	31
chr6	32554653	32554653	C	A	0.2581	31	0.0000	31		77	HLA-DRB1	intron_variant	HLA-DRB1:ENST00000360004:intron_variant:MODIFIER:exon1/5:c.101-2498G>T:		Cell adhesion molecules (CAMs);Antigen processing and presentation;Hematopoietic cell lineage;Type I diabetes mellitus;Asthma;Autoimmune thyroid disease;Systemic lupus erythematosus;Allograft rejection;Graft-versus-host disease	Binds peptides derived from antigens that access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for recognition by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mostly by degradation of proteins that access the endocytic route, where they are processed by lysosomal proteases and other hydrolases. Exogenous antigens that have been endocytosed by the APC are thus readily available for presentation via MHC II molecules, and for this reason this antigen presentation pathway is usually referred to as exogenous. As membrane proteins on their way to degradation in lysosomes as part of their normal turn-over are also contained in the endosomal/lysosomal compartments, exogenous antigens must compete with those derived from endogenous components. Autophagy is also a source of endogenous peptides, autophagosomes constitutively fuse with MHC class II loading compartments. In addition to APCs, other cells of the gastrointestinal tract, such as epithelial cells, express MHC class II molecules and CD74 and act as APCs, which is an unusual trait of the GI tract. To produce a MHC class II molecule that presents an antigen, three MHC class II molecules (heterodimers of an alpha and a beta chain) associate with a CD74 trimer in the ER to form a heterononamer. Soon after the entry of this complex into the endosomal/lysosomal system where antigen processing occurs, CD74 undergoes a sequential degradation by various proteases, including CTSS and CTSL, leaving a small fragment termed CLIP (class-II-associated invariant chain peptide). The removal of CLIP is facilitated by HLA-DM via direct binding to the alpha-beta-CLIP complex so that CLIP is released. HLA-DM stabilizes MHC class II molecules until primary high affinity antigenic peptides are bound. The MHC II molecule bound to a peptide is then transported to the cell membrane surface. In B-cells, the interaction between HLA-DM and MHC class II molecules is regulated by HLA-DO. Primary dendritic cells (DCs) also to express HLA-DO. Lysosomal miroenvironment has been implicated in the regulation of antigen loading into MHC II molecules, increased acidification produces increased proteolysis and efficient peptide loading	Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor;Antigen Dependent B Cell Activation;Antigen Processing and Presentation;B Lymphocyte Cell Surface Molecules;Bystander B Cell Activation;Cytokines and Inflammatory Response;IL 5 Signaling Pathway;Lck and Fyn tyrosine kinases in initiation of TCR Activation;Th1/Th2 Differentiation;The Co-Stimulatory Signal During T-cell Activation;The Role of Eosinophils in the Chemokine Network of Allergy		rs35675330	0.264177	0.0000	0.0000		142857 [HLA-DRB1 (confirmed) Pemphigoid,susceptibility to|Sarcoidosis,susceptibility to,1,181000|Multiple sclerosis,susceptibility to,1,126200|Rheumatoid arthritis,susceptibility to,180300];																			0		0.2500	32	0.0000	35
chr6	33270551	33270551	T	C	0.1905	22	0.0000	30		64	TAPBP	intron_variant	TAPBP:ENST00000434618:intron_variant:MODIFIER:exon7/7:c.1336-1003A>G:,TAPBP:ENST00000475304:intron_variant:MODIFIER:exon8/8:c.1390-1003A>G:,TAPBP:ENST00000489157:intron_variant:MODIFIER:exon6/6:c.1075-1003A>G:		Antigen processing and presentation	Involved in the association of MHC class I with transporter associated with antigen processing (TAP) and in the assembly of MHC class I with peptide (peptide loading)				0.0000	0.0000	0.0000		601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];																			0		0.2273	22	0.0000	30
chr6	33270647	33270647	T	C	0.1111	45	0.0000	75		70	TAPBP	intron_variant	TAPBP:ENST00000434618:intron_variant:MODIFIER:exon7/7:c.1335+1085A>G:,TAPBP:ENST00000475304:intron_variant:MODIFIER:exon8/8:c.1389+1085A>G:,TAPBP:ENST00000489157:intron_variant:MODIFIER:exon6/6:c.1074+1085A>G:		Antigen processing and presentation	Involved in the association of MHC class I with transporter associated with antigen processing (TAP) and in the assembly of MHC class I with peptide (peptide loading)				0.0000	0.0000	0.0000		601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];																			0		0.1111	45	0.0000	75
chr6	33278161	33278161	T	C	0.2632	19	0.0000	20		51	TAPBP	intron_variant	TAPBP:ENST00000426633:intron_variant:MODIFIER:exon3/6:c.469+2833A>G:,TAPBP:ENST00000434618:intron_variant:MODIFIER:exon3/7:c.469+2833A>G:,TAPBP:ENST00000475304:intron_variant:MODIFIER:exon3/8:c.470-2226A>G:,TAPBP:ENST00000489157:intron_variant:MODIFIER:exon2/6:c.208+3310A>G:,TAPBP:ENST00000480730:intron_variant:MODIFIER:exon3/3:n.477+2833A>G:,TAPBP:ENST00000456592:intron_variant:MODIFIER:exon3/7:c.469+2833A>G:,TAPBP:ENST00000437116:intron_variant:MODIFIER:exon3/4:n.469+2833A>G:,TAPBP:ENST00000467025:intron_variant:MODIFIER:exon2/2:c.298+2833A>G:		Antigen processing and presentation	Involved in the association of MHC class I with transporter associated with antigen processing (TAP) and in the assembly of MHC class I with peptide (peptide loading)				0.0000	0.0000	0.0000		601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];																			0		0.2632	19	0.0000	20
chr6	36479261	36479261	T	C	0.3333	9	0.0000	24		50	STK38	intron_variant	STK38:ENST00000229812:intron_variant:MODIFIER:exon7/13:c.669+3854A>G:			Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2				0.0000	0.0000	0.0000																					0		0.3333	9	0.0000	24
chr6	37791697	37791697	A	G	0.3333	9	0.0000	17		36	ZFAND3	intron_variant	ZFAND3:ENST00000287218:intron_variant:MODIFIER:exon1/5:c.71+3905A>G:,ZFAND3:ENST00000373391:intron_variant:MODIFIER:exon1/4:c.71+3905A>G:,ZFAND3:ENST00000474522:intron_variant:MODIFIER:exon1/5:c.71+3905A>G:							0.0000	0.0000	0.0000																					0		0.3333	9	0.0000	17
chr6	37812326	37812326	A	G	0.1739	23	0.0000	18		56	ZFAND3	intron_variant	ZFAND3:ENST00000287218:intron_variant:MODIFIER:exon1/5:c.71+24534A>G:,ZFAND3:ENST00000373391:intron_variant:MODIFIER:exon1/4:c.71+24534A>G:,ZFAND3:ENST00000474522:intron_variant:MODIFIER:exon1/5:c.71+24534A>G:							0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	18
chr6	37968487	37968487	A	G	0.1905	22	0.0000	27		53	ZFAND3	intron_variant	ZFAND3:ENST00000287218:intron_variant:MODIFIER:exon2/5:c.113-60882A>G:,ZFAND3:ENST00000373391:intron_variant:MODIFIER:exon2/4:c.113-60882A>G:,ZFAND3:ENST00000474522:intron_variant:MODIFIER:exon2/5:c.113-2980A>G:,ZFAND3:ENST00000373389:intron_variant:MODIFIER:exon1/4:c.41-60882A>G:							0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	27
chr6	37968496	37968496	A	G	0.2083	25	0.0323	33		53	ZFAND3	intron_variant	ZFAND3:ENST00000287218:intron_variant:MODIFIER:exon2/5:c.113-60873A>G:,ZFAND3:ENST00000373391:intron_variant:MODIFIER:exon2/4:c.113-60873A>G:,ZFAND3:ENST00000474522:intron_variant:MODIFIER:exon2/5:c.113-2971A>G:,ZFAND3:ENST00000373389:intron_variant:MODIFIER:exon1/4:c.41-60873A>G:							0.0000	0.0000	0.0000																					0		0.2000	25	0.0303	33
chr6	42001105	42001105	T	C	0.3125	16	0.0000	19		44	CCND3	intron_variant	CCND3:ENST00000511642:intron_variant:MODIFIER:exon1/4:c.-46+16284A>G:,CCND3:ENST00000415497:intron_variant:MODIFIER:exon1/3:c.-175+15134A>G:,CCND3:ENST00000372988:intron_variant:MODIFIER:exon1/4:c.-46+15134A>G:,CCND3:ENST00000510503:intron_variant:MODIFIER:exon1/3:c.-46+15134A>G:,CCND3:ENST00000511686:intron_variant:MODIFIER:exon1/2:n.204+15134A>G:,CCND3:ENST00000513956:intron_variant:MODIFIER:exon1/2:n.190+15134A>G:,CCND3:ENST00000508143:intron_variant:MODIFIER:exon1/3:c.-356-3177A>G:,CCND3:ENST00000505672:intron_variant:MODIFIER:exon1/2:n.176+15134A>G:,CCND3:ENST00000511161:intron_variant:MODIFIER:exon1/1:n.190+15134A>G:,CCND3:ENST00000505884:intron_variant:MODIFIER:exon1/2:n.191-3177A>G:,CCND3:ENST00000514382:intron_variant:MODIFIER:exon1/2:n.188+15134A>G:,CCND3:ENST00000502771:intron_variant:MODIFIER:exon1/2:c.-227-3177A>G:,CCND3:ENST00000514588:intron_variant:MODIFIER:exon1/2:c.-163+15134A>G:,CCND3:ENST00000512381:intron_variant:MODIFIER:exon1/1:n.202+15134A>G:		Cell cycle;p53 signaling pathway;Wnt signaling pathway;Focal adhesion;Jak-STAT signaling pathway	Regulatory component of the cyclin D3-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D3/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex	Cyclins and Cell Cycle Regulation			0.0000	0.0000	0.0000																					0		0.3125	16	0.0000	19
chr6	42048348	42048348	A	G	0.1818	22	0.0000	32		66	TAF8	3_prime_UTR_variant,intron_variant	TAF8:ENST00000372977:3_prime_UTR_variant:MODIFIER:exon9/9:c.*3065A>G:,TAF8:ENST00000372982:intron_variant:MODIFIER:exon9/9:c.*25+3371A>G:,TAF8:ENST00000456846:intron_variant:MODIFIER:exon8/8:c.920+3371A>G:			Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. Mediates both basal and activator-dependent transcription. Plays a role in the differentiation of preadipocyte fibroblasts to adipocytes, however, does not seem to play a role in differentiation of myoblasts. Required for the integration of TAF10 in the TAF complex. May be important for survival of cells of the inner cell mass which constitute the pluripotent cell population of the early embryo (By similarity)				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	32
chr6	46625038	46625038	A	G	0.3125	16	0.0000	21		50	SLC25A27	intron_variant	SLC25A27:ENST00000371347:intron_variant:MODIFIER:exon2/8:c.298+1267A>G:,SLC25A27:ENST00000411689:intron_variant:MODIFIER:exon2/6:c.298+1267A>G:,SLC25A27:ENST00000452689:intron_variant:MODIFIER:exon2/9:c.-64-1124A>G:			UCP are mitochondrial transporter proteins that create proton leaks across the inner mitochondrial membrane, thus uncoupling oxidative phosphorylation from ATP synthesis. As a result, energy is dissipated in the form of heat. May play a role in thermoregulatory heat production and metabolism in brain				0.0000	0.0000	0.0000																					0		0.3125	16	0.0000	21
chr6	53184966	53184966	T	C	0.3333	9	0.0000	17		37	ELOVL5	intron_variant	ELOVL5:ENST00000541407:intron_variant:MODIFIER:exon1/8:c.-8-24461A>G:,ELOVL5:ENST00000370918:intron_variant:MODIFIER:exon1/8:c.-8-24461A>G:,ELOVL5:ENST00000304434:intron_variant:MODIFIER:exon1/7:c.-8-24461A>G:,ELOVL5:ENST00000542638:intron_variant:MODIFIER:exon1/7:c.-8-24461A>G:,ELOVL5:ENST00000485336:intron_variant:MODIFIER:exon1/5:n.158-24461A>G:,ELOVL5:ENST00000465983:intron_variant:MODIFIER:exon1/5:n.135-24461A>G:,ELOVL5:ENST00000486973:intron_variant:MODIFIER:exon1/6:n.135-24461A>G:,ELOVL5:ENST00000370913:intron_variant:MODIFIER:exon1/2:c.-8-24461A>G:		Biosynthesis of unsaturated fatty acids	Condensing enzyme that catalyzes the synthesis of monounsaturated and of polyunsaturated very long chain fatty acids Acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA				0.0000	0.0000	0.0000		611805 [ELOVL5 (provisional) Spinocerebellar ataxia 38,615957];																			0		0.3333	9	0.0000	17
chr6	64246125	64246125	A	G	0.0833	84	0.0000	92		75	PTP4A1	intron_variant	PTP4A1:ENST00000470661:intron_variant:MODIFIER:exon2/2:n.332+8136A>G:			Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. May play a role in the development and maintenance of differentiating epithelial tissues. Enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis				0.0000	0.0000	0.0000																					0		0.0833	84	0.0000	92
chr6	64256412	64256412	A	G	0.1739	23	0.0000	19		58	PTP4A1	intron_variant	PTP4A1:ENST00000470661:intron_variant:MODIFIER:exon2/2:n.332+18423A>G:			Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. May play a role in the development and maintenance of differentiating epithelial tissues. Enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	19
chr6	64276667	64276667	-	A	0.2400	27	0.0000	33		51	PTP4A1	intron_variant	PTP4A1:ENST00000470661:intron_variant:MODIFIER:exon2/2:n.333-9668dupA:			Protein tyrosine phosphatase which stimulates progression from G1 into S phase during mitosis. May play a role in the development and maintenance of differentiating epithelial tissues. Enhances cell proliferation, cell motility and invasive activity, and promotes cancer metastasis				0.0000	0.0000	0.0000																					0		0.0741	54	0.0000	34
chr6	64385149	64385149	A	G	0.1905	21	0.0000	22		61	PHF3	intron_variant	PHF3:ENST00000262043:intron_variant:MODIFIER:exon2/15:c.245-4752A>G:,PHF3:ENST00000506783:intron_variant:MODIFIER:exon1/11:c.-152-8881A>G:,PHF3:ENST00000481385:intron_variant:MODIFIER:exon1/5:c.-20-4752A>G:,PHF3:ENST00000515594:intron_variant:MODIFIER:exon1/13:c.-166-4752A>G:,PHF3:ENST00000494284:intron_variant:MODIFIER:exon2/5:c.104-4752A>G:,PHF3:ENST00000509876:intron_variant:MODIFIER:exon2/16:c.245-3580A>G:,PHF3:ENST00000509330:intron_variant:MODIFIER:exon2/3:c.245-4752A>G:,PHF3:ENST00000393387:intron_variant:MODIFIER:exon1/14:c.245-4752A>G:						rs535183214	0.0000	0.0000	0.0000																					0		0.1905	21	0.0000	22
chr6	74134075	74134075	T	C	0.2727	22	0.0571	35		56	MB21D1	3_prime_UTR_variant,intron_variant	MB21D1:ENST00000370315:3_prime_UTR_variant:MODIFIER:exon5/5:c.*875A>G:,MB21D1:ENST00000370318:intron_variant:MODIFIER:exon5/5:c.1332+1112A>G:			Nucleotidyltransferase that catalyzes the formation of cyclic GMP-AMP (cGAMP) from ATP and GTP. Catalysis involves both the formation of a 2',5' phosphodiester linkage at the GpA step and the formation of a 3',5' phosphodiester linkage at the ApG step, producing c[G(2',5')pA(3',5')p]. Has antiviral activity by acting as a key cytosolic DNA sensor, the presence of double- stranded DNA (dsDNA) in the cytoplasm being a danger signal that triggers the immune responses. Binds cytosolic DNA directly, leading to activation and synthesis of cGAMP, a second messenger that binds to and activates TMEM173/STING, thereby triggering type-I interferon production				0.0000	0.0000	0.0000																					0		0.2727	22	0.0571	35
chr6	75948599	75948599	T	C	0.0943	53	0.0000	58		60	COX7A2	intron_variant	COX7A2:ENST00000370081:intron_variant:MODIFIER:exon4/4:c.290-895A>G:,COX7A2:ENST00000230459:intron_variant:MODIFIER:exon3/3:c.194-895A>G:,COX7A2:ENST00000370089:intron_variant:MODIFIER:exon3/3:c.290-895A>G:,COX7A2:ENST00000459637:intron_variant:MODIFIER:exon3/3:c.*97-895A>G:,COX7A2:ENST00000509698:intron_variant:MODIFIER:exon3/3:c.218-895A>G:,COX7A2:ENST00000460985:intron_variant:MODIFIER:exon2/2:c.104-895A>G:,COX7A2:ENST00000472311:intron_variant:MODIFIER:exon2/2:c.109-895A>G:		Oxidative phosphorylation	This protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport				0.0000	0.0000	0.0000																					0		0.0943	53	0.0000	58
chr6	75948638	75948638	T	C	0.1132	54	0.0000	52		71	COX7A2	intron_variant	COX7A2:ENST00000370081:intron_variant:MODIFIER:exon4/4:c.290-934A>G:,COX7A2:ENST00000230459:intron_variant:MODIFIER:exon3/3:c.194-934A>G:,COX7A2:ENST00000370089:intron_variant:MODIFIER:exon3/3:c.290-934A>G:,COX7A2:ENST00000459637:intron_variant:MODIFIER:exon3/3:c.*97-934A>G:,COX7A2:ENST00000509698:intron_variant:MODIFIER:exon3/3:c.218-934A>G:,COX7A2:ENST00000460985:intron_variant:MODIFIER:exon2/2:c.104-934A>G:,COX7A2:ENST00000472311:intron_variant:MODIFIER:exon2/2:c.109-934A>G:		Oxidative phosphorylation	This protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport				0.0000	0.0000	0.0000																					0		0.1111	54	0.0000	52
chr6	75948651	75948651	T	C	0.0909	56	0.0000	46		65	COX7A2	intron_variant	COX7A2:ENST00000370081:intron_variant:MODIFIER:exon4/4:c.290-947A>G:,COX7A2:ENST00000230459:intron_variant:MODIFIER:exon3/3:c.194-947A>G:,COX7A2:ENST00000370089:intron_variant:MODIFIER:exon3/3:c.290-947A>G:,COX7A2:ENST00000459637:intron_variant:MODIFIER:exon3/3:c.*97-947A>G:,COX7A2:ENST00000509698:intron_variant:MODIFIER:exon3/3:c.218-947A>G:,COX7A2:ENST00000460985:intron_variant:MODIFIER:exon2/2:c.104-947A>G:,COX7A2:ENST00000472311:intron_variant:MODIFIER:exon2/2:c.109-947A>G:		Oxidative phosphorylation	This protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport				0.0000	0.0000	0.0000																					0		0.0893	56	0.0000	46
chr6	87948029	87948029	A	G	0.3750	24	0.0000	17		36	ZNF292	intron_variant	ZNF292:ENST00000369577:intron_variant:MODIFIER:exon5/7:c.741+4784A>G:,ZNF292:ENST00000518845:intron_variant:MODIFIER:exon1/1:c.169-5164A>G:,ZNF292:ENST00000339907:intron_variant:MODIFIER:exon5/7:c.726+4784A>G:,ZNF292:ENST00000496806:intron_variant:MODIFIER:exon2/2:c.200-21764A>G:,ZNF292:ENST00000466062:intron_variant:MODIFIER:exon1/4:c.3+4784A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.3750	24	0.0000	17
chr6	89857376	89857376	A	G	0.2000	30	0.0000	29		72	PM20D2	intron_variant	PM20D2:ENST00000275072:intron_variant:MODIFIER:exon1/6:c.465+1048A>G:						rs370256822	0.0000	0.0000	0.0000																					0		0.2000	30	0.0000	29
chr6	90497583	90497583	-	A	0.1628	65	0.0000	81		53	MDN1	frameshift_variant,intron_variant	MDN1:ENST00000369393:frameshift_variant:HIGH:exon8/102:c.1323dupT:p.Ala442fs,MDN1:ENST00000428876:frameshift_variant:HIGH:exon8/102:c.1323dupT:p.Ala442fs,MDN1:ENST00000439638:intron_variant:MODIFIER:exon7/23:c.1230+1915dupT:			Nuclear chaperone required for maturation and nuclear export of pre-60S ribosome subunits (By similarity)				0.0000	0.0000	0.00000																					0		0.0893	56	0.0000	70
chr6	90572448	90572448	-	A	0.3125	16	0.0323	34		40	CASP8AP2	intron_variant,non_coding_transcript_exon_variant	CASP8AP2:ENST00000548224:intron_variant:MODIFIER:exon6/7:n.571+5536dupA:,CASP8AP2:ENST00000551025:non_coding_transcript_exon_variant:MODIFIER:exon7/9:n.2463dupA:,CASP8AP2:ENST00000552401:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1095dupA:,CASP8AP2:ENST00000419040:non_coding_transcript_exon_variant:MODIFIER:exon7/7:n.1222dupA:,CASP8AP2:ENST00000237177:non_coding_transcript_exon_variant:MODIFIER:exon7/10:n.1222dupA:			Participates in TNF-alpha-induced blockade of glucocorticoid receptor (GR) transactivation at the nuclear receptor coactivator level, upstream and independently of NF- kappa-B. Suppresses both NCOA2- and NCOA3-induced enhancement of GR transactivation. Involved in TNF-alpha-induced activation of NF-kappa-B via a TRAF2-dependent pathway. Acts as a downstream mediator for CASP8-induced activation of NF-kappa-B. Required for the activation of CASP8 in FAS-mediated apoptosis. Required for histone gene transcription and progression through S phase				0.0000	0.0000	0.0000																					0		0.3125	16	0.0323	31
chr6	107208870	107208870	T	C	0.2857	14	0.0000	23		57	RP1-60O19.1	intron_variant	RP1-60O19.1:ENST00000436659:intron_variant:MODIFIER:exon1/6:n.168-21225A>G:,RP1-60O19.1:ENST00000428750:intron_variant:MODIFIER:exon1/5:n.174-21225A>G:,RP1-60O19.1:ENST00000415714:intron_variant:MODIFIER:exon1/1:n.56+11243A>G:,RP1-60O19.1:ENST00000433965:intron_variant:MODIFIER:exon1/2:n.217-11207A>G:,RP1-60O19.1:ENST00000427903:intron_variant:MODIFIER:exon1/3:n.178-4734A>G:,RP1-60O19.1:ENST00000606430:intron_variant:MODIFIER:exon1/3:n.284-4734A>G:							0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	23
chr6	128786104	128786104	-	T	0.3889	18	0.0000	24		44	PTPRK	intron_variant	PTPRK:ENST00000368207:intron_variant:MODIFIER:exon1/33:c.100+55299dupA:,PTPRK:ENST00000368226:intron_variant:MODIFIER:exon1/29:c.100+55299dupA:,PTPRK:ENST00000368227:intron_variant:MODIFIER:exon1/30:c.100+55299dupA:,PTPRK:ENST00000532331:intron_variant:MODIFIER:exon1/32:c.100+55299dupA:,PTPRK:ENST00000368213:intron_variant:MODIFIER:exon1/30:c.100+55299dupA:,PTPRK:ENST00000368210:intron_variant:MODIFIER:exon1/31:c.100+55299dupA:,PTPRK:ENST00000368215:intron_variant:MODIFIER:exon1/29:c.100+55299dupA:,PTPRK:ENST00000524481:intron_variant:MODIFIER:exon1/18:n.341+55299dupA:,PTPRK:ENST00000524534:intron_variant:MODIFIER:exon1/13:n.257+55299dupA:,PTPRK:ENST00000495748:intron_variant:MODIFIER:exon1/5:n.126+26772dupA:,PTPRK:ENST00000525459:intron_variant:MODIFIER:exon1/2:c.100+55299dupA:,PTPRK:ENST00000392449:intron_variant:MODIFIER:exon2/3:c.218+26772dupA:,PTPRK:ENST00000532751:intron_variant:MODIFIER:exon1/3:c.100+55299dupA:			Regulation of processes involving cell contact and adhesion such as growth control, tumor invasion, and metastasis. Negative regulator of EGFR signaling pathway. Forms complexes with beta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be a substrate for the catalytic activity of PTPRK/PTP-kappa				0.0000	0.0000	0.0000																					0		0.3529	17	0.0000	24
chr6	131380079	131380079	T	C	0.2500	16	0.0000	20		50	EPB41L2	intron_variant	EPB41L2:ENST00000337057:intron_variant:MODIFIER:exon1/19:c.-15+4216A>G:,EPB41L2:ENST00000530481:intron_variant:MODIFIER:exon1/17:c.-15+4203A>G:,EPB41L2:ENST00000445890:intron_variant:MODIFIER:exon1/16:c.-15+4203A>G:,EPB41L2:ENST00000392427:intron_variant:MODIFIER:exon1/14:c.-15+4216A>G:,EPB41L2:ENST00000368128:intron_variant:MODIFIER:exon1/19:c.-15+4203A>G:,EPB41L2:ENST00000527411:intron_variant:MODIFIER:exon1/17:c.-15+4203A>G:,EPB41L2:ENST00000525271:intron_variant:MODIFIER:exon1/14:c.-15+4203A>G:,EPB41L2:ENST00000528179:intron_variant:MODIFIER:exon1/5:n.91+4216A>G:,EPB41L2:ENST00000526333:intron_variant:MODIFIER:exon1/5:n.102+4203A>G:,EPB41L2:ENST00000530707:intron_variant:MODIFIER:exon1/1:c.-15+3441A>G:		Tight junction					0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	20
chr6	137522047	137522047	C	T	0.0769	78	0.0000	86		75	IFNGR1	missense_variant	IFNGR1:ENST00000367739:missense_variant:MODERATE:exon6/7:c.832G>A:p.Glu278Lys,IFNGR1:ENST00000543628:missense_variant:MODERATE:exon6/7:c.748G>A:p.Glu250Lys	Interferon_gamma_receptor__poxvirus/mammal__1_	Cytokine-cytokine receptor interaction;Jak-STAT signaling pathway;Natural killer cell mediated cytotoxicity	Receptor for interferon gamma. Two receptors bind one interferon gamma dimer	Chaperones modulate interferon Signaling Pathway;IFN gamma signaling pathway ;Selective expression of chemokine receptors during T-cell polarization;Th1/Th2 Differentiation			0.0000	0.0000	0.00000		107470 [IFNGR1 (confirmed) Immunodeficiency 27A,mycobacteriosis,AR,209950|H. pylori infection,susceptibility to,600263|Tuberculosis,susceptibility to,607948|Immunodeficiency 27B,mycobacteriosis,AD,615978|Tuberculosis infection,protection against,607948|Hepatitis B virus infection,susceptibility to,610424];			1.267000	T	T,T	B,B	T,T	9.03											0		0.0769	78	0.0000	86
chr6	143257451	143257451	T	C	0.1538	39	0.0000	37		65	HIVEP2	intron_variant	HIVEP2:ENST00000367603:intron_variant:MODIFIER:exon1/9:c.-641+8785A>G:			This protein specifically binds to the DNA sequence 5'- GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, somatostatin receptor II, and interferon- beta genes. It may act in T-cell activation				0.0000	0.0000	0.0000		143054 [HIVEP2 (provisional) Mental retardation,autosomal dominant 43,616977];																			0		0.1538	39	0.0000	37
chr6	150017108	150017108	T	C	0.4000	10	0.0000	17		36	LATS1	intron_variant	LATS1:ENST00000253339:intron_variant:MODIFIER:exon1/6:c.349-751A>G:,LATS1:ENST00000543571:intron_variant:MODIFIER:exon2/7:c.349-751A>G:,LATS1:ENST00000441107:intron_variant:MODIFIER:exon3/8:c.*36-751A>G:,LATS1:ENST00000542747:intron_variant:MODIFIER:exon1/5:n.186-751A>G:,LATS1:ENST00000392273:intron_variant:MODIFIER:exon2/3:c.349-751A>G:,LATS1:ENST00000458696:intron_variant:MODIFIER:exon1/2:c.187-751A>G:,LATS1:ENST00000542720:intron_variant:MODIFIER:exon3/4:c.*36-751A>G:			Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in maintenance of ploidy through its actions in both mitotic progression and the G1 tetraploidy checkpoint. Negatively regulates G2/M transition by down-regulating CDK1 kinase activity. Involved in the control of p53 expression. Affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1. May also play a role in endocrine function				0.0000	0.0000	0.0000																					0		0.4000	10	0.0000	17
chr6	150047362	150047362	T	C	0.1429	28	0.0000	27		61	NUP43	3_prime_UTR_variant,intron_variant	NUP43:ENST00000340413:3_prime_UTR_variant:MODIFIER:exon8/8:c.*743A>G:,NUP43:ENST00000367403:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1186A>G:,NUP43:ENST00000460354:intron_variant:MODIFIER:exon8/8:c.*640+103A>G:			Component of the Nup107-160 subcomplex of the nuclear pore complex (NPC). The Nup107-160 subcomplex is required for the assembly of a functional NPC. The Nup107-160 subcomplex is also required for normal kinetochore microtubule attachment, mitotic progression and chromosome segregation				0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	27
chr6	160139093	160139093	T	C	0.1667	25	0.0000	28		63	SOD2	intron_variant	SOD2:ENST00000546087:intron_variant:MODIFIER:exon3/7:c.-116+12824A>G:,SOD2:ENST00000545162:intron_variant:MODIFIER:exon1/3:c.92+9205A>G:,SOD2:ENST00000535561:intron_variant:MODIFIER:exon1/3:c.92+8791A>G:,SOD2:ENST00000537657:intron_variant:MODIFIER:exon1/3:c.-115-25198A>G:,SOD2:ENST00000401980:intron_variant:MODIFIER:exon1/2:c.-116+9068A>G:			Destroys superoxide anion radicals which are normally produced within the cells and which are toxic to biological systems	Erythropoietin mediated neuroprotection through NF-kB;The IGF-1 Receptor and Longevity			0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	28
chr6	163844223	163844223	A	G	0.4545	11	0.0667	30		40	QKI	5_prime_UTR_variant,intron_variant	QKI:ENST00000537041:5_prime_UTR_variant:MODIFIER:exon1/6:c.-46A>G:,QKI:ENST00000361752:intron_variant:MODIFIER:exon1/7:c.142+7856A>G:,QKI:ENST00000361758:intron_variant:MODIFIER:exon1/7:c.142+7856A>G:,QKI:ENST00000275262:intron_variant:MODIFIER:exon1/6:c.142+7856A>G:,QKI:ENST00000392127:intron_variant:MODIFIER:exon1/5:c.142+7856A>G:,QKI:ENST00000453779:intron_variant:MODIFIER:exon1/6:c.142+7856A>G:,QKI:ENST00000361195:intron_variant:MODIFIER:exon1/7:c.142+7856A>G:,QKI:ENST00000424802:intron_variant:MODIFIER:exon1/6:c.142+7856A>G:,QKI:ENST00000545607:intron_variant:MODIFIER:exon1/6:c.97+7856A>G:,QKI:ENST00000544436:intron_variant:MODIFIER:exon1/3:c.-24+6705A>G:			RNA-binding protein that plays a central role in myelinization. Binds to the 5'-NACUAAY-N(1,20)-UAAY-3' RNA core sequence. Acts by regulating pre-mRNA splicing, mRNA export, mRNA stability and protein translation. Required to protect and promote stability of mRNAs such as MBP and CDKN1B. Regulator of oligodendrocyte differentiation and maturation in the brain that may play a role in myelin and oligodendrocyte dysfunction in schizophrenia. Participates in mRNA transport by regulating the nuclear export of MBP mRNA. Also involved in regulation of mRNA splicing of MAG pre-mRNA. Acts as a translational repressor (By similarity)				0.0000	0.0000	0.0000																					0		0.4545	11	0.0667	30
chr7	5361746	5361746	T	C	0.2500	16	0.0345	29		52	TNRC18	intron_variant	TNRC18:ENST00000399537:intron_variant:MODIFIER:exon21/29:c.6443-925A>G:,TNRC18:ENST00000430969:intron_variant:MODIFIER:exon21/29:c.6443-925A>G:							0.0000	0.0000	0.0000																					0		0.2500	16	0.0345	29
chr7	5456985	5456985	T	C	0.3750	8	0.0000	17		36	TNRC18	intron_variant	TNRC18:ENST00000399537:intron_variant:MODIFIER:exon2/29:c.187+3706A>G:,TNRC18:ENST00000430969:intron_variant:MODIFIER:exon2/29:c.187+3706A>G:,TNRC18:ENST00000399434:intron_variant:MODIFIER:exon1/2:c.-36+7937A>G:							0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	17
chr7	11099148	11099148	A	G	0.1081	37	0.0000	41		56	PHF14	intron_variant	PHF14:ENST00000403050:intron_variant:MODIFIER:exon14/16:c.2482-2270A>G:,PHF14:ENST00000521747:intron_variant:MODIFIER:exon13/15:c.*1565-2270A>G:,PHF14:ENST00000445996:intron_variant:MODIFIER:exon13/16:c.1627-2270A>G:,PHF14:ENST00000423760:intron_variant:MODIFIER:exon13/16:c.*1565-2270A>G:,PHF14:ENST00000490957:intron_variant:MODIFIER:exon14/15:n.2899-2270A>G:,PHF14:ENST00000481418:intron_variant:MODIFIER:exon2/4:n.305-2270A>G:							0.0000	0.0000	0.0000																					0		0.1081	37	0.0000	41
chr7	17427586	17427586	C	T	0.2105	20	0.0000	33		54	AC019117.1	intron_variant	AC019117.1:ENST00000419463:intron_variant:MODIFIER:exon1/3:n.189+12907C>T:							0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	33
chr7	17464111	17464111	T	C	0.1216	76	0.0000	60		55	AC019117.1	intron_variant	AC019117.1:ENST00000419463:intron_variant:MODIFIER:exon1/3:n.190-24394T>C:							0.0000	0.0000	0.0000																					0		0.1333	75	0.0167	60
chr7	17591584	17591584	-	T	0.1538	46	0.0000	30		40	AC017060.1	intron_variant	AC017060.1:ENST00000451792:intron_variant:MODIFIER:exon1/3:n.158+6791dupA:							0.0000	0.0000	0.0000																					0		0.0106	377	0.0000	310
chr7	22198422	22198422	T	C	0.4211	19	0.0435	23		33	RAPGEF5	intron_variant	RAPGEF5:ENST00000344041:intron_variant:MODIFIER:exon14/25:c.1068-919A>G:,RAPGEF5:ENST00000401957:intron_variant:MODIFIER:exon4/15:c.618-919A>G:,RAPGEF5:ENST00000458533:intron_variant:MODIFIER:exon6/8:c.282-919A>G:,RAPGEF5:ENST00000451559:intron_variant:MODIFIER:exon5/5:c.*357-919A>G:			Guanine nucleotide exchange factor (GEF) for RAP1A, RAP2A and MRAS/M-Ras-GTP. Its association with MRAS inhibits Rap1 activation				0.0000	0.0000	0.0000																					0		0.4211	19	0.0435	23
chr7	22614274	22614274	A	G	0.1389	36	0.0000	17		60	AC002480.5,STEAP1B	intron_variant	AC002480.5:ENST00000442252:intron_variant:MODIFIER:exon1/1:n.129-1895T>C:,STEAP1B:ENST00000439708:intron_variant:MODIFIER:exon1/3:c.-32+58155T>C:							0.0000	0.0000	0.0000																					0		0.1389	36	0.0000	17
chr7	22626124	22626124	A	G	0.1064	47	0.0000	32		52	AC002480.5,STEAP1B	intron_variant	AC002480.5:ENST00000442252:intron_variant:MODIFIER:exon1/1:n.129-13745T>C:,STEAP1B:ENST00000439708:intron_variant:MODIFIER:exon1/3:c.-32+46305T>C:							0.0000	0.0000	0.0000																					0		0.1064	47	0.0000	32
chr7	27861740	27861740	A	G	0.0909	45	0.0000	82		52	TAX1BP1	intron_variant	TAX1BP1:ENST00000409980:intron_variant:MODIFIER:exon16/17:c.2157+5083A>G:,TAX1BP1:ENST00000543117:intron_variant:MODIFIER:exon15/16:c.1959+5083A>G:,TAX1BP1:ENST00000265393:intron_variant:MODIFIER:exon15/16:c.1959+5083A>G:,TAX1BP1:ENST00000416801:intron_variant:MODIFIER:exon14/15:c.*1495+5083A>G:,TAX1BP1:ENST00000433216:intron_variant:MODIFIER:exon14/15:c.1488+5083A>G:,TAX1BP1:ENST00000396319:intron_variant:MODIFIER:exon15/16:c.2085+5083A>G:,TAX1BP1:ENST00000457186:intron_variant:MODIFIER:exon7/8:c.696+5083A>G:			Inhibits TNF-induced apoptosis by mediating the TNFAIP3 anti-apoptotic activity. Degraded by caspase-3-like family proteins upon TNF-induced apoptosis. May also play a role in the pro-inflammatory cytokine IL-1 signaling cascade				0.0000	0.0000	0.0000																					0		0.1111	45	0.0000	82
chr7	43940322	43940322	T	C	0.2500	16	0.0370	27		51	URGCP-MRPS24,URGCP	intron_variant	URGCP-MRPS24:ENST00000603700:intron_variant:MODIFIER:exon1/6:c.14+5839A>G:,URGCP:ENST00000453200:intron_variant:MODIFIER:exon1/5:c.14+5839A>G:,URGCP:ENST00000497914:intron_variant:MODIFIER:exon1/6:n.691+4898A>G:,URGCP:ENST00000223341:intron_variant:MODIFIER:exon1/4:c.-97-13229A>G:,URGCP:ENST00000402306:intron_variant:MODIFIER:exon1/4:c.14+5839A>G:,URGCP:ENST00000443736:intron_variant:MODIFIER:exon1/5:c.-111+5839A>G:,URGCP:ENST00000447717:intron_variant:MODIFIER:exon2/6:c.-116+10008A>G:,URGCP:ENST00000439702:intron_variant:MODIFIER:exon1/3:c.14+5839A>G:,URGCP:ENST00000426198:intron_variant:MODIFIER:exon1/5:c.-115-12907A>G:,URGCP:ENST00000455877:intron_variant:MODIFIER:exon1/3:c.-17-18766A>G:,URGCP:ENST00000446958:intron_variant:MODIFIER:exon1/4:c.14+5839A>G:,URGCP:ENST00000477768:intron_variant:MODIFIER:exon2/3:n.402+10008A>G:			May be involved in cell cycle progression through the regulation of cyclin D1 expression. May participate in the development of hepatocellular carcinoma (HCC) by promoting hepatocellular growth and survival. May play an important role in development of gastric cancer				0.0000	0.0000	0.0000																					0		0.2500	16	0.0370	27
chr7	50844008	50844008	T	C	0.2353	18	0.0000	25		62	GRB10	intron_variant	GRB10:ENST00000335866:intron_variant:MODIFIER:exon1/16:c.-294+16913A>G:,GRB10:ENST00000403097:intron_variant:MODIFIER:exon1/17:c.-254+16131A>G:,GRB10:ENST00000401949:intron_variant:MODIFIER:exon2/18:c.-217+4316A>G:,GRB10:ENST00000402497:intron_variant:MODIFIER:exon1/15:c.-124+16913A>G:,GRB10:ENST00000439044:intron_variant:MODIFIER:exon1/4:c.-181+16913A>G:,GRB10:ENST00000483819:intron_variant:MODIFIER:exon1/1:n.487+6113A>G:,GRB10:ENST00000470992:intron_variant:MODIFIER:exon3/3:n.379+2824A>G:,GRB10:ENST00000483157:intron_variant:MODIFIER:exon4/4:n.406+2824A>G:,GRB10:ENST00000492265:intron_variant:MODIFIER:exon2/2:n.90+2824A>G:			Adapter protein which modulates coupling of a number of cell surface receptor kinases with specific signaling pathways. Binds to, and suppress signals from, activated receptors tyrosine kinases, including the insulin (INSR) and insulin-like growth factor (IGF1R) receptors. The inhibitory effect can be achieved by 2 mechanisms: interference with the signaling pathway and increased receptor degradation. Delays and reduces AKT1 phosphorylation in response to insulin stimulation. Blocks association between INSR and IRS1 and IRS2 and prevents insulin- stimulated IRS1 and IRS2 tyrosine phosphorylation. Recruits NEDD4 to IGF1R, leading to IGF1R ubiquitination, increased internalization and degradation by both the proteasomal and lysosomal pathways. May play a role in mediating insulin- stimulated ubiquitination of INSR, leading to proteasomal degradation. Negatively regulates Wnt signaling by interacting with LRP6 intracellular portion and interfering with the binding of AXIN1 to LRP6. Positive regulator of the KDR/VEGFR-2 signaling pathway. May inhibit NEDD4-mediated degradation of KDR/VEGFR-2				0.0000	0.0000	0.0000																					0		0.2778	18	0.0000	25
chr7	55803749	55803749	T	C	0.1613	31	0.0000	17		60	SUMO2P3-CICP11	intergenic_region	SUMO2P3-CICP11:ENSG00000224971-ENSG00000237799:intergenic_region:MODIFIER::n.55803749T>C:							0.0000	0.0000	0.0000																					0		0.1111	45	0.0000	34
chr7	56120604	56120604	A	G	0.1750	40	0.0263	38		58	CCT6A	intron_variant	CCT6A:ENST00000275603:intron_variant:MODIFIER:exon2/13:c.201+426A>G:,CCT6A:ENST00000335503:intron_variant:MODIFIER:exon2/12:c.201+426A>G:,CCT6A:ENST00000540286:intron_variant:MODIFIER:exon3/14:c.108+426A>G:			Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. Known to play a role, in vitro, in the folding of actin and tubulin				0.0000	0.0000	0.0000		172480 [PSPH (confirmed) Phosphoserine phosphatase deficiency,614023];																			0		0.1707	41	0.0250	40
chr7	65543708	65543708	A	G	0.2500	20	0.0000	27		68	ASL	intron_variant	ASL:ENST00000304874:intron_variant:MODIFIER:exon2/16:c.12+2628A>G:,ASL:ENST00000487982:intron_variant:MODIFIER:exon2/7:n.78+2628A>G:,ASL:ENST00000496336:intron_variant:MODIFIER:exon1/3:n.253+2628A>G:,ASL:ENST00000380839:intron_variant:MODIFIER:exon1/14:c.12+2628A>G:,ASL:ENST00000395332:intron_variant:MODIFIER:exon1/15:c.12+2628A>G:,ASL:ENST00000362000:intron_variant:MODIFIER:exon1/9:c.12+2628A>G:,ASL:ENST00000395331:intron_variant:MODIFIER:exon1/14:c.12+2628A>G:		Urea cycle and metabolism of amino groups;Alanine and aspartate metabolism;Arginine and proline metabolism					0.0000	0.0000	0.0000		608310 [ASL (confirmed) Argininosuccinic aciduria,207900];																			0		0.2381	21	0.0000	26
chr7	65619263	65619263	A	G	0.0909	67	0.0000	61		62	CRCP,RP5-1132H15.1	3_prime_UTR_variant,intron_variant	CRCP:ENST00000395326:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1919A>G:,CRCP:ENST00000360415:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2359A>G:,CRCP:ENST00000415001:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1919A>G:,RP5-1132H15.1:ENST00000435524:intron_variant:MODIFIER:exon1/3:n.29+10707T>C:			DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Specific peripheric component of RNA polymerase III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Plays a key role in sensing and limiting infection by intracellular bacteria and DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in innate immune response. Can sense non-self dsDNA that serves as template for transcription into dsRNA. The non-self RNA polymerase III transcripts induce type I interferon and NF- Kappa- B through the RIG-I pathway (By similarity)				0.0000	0.0000	0.0000																					0		0.0896	67	0.0000	61
chr7	65622635	65622635	A	G	0.2222	30	0.0476	45		53	RP5-1132H15.1	intron_variant	RP5-1132H15.1:ENST00000435524:intron_variant:MODIFIER:exon1/3:n.29+7335T>C:							0.0000	0.0000	0.0000																					0		0.2667	30	0.0889	45
chr7	66148950	66148950	A	G	0.2000	25	0.0000	17		52	KCTD7,RABGEF1	intron_variant	KCTD7:ENST00000503687:intron_variant:MODIFIER:exon3/12:c.397+45034A>G:,RABGEF1:ENST00000607882:intron_variant:MODIFIER:exon1/9:c.-873+1705A>G:			May be involved in the control of excitability of cortical neurons (By similarity).,Rab effector protein acting as linker between gamma- adaptin, RAB4A or RAB5A. Involved in endocytic membrane fusion and membrane trafficking of recycling endosomes. Stimulates nucleotide exchange on RAB5A. Can act as a ubiquitin ligase (By similarity)			rs547420113	0.000199681	0.0000	0.0000																					0		0.2000	25	0.0000	17
chr7	72957936	72957936	T	C	0.3846	13	0.0000	25		59	BCL7B	synonymous_variant,3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	BCL7B:ENST00000223368:synonymous_variant:LOW:exon3/6:c.207A>G:p.Glu69Glu,BCL7B:ENST00000411832:synonymous_variant:LOW:exon3/5:c.207A>G:p.Glu69Glu,BCL7B:ENST00000455335:3_prime_UTR_variant:MODIFIER:exon4/7:c.*236A>G:,BCL7B:ENST00000454871:intron_variant:MODIFIER:exon2/4:c.169-3554A>G:,BCL7B:ENST00000448175:intron_variant:MODIFIER:exon2/5:c.169-699A>G:,BCL7B:ENST00000464288:intron_variant:MODIFIER:exon2/4:n.278-3554A>G:,BCL7B:ENST00000416906:intron_variant:MODIFIER:exon1/3:c.93-3554A>G:,BCL7B:ENST00000482231:non_coding_transcript_exon_variant:MODIFIER:exon3/6:n.326A>G:,BCL7B:ENST00000463858:non_coding_transcript_exon_variant:MODIFIER:exon3/5:n.286A>G:,BCL7B:ENST00000493592:non_coding_transcript_exon_variant:MODIFIER:exon3/4:n.187A>G:,BCL7B:ENST00000481667:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.288A>G:			May play a role in lung tumor development or progression				0.0000	0.0000	0.0000		608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1,233700];																			2	eMed-HCC,	0.3846	13	0.0000	26
chr7	74087326	74087326	A	G	0.4286	7	0.0000	18		39	GTF2I	intron_variant	GTF2I:ENST00000324896:intron_variant:MODIFIER:exon1/34:c.-6+14932A>G:,GTF2I:ENST00000485000:intron_variant:MODIFIER:exon1/1:n.401+14932A>G:,GTF2I:ENST00000346152:intron_variant:MODIFIER:exon1/33:c.-6+14932A>G:,GTF2I:ENST00000353920:intron_variant:MODIFIER:exon1/33:c.-6+14932A>G:,GTF2I:ENST00000416070:intron_variant:MODIFIER:exon1/32:c.-6+14932A>G:,GTF2I:ENST00000443166:intron_variant:MODIFIER:exon1/9:c.-6+14932A>G:		Basal transcription factors	Interacts with the basal transcription machinery by coordinating the formation of a multiprotein complex at the C-FOS promoter, and linking specific signal responsive activator complexes. Promotes the formation of stable high-order complexes of SRF and PHOX1 and interacts cooperatively with PHOX1 to promote serum-inducible transcription of a reporter gene deriven by the C- FOS serum response element (SRE). Acts as a coregulator for USF1 by binding independently two promoter elements, a pyrimidine-rich initiator (Inr) and an upstream E-box. Required for the formation of functional ARID3A DNA-binding complexes and for activation of immunoglobulin heavy-chain transcription upon B-lymphocyte activation				0.0000	0.0000	0.0000		608512 [NCF1 (provisional) Chronic granulomatous disease due to deficiency of NCF-1,233700];																			0		0.4286	7	0.0000	18
chr7	75976827	75976827	T	C	0.2609	23	0.0000	24		64	YWHAG	intron_variant	YWHAG:ENST00000307630:intron_variant:MODIFIER:exon1/1:c.87+11212A>G:		Cell cycle	Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner				0.0000	0.0000	0.0000																					0		0.2500	24	0.0000	25
chr7	77195863	77195863	A	G	0.2174	23	0.0000	31		54	PTPN12	intron_variant	PTPN12:ENST00000248594:intron_variant:MODIFIER:exon1/17:c.100-4532A>G:,PTPN12:ENST00000460731:intron_variant:MODIFIER:exon1/3:n.130-4532A>G:,PTPN12:ENST00000523952:intron_variant:MODIFIER:exon2/3:c.*221+2351A>G:,PTPN12:ENST00000433369:intron_variant:MODIFIER:exon2/6:c.-258-4532A>G:,PTPN12:ENST00000415482:intron_variant:MODIFIER:exon1/17:c.-258-4532A>G:,PTPN12:ENST00000435495:intron_variant:MODIFIER:exon1/16:c.-195-4532A>G:,PTPN12:ENST00000418110:intron_variant:MODIFIER:exon1/7:c.-258-4532A>G:			Dephosphorylates cellular tyrosine kinases, including PTK2B/PYK2, and thereby regulates signaling via PTK2B/PYK2				0.0000	0.0000	0.0000		600079 [PTPN12 (provisional) Colon cancer,somatic,114500];																			0		0.2174	23	0.0323	31
chr7	86816654	86816654	A	G	0.2581	33	0.0526	38		59	DMTF1	intron_variant,non_coding_transcript_exon_variant	DMTF1:ENST00000331242:intron_variant:MODIFIER:exon12/17:c.1202-754A>G:,DMTF1:ENST00000413276:intron_variant:MODIFIER:exon12/16:c.1201+1358A>G:,DMTF1:ENST00000447863:intron_variant:MODIFIER:exon12/17:c.*555-754A>G:,DMTF1:ENST00000579677:intron_variant:MODIFIER:exon12/17:c.*555-754A>G:,DMTF1:ENST00000425406:intron_variant:MODIFIER:exon11/16:c.*555-701A>G:,DMTF1:ENST00000547146:intron_variant:MODIFIER:exon12/17:c.*138-754A>G:,DMTF1:ENST00000579850:intron_variant:MODIFIER:exon11/16:c.1079-860A>G:,DMTF1:ENST00000432937:intron_variant:MODIFIER:exon11/16:c.938-754A>G:,DMTF1:ENST00000584619:intron_variant:MODIFIER:exon12/12:c.*554+1358A>G:,DMTF1:ENST00000394703:intron_variant:MODIFIER:exon14/19:c.1202-754A>G:,DMTF1:ENST00000412139:intron_variant:MODIFIER:exon12/17:c.*555-754A>G:,DMTF1:ENST00000414194:intron_variant:MODIFIER:exon12/17:c.404-754A>G:,DMTF1:ENST00000480982:non_coding_transcript_exon_variant:MODIFIER:exon1/3:n.1343A>G:			Transcriptional activator which activates the CDKN2A/ARF locus in response to Ras-Raf signaling, thereby promoting p53/TP53-dependent growth arrest (By similarity). Binds to the consensus sequence 5'-CCCG[GT]ATGT-3' (By similarity). Isoform 1 may cooperate with MYB to activate transcription of the ANPEP gene. Isoform 2 may antagonize transcriptional activation by isoform 1				0.0000	0.0000	0.0000																					0		0.3030	33	0.0513	39
chr7	89988213	89988213	A	G	0.2000	20	0.0000	26		64	GTPBP10	sequence_feature,intron_variant	GTPBP10:ENST00000222511:sequence_feature:LOW::c.464+3669A>G:,GTPBP10:ENST00000222511:intron_variant:MODIFIER:exon4/9:c.464+3669A>G:,GTPBP10:ENST00000421719:intron_variant:MODIFIER:exon3/5:c.*132+3669A>G:,GTPBP10:ENST00000426366:intron_variant:MODIFIER:exon4/6:c.437+3669A>G:,GTPBP10:ENST00000450619:intron_variant:MODIFIER:exon5/7:c.515+3669A>G:,GTPBP10:ENST00000453512:intron_variant:MODIFIER:exon3/5:c.292+4350A>G:,GTPBP10:ENST00000257659:intron_variant:MODIFIER:exon2/7:c.227+5890A>G:,GTPBP10:ENST00000417207:intron_variant:MODIFIER:exon3/7:c.319+4350A>G:,GTPBP10:ENST00000380058:intron_variant:MODIFIER:exon3/8:c.319+4350A>G:,GTPBP10:ENST00000439832:intron_variant:MODIFIER:exon3/4:c.*132+3669A>G:,GTPBP10:ENST00000474503:intron_variant:MODIFIER:exon2/6:n.167+3669A>G:			May be involved in the ribosome maturation process. Complements an ObgE(CgtA) function in E.coli ribosome maturation. Plays a role of GTPase in vitro. When missing, disorganization of the nuceleolar architecture is observed				0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	26
chr7	92341344	92341344	T	C	0.2105	19	0.0323	31		53	CDK6	intron_variant	CDK6:ENST00000265734:intron_variant:MODIFIER:exon4/7:c.537+13596A>G:,CDK6:ENST00000424848:intron_variant:MODIFIER:exon4/7:c.537+13596A>G:,CDK6:ENST00000473078:intron_variant:MODIFIER:exon1/1:n.85+13596A>G:		Cell cycle;p53 signaling pathway;Pancreatic cancer;Glioma;Melanoma;Chronic myeloid leukemia;Small cell lung cancer;Non-small cell lung cancer	Serine/threonine-protein kinase involved in the control of the cell cycle and differentiation; promotes G1/S transition. Phosphorylates pRB/RB1 and NPM1. Interacts with D-type G1 cyclins during interphase at G1 to form a pRB/RB1 kinase and controls the entrance into the cell cycle. Involved in initiation and maintenance of cell cycle exit during cell differentiation; prevents cell proliferation and regulates negatively cell differentiation, but is required for the proliferation of specific cell types (e.g. erythroid and hematopoietic cells). Essential for cell proliferation within the dentate gyrus of the hippocampus and the subventricular zone of the lateral ventricles. Required during thymocyte development. Promotes the production of newborn neurons, probably by modulating G1 length. Promotes, at least in astrocytes, changes in patterns of gene expression, changes in the actin cytoskeleton including loss of stress fibers, and enhanced motility during cell differentiation. Prevents myeloid differentiation by interfering with RUNX1 and reducing its transcription transactivation activity, but promotes proliferation of normal myeloid progenitors. Delays senescence. Promotes the proliferation of beta-cells in pancreatic islets of Langerhans	Cell Cycle: G1/S Check Point ;Cyclins and Cell Cycle Regulation;Influence of Ras and Rho proteins on G1 to S Transition			0.0000	0.0000	0.0000		603368 [CDK6 (confirmed) Microcephaly 12,primary,autosomal recessive,616080];																			0		0.2105	19	0.0323	31
chr7	98974316	98974316	A	G	0.3333	9	0.0000	21		45	ARPC1B,ARPC1A	intron_variant	ARPC1B:ENST00000252725:intron_variant:MODIFIER:exon1/9:c.-14+1912A>G:,ARPC1A:ENST00000432884:intron_variant:MODIFIER:exon11/13:c.934-9009A>G:,ARPC1A:ENST00000441989:intron_variant:MODIFIER:exon11/13:c.*1097-9009A>G:,ARPC1B:ENST00000443222:intron_variant:MODIFIER:exon1/3:c.-14+2115A>G:,ARPC1B:ENST00000414376:intron_variant:MODIFIER:exon1/3:c.-14+2182A>G:,ARPC1B:ENST00000455009:intron_variant:MODIFIER:exon1/4:c.-119-641A>G:,ARPC1B:ENST00000484375:intron_variant:MODIFIER:exon1/5:n.75+1912A>G:,ARPC1B:ENST00000418347:intron_variant:MODIFIER:exon2/5:c.-132+119A>G:,ARPC1B:ENST00000429246:intron_variant:MODIFIER:exon1/3:c.-232-665A>G:,ARPC1B:ENST00000417330:intron_variant:MODIFIER:exon1/4:c.-115-645A>G:,ARPC1B:ENST00000427217:intron_variant:MODIFIER:exon1/4:c.-95-665A>G:,ARPC1B:ENST00000431816:intron_variant:MODIFIER:exon1/4:c.-131-645A>G:,ARPC1B:ENST00000458033:intron_variant:MODIFIER:exon1/4:c.-111-665A>G:,ARPC1B:ENST00000484600:intron_variant:MODIFIER:exon1/4:n.52+1912A>G:,ARPC1B:ENST00000451682:intron_variant:MODIFIER:exon2/11:c.-116+119A>G:		Regulation of actin cytoskeleton	Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks.,Probably functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks	How does salmonella hijack a cell;How Progesterone Initiates Oocyte Membrane;Rho cell motility signaling pathway;Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration;Y branching of actin filaments			0.0000	0.0000	0.0000																					0		0.3333	9	0.0000	21
chr7	101574869	101574869	A	G	0.1905	21	0.0000	18		53	CUX1	intron_variant	CUX1:ENST00000360264:intron_variant:MODIFIER:exon2/23:c.174+15364A>G:,CUX1:ENST00000437600:intron_variant:MODIFIER:exon2/22:c.174+15364A>G:,CUX1:ENST00000497815:intron_variant:MODIFIER:exon2/6:n.245+15364A>G:,CUX1:ENST00000292538:intron_variant:MODIFIER:exon2/22:c.174+15364A>G:,CUX1:ENST00000393824:intron_variant:MODIFIER:exon1/21:c.64-96509A>G:,CUX1:ENST00000547394:intron_variant:MODIFIER:exon2/21:c.174+15364A>G:,CUX1:ENST00000425244:intron_variant:MODIFIER:exon2/21:c.174+15364A>G:,CUX1:ENST00000292535:intron_variant:MODIFIER:exon2/23:c.141+15364A>G:,CUX1:ENST00000546411:intron_variant:MODIFIER:exon2/23:c.141+15364A>G:,CUX1:ENST00000549414:intron_variant:MODIFIER:exon2/22:c.141+15364A>G:,CUX1:ENST00000550008:intron_variant:MODIFIER:exon2/21:c.141+15364A>G:,CUX1:ENST00000556210:intron_variant:MODIFIER:exon2/21:c.141+15364A>G:,CUX1:ENST00000558469:intron_variant:MODIFIER:exon2/6:n.170+15364A>G:,CUX1:ENST00000560541:intron_variant:MODIFIER:exon2/22:n.762+15364A>G:			Probably has a broad role in mammalian development as a repressor of developmentally regulated gene expression. May act by preventing binding of positively-activing CCAAT factors to promoters. Component of nf-munr repressor; binds to the matrix attachment regions (MARs) (5' and 3') of the immunoglobulin heavy chain enhancer. Represses T-cell receptor (TCR) beta enhancer function by binding to MARbeta, an ATC-rich DNA sequence located upstream of the TCR beta enhancer (By similarity)				0.0000	0.0000	0.0000																					0		0.1905	21	0.0000	18
chr7	102277601	102277601	T	C	0.1538	28	0.0000	25		62	UPK3BL,POLR2J2,RP11-514P8.6	3_prime_UTR_variant,intron_variant	UPK3BL:ENST00000340457:3_prime_UTR_variant:MODIFIER:exon6/6:c.*371A>G:,POLR2J2:ENST00000476151:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1105A>G:,POLR2J2:ENST00000591000:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1105A>G:,RP11-514P8.6:ENST00000519541:intron_variant:MODIFIER:exon5/25:c.683+1560A>G:			DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB11 is part of the core element with the central large cleft (By similarity)			rs1140582	0.0000	0.0000	0.0000																					0		0.1935	31	0.0000	26
chr7	104632107	104632107	T	C	0.1220	41	0.0000	31		64	LINC01004	intron_variant	LINC01004:ENST00000445184:intron_variant:MODIFIER:exon1/1:n.94-8969A>G:,LINC01004:ENST00000450686:intron_variant:MODIFIER:exon1/2:n.113+21272A>G:							0.0000	0.0000	0.0000																					0		0.1220	41	0.0000	31
chr7	104951756	104951756	T	C	0.1600	25	0.0256	39		53	SRPK2	intron_variant	SRPK2:ENST00000393651:intron_variant:MODIFIER:exon2/15:c.71+77339A>G:,SRPK2:ENST00000482897:intron_variant:MODIFIER:exon2/6:c.182+77339A>G:,SRPK2:ENST00000460391:intron_variant:MODIFIER:exon2/6:c.-26-42440A>G:,SRPK2:ENST00000462282:intron_variant:MODIFIER:exon1/3:n.154-42440A>G:,SRPK2:ENST00000465112:intron_variant:MODIFIER:exon2/5:c.72-4738A>G:,SRPK2:ENST00000482862:intron_variant:MODIFIER:exon2/3:n.203-42440A>G:			Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing. Promotes neuronal apoptosis by up-regulating cyclin-D1 (CCND1) expression. This is done by the phosphorylation of SRSF2, leading to the suppression of p53/TP53 phosphorylation thereby relieving the repressive effect of p53/TP53 on cyclin-D1 (CCND1) expression. Phosphorylates ACIN1, and redistributes it from the nuclear speckles to the nucleoplasm, resulting in cyclin A1 but not cyclin A2 up- regulation. Plays an essential role in spliceosomal B complex formation via the phosphorylation of DDX23/PRP28. Can mediate hepatitis B virus (HBV) core protein phosphorylation. Plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles				0.0000	0.0000	0.0000																					0		0.1600	25	0.0256	39
chr7	105898535	105898535	-	T	0.0556	122	0.0000	80		42	NAMPT	intron_variant	NAMPT:ENST00000222553:intron_variant:MODIFIER:exon8/10:c.1089+3498dupA:		Nicotinate and nicotinamide metabolism	Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity)				0.0000	0.0000	0.0000																					0		0.0118	507	0.0000	367
chr7	105918162	105918162	-	A	0.2453	58	0.0000	37		50	NAMPT	intron_variant	NAMPT:ENST00000222553:intron_variant:MODIFIER:exon1/10:c.58-538dupT:,NAMPT:ENST00000354289:intron_variant:MODIFIER:exon1/7:c.58-538dupT:,NAMPT:ENST00000491027:intron_variant:MODIFIER:exon1/4:n.125-5059dupT:,NAMPT:ENST00000484527:intron_variant:MODIFIER:exon1/4:n.286-538dupT:,NAMPT:ENST00000393618:intron_variant:MODIFIER:exon1/4:n.125-538dupT:,NAMPT:ENST00000441045:intron_variant:MODIFIER:exon1/4:n.125-538dupT:,NAMPT:ENST00000486949:intron_variant:MODIFIER:exon1/3:n.61-538dupT:,NAMPT:ENST00000489358:intron_variant:MODIFIER:exon1/4:n.124-538dupT:,NAMPT:ENST00000424768:intron_variant:MODIFIER:exon2/3:c.58-538dupT:,NAMPT:ENST00000489732:intron_variant:MODIFIER:exon1/1:n.124-538dupT:,NAMPT:ENST00000417537:intron_variant:MODIFIER:exon2/2:c.58-538dupT:		Nicotinate and nicotinamide metabolism	Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity)				0.0000	0.0000	0.0000																					0		0.0309	388	0.0000	153
chr7	111125020	111125020	T	C	0.1905	24	0.0000	36		64	IMMP2L	intron_variant	IMMP2L:ENST00000331762:intron_variant:MODIFIER:exon4/6:c.239+2274A>G:,IMMP2L:ENST00000405709:intron_variant:MODIFIER:exon3/5:c.239+2274A>G:,IMMP2L:ENST00000452895:intron_variant:MODIFIER:exon4/6:c.239+2274A>G:,IMMP2L:ENST00000415362:intron_variant:MODIFIER:exon2/4:c.239+2274A>G:,IMMP2L:ENST00000447215:intron_variant:MODIFIER:exon3/4:c.239+2274A>G:,IMMP2L:ENST00000437687:intron_variant:MODIFIER:exon2/3:c.239+2274A>G:,IMMP2L:ENST00000492938:intron_variant:MODIFIER:exon3/3:n.293-1236A>G:			Catalyzes the removal of transit peptides required for the targeting of proteins from the mitochondrial matrix, across the inner membrane, into the inter-membrane space. Known to process the nuclear encoded protein DIABLO				0.0000	0.0000	0.0000																					0		0.2083	24	0.0000	36
chr7	111580272	111580272	-	TT	0.0769	99	0.0000	129		44	DOCK4	frameshift_variant,non_coding_transcript_exon_variant	DOCK4:ENST00000445943:frameshift_variant:HIGH:exon10/53:c.829_830dupAA:p.Asn278fs,DOCK4:ENST00000428084:frameshift_variant:HIGH:exon11/53:c.868_869dupAA:p.Asn291fs,DOCK4:ENST00000437633:frameshift_variant:HIGH:exon11/52:c.868_869dupAA:p.Asn291fs,DOCK4:ENST00000476846:non_coding_transcript_exon_variant:MODIFIER:exon11/23:n.1124_1125dupAA:			Involved in regulation of adherens junction between cells. Plays a role in cell migration. Functions as a guanine nucleotide exchange factor (GEF), which activates Rap1 small GTPase by exchanging bound GDP for free GTP				0.0000	0.0000	0.0000																					0		0.0617	81	0.0000	103
chr7	111736510	111736510	T	C	0.3846	14	0.0000	20		45	DOCK4	intron_variant	DOCK4:ENST00000428084:intron_variant:MODIFIER:exon1/52:c.38-92324A>G:,DOCK4:ENST00000437633:intron_variant:MODIFIER:exon1/51:c.38-92324A>G:,DOCK4:ENST00000476846:intron_variant:MODIFIER:exon1/22:n.294-92324A>G:			Involved in regulation of adherens junction between cells. Plays a role in cell migration. Functions as a guanine nucleotide exchange factor (GEF), which activates Rap1 small GTPase by exchanging bound GDP for free GTP				0.0000	0.0000	0.0000																					0		0.4286	14	0.0000	21
chr7	111779707	111779707	T	C	0.1538	27	0.0000	21		58	DOCK4	intron_variant	DOCK4:ENST00000428084:intron_variant:MODIFIER:exon1/52:c.37+66450A>G:,DOCK4:ENST00000437633:intron_variant:MODIFIER:exon1/51:c.37+66450A>G:,DOCK4:ENST00000476846:intron_variant:MODIFIER:exon1/22:n.293+66450A>G:			Involved in regulation of adherens junction between cells. Plays a role in cell migration. Functions as a guanine nucleotide exchange factor (GEF), which activates Rap1 small GTPase by exchanging bound GDP for free GTP				0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	21
chr7	128188937	128188937	A	G	0.3750	8	0.0000	27		44	RP11-274B21.1	intron_variant	RP11-274B21.1:ENST00000605862:intron_variant:MODIFIER:exon2/15:n.189+15153A>G:,RP11-274B21.1:ENST00000479267:intron_variant:MODIFIER:exon1/8:n.79+15153A>G:							0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	27
chr7	129539887	129539887	T	C	0.2162	37	0.0182	55		67	UBE2H	intron_variant	UBE2H:ENST00000355621:intron_variant:MODIFIER:exon1/6:c.54-19076A>G:,UBE2H:ENST00000473814:intron_variant:MODIFIER:exon1/4:c.54-19076A>G:,UBE2H:ENST00000496698:intron_variant:MODIFIER:exon1/6:c.-62-19076A>G:,UBE2H:ENST00000472396:intron_variant:MODIFIER:exon1/5:c.54-19076A>G:,UBE2H:ENST00000480245:intron_variant:MODIFIER:exon1/6:c.30-19076A>G:,UBE2H:ENST00000490974:intron_variant:MODIFIER:exon2/5:c.102-19076A>G:		Ubiquitin mediated proteolysis	Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys- 11'- and 'Lys-48'-linked polyubiquitination. Capable, in vitro, to ubiquitinate histone H2A				0.0000	0.0000	0.0000																					0		0.2162	37	0.0182	55
chr7	131112815	131112815	A	G	0.2381	22	0.0000	22		59	MKLN1	intron_variant	MKLN1:ENST00000352689:intron_variant:MODIFIER:exon8/17:c.848-977A>G:,MKLN1:ENST00000421797:intron_variant:MODIFIER:exon9/18:c.572-977A>G:,MKLN1:ENST00000494785:intron_variant:MODIFIER:exon8/16:n.865-977A>G:,MKLN1:ENST00000458153:intron_variant:MODIFIER:exon8/17:c.*338-977A>G:			Acts as a mediator of cell spreading and cytoskeletal responses to the extracellular matrix component THBS1 (By similarity)				0.0000	0.0000	0.0000																					0		0.2273	22	0.0000	22
chr7	134636967	134636967	A	G	0.2308	13	0.0333	30		52	CALD1	intron_variant	CALD1:ENST00000361675:intron_variant:MODIFIER:exon9/14:c.1935+1702A>G:,CALD1:ENST00000417172:intron_variant:MODIFIER:exon8/13:c.1170+1702A>G:,CALD1:ENST00000436461:intron_variant:MODIFIER:exon8/10:c.1170+1702A>G:,CALD1:ENST00000361388:intron_variant:MODIFIER:exon9/14:c.1248+1702A>G:,CALD1:ENST00000422748:intron_variant:MODIFIER:exon9/14:c.1248+1702A>G:,CALD1:ENST00000430085:intron_variant:MODIFIER:exon8/13:c.*683+1702A>G:,CALD1:ENST00000482470:intron_variant:MODIFIER:exon8/10:n.1399+1702A>G:,CALD1:ENST00000361901:intron_variant:MODIFIER:exon8/13:c.1170+1702A>G:,CALD1:ENST00000393118:intron_variant:MODIFIER:exon7/12:c.1230+1702A>G:,CALD1:ENST00000443197:intron_variant:MODIFIER:exon6/12:c.1152+1702A>G:,CALD1:ENST00000424922:intron_variant:MODIFIER:exon6/11:c.1152+1702A>G:,CALD1:ENST00000495522:intron_variant:MODIFIER:exon7/12:c.1230+1702A>G:,CALD1:ENST00000543443:intron_variant:MODIFIER:exon6/11:c.1185+1702A>G:,CALD1:ENST00000466704:intron_variant:MODIFIER:exon1/6:n.140+1702A>G:			Actin- and myosin-binding protein implicated in the regulation of actomyosin interactions in smooth muscle and nonmuscle cells (could act as a bridge between myosin and actin filaments). Stimulates actin binding of tropomyosin which increases the stabilization of actin filament structure. In muscle tissues, inhibits the actomyosin ATPase by binding to F-actin. This inhibition is attenuated by calcium-calmodulin and is potentiated by tropomyosin. Interacts with actin, myosin, two molecules of tropomyosin and with calmodulin. Also play an essential role during cellular mitosis and receptor capping. Involved in Schwann cell migration during peripheral nerve regeneration (By similarity)				0.0000	0.0000	0.0000																					0		0.2308	13	0.0333	30
chr7	148702233	148702233	-	T	1.0000	282	0.0355	279		58	PDIA4	frameshift_variant&splice_region_variant,splice_region_variant&non_coding_transcript_exon_variant	PDIA4:ENST00000286091:frameshift_variant&splice_region_variant:HIGH:exon9/10:c.1521dupA:p.Gly508fs,PDIA4:ENST00000466592:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon2/3:n.620dupA:		Vibrio cholerae infection					0.0000	0.0000	0.0000																					0		0.0149	268	0.0190	263
chr7	152111129	152111129	T	C	0.4286	7	0.0000	16		33	KMT2C	intron_variant	KMT2C:ENST00000355193:intron_variant:MODIFIER:exon1/59:c.161+21582A>G:,KMT2C:ENST00000262189:intron_variant:MODIFIER:exon1/58:c.161+21582A>G:,KMT2C:ENST00000558084:intron_variant:MODIFIER:exon1/58:c.161+21582A>G:,KMT2C:ENST00000452749:intron_variant:MODIFIER:exon1/3:c.161+21582A>G:			Histone methyltransferase. Methylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Central component of the MLL2/3 complex, a coactivator complex of nuclear receptors, involved in transcriptional coactivation. KMT2C/MLL3 may be a catalytic subunit of this complex. May be involved in leukemogenesis and developmental disorder				0.0000	0.0000	0.0000																					0		0.4286	7	0.0000	16
chr7	155571020	155571020	-	T	0.5455	16	0.0345	32		41	RBM33	3_prime_UTR_variant	RBM33:ENST00000401878:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3292dupT:,RBM33:ENST00000341148:3_prime_UTR_variant:MODIFIER:exon5/5:c.*3292dupT:							0.0000	0.0000	0.0000																					0		0.3571	14	0.0333	30
chr7	156993512	156993512	A	G	0.1481	27	0.0000	14		52	UBE3C	intron_variant	UBE3C:ENST00000348165:intron_variant:MODIFIER:exon10/22:c.1332-903A>G:		Ubiquitin mediated proteolysis	E3 ubiquitin-protein ligase that accepts ubiquitin from the E2 ubiquitin-conjugating enzyme UBE2D1 in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Can assemble unanchored poly-ubiquitin chains in either 'Lys-29'- or 'Lys-48'-linked polyubiquitin chains. Has preference for 'Lys-48' linkages. It can target itself for ubiquitination in vitro and may promote its own degradation in vivo				0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	14
chr7	158531274	158531274	T	C	0.2174	23	0.0000	32		74	ESYT2	intron_variant	ESYT2:ENST00000251527:intron_variant:MODIFIER:exon18/21:c.2348+440A>G:,ESYT2:ENST00000275418:intron_variant:MODIFIER:exon19/22:c.2321+440A>G:,ESYT2:ENST00000435514:intron_variant:MODIFIER:exon3/6:c.653+440A>G:			May play a role as calcium-regulated intrinsic membrane protein				0.0000	0.0000	0.0000																					0		0.2174	23	0.0000	32
chr8	11707293	11707293	T	C	0.2000	35	0.0196	51		58	CTSB	intron_variant	CTSB:ENST00000345125:intron_variant:MODIFIER:exon5/10:c.328-620A>G:,CTSB:ENST00000434271:intron_variant:MODIFIER:exon4/9:c.328-620A>G:,CTSB:ENST00000353047:intron_variant:MODIFIER:exon4/9:c.328-620A>G:,CTSB:ENST00000530640:intron_variant:MODIFIER:exon4/10:c.328-620A>G:,CTSB:ENST00000531089:intron_variant:MODIFIER:exon5/11:c.328-620A>G:,CTSB:ENST00000453527:intron_variant:MODIFIER:exon5/10:c.328-620A>G:,CTSB:ENST00000531551:intron_variant:MODIFIER:exon5/9:c.327+1082A>G:,CTSB:ENST00000415599:intron_variant:MODIFIER:exon3/7:c.327+1082A>G:,CTSB:ENST00000533455:intron_variant:MODIFIER:exon5/10:c.328-620A>G:,CTSB:ENST00000534510:intron_variant:MODIFIER:exon5/10:c.328-620A>G:,CTSB:ENST00000533110:intron_variant:MODIFIER:exon1/3:n.50+214A>G:,CTSB:ENST00000534636:intron_variant:MODIFIER:exon4/5:c.328-620A>G:,CTSB:ENST00000533572:intron_variant:MODIFIER:exon4/5:c.328-620A>G:,CTSB:ENST00000530296:intron_variant:MODIFIER:exon4/5:c.328-620A>G:,CTSB:ENST00000525076:intron_variant:MODIFIER:exon4/5:n.411-620A>G:,CTSB:ENST00000526195:intron_variant:MODIFIER:exon4/4:c.328-620A>G:,CTSB:ENST00000527243:intron_variant:MODIFIER:exon4/4:c.328-620A>G:,CTSB:ENST00000534149:intron_variant:MODIFIER:exon4/4:c.328-620A>G:,CTSB:ENST00000526645:intron_variant:MODIFIER:exon5/5:c.328-620A>G:		Antigen processing and presentation	Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Has also been implicated in tumor invasion and metastasis			rs140237205	0.00858626	0.0000	0.0000																					0		0.2000	35	0.0196	51
chr8	11724206	11724206	T	C	0.1081	37	0.0000	39		56	CTSB	intron_variant	CTSB:ENST00000345125:intron_variant:MODIFIER:exon1/10:c.-145+1304A>G:,CTSB:ENST00000434271:intron_variant:MODIFIER:exon1/9:c.-61+1263A>G:,CTSB:ENST00000353047:intron_variant:MODIFIER:exon1/9:c.-26+1304A>G:,CTSB:ENST00000530640:intron_variant:MODIFIER:exon1/10:c.-26+1304A>G:,CTSB:ENST00000531089:intron_variant:MODIFIER:exon1/11:c.-114+1304A>G:,CTSB:ENST00000453527:intron_variant:MODIFIER:exon1/10:c.-100+1304A>G:,CTSB:ENST00000531551:intron_variant:MODIFIER:exon1/9:c.-114+1304A>G:,CTSB:ENST00000533455:intron_variant:MODIFIER:exon1/10:c.-114+1304A>G:,CTSB:ENST00000534510:intron_variant:MODIFIER:exon1/10:c.-109+1304A>G:,CTSB:ENST00000534636:intron_variant:MODIFIER:exon1/5:c.-26+1273A>G:,CTSB:ENST00000533572:intron_variant:MODIFIER:exon1/5:c.-26+557A>G:,CTSB:ENST00000530296:intron_variant:MODIFIER:exon1/5:c.-26+2180A>G:,CTSB:ENST00000525076:intron_variant:MODIFIER:exon1/5:n.58+1304A>G:,CTSB:ENST00000526195:intron_variant:MODIFIER:exon1/4:c.-26+1950A>G:,CTSB:ENST00000534149:intron_variant:MODIFIER:exon1/4:c.-26+1974A>G:,CTSB:ENST00000526645:intron_variant:MODIFIER:exon1/5:c.-109+1974A>G:,CTSB:ENST00000505496:intron_variant:MODIFIER:exon1/5:c.-197+1304A>G:,CTSB:ENST00000524500:intron_variant:MODIFIER:exon1/5:c.-208+1304A>G:,CTSB:ENST00000531502:intron_variant:MODIFIER:exon2/4:c.-26+557A>G:,CTSB:ENST00000532656:intron_variant:MODIFIER:exon1/4:c.-248+1304A>G:,CTSB:ENST00000534382:intron_variant:MODIFIER:exon1/2:c.-26+2225A>G:,CTSB:ENST00000527215:intron_variant:MODIFIER:exon2/4:c.-114+557A>G:,CTSB:ENST00000528965:intron_variant:MODIFIER:exon1/3:c.-114+557A>G:,CTSB:ENST00000532392:intron_variant:MODIFIER:exon2/3:c.-147+557A>G:		Antigen processing and presentation	Thiol protease which is believed to participate in intracellular degradation and turnover of proteins. Has also been implicated in tumor invasion and metastasis				0.0000	0.0000	0.0000																					0		0.1081	37	0.0000	39
chr8	17388859	17388859	A	G	0.0746	68	0.0000	28		59	SLC7A2	intron_variant	SLC7A2:ENST00000494857:intron_variant:MODIFIER:exon2/12:c.-22-11968A>G:,SLC7A2:ENST00000522656:intron_variant:MODIFIER:exon1/11:c.-22-11968A>G:,SLC7A2:ENST00000470360:intron_variant:MODIFIER:exon2/13:c.-48-7427A>G:			Low-affinity, high capacity permease involved in the transport of the cationic amino acids (arginine, lysine and ornithine). Plays a regulatory role in classical or alternative activation of macrophages (By similarity)				0.0000	0.0000	0.0000																					0		0.0882	68	0.0000	28
chr8	17388940	17388940	A	G	0.0806	62	0.0000	31		60	SLC7A2	intron_variant	SLC7A2:ENST00000494857:intron_variant:MODIFIER:exon2/12:c.-22-11887A>G:,SLC7A2:ENST00000522656:intron_variant:MODIFIER:exon1/11:c.-22-11887A>G:,SLC7A2:ENST00000470360:intron_variant:MODIFIER:exon2/13:c.-48-7346A>G:			Low-affinity, high capacity permease involved in the transport of the cationic amino acids (arginine, lysine and ornithine). Plays a regulatory role in classical or alternative activation of macrophages (By similarity)				0.0000	0.0000	0.0000																					0		0.0806	62	0.0000	31
chr8	17390377	17390377	A	G	0.1176	51	0.0000	36		67	SLC7A2	intron_variant	SLC7A2:ENST00000494857:intron_variant:MODIFIER:exon2/12:c.-22-10450A>G:,SLC7A2:ENST00000522656:intron_variant:MODIFIER:exon1/11:c.-22-10450A>G:,SLC7A2:ENST00000470360:intron_variant:MODIFIER:exon2/13:c.-48-5909A>G:			Low-affinity, high capacity permease involved in the transport of the cationic amino acids (arginine, lysine and ornithine). Plays a regulatory role in classical or alternative activation of macrophages (By similarity)				0.0000	0.0000	0.0000																					0		0.1176	51	0.0000	36
chr8	22921149	22921149	A	G	0.4286	7	0.0000	17		34	TNFRSF10B	intron_variant	TNFRSF10B:ENST00000276431:intron_variant:MODIFIER:exon1/8:c.144+5115T>C:,TNFRSF10B:ENST00000347739:intron_variant:MODIFIER:exon1/9:c.144+5115T>C:,TNFRSF10B:ENST00000523504:intron_variant:MODIFIER:exon1/8:c.144+5115T>C:,TNFRSF10B:ENST00000542226:intron_variant:MODIFIER:exon1/8:c.-204+5115T>C:,TNFRSF10B:ENST00000519028:intron_variant:MODIFIER:exon1/1:n.272+5115T>C:		Cytokine-cytokine receptor interaction;p53 signaling pathway;Apoptosis;Natural killer cell mediated cytotoxicity	Receptor for the cytotoxic ligand TNFSF10/TRAIL. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Promotes the activation of NF- kappa-B. Essential for ER stress-induced apoptosis	Induction of apoptosis through DR3 and DR4/5 Death Receptors 			0.0000	0.0000	0.0000		603612 [TNFRSF10B (confirmed) Squamous cell carcinoma,head and neck,275355];																			0		0.4286	7	0.0000	17
chr8	25129780	25129780	A	G	0.2105	19	0.0000	20		52	DOCK5	intron_variant	DOCK5:ENST00000276440:intron_variant:MODIFIER:exon3/51:c.169-3122A>G:,DOCK5:ENST00000481100:intron_variant:MODIFIER:exon3/10:c.169-3122A>G:			Guanine nucleotide exchange factor (GEF) for Rho and Rac. GEF proteins activate small GTPases by exchanging bound GDP for free GTP				0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	20
chr8	33657604	33657604	A	G	0.1724	29	0.0000	17		58	RP11-317N12.1	intron_variant	RP11-317N12.1:ENST00000523063:intron_variant:MODIFIER:exon3/5:n.504+3650A>G:							0.0000	0.0000	0.0000																					0		0.1724	29	0.0000	17
chr8	33657630	33657630	A	G	0.1429	28	0.0000	20		57	RP11-317N12.1	intron_variant	RP11-317N12.1:ENST00000523063:intron_variant:MODIFIER:exon3/5:n.504+3676A>G:							0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	20
chr8	37451510	37451510	T	C	0.2075	53	0.0000	23		70	RP11-150O12.5-RP11-150O12.3	intergenic_region	RP11-150O12.5-RP11-150O12.3:ENSG00000254111-ENSG00000254290:intergenic_region:MODIFIER::n.37451510T>C:							0.0000	0.0000	0.0000																					0		0.2075	53	0.0000	23
chr8	38122618	38122618	T	C	0.2564	40	0.0800	53		55	PPAPDC1B,DDHD2	intron_variant	PPAPDC1B:ENST00000424479:intron_variant:MODIFIER:exon6/6:c.635-496A>G:,DDHD2:ENST00000526071:intron_variant:MODIFIER:exon1/1:n.87+4953T>C:,DDHD2:ENST00000529872:intron_variant:MODIFIER:exon2/3:n.137+3501T>C:,PPAPDC1B:ENST00000529359:intron_variant:MODIFIER:exon5/5:c.512-496A>G:,PPAPDC1B:ENST00000530193:intron_variant:MODIFIER:exon2/2:n.227+1041A>G:,PPAPDC1B:ENST00000530432:intron_variant:MODIFIER:exon1/1:n.320-496A>G:,PPAPDC1B:ENST00000524616:intron_variant:MODIFIER:exon6/6:c.578-496A>G:,PPAPDC1B:ENST00000531823:intron_variant:MODIFIER:exon6/6:c.239-496A>G:,PPAPDC1B:ENST00000534339:intron_variant:MODIFIER:exon6/6:c.572-496A>G:,PPAPDC1B:ENST00000531109:intron_variant:MODIFIER:exon5/5:c.*337-496A>G:,PPAPDC1B:ENST00000527758:intron_variant:MODIFIER:exon1/1:n.84-27A>G:,PPAPDC1B:ENST00000530588:intron_variant:MODIFIER:exon1/1:n.396-27A>G:,PPAPDC1B:ENST00000422581:intron_variant:MODIFIER:exon6/6:c.635-151A>G:			Displays magnesium-independent phosphatidate phosphatase activity in vitro. Catalyzes the conversion of phosphatidic acid to diacylglycerol. May be a metastatic suppressor for hepatocellular carcinoma.,Phospholipase that hydrolyzes preferentially phosphatidic acid, including 1,2-dioleoyl-sn-phosphatidic acid, and phosphatidylethanolamine. Specifically binds to phosphatidylinositol 3-phosphate (PI(3)P), phosphatidylinositol 4- phosphate (PI(4)P), phosphatidylinositol 5-phosphate (PI(5)P) and possibly phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). May be involved in the maintenance of the endoplasmic reticulum and/or Golgi structures. May regulate the transport between Golgi apparatus and plasma membrane			rs558154383	0.0000	0.0000	0.0000																					0		0.2500	40	0.0755	53
chr8	42876147	42876147	A	G	0.2857	21	0.0606	33		51	HOOK3,RP11-598P20.5	3_prime_UTR_variant,intron_variant	HOOK3:ENST00000307602:3_prime_UTR_variant:MODIFIER:exon22/22:c.*2506A>G:,RP11-598P20.5:ENST00000534420:intron_variant:MODIFIER:exon1/5:c.71+2510A>G:,HOOK3:ENST00000533338:intron_variant:MODIFIER:exon1/1:c.89+2510A>G:		Glycolysis / Gluconeogenesis;Fructose and mannose metabolism;Galactose metabolism;Starch and sucrose metabolism;Streptomycin biosynthesis;Aminosugars metabolism	Probably serves as a target for the spiC protein from Salmonella typhimurium, which inactivates it, leading to a strong alteration in cellular trafficking (By similarity). Component of the FTS/Hook/FHIP complex (FHF complex). The FHF complex may function to promote vesicle trafficking and/or fusion via the homotypic vesicular protein sorting complex (the HOPS complex). May regulate clearance of endocytosed receptors such as MSR1. Participates in defining the architecture and localization of the Golgi complex				0.0000	0.0000	0.0000																					0		0.2857	21	0.0588	34
chr8	52767271	52767271	T	C	0.1739	23	0.0000	24		52	PCMTD1	intron_variant	PCMTD1:ENST00000360540:intron_variant:MODIFIER:exon3/6:c.307+6134A>G:,PCMTD1:ENST00000544451:intron_variant:MODIFIER:exon1/3:c.183-21022A>G:,PCMTD1:ENST00000519559:intron_variant:MODIFIER:exon1/5:n.42-8948A>G:,PCMTD1:ENST00000522514:intron_variant:MODIFIER:exon2/5:c.307+6134A>G:,PCMTD1:ENST00000519975:intron_variant:MODIFIER:exon1/1:n.40+6134A>G:,PCMTD1:ENST00000521344:intron_variant:MODIFIER:exon2/2:c.292-4625A>G:							0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	24
chr8	56810392	56810392	A	G	0.2174	23	0.0000	33		73	LYN	intron_variant	LYN:ENST00000519728:intron_variant:MODIFIER:exon1/12:c.-6+17730A>G:,LYN:ENST00000520220:intron_variant:MODIFIER:exon1/12:c.-6+17730A>G:		B cell receptor signaling pathway;Fc epsilon RI signaling pathway;Long-term depression;Epithelial cell signaling in Helicobacter pylori infection	Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down- regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Down- regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, PTK2B/PYK2, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3- kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr- 72'	BCR Signaling Pathway;Eph Kinases and ephrins support platelet aggregation;Fc Epsilon Receptor I Signaling in Mast Cells;Phosphoinositides and their downstream targets			0.0000	0.0000	0.0000																					0		0.2174	23	0.0000	33
chr8	56819099	56819099	A	G	0.2857	14	0.0313	32		58	LYN	intron_variant	LYN:ENST00000519728:intron_variant:MODIFIER:exon1/12:c.-6+26437A>G:,LYN:ENST00000520220:intron_variant:MODIFIER:exon1/12:c.-6+26437A>G:		B cell receptor signaling pathway;Fc epsilon RI signaling pathway;Long-term depression;Epithelial cell signaling in Helicobacter pylori infection	Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down- regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Down- regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, PTK2B/PYK2, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3- kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr- 72'	BCR Signaling Pathway;Eph Kinases and ephrins support platelet aggregation;Fc Epsilon Receptor I Signaling in Mast Cells;Phosphoinositides and their downstream targets			0.0000	0.0000	0.0000																					0		0.2857	14	0.0312	32
chr8	63973020	63973020	T	C	0.4545	11	0.0000	22		50	TTPA	3_prime_UTR_variant,intron_variant	TTPA:ENST00000260116:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791A>G:,TTPA:ENST00000521138:intron_variant:MODIFIER:exon1/1:n.233-11858A>G:			Binds alpha-tocopherol, enhances its transfer between separate membranes, and stimulates its release from liver cells. Binds both phosphatidylinol 3,4-bisphosphate and phosphatidylinol 4,5-bisphosphate; the resulting conformation change is important for the release of the bound alpha-tocopherol (By similarity)				0.0000	0.0000	0.0000		600415 [TTPA (confirmed) Ataxia with isolated vitamin E deficiency,277460];																			0		0.4545	11	0.0000	22
chr8	66643014	66643014	T	C	0.2083	26	0.0238	42		54	PDE7A,MTFR1	intron_variant	PDE7A:ENST00000401827:intron_variant:MODIFIER:exon7/12:c.697-3478A>G:,MTFR1:ENST00000521247:intron_variant:MODIFIER:exon3/3:c.*48+11298T>C:,MTFR1:ENST00000527155:intron_variant:MODIFIER:exon2/2:c.372+22768T>C:,PDE7A:ENST00000379419:intron_variant:MODIFIER:exon7/12:c.619-3478A>G:,PDE7A:ENST00000396642:intron_variant:MODIFIER:exon7/11:c.697-3478A>G:,PDE7A:ENST00000518667:intron_variant:MODIFIER:exon6/7:n.613+782A>G:		Purine metabolism	Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May have a role in muscle signal transduction.,May play a role in mitochondrial aerobic respiration. May also regulate mitochondrial organization and fission (By similarity)				0.0000	0.0000	0.0000																					0		0.1923	26	0.0238	42
chr8	70545150	70545150	A	G	0.2105	19	0.0000	24		61	SULF1	intron_variant	SULF1:ENST00000260128:intron_variant:MODIFIER:exon19/22:c.2284+3236A>G:,SULF1:ENST00000458141:intron_variant:MODIFIER:exon18/21:c.2284+3236A>G:,SULF1:ENST00000402687:intron_variant:MODIFIER:exon19/22:c.2284+3236A>G:,SULF1:ENST00000419716:intron_variant:MODIFIER:exon18/21:c.2284+3236A>G:,SULF1:ENST00000521946:intron_variant:MODIFIER:exon12/16:n.1624+3236A>G:,SULF1:ENST00000531512:intron_variant:MODIFIER:exon3/5:c.304+3236A>G:			Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity. It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin. Diminishes HSPG (heparan sulfate proteoglycans) sulfation, inhibits signaling by heparin-dependent growth factors, diminishes proliferation, and facilitates apoptosis in response to exogenous stimulation				0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	24
chr8	86202259	86202259	A	G	0.2667	15	0.0000	25		55	CA13-CA1	intergenic_region	CA13-CA1:ENSG00000185015-ENSG00000133742:intergenic_region:MODIFIER::n.86202259A>G:							0.0000	0.0000	0.0000																					0		0.2667	15	0.0000	25
chr8	90761470	90761470	T	C	0.2857	14	0.0000	22		54	RP11-37B2.1	intron_variant	RP11-37B2.1:ENST00000504145:intron_variant:MODIFIER:exon1/4:n.667+7803A>G:,RP11-37B2.1:ENST00000519655:intron_variant:MODIFIER:exon1/6:n.683+7803A>G:,RP11-37B2.1:ENST00000524190:intron_variant:MODIFIER:exon1/2:n.150+7803A>G:							0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	22
chr8	98663037	98663037	A	G	0.2500	16	0.0000	25		63	MTDH	intron_variant	MTDH:ENST00000336273:intron_variant:MODIFIER:exon1/11:c.381+5922A>G:,MTDH:ENST00000519934:intron_variant:MODIFIER:exon1/10:c.312+5922A>G:,MTDH:ENST00000522313:intron_variant:MODIFIER:exon1/4:c.93+5922A>G:			Downregulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activates the nuclear factor kappa-B (NF- kappa-B) transcription factor. Promotes anchorage-independent growth of immortalized melanocytes and astrocytes which is a key component in tumor cell expansion. Promotes lung metastasis and also has an effect on bone and brain metastasis, possibly by enhancing the seeding of tumor cells to the target organ endothelium. Induces chemoresistance				0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	25
chr8	101931662	101931662	C	T	0.0435	254	0.0000	279		112	YWHAZ	3_prime_UTR_variant,intron_variant	YWHAZ:ENST00000395957:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1259G>A:,YWHAZ:ENST00000395958:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1259G>A:,YWHAZ:ENST00000457309:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1259G>A:,YWHAZ:ENST00000395956:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1259G>A:,YWHAZ:ENST00000353245:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1259G>A:,YWHAZ:ENST00000523848:intron_variant:MODIFIER:exon4/4:c.*104-205G>A:		Cell cycle;Pathogenic Escherichia coli infection;EPEC	Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner				0.0000	0.0000	0.0000																					0		0.0430	256	0.0000	279
chr8	104344561	104344561	-	T	0.2308	30	0.0000	33		50	FZD6	3_prime_UTR_variant	FZD6:ENST00000358755:3_prime_UTR_variant:MODIFIER:exon7/7:c.*830dupT:,FZD6:ENST00000522566:3_prime_UTR_variant:MODIFIER:exon7/7:c.*830dupT:,FZD6:ENST00000522484:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1398dupT:		Wnt signaling pathway;Melanogenesis;Colorectal cancer;Basal cell carcinoma	Receptor for Wnt proteins. Most of frizzled receptors are coupled to the beta-catenin canonical signaling pathway, which leads to the activation of disheveled proteins, inhibition of GSK- 3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues				0.0000	0.0000	0.0000		603409 [FZD6 (provisional) Nail disorder,nonsyndromic congenital,10,(claw-shaped nails),614157];																			0		0.2143	28	0.0000	32
chr8	116560392	116560392	T	C	0.1538	26	0.0000	28		59	TRPS1	intron_variant	TRPS1:ENST00000395715:intron_variant:MODIFIER:exon5/6:c.2700+38836A>G:,TRPS1:ENST00000220888:intron_variant:MODIFIER:exon4/5:c.2661+38836A>G:,TRPS1:ENST00000519076:intron_variant:MODIFIER:exon5/6:c.1923+38836A>G:,TRPS1:ENST00000520276:intron_variant:MODIFIER:exon4/5:c.2673+38836A>G:,TRPS1:ENST00000519674:intron_variant:MODIFIER:exon4/4:c.2662-32882A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes				0.0000	0.0000	0.0000		604386 [TRPS1 (confirmed) Trichorhinophalangeal syndrome,type I,190350|Trichorhinophalangeal syndrome,type III,190351];																			0		0.1538	26	0.0000	28
chr8	116569950	116569950	T	C	0.1600	25	0.0000	20		60	TRPS1	intron_variant	TRPS1:ENST00000395715:intron_variant:MODIFIER:exon5/6:c.2700+29278A>G:,TRPS1:ENST00000220888:intron_variant:MODIFIER:exon4/5:c.2661+29278A>G:,TRPS1:ENST00000519076:intron_variant:MODIFIER:exon5/6:c.1923+29278A>G:,TRPS1:ENST00000520276:intron_variant:MODIFIER:exon4/5:c.2673+29278A>G:,TRPS1:ENST00000519674:intron_variant:MODIFIER:exon4/4:c.2661+29278A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes				0.0000	0.0000	0.0000		604386 [TRPS1 (confirmed) Trichorhinophalangeal syndrome,type I,190350|Trichorhinophalangeal syndrome,type III,190351];																			0		0.1600	25	0.0000	20
chr8	116584655	116584655	-	A	0.2381	25	0.0000	21		45	TRPS1	intron_variant	TRPS1:ENST00000395715:intron_variant:MODIFIER:exon5/6:c.2700+14572dupT:,TRPS1:ENST00000220888:intron_variant:MODIFIER:exon4/5:c.2661+14572dupT:,TRPS1:ENST00000519076:intron_variant:MODIFIER:exon5/6:c.1923+14572dupT:,TRPS1:ENST00000520276:intron_variant:MODIFIER:exon4/5:c.2673+14572dupT:,TRPS1:ENST00000519674:intron_variant:MODIFIER:exon4/4:c.2661+14572dupT:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Transcriptional repressor. Binds specifically to GATA sequences and represses expression of GATA-regulated genes at selected sites and stages in vertebrate development. Regulates chondrocyte proliferation and differentiation. Executes multiple functions in proliferating chondrocytes, expanding the region of distal chondrocytes, activating proliferation in columnar cells and supporting the differentiation of columnar into hypertrophic chondrocytes				0.0000	0.0000	0.0000		604386 [TRPS1 (confirmed) Trichorhinophalangeal syndrome,type I,190350|Trichorhinophalangeal syndrome,type III,190351];																			0		0.1304	23	0.0000	21
chr8	118919205	118919205	-	A	0.2400	30	0.0000	28		48	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.963-69766dupT:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.74-71416dupT:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.330-69766dupT:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.1600	25	0.0000	123
chr8	118922226	118922226	T	C	0.1163	43	0.0000	34		65	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.963-72786A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.74-74436A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.330-72786A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor			rs7842917	0.252396	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.1163	43	0.0000	34
chr8	118922273	118922273	T	C	0.1224	49	0.0000	34		66	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.963-72833A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.74-74483A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.330-72833A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.1224	49	0.0000	34
chr8	118958234	118958234	T	C	0.2558	43	0.0588	34		56	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.963-108794A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.74-110444A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.330-108794A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.2558	43	0.0588	34
chr8	118996576	118996576	T	C	0.1429	28	0.0000	26		53	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.962+125748A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.73+126637A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.329+125748A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.1429	28	0.0000	26
chr8	118997899	118997899	-	A	0.2439	51	0.0000	25		40	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.962+124424dupT:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.73+125313dupT:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.329+124424dupT:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.0833	48	0.0000	20
chr8	118998606	118998606	T	C	0.1190	43	0.0000	41		67	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.962+123718A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.73+124607A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.329+123718A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.1163	43	0.0000	41
chr8	119025516	119025516	T	C	0.0968	62	0.0000	43		68	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.962+96808A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.73+97697A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.329+96808A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.0968	62	0.0000	43
chr8	119042977	119042977	T	C	0.0686	103	0.0109	95		54	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.962+79347A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.73+80236A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.329+79347A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.0680	103	0.0105	95
chr8	119044861	119044861	T	C	0.0741	82	0.0000	70		62	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.962+77463A>G:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.73+78352A>G:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.329+77463A>G:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor				0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.0732	82	0.0000	70
chr8	119119524	119119524	-	T	0.1667	69	0.0000	34		42	EXT1	intron_variant	EXT1:ENST00000378204:intron_variant:MODIFIER:exon1/10:c.962+2799dupA:,EXT1:ENST00000437196:intron_variant:MODIFIER:exon1/9:c.73+3688dupA:,EXT1:ENST00000436216:intron_variant:MODIFIER:exon1/4:c.329+2799dupA:		Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor			rs368025739	0.0000	0.0000	0.0000		608177 [EXT1 (confirmed) Exostoses,multiple,type 1,133700|Chondrosarcoma,215300];																			0		0.0984	61	0.0000	33
chr8	120743556	120743556	-	A	0.2500	25	0.0000	24		45	TAF2	3_prime_UTR_variant	TAF2:ENST00000378164:3_prime_UTR_variant:MODIFIER:exon26/26:c.*607dupT:		Basal transcription factors	Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. TFIID is a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. It requires core promoter-specific cofactors for productive transcription stimulation. TAF2 stabilizes TFIID binding to core promoter				0.0000	0.0000	0.0000		604912 [TAF2 (provisional) Mental retardation,autosomal recessive 40,615599];																			0		0.2083	24	0.0000	29
chr8	125590911	125590911	T	C	0.4167	13	0.0000	20		41	MTSS1	intron_variant	MTSS1:ENST00000325064:intron_variant:MODIFIER:exon7/14:c.472+1881A>G:,MTSS1:ENST00000378017:intron_variant:MODIFIER:exon6/13:c.460+6417A>G:,MTSS1:ENST00000518547:intron_variant:MODIFIER:exon6/13:c.460+6417A>G:,MTSS1:ENST00000354184:intron_variant:MODIFIER:exon6/12:c.-141+6417A>G:,MTSS1:ENST00000522162:intron_variant:MODIFIER:exon6/6:c.442+6417A>G:			May be related to cancer progression or tumor metastasis in a variety of organ sites, most likely through an interaction with the actin cytoskeleton				0.0000	0.0000	0.0000																					0		0.3846	13	0.0000	20
chr8	130712411	130712411	T	C	0.2000	26	0.0000	29		54	RP11-419K12.1-RP11-274M4.1	intergenic_region	RP11-419K12.1-RP11-274M4.1:ENSG00000254223-ENSG00000224110:intergenic_region:MODIFIER::n.130712411T>C:							0.0000	0.0000	0.0000																					0		0.1923	26	0.0000	29
chr8	130902247	130902247	T	C	0.3333	9	0.0000	22		46	FAM49B	intron_variant	FAM49B:ENST00000401979:intron_variant:MODIFIER:exon5/14:c.-11+6748A>G:,FAM49B:ENST00000519824:intron_variant:MODIFIER:exon2/11:c.-10-10530A>G:,FAM49B:ENST00000522746:intron_variant:MODIFIER:exon4/14:c.-94+6671A>G:,FAM49B:ENST00000523509:intron_variant:MODIFIER:exon4/13:c.-11+6671A>G:,FAM49B:ENST00000519110:intron_variant:MODIFIER:exon4/13:c.-10-10530A>G:,FAM49B:ENST00000523288:intron_variant:MODIFIER:exon3/10:n.184-10530A>G:,FAM49B:ENST00000522250:intron_variant:MODIFIER:exon1/9:c.-365-18505A>G:,FAM49B:ENST00000517654:intron_variant:MODIFIER:exon3/12:c.-10-10530A>G:,FAM49B:ENST00000519540:intron_variant:MODIFIER:exon3/12:c.-10-10530A>G:,FAM49B:ENST00000522941:intron_variant:MODIFIER:exon3/10:c.-260+13311A>G:,FAM49B:ENST00000519142:intron_variant:MODIFIER:exon4/7:c.-10-10530A>G:,FAM49B:ENST00000518879:intron_variant:MODIFIER:exon5/6:n.577+13311A>G:,FAM49B:ENST00000522702:intron_variant:MODIFIER:exon5/7:n.256+13311A>G:,FAM49B:ENST00000521223:intron_variant:MODIFIER:exon5/7:n.309+13311A>G:,FAM49B:ENST00000520204:intron_variant:MODIFIER:exon2/5:c.-203-10212A>G:,FAM49B:ENST00000518283:intron_variant:MODIFIER:exon5/7:c.-10-10530A>G:,FAM49B:ENST00000523993:intron_variant:MODIFIER:exon4/6:c.-10-10530A>G:,FAM49B:ENST00000520254:intron_variant:MODIFIER:exon2/5:c.-93-9543A>G:,FAM49B:ENST00000519020:intron_variant:MODIFIER:exon4/6:c.-11+4486A>G:,FAM49B:ENST00000518167:intron_variant:MODIFIER:exon2/4:c.-93-9543A>G:,FAM49B:ENST00000517672:intron_variant:MODIFIER:exon3/5:c.-203-10212A>G:,FAM49B:ENST00000519070:intron_variant:MODIFIER:exon3/5:c.-93-9543A>G:,FAM49B:ENST00000522361:intron_variant:MODIFIER:exon4/5:c.-10-10530A>G:							0.0000	0.0000	0.0000																					0		0.3333	9	0.0000	22
chr8	131284610	131284610	-	A	0.1724	31	0.0000	26		41	ASAP1	intron_variant	ASAP1:ENST00000357668:intron_variant:MODIFIER:exon2/28:c.187-35371dupT:,ASAP1:ENST00000521075:intron_variant:MODIFIER:exon3/29:c.*169-35371dupT:,ASAP1:ENST00000518721:intron_variant:MODIFIER:exon3/29:c.187-35371dupT:,ASAP1:ENST00000524367:intron_variant:MODIFIER:exon1/10:c.97-35371dupT:,ASAP1:ENST00000520927:intron_variant:MODIFIER:exon4/8:c.*169-35371dupT:,ASAP1:ENST00000524299:intron_variant:MODIFIER:exon4/5:c.*169-35371dupT:,ASAP1:ENST00000521426:intron_variant:MODIFIER:exon3/4:c.166-35371dupT:			Possesses phosphatidylinositol 4,5-bisphosphate- dependent GTPase-activating protein activity for ARF1 (ADP ribosylation factor 1) and ARF5 and a lesser activity towards ARF6. May coordinate membrane trafficking with cell growth or actin cytoskeleton remodeling by binding to both SRC and PIP2. May function as a signal transduction protein involved in the differentiation of fibroblasts into adipocytes and possibly other cell types (By similarity). Plays a role in ciliogenesis				0.0000	0.0000	0.0000																					0		0.0312	160	0.0000	26
chr8	131366022	131366022	T	C	0.0864	83	0.0000	82		74	ASAP1	intron_variant	ASAP1:ENST00000357668:intron_variant:MODIFIER:exon2/28:c.186+4241A>G:,ASAP1:ENST00000521075:intron_variant:MODIFIER:exon3/29:c.*168+4241A>G:,ASAP1:ENST00000518721:intron_variant:MODIFIER:exon3/29:c.186+4241A>G:,ASAP1:ENST00000520927:intron_variant:MODIFIER:exon4/8:c.*168+4241A>G:,ASAP1:ENST00000524299:intron_variant:MODIFIER:exon4/5:c.*168+4241A>G:,ASAP1:ENST00000521426:intron_variant:MODIFIER:exon3/4:c.165+4241A>G:			Possesses phosphatidylinositol 4,5-bisphosphate- dependent GTPase-activating protein activity for ARF1 (ADP ribosylation factor 1) and ARF5 and a lesser activity towards ARF6. May coordinate membrane trafficking with cell growth or actin cytoskeleton remodeling by binding to both SRC and PIP2. May function as a signal transduction protein involved in the differentiation of fibroblasts into adipocytes and possibly other cell types (By similarity). Plays a role in ciliogenesis				0.0000	0.0000	0.0000																					0		0.0899	89	0.0000	95
chr8	133300936	133300936	-	T	0.2500	27	0.0000	25		44	KCNQ3	intron_variant	KCNQ3:ENST00000388996:intron_variant:MODIFIER:exon1/14:c.387-102509dupA:,KCNQ3:ENST00000521134:intron_variant:MODIFIER:exon1/14:c.27-102509dupA:,KCNQ3:ENST00000519445:intron_variant:MODIFIER:exon1/14:c.387-102509dupA:,KCNQ3:ENST00000519589:intron_variant:MODIFIER:exon1/13:n.165-102509dupA:			Probably important in the regulation of neuronal excitability. Associates with KCNQ2 or KCNQ5 to form a potassium channel with essentially identical properties to the channel underlying the native M-current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons as well as the responsiveness to synaptic inputs				0.0000	0.0000	0.0000		602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];																			0		0.1739	23	0.0000	24
chr8	133323635	133323635	T	C	0.1667	30	0.0000	20		63	KCNQ3	intron_variant	KCNQ3:ENST00000388996:intron_variant:MODIFIER:exon1/14:c.387-125207A>G:,KCNQ3:ENST00000521134:intron_variant:MODIFIER:exon1/14:c.27-125207A>G:,KCNQ3:ENST00000519445:intron_variant:MODIFIER:exon1/14:c.387-125207A>G:,KCNQ3:ENST00000519589:intron_variant:MODIFIER:exon1/13:n.165-125207A>G:			Probably important in the regulation of neuronal excitability. Associates with KCNQ2 or KCNQ5 to form a potassium channel with essentially identical properties to the channel underlying the native M-current, a slowly activating and deactivating potassium conductance which plays a critical role in determining the subthreshold electrical excitability of neurons as well as the responsiveness to synaptic inputs				0.0000	0.0000	0.0000		602232 [KCNQ3 (confirmed) Seizures,benign neonatal,type 2,121201];																			0		0.1379	29	0.0000	16
chr8	134214417	134214417	A	G	0.1481	28	0.0000	25		60	WISP1	intron_variant	WISP1:ENST00000250160:intron_variant:MODIFIER:exon1/4:c.70-10690A>G:,WISP1:ENST00000377862:intron_variant:MODIFIER:exon1/2:c.69+10961A>G:,WISP1:ENST00000519433:intron_variant:MODIFIER:exon1/1:c.69+10961A>G:,WISP1:ENST00000377863:intron_variant:MODIFIER:exon1/2:c.94+10961A>G:,WISP1:ENST00000517423:intron_variant:MODIFIER:exon1/2:c.70-10690A>G:,WISP1:ENST00000220856:intron_variant:MODIFIER:exon1/3:c.70-10690A>G:			Downstream regulator in the Wnt/Frizzled-signaling pathway. Associated with cell survival. Attenuates p53-mediated apoptosis in response to DNA damage through activation of AKT kinase. Up-regulates the anti-apoptotic Bcl-X(L) protein. Adheres to skin and melanoma fibroblasts. In vitro binding to skin fibroblasts occurs through the proteoglycans, decorin and biglycan				0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	25
chr8	134214463	134214463	A	G	0.1905	27	0.0000	35		61	WISP1	intron_variant	WISP1:ENST00000250160:intron_variant:MODIFIER:exon1/4:c.70-10644A>G:,WISP1:ENST00000377862:intron_variant:MODIFIER:exon1/2:c.69+11007A>G:,WISP1:ENST00000519433:intron_variant:MODIFIER:exon1/1:c.69+11007A>G:,WISP1:ENST00000377863:intron_variant:MODIFIER:exon1/2:c.94+11007A>G:,WISP1:ENST00000517423:intron_variant:MODIFIER:exon1/2:c.70-10644A>G:,WISP1:ENST00000220856:intron_variant:MODIFIER:exon1/3:c.70-10644A>G:			Downstream regulator in the Wnt/Frizzled-signaling pathway. Associated with cell survival. Attenuates p53-mediated apoptosis in response to DNA damage through activation of AKT kinase. Up-regulates the anti-apoptotic Bcl-X(L) protein. Adheres to skin and melanoma fibroblasts. In vitro binding to skin fibroblasts occurs through the proteoglycans, decorin and biglycan				0.0000	0.0000	0.0000																					0		0.2593	27	0.0286	35
chr8	134519430	134519430	T	C	0.1017	60	0.0137	75		55	ST3GAL1	intron_variant	ST3GAL1:ENST00000319914:intron_variant:MODIFIER:exon3/8:c.-579-30584A>G:,ST3GAL1:ENST00000521180:intron_variant:MODIFIER:exon2/8:c.-631-7998A>G:,ST3GAL1:ENST00000522652:intron_variant:MODIFIER:exon2/9:c.-428-7998A>G:,ST3GAL1:ENST00000517668:intron_variant:MODIFIER:exon2/4:c.-139-7998A>G:,ST3GAL1:ENST00000519435:intron_variant:MODIFIER:exon2/3:n.424-7998A>G:,ST3GAL1:ENST00000518298:intron_variant:MODIFIER:exon2/2:n.350-30587A>G:,ST3GAL1:ENST00000522873:intron_variant:MODIFIER:exon3/4:n.481-7998A>G:		O-Glycan biosynthesis;Keratan sulfate biosynthesis;Glycosphingolipid biosynthesis - globoseries;Glycosphingolipid biosynthesis - ganglioseries;Glycan structures - biosynthesis 1;Glycan structures - biosynthesis 2	It may be responsible for the synthesis of the sequence NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc- found on sugar chains O- linked to Thr or Ser and also as a terminal sequence on certain gangliosides. SIAT4A and SIAT4B sialylate the same acceptor substrates but exhibit different Km values				0.0000	0.0000	0.0000																					0		0.1167	60	0.0133	75
chr8	134533091	134533091	T	C	0.2250	41	0.0323	31		54	ST3GAL1	intron_variant	ST3GAL1:ENST00000319914:intron_variant:MODIFIER:exon3/8:c.-580+23210A>G:,ST3GAL1:ENST00000521180:intron_variant:MODIFIER:exon2/8:c.-631-21659A>G:,ST3GAL1:ENST00000522652:intron_variant:MODIFIER:exon2/9:c.-428-21659A>G:,ST3GAL1:ENST00000517668:intron_variant:MODIFIER:exon2/4:c.-139-21659A>G:,ST3GAL1:ENST00000519435:intron_variant:MODIFIER:exon2/3:n.424-21659A>G:,ST3GAL1:ENST00000518298:intron_variant:MODIFIER:exon2/2:n.349+24926A>G:,ST3GAL1:ENST00000522873:intron_variant:MODIFIER:exon3/4:n.480+18789A>G:		O-Glycan biosynthesis;Keratan sulfate biosynthesis;Glycosphingolipid biosynthesis - globoseries;Glycosphingolipid biosynthesis - ganglioseries;Glycan structures - biosynthesis 1;Glycan structures - biosynthesis 2	It may be responsible for the synthesis of the sequence NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc- found on sugar chains O- linked to Thr or Ser and also as a terminal sequence on certain gangliosides. SIAT4A and SIAT4B sialylate the same acceptor substrates but exhibit different Km values				0.0000	0.0000	0.0000																					0		0.2326	43	0.0500	40
chr8	137672068	137672068	-	A	0.3000	22	0.0000	22		42	RP11-30J20.1	intron_variant	RP11-30J20.1:ENST00000524346:intron_variant:MODIFIER:exon2/5:n.291+122772dupA:,RP11-30J20.1:ENST00000520060:intron_variant:MODIFIER:exon2/2:n.281-71488dupA:,RP11-30J20.1:ENST00000517345:intron_variant:MODIFIER:exon1/3:n.84+122772dupA:							0.0000	0.0000	0.0000																					0		0.2500	20	0.0000	25
chr8	141926803	141926803	T	C	0.2000	30	0.0000	21		65	PTK2	intron_variant	PTK2:ENST00000517887:intron_variant:MODIFIER:exon1/30:c.100+4110A>G:,PTK2:ENST00000522684:intron_variant:MODIFIER:exon2/31:c.-33+8957A>G:,PTK2:ENST00000521059:intron_variant:MODIFIER:exon2/31:c.-32-25935A>G:,PTK2:ENST00000395218:intron_variant:MODIFIER:exon2/32:c.-33+8957A>G:,PTK2:ENST00000340930:intron_variant:MODIFIER:exon2/32:c.-33+8957A>G:,PTK2:ENST00000519993:intron_variant:MODIFIER:exon1/32:c.-32-25935A>G:,PTK2:ENST00000519419:intron_variant:MODIFIER:exon2/31:c.100+4110A>G:,PTK2:ENST00000524357:intron_variant:MODIFIER:exon1/4:c.-32-25935A>G:,PTK2:ENST00000521791:intron_variant:MODIFIER:exon1/5:c.-32-25935A>G:,PTK2:ENST00000523067:intron_variant:MODIFIER:exon2/4:c.-32-25935A>G:,PTK2:ENST00000520828:intron_variant:MODIFIER:exon2/5:c.-170+8858A>G:,PTK2:ENST00000520475:intron_variant:MODIFIER:exon1/4:c.-33+17789A>G:,PTK2:ENST00000519881:intron_variant:MODIFIER:exon1/2:c.-32-25935A>G:,PTK2:ENST00000520892:intron_variant:MODIFIER:exon2/3:c.-33+8957A>G:,PTK2:ENST00000523803:intron_variant:MODIFIER:exon3/4:c.-33+8957A>G:,PTK2:ENST00000521907:intron_variant:MODIFIER:exon1/2:c.-32-25935A>G:,PTK2:ENST00000517453:intron_variant:MODIFIER:exon2/3:c.-33+8957A>G:,PTK2:ENST00000520045:intron_variant:MODIFIER:exon2/3:c.-32-25935A>G:,PTK2:ENST00000521395:intron_variant:MODIFIER:exon2/3:c.-33+8957A>G:,PTK2:ENST00000523675:intron_variant:MODIFIER:exon1/1:n.196+4110A>G:,PTK2:ENST00000521332:intron_variant:MODIFIER:exon2/3:c.-105-7083A>G:,PTK2:ENST00000524040:intron_variant:MODIFIER:exon3/3:c.-33+8957A>G:		ErbB signaling pathway;Axon guidance;VEGF signaling pathway;Focal adhesion;Leukocyte transendothelial migration;Regulation of actin cytoskeleton;Small cell lung cancer	Non-receptor protein-tyrosine kinase that plays an essential role in regulating cell migration, adhesion, spreading, reorganization of the actin cytoskeleton, formation and disassembly of focal adhesions and cell protrusions, cell cycle progression, cell proliferation and apoptosis. Required for early embryonic development and placenta development. Required for embryonic angiogenesis, normal cardiomyocyte migration and proliferation, and normal heart development. Regulates axon growth and neuronal cell migration, axon branching and synapse formation; required for normal development of the nervous system. Plays a role in osteogenesis and differentiation of osteoblasts. Functions in integrin signal transduction, but also in signaling downstream of numerous growth factor receptors, G-protein coupled receptors (GPCR), EPHA2, netrin receptors and LDL receptors. Forms multisubunit signaling complexes with SRC and SRC family members upon activation; this leads to the phosphorylation of additional tyrosine residues, creating binding sites for scaffold proteins, effectors and substrates. Regulates numerous signaling pathways. Promotes activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade. Promotes activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling cascade. Promotes localized and transient activation of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs), and thereby modulates the activity of Rho family GTPases. Signaling via CAS family members mediates activation of RAC1. Recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, and thereby regulates P53/TP53 activity, P53/TP53 ubiquitination and proteasomal degradation. Phosphorylates SRC; this increases SRC kinase activity. Phosphorylates ACTN1, ARHGEF7, GRB7, RET and WASL. Promotes phosphorylation of PXN and STAT1; most likely PXN and STAT1 are phosphorylated by a SRC family kinase that is recruited to autophosphorylated PTK2/FAK1, rather than by PTK2/FAK1 itself. Promotes phosphorylation of BCAR1; GIT2 and SHC1; this requires both SRC and PTK2/FAK1. Promotes phosphorylation of BMX and PIK3R1. Isoform 6 (FRNK) does not contain a kinase domain and inhibits PTK2/FAK1 phosphorylation and signaling. Its enhanced expression can attenuate the nuclear accumulation of LPXN and limit its ability to enhance serum response factor (SRF)-dependent gene transcription	Agrin in Postsynaptic Differentiation;Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling;Apoptotic Signaling in Response to DNA Damage;Aspirin Blocks Signaling Pathway Involved in Platelet Activation;CCR3 signaling in Eosinophils;Cell to Cell Adhesion Signaling;CXCR4 Signaling Pathway;Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia;HIV-I Nef: negative effector of Fas and TNF;Integrin Signaling Pathway;mCalpain and friends in Cell motility;Phospholipids as signalling intermediaries;PTEN dependent cell cycle arrest and apoptosis;Role of nicotinic acetylcholine receptors in the regulation of apoptosis;Signaling of Hepatocyte Growth Factor Receptor;Trefoil Factors Initiate  Mucosal Healing;uCalpain and friends in Cell spread;VEGF, Hypoxia, and Angiogenesis			0.0000	0.0000	0.0000																					0		0.2000	30	0.0000	21
chr9	2767790	2767790	T	C	0.1600	25	0.0000	18		58	KIAA0020	intron_variant	KIAA0020:ENST00000490444:intron_variant:MODIFIER:exon3/3:c.*126+14966A>G:							0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	18
chr9	2804383	2804383	-	T	0.0741	95	0.0000	115		53	KIAA0020	frameshift_variant,non_coding_transcript_exon_variant	KIAA0020:ENST00000397885:frameshift_variant:HIGH:exon18/18:c.1894dupA:p.Thr632fs,KIAA0020:ENST00000490444:frameshift_variant:HIGH:exon2/4:c.97dupA:p.Thr33fs,KIAA0020:ENST00000382032:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.241dupA:							0.0000	0.0000	0.0000																					0		0.0714	84	0.0000	108
chr9	4737535	4737535	T	C	0.1463	41	0.0000	32		68	AK3	sequence_feature,intron_variant	AK3:ENST00000381809:sequence_feature:LOW::c.151+3402A>G:,AK3:ENST00000381809:intron_variant:MODIFIER:exon1/4:c.151+3402A>G:,AK3:ENST00000359883:intron_variant:MODIFIER:exon1/4:c.-60+4437A>G:,AK3:ENST00000447596:intron_variant:MODIFIER:exon1/3:c.151+3402A>G:		Purine metabolism;Pyrimidine metabolism	Involved in maintaining the homeostasis of cellular nucleotides by catalyzing the interconversion of nucleoside phosphates. Has GTP:AMP phosphotransferase and ITP:AMP phosphotransferase activities				0.0000	0.0000	0.0000																					0		0.1463	41	0.0000	32
chr9	21810336	21810336	A	G	0.1600	25	0.0000	16		54	RP11-145E5.5,MTAP	intron_variant	RP11-145E5.5:ENST00000404796:intron_variant:MODIFIER:exon1/5:c.34-5096A>G:,MTAP:ENST00000580900:intron_variant:MODIFIER:exon1/7:c.34-5096A>G:,MTAP:ENST00000380172:intron_variant:MODIFIER:exon1/7:c.34-5096A>G:,MTAP:ENST00000460874:intron_variant:MODIFIER:exon1/7:c.85-5096A>G:,MTAP:ENST00000580675:intron_variant:MODIFIER:exon1/1:n.136-5096A>G:,MTAP:ENST00000419385:intron_variant:MODIFIER:exon1/7:c.34-5096A>G:,MTAP:ENST00000580718:intron_variant:MODIFIER:exon1/7:c.34-5096A>G:,MTAP:ENST00000579422:intron_variant:MODIFIER:exon1/3:n.422-5096A>G:,MTAP:ENST00000427788:intron_variant:MODIFIER:exon2/6:n.298+1337A>G:		Methionine metabolism	Catalyzes the reversible phosphorylation of S-methyl-5'- thioadenosine (MTA) to adenine and 5-methylthioribose-1-phosphate. Involved in the breakdown of MTA, a major by-product of polyamine biosynthesis. Responsible for the first step in the methionine salvage pathway after MTA has been generated from S- adenosylmethionine. Has broad substrate specificity with 6- aminopurine nucleosides as preferred substrates				0.0000	0.0000	0.0000		156540 [MTAP (confirmed) Diaphyseal medullary stenosis with malignant fibrous histiocytoma,112250];																			0		0.1600	25	0.0000	16
chr9	34202218	34202218	A	G	0.2941	17	0.0000	38		82	UBAP1	intron_variant	UBAP1:ENST00000545103:intron_variant:MODIFIER:exon1/5:c.226+22980A>G:,UBAP1:ENST00000536252:intron_variant:MODIFIER:exon1/7:c.-162-1161A>G:,UBAP1:ENST00000540348:intron_variant:MODIFIER:exon2/7:c.-8+5762A>G:,UBAP1:ENST00000543944:intron_variant:MODIFIER:exon1/5:c.227-18688A>G:,UBAP1:ENST00000297661:intron_variant:MODIFIER:exon1/6:c.-7-18688A>G:,UBAP1:ENST00000379186:intron_variant:MODIFIER:exon1/5:c.-7-18688A>G:			Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs). Plays a role in the proteasomal degradation of ubiquitinated cell-surface proteins, such as EGFR and BST2				0.0000	0.0000	0.0000																					0		0.2941	17	0.0000	38
chr9	34204139	34204139	A	G	0.4000	6	0.0435	23		33	UBAP1	intron_variant	UBAP1:ENST00000545103:intron_variant:MODIFIER:exon1/5:c.226+24901A>G:,UBAP1:ENST00000536252:intron_variant:MODIFIER:exon2/7:c.-8+606A>G:,UBAP1:ENST00000540348:intron_variant:MODIFIER:exon2/7:c.-8+7683A>G:,UBAP1:ENST00000543944:intron_variant:MODIFIER:exon1/5:c.227-16767A>G:,UBAP1:ENST00000297661:intron_variant:MODIFIER:exon1/6:c.-7-16767A>G:,UBAP1:ENST00000379186:intron_variant:MODIFIER:exon1/5:c.-7-16767A>G:			Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs). Plays a role in the proteasomal degradation of ubiquitinated cell-surface proteins, such as EGFR and BST2				0.0000	0.0000	0.0000																					0		0.5000	6	0.0435	23
chr9	37196886	37196886	-	T	0.3636	13	0.0000	27		50	ZCCHC7	intron_variant	ZCCHC7:ENST00000336755:intron_variant:MODIFIER:exon2/8:c.610+69953dupT:,ZCCHC7:ENST00000534928:intron_variant:MODIFIER:exon1/7:c.-261+76272dupT:,ZCCHC7:ENST00000461038:intron_variant:MODIFIER:exon2/8:n.890+69953dupT:,ZCCHC7:ENST00000488607:intron_variant:MODIFIER:exon2/8:n.150+49450dupT:							0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	27
chr9	91012773	91012773	A	G	0.1818	22	0.0000	36		59	SPIN1	intron_variant	SPIN1:ENST00000375859:intron_variant:MODIFIER:exon1/5:c.-159+9320A>G:,SPIN1:ENST00000485804:intron_variant:MODIFIER:exon1/4:n.109+9320A>G:,SPIN1:ENST00000469017:intron_variant:MODIFIER:exon1/8:n.108+9320A>G:,SPIN1:ENST00000541629:intron_variant:MODIFIER:exon1/8:c.-549+9320A>G:,SPIN1:ENST00000462844:intron_variant:MODIFIER:exon1/4:n.95+9320A>G:,SPIN1:ENST00000485565:intron_variant:MODIFIER:exon1/4:n.87+9320A>G:,SPIN1:ENST00000483785:intron_variant:MODIFIER:exon1/4:n.40+8448A>G:			May play a role in cell-cycle regulation during the transition from gamete to embryo (By similarity)				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	36
chr9	99708759	99708759	T	C	0.1905	21	0.0000	28		64	HIATL2	intron_variant	HIATL2:ENST00000602917:intron_variant:MODIFIER:exon4/4:c.396-256A>G:,HIATL2:ENST00000506067:intron_variant:MODIFIER:exon1/4:n.31+3078A>G:							0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	36
chr9	111778702	111778702	-	A	0.2333	41	0.0000	19		40	TMEM245	3_prime_UTR_variant	TMEM245:ENST00000374586:3_prime_UTR_variant:MODIFIER:exon18/18:c.*4037dupT:							0.0000	0.0000	0.0000																					0		0.1471	34	0.0000	19
chr9	114665846	114665846	G	A	0.1111	36	0.0000	28		52	UGCG	sequence_feature,intron_variant	UGCG:ENST00000374279:sequence_feature:LOW::c.98+6253G>A:,UGCG:ENST00000374279:intron_variant:MODIFIER:exon1/8:c.98+6253G>A:,UGCG:ENST00000489355:intron_variant:MODIFIER:exon1/1:n.137+6253G>A:,UGCG:ENST00000490110:intron_variant:MODIFIER:exon1/5:n.113+6253G>A:,UGCG:ENST00000495085:intron_variant:MODIFIER:exon1/5:n.113+6253G>A:		Sphingolipid metabolism;Glycan structures - biosynthesis 2	Catalyzes the first glycosylation step in glycosphingolipid biosynthesis, the transfer of glucose to ceramide. May also serve as a "flippase"				0.0000	0.0000	0.0000																					0		0.1111	36	0.0000	28
chr9	114678981	114678981	A	G	0.1481	28	0.0263	38		54	UGCG	intron_variant	UGCG:ENST00000374279:intron_variant:MODIFIER:exon2/8:c.240+1955A>G:,UGCG:ENST00000490110:intron_variant:MODIFIER:exon3/5:n.333+865A>G:,UGCG:ENST00000495085:intron_variant:MODIFIER:exon2/5:n.255+1955A>G:		Sphingolipid metabolism;Glycan structures - biosynthesis 2	Catalyzes the first glycosylation step in glycosphingolipid biosynthesis, the transfer of glucose to ceramide. May also serve as a "flippase"				0.0000	0.0000	0.0000																					0		0.1429	28	0.0263	38
chr9	114681642	114681642	A	G	0.3143	36	0.0980	51		59	UGCG	intron_variant	UGCG:ENST00000374279:intron_variant:MODIFIER:exon2/8:c.241-3487A>G:,UGCG:ENST00000490110:intron_variant:MODIFIER:exon3/5:n.334-3487A>G:,UGCG:ENST00000495085:intron_variant:MODIFIER:exon2/5:n.256-3455A>G:		Sphingolipid metabolism;Glycan structures - biosynthesis 2	Catalyzes the first glycosylation step in glycosphingolipid biosynthesis, the transfer of glucose to ceramide. May also serve as a "flippase"				0.0000	0.0000	0.0000																					0		0.3333	36	0.0980	51
chr9	125660970	125660970	G	C	0.7778	9	0.0455	22		37	RC3H2	intron_variant	RC3H2:ENST00000357244:intron_variant:MODIFIER:exon1/20:c.-67-1115C>G:,RC3H2:ENST00000498479:intron_variant:MODIFIER:exon1/21:c.-67-1115C>G:,RC3H2:ENST00000423239:intron_variant:MODIFIER:exon1/17:c.-67-1115C>G:,RC3H2:ENST00000373665:intron_variant:MODIFIER:exon1/10:c.-67-1115C>G:,RC3H2:ENST00000335387:intron_variant:MODIFIER:exon1/9:c.-67-1115C>G:,RC3H2:ENST00000478216:intron_variant:MODIFIER:exon1/1:n.171+6419C>G:			Post-transcriptional repressor of mRNAs containing a conserved stem loop motif, called constitutive decay element (CDE), which is often located in the 3'-UTR, as in HMGXB3, ICOS, IER3, NFKBID, NFKBIZ, PPP1R10, TNF and in many more mRNAs (By similarity). Binds to CDE and promotes mRNA deadenylation and degradation. This process does not involve miRNAs (By similarity). In follicular helper T (Tfh) cells, represses of ICOS and TNFRSF4 expression, thus preventing spontaneous Tfh cell differentiation, germinal center B-cell differentiation in the absence of immunization and autoimmunity (By similarity). In resting or LPS- stimulated macrophages, controls inflammation by suppressing TNF expression (By similarity). Also recognizes CDE in its own mRNA and in that of paralogous RC3H2, possibly leading to feedback loop regulation (By similarity)			rs10985810	0.341054	0.0000	0.0000																					0		0.7778	9	0.0455	22
chr9	125665067	125665067	T	C	0.3333	12	0.0000	24		57	RC3H2	intron_variant	RC3H2:ENST00000357244:intron_variant:MODIFIER:exon1/20:c.-68+2322A>G:,RC3H2:ENST00000498479:intron_variant:MODIFIER:exon1/21:c.-68+2322A>G:,RC3H2:ENST00000423239:intron_variant:MODIFIER:exon1/17:c.-68+2322A>G:,RC3H2:ENST00000373665:intron_variant:MODIFIER:exon1/10:c.-68+2322A>G:,RC3H2:ENST00000335387:intron_variant:MODIFIER:exon1/9:c.-68+2322A>G:,RC3H2:ENST00000478216:intron_variant:MODIFIER:exon1/1:n.171+2322A>G:			Post-transcriptional repressor of mRNAs containing a conserved stem loop motif, called constitutive decay element (CDE), which is often located in the 3'-UTR, as in HMGXB3, ICOS, IER3, NFKBID, NFKBIZ, PPP1R10, TNF and in many more mRNAs (By similarity). Binds to CDE and promotes mRNA deadenylation and degradation. This process does not involve miRNAs (By similarity). In follicular helper T (Tfh) cells, represses of ICOS and TNFRSF4 expression, thus preventing spontaneous Tfh cell differentiation, germinal center B-cell differentiation in the absence of immunization and autoimmunity (By similarity). In resting or LPS- stimulated macrophages, controls inflammation by suppressing TNF expression (By similarity). Also recognizes CDE in its own mRNA and in that of paralogous RC3H2, possibly leading to feedback loop regulation (By similarity)				0.0000	0.0000	0.0000																					0		0.3333	12	0.0000	24
chr9	127050625	127050625	A	G	0.1667	24	0.0000	22		62	NEK6	intron_variant	NEK6:ENST00000373600:intron_variant:MODIFIER:exon1/10:c.-92-4503A>G:,NEK6:ENST00000540326:intron_variant:MODIFIER:exon1/9:c.26-13590A>G:,NEK6:ENST00000373603:intron_variant:MODIFIER:exon1/9:c.-29-13590A>G:,NEK6:ENST00000320246:intron_variant:MODIFIER:exon1/9:c.-29-13590A>G:,NEK6:ENST00000545174:intron_variant:MODIFIER:exon1/9:c.-29-13590A>G:,NEK6:ENST00000444973:intron_variant:MODIFIER:exon1/7:c.-29-13590A>G:,NEK6:ENST00000454453:intron_variant:MODIFIER:exon1/6:c.-29-13590A>G:,NEK6:ENST00000373596:intron_variant:MODIFIER:exon1/6:c.-29-13590A>G:,NEK6:ENST00000425237:intron_variant:MODIFIER:exon1/7:c.-29-13590A>G:,NEK6:ENST00000423785:intron_variant:MODIFIER:exon1/6:c.-93+1856A>G:			Protein kinase which plays an important role in mitotic cell cycle progression. Required for chromosome segregation at metaphase-anaphase transition, robust mitotic spindle formation and cytokinesis. Phosphorylates ATF4, CIR1, PTN, RAD26L, RBBP6, RPS7, RPS6KB1, TRIP4, STAT3 and histones H1 and H3. Phosphorylates KIF11 to promote mitotic spindle formation. Involved in G2/M phase cell cycle arrest induced by DNA damage. Inhibition of activity results in apoptosis. May contribute to tumorigenesis by suppressing p53/TP53-induced cancer cell senescence				0.0000	0.0000	0.0000																					0		0.1667	24	0.0000	22
chr9	130553175	130553175	A	G	0.2353	17	0.0000	26		66	CDK9-FPGS	intergenic_region	CDK9-FPGS:ENSG00000136807-ENSG00000136877:intergenic_region:MODIFIER::n.130553175A>G:							0.0000	0.0000	0.0000																					0		0.2353	17	0.0000	27
chr9	130554137	130554137	A	G	0.1333	31	0.0000	25		56	CDK9-FPGS	intergenic_region	CDK9-FPGS:ENSG00000136807-ENSG00000136877:intergenic_region:MODIFIER::n.130554137A>G:							0.0000	0.0000	0.0000																					0		0.1613	31	0.0000	25
chr9	131444204	131444204	T	C	0.2000	31	0.0000	20		60	HMGA1P4-SET	intergenic_region	HMGA1P4-SET:ENSG00000234705-ENSG00000119335:intergenic_region:MODIFIER::n.131444204T>C:						rs574753516	0.000199681	0.0000	0.0000																					0		0.1935	31	0.0000	20
chr9	133513474	133513474	G	A	0.1136	45	0.0000	38		66	FUBP3	3_prime_UTR_variant	FUBP3:ENST00000319725:3_prime_UTR_variant:MODIFIER:exon19/19:c.*1065G>A:			May interact with single-stranded DNA from the far- upstream element (FUSE). May activate gene expression				0.0000	0.0000	0.0000																					0		0.1333	45	0.0000	38
chr9	133580583	133580583	A	G	0.2069	29	0.0294	35		56	EXOSC2-ABL1	intergenic_region	EXOSC2-ABL1:ENSG00000130713-ENSG00000097007:intergenic_region:MODIFIER::n.133580583A>G:							0.0000	0.0000	0.0000																					0		0.2069	29	0.0286	35
chr9	138961309	138961309	T	C	0.4286	7	0.0000	17		36	NACC2	intron_variant	NACC2:ENST00000277554:intron_variant:MODIFIER:exon1/5:c.-59-18883A>G:						rs755148968	0.0000	0.0000	0.0000																					0		0.4286	7	0.0000	17
chr9	140526995	140526995	A	G	0.2381	21	0.0638	47		55	EHMT1	intron_variant	EHMT1:ENST00000460843:intron_variant:MODIFIER:exon1/26:c.21+13494A>G:,EHMT1:ENST00000462484:intron_variant:MODIFIER:exon1/15:c.21+13494A>G:,EHMT1:ENST00000334856:intron_variant:MODIFIER:exon1/16:c.-73+13494A>G:,EHMT1:ENST00000371394:intron_variant:MODIFIER:exon1/15:n.37+13494A>G:		Lysine degradation	Histone methyltransferase that specifically mono- and dimethylates 'Lys-9' of histone H3 (H3K9me1 and H3K9me2, respectively) in euchromatin. H3K9me represents a specific tag for epigenetic transcriptional repression by recruiting HP1 proteins to methylated histones. Also weakly methylates 'Lys-27' of histone H3 (H3K27me). Also required for DNA methylation, the histone methyltransferase activity is not required for DNA methylation, suggesting that these 2 activities function independently. Probably targeted to histone H3 by different DNA-binding proteins like E2F6, MGA, MAX and/or DP1. During G0 phase, it probably contributes to silencing of MYC- and E2F-responsive genes, suggesting a role in G0/G1 transition in cell cycle. In addition to the histone methyltransferase activity, also methylates non- histone proteins: mediates dimethylation of 'Lys-373' of p53/TP53				0.0000	0.0000	0.0000		607001 [EHMT1 (confirmed) Kleefstra syndrome,610253];																			0		0.2273	22	0.0638	47
chr10	962511	962511	T	C	0.2500	53	0.0714	57		56	LARP4B	intron_variant	LARP4B:ENST00000476529:intron_variant:MODIFIER:exon1/5:c.-40+14857A>G:,LARP4B:ENST00000406525:intron_variant:MODIFIER:exon2/5:c.-40+7812A>G:,LARP4B:ENST00000481118:intron_variant:MODIFIER:exon1/4:n.49+14857A>G:			Stimulates mRNA translation				0.0000	0.0000	0.0000																					0		0.2453	53	0.0702	57
chr10	5148699	5148699	T	C	0.2143	28	0.0278	36		56	AKR1C3	intron_variant	AKR1C3:ENST00000380554:intron_variant:MODIFIER:exon8/8:c.929+830T>C:,AKR1C3:ENST00000605149:intron_variant:MODIFIER:exon8/8:c.860+830T>C:,AKR1C3:ENST00000439082:intron_variant:MODIFIER:exon8/8:c.572+830T>C:,AKR1C3:ENST00000603484:intron_variant:MODIFIER:exon1/1:n.403+830T>C:		Arachidonic acid metabolism;Metabolism of xenobiotics by cytochrome P450	Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta- PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone				0.0000	0.0000	0.0000																					0		0.2143	28	0.0278	36
chr10	17728453	17728453	A	G	0.2632	19	0.0000	23		60	STAM	intron_variant	STAM:ENST00000377524:intron_variant:MODIFIER:exon4/13:c.297+1527A>G:,STAM:ENST00000445846:intron_variant:MODIFIER:exon5/6:c.*272+1527A>G:,STAM:ENST00000377500:intron_variant:MODIFIER:exon1/5:c.-36-1573A>G:,STAM:ENST00000540523:intron_variant:MODIFIER:exon2/11:c.-36-1573A>G:,STAM:ENST00000486183:intron_variant:MODIFIER:exon1/1:n.143+1527A>G:		Jak-STAT signaling pathway	Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes			rs374258125	0.0000	0.0000	0.0000																					0		0.2632	19	0.0000	23
chr10	17728476	17728476	A	G	0.2941	17	0.0000	25		63	STAM	intron_variant	STAM:ENST00000377524:intron_variant:MODIFIER:exon4/13:c.297+1550A>G:,STAM:ENST00000445846:intron_variant:MODIFIER:exon5/6:c.*272+1550A>G:,STAM:ENST00000377500:intron_variant:MODIFIER:exon1/5:c.-36-1550A>G:,STAM:ENST00000540523:intron_variant:MODIFIER:exon2/11:c.-36-1550A>G:,STAM:ENST00000486183:intron_variant:MODIFIER:exon1/1:n.143+1550A>G:		Jak-STAT signaling pathway	Involved in intracellular signal transduction mediated by cytokines and growth factors. Upon IL-2 and GM-CSL stimulation, it plays a role in signaling leading to DNA synthesis and MYC induction. May also play a role in T-cell development. Involved in down-regulation of receptor tyrosine kinase via multivesicular body (MVBs) when complexed with HGS (ESCRT-0 complex). The ESCRT-0 complex binds ubiquitin and acts as sorting machinery that recognizes ubiquitinated receptors and transfers them to further sequential lysosomal sorting/trafficking processes				0.0000	0.0000	0.0000																					0		0.2941	17	0.0000	25
chr10	22166127	22166127	T	C	0.2857	14	0.0000	24		60	DNAJC1	intron_variant	DNAJC1:ENST00000376980:intron_variant:MODIFIER:exon8/11:c.978+5084A>G:			May modulate protein synthesis (By similarity)				0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	24
chr10	22208774	22208774	C	T	0.0488	123	0.0000	107		75	DNAJC1	missense_variant	DNAJC1:ENST00000376980:missense_variant:MODERATE:exon5/12:c.622G>A:p.Glu208Lys			May modulate protein synthesis (By similarity)				0.0000	0.0000	0.0000					5.729000	T	D	B	T	31.00											0		0.0480	125	0.0000	109
chr10	32298578	32298578	-	A	0.1071	62	0.0000	60		46	KIF5B	3_prime_UTR_variant	KIF5B:ENST00000302418:3_prime_UTR_variant:MODIFIER:exon26/26:c.*1886dupT:			Microtubule-dependent motor required for normal distribution of mitochondria and lysosomes (By similarity)				0.0000	0.0000	0.0000																					0		0.0656	61	0.0000	56
chr10	33569798	33569798	T	C	0.2222	45	0.0408	50		53	NRP1	intron_variant	NRP1:ENST00000265371:intron_variant:MODIFIER:exon3/17:c.249-10014A>G:,NRP1:ENST00000374875:intron_variant:MODIFIER:exon2/15:c.-113-16997A>G:,NRP1:ENST00000374867:intron_variant:MODIFIER:exon2/16:c.249-10014A>G:,NRP1:ENST00000395995:intron_variant:MODIFIER:exon2/15:c.249-10014A>G:,NRP1:ENST00000374821:intron_variant:MODIFIER:exon2/10:c.249-10014A>G:,NRP1:ENST00000374822:intron_variant:MODIFIER:exon2/11:c.249-10014A>G:,NRP1:ENST00000374823:intron_variant:MODIFIER:exon2/10:c.249-10014A>G:,NRP1:ENST00000374816:intron_variant:MODIFIER:exon2/10:c.249-10014A>G:,NRP1:ENST00000432372:intron_variant:MODIFIER:exon3/9:c.249-10014A>G:		Axon guidance	The membrane-bound isoform 1 is a receptor involved in the development of the cardiovascular system, in angiogenesis, in the formation of certain neuronal circuits and in organogenesis outside the nervous system. It mediates the chemorepulsant activity of semaphorins. It binds to semaphorin 3A, The PLGF-2 isoform of PGF, The VEGF-165 isoform of VEGF and VEGF-B. Coexpression with KDR results in increased VEGF-165 binding to KDR as well as increased chemotaxis. It may regulate VEGF-induced angiogenesis				0.0000	0.0000	0.0000																					0		0.2222	45	0.0600	50
chr10	34841174	34841174	T	C	0.3750	8	0.0000	16		33	PARD3	intron_variant	PARD3:ENST00000374789:intron_variant:MODIFIER:exon2/24:c.223-35087A>G:,PARD3:ENST00000545260:intron_variant:MODIFIER:exon2/22:c.223-35087A>G:,PARD3:ENST00000545693:intron_variant:MODIFIER:exon2/23:c.223-35087A>G:,PARD3:ENST00000346874:intron_variant:MODIFIER:exon2/23:c.223-35087A>G:,PARD3:ENST00000350537:intron_variant:MODIFIER:exon2/23:c.223-35087A>G:,PARD3:ENST00000374788:intron_variant:MODIFIER:exon2/24:c.223-35087A>G:,PARD3:ENST00000374790:intron_variant:MODIFIER:exon2/22:c.223-35087A>G:,PARD3:ENST00000374794:intron_variant:MODIFIER:exon2/20:c.223-35087A>G:,PARD3:ENST00000374776:intron_variant:MODIFIER:exon2/19:c.223-35087A>G:,PARD3:ENST00000340077:intron_variant:MODIFIER:exon2/20:c.223-35087A>G:,PARD3:ENST00000374773:intron_variant:MODIFIER:exon2/20:c.223-35087A>G:		Neuroactive ligand-receptor interaction;Adherens junction;Tight junction	Adapter protein involved in asymmetrical cell division and cell polarization processes. Seems to play a central role in the formation of epithelial tight junctions. Targets the phosphatase PTEN to cell junctions (By similarity). Association with PARD6B may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly. The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins. Required for establishment of neuronal polarity and normal axon formation in cultured hippocampal neurons				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	16
chr10	34932640	34932640	T	C	0.1290	31	0.0000	14		55	PARD3	intron_variant	PARD3:ENST00000374789:intron_variant:MODIFIER:exon2/24:c.222+52606A>G:,PARD3:ENST00000545260:intron_variant:MODIFIER:exon2/22:c.222+52606A>G:,PARD3:ENST00000545693:intron_variant:MODIFIER:exon2/23:c.222+52606A>G:,PARD3:ENST00000346874:intron_variant:MODIFIER:exon2/23:c.222+52606A>G:,PARD3:ENST00000350537:intron_variant:MODIFIER:exon2/23:c.222+52606A>G:,PARD3:ENST00000374788:intron_variant:MODIFIER:exon2/24:c.222+52606A>G:,PARD3:ENST00000374790:intron_variant:MODIFIER:exon2/22:c.222+52606A>G:,PARD3:ENST00000374794:intron_variant:MODIFIER:exon2/20:c.222+52606A>G:,PARD3:ENST00000374776:intron_variant:MODIFIER:exon2/19:c.222+52606A>G:,PARD3:ENST00000340077:intron_variant:MODIFIER:exon2/20:c.222+52606A>G:,PARD3:ENST00000374773:intron_variant:MODIFIER:exon2/20:c.222+52606A>G:		Neuroactive ligand-receptor interaction;Adherens junction;Tight junction	Adapter protein involved in asymmetrical cell division and cell polarization processes. Seems to play a central role in the formation of epithelial tight junctions. Targets the phosphatase PTEN to cell junctions (By similarity). Association with PARD6B may prevent the interaction of PARD3 with F11R/JAM1, thereby preventing tight junction assembly. The PARD6-PARD3 complex links GTP-bound Rho small GTPases to atypical protein kinase C proteins. Required for establishment of neuronal polarity and normal axon formation in cultured hippocampal neurons				0.0000	0.0000	0.0000																					0		0.1290	31	0.0000	14
chr10	60409139	60409139	-	CT	0.1563	34	0.0000	42		53	BICC1	intron_variant	BICC1:ENST00000373886:intron_variant:MODIFIER:exon2/20:c.237+28487_237+28488dupCT:,BICC1:ENST00000476684:intron_variant:MODIFIER:exon1/1:n.54-720_54-719dupCT:			Putative RNA-binding protein. Acts as a negative regulator of Wnt signaling. May be involved in regulating gene expression during embryonic development				0.0000	0.0000	0.0000		614295 [BICC1 (provisional) Renal dysplasia,cystic,susceptibility to,601331];																			0		0.1290	31	0.0000	165
chr10	65011580	65011580	T	C	0.3000	10	0.0345	29		50	JMJD1C	intron_variant	JMJD1C:ENST00000399262:intron_variant:MODIFIER:exon3/25:c.447+12831A>G:,JMJD1C:ENST00000402544:intron_variant:MODIFIER:exon1/22:c.-105+16843A>G:,JMJD1C:ENST00000399251:intron_variant:MODIFIER:exon3/24:c.-211+12831A>G:,JMJD1C:ENST00000542921:intron_variant:MODIFIER:exon2/24:c.-100+12831A>G:,JMJD1C:ENST00000469152:intron_variant:MODIFIER:exon2/5:n.327+12831A>G:,JMJD1C:ENST00000489372:intron_variant:MODIFIER:exon2/4:n.705+12831A>G:			Probable histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May be involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes (By similarity)				0.0000	0.0000	0.0000																					0		0.3000	10	0.0345	29
chr10	65094326	65094326	T	C	0.3000	10	0.0000	23		47	JMJD1C	intron_variant	JMJD1C:ENST00000399262:intron_variant:MODIFIER:exon2/25:c.333+45752A>G:,JMJD1C:ENST00000399251:intron_variant:MODIFIER:exon2/24:c.-325+45752A>G:			Probable histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May be involved in hormone-dependent transcriptional activation, by participating in recruitment to androgen-receptor target genes (By similarity)				0.0000	0.0000	0.0000																					0		0.2727	11	0.0000	23
chr10	69565515	69565515	-	T	0.2258	36	0.0000	30		46	DNAJC12	frameshift_variant,3_prime_UTR_variant	DNAJC12:ENST00000483798:frameshift_variant:HIGH:exon5/6:c.417dupA:p.Asp140fs,DNAJC12:ENST00000225171:frameshift_variant:HIGH:exon4/5:c.327dupA:p.Asp110fs,DNAJC12:ENST00000480963:3_prime_UTR_variant:MODIFIER:exon5/5:c.*247dupA:							0.0000	0.0000	0.0000		606060 [DNAJC12 (provisional) Hyperphenylalaninemia,mild,non-BH4-deficient,617384];																			0		0.2059	34	0.0000	27
chr10	69802045	69802045	T	C	0.2500	25	0.0357	28		52	HERC4	intron_variant	HERC4:ENST00000395198:intron_variant:MODIFIER:exon4/25:c.386+2116A>G:,HERC4:ENST00000412272:intron_variant:MODIFIER:exon4/23:c.386+2116A>G:,HERC4:ENST00000427635:intron_variant:MODIFIER:exon2/24:c.374+2116A>G:,HERC4:ENST00000473533:intron_variant:MODIFIER:exon3/22:c.227-4119A>G:,HERC4:ENST00000373700:intron_variant:MODIFIER:exon4/24:c.386+2116A>G:,HERC4:ENST00000395187:intron_variant:MODIFIER:exon3/23:c.227-4119A>G:,HERC4:ENST00000513996:intron_variant:MODIFIER:exon4/6:c.386+2116A>G:			Probable E3 ubiquitin-protein ligase involved in either protein trafficking or in the distribution of cellular structures. Required for spermatozoon maturation and fertility, and for the removal of the cytoplasmic droplet of the spermatozoon. E3 ubiquitin-protein ligases accept ubiquitin from an E2 ubiquitin- conjugating enzyme in the form of a thioester and then directly transfer it to targeted substrates (By similarity)				0.0000	0.0000	0.0000																					0		0.2400	25	0.0333	30
chr10	69802318	69802318	T	C	0.1389	72	0.0217	46		53	HERC4	intron_variant	HERC4:ENST00000395198:intron_variant:MODIFIER:exon4/25:c.386+1843A>G:,HERC4:ENST00000412272:intron_variant:MODIFIER:exon4/23:c.386+1843A>G:,HERC4:ENST00000427635:intron_variant:MODIFIER:exon2/24:c.374+1843A>G:,HERC4:ENST00000473533:intron_variant:MODIFIER:exon3/22:c.227-4392A>G:,HERC4:ENST00000373700:intron_variant:MODIFIER:exon4/24:c.386+1843A>G:,HERC4:ENST00000395187:intron_variant:MODIFIER:exon3/23:c.227-4392A>G:,HERC4:ENST00000513996:intron_variant:MODIFIER:exon4/6:c.386+1843A>G:			Probable E3 ubiquitin-protein ligase involved in either protein trafficking or in the distribution of cellular structures. Required for spermatozoon maturation and fertility, and for the removal of the cytoplasmic droplet of the spermatozoon. E3 ubiquitin-protein ligases accept ubiquitin from an E2 ubiquitin- conjugating enzyme in the form of a thioester and then directly transfer it to targeted substrates (By similarity)				0.0000	0.0000	0.0000																					0		0.1389	72	0.0217	46
chr10	69809855	69809855	T	C	0.1333	45	0.0000	28		63	HERC4	intron_variant	HERC4:ENST00000395198:intron_variant:MODIFIER:exon3/25:c.227-5535A>G:,HERC4:ENST00000412272:intron_variant:MODIFIER:exon3/23:c.227-5535A>G:,HERC4:ENST00000427635:intron_variant:MODIFIER:exon1/24:c.215-5535A>G:,HERC4:ENST00000473533:intron_variant:MODIFIER:exon3/22:c.227-11929A>G:,HERC4:ENST00000373700:intron_variant:MODIFIER:exon3/24:c.227-5535A>G:,HERC4:ENST00000395187:intron_variant:MODIFIER:exon3/23:c.227-11929A>G:,HERC4:ENST00000513996:intron_variant:MODIFIER:exon3/6:c.227-5535A>G:			Probable E3 ubiquitin-protein ligase involved in either protein trafficking or in the distribution of cellular structures. Required for spermatozoon maturation and fertility, and for the removal of the cytoplasmic droplet of the spermatozoon. E3 ubiquitin-protein ligases accept ubiquitin from an E2 ubiquitin- conjugating enzyme in the form of a thioester and then directly transfer it to targeted substrates (By similarity)				0.0000	0.0000	0.0000																					0		0.1333	45	0.0345	29
chr10	70043677	70043677	T	C	0.1351	37	0.0000	28		65	PBLD	3_prime_UTR_variant,intron_variant	PBLD:ENST00000309049:3_prime_UTR_variant:MODIFIER:exon10/10:c.*257A>G:,PBLD:ENST00000336578:3_prime_UTR_variant:MODIFIER:exon8/8:c.*257A>G:,PBLD:ENST00000358769:3_prime_UTR_variant:MODIFIER:exon10/10:c.*257A>G:,PBLD:ENST00000468798:intron_variant:MODIFIER:exon2/2:c.212-630A>G:							0.0000	0.0000	0.0000																					0		0.1351	37	0.0000	28
chr10	70045977	70045977	T	C	0.4444	10	0.0000	21		47	PBLD	intron_variant	PBLD:ENST00000309049:intron_variant:MODIFIER:exon8/9:c.692-810A>G:,PBLD:ENST00000336578:intron_variant:MODIFIER:exon6/7:c.593-810A>G:,PBLD:ENST00000358769:intron_variant:MODIFIER:exon8/9:c.692-810A>G:,PBLD:ENST00000468798:intron_variant:MODIFIER:exon2/2:c.211+2263A>G:,PBLD:ENST00000432941:intron_variant:MODIFIER:exon8/8:c.692-810A>G:,PBLD:ENST00000495025:intron_variant:MODIFIER:exon8/8:c.692-810A>G:							0.0000	0.0000	0.0000																					0		0.5000	10	0.0000	21
chr10	70046762	70046762	T	C	0.1429	42	0.0000	33		68	PBLD	intron_variant	PBLD:ENST00000309049:intron_variant:MODIFIER:exon8/9:c.691+1478A>G:,PBLD:ENST00000336578:intron_variant:MODIFIER:exon6/7:c.592+1478A>G:,PBLD:ENST00000358769:intron_variant:MODIFIER:exon8/9:c.691+1478A>G:,PBLD:ENST00000468798:intron_variant:MODIFIER:exon2/2:c.211+1478A>G:,PBLD:ENST00000432941:intron_variant:MODIFIER:exon8/8:c.691+1478A>G:,PBLD:ENST00000495025:intron_variant:MODIFIER:exon8/8:c.691+1478A>G:							0.0000	0.0000	0.0000																					0		0.1429	42	0.0000	33
chr10	70517992	70517992	A	G	0.1538	26	0.0000	21		58	CCAR1	intron_variant	CCAR1:ENST00000265872:intron_variant:MODIFIER:exon15/24:c.1920+858A>G:,CCAR1:ENST00000535016:intron_variant:MODIFIER:exon14/23:c.1875+858A>G:,CCAR1:ENST00000543719:intron_variant:MODIFIER:exon14/23:c.1875+858A>G:,CCAR1:ENST00000541012:intron_variant:MODIFIER:exon14/16:c.*2+858A>G:,CCAR1:ENST00000543229:intron_variant:MODIFIER:exon13/15:c.*1535+858A>G:,CCAR1:ENST00000539539:intron_variant:MODIFIER:exon14/21:c.1875+858A>G:,CCAR1:ENST00000543225:intron_variant:MODIFIER:exon13/15:c.1842+858A>G:,CCAR1:ENST00000536012:intron_variant:MODIFIER:exon13/15:c.1335+858A>G:,CCAR1:ENST00000540210:intron_variant:MODIFIER:exon14/23:c.*2+858A>G:,CCAR1:ENST00000479143:intron_variant:MODIFIER:exon3/4:c.*106+858A>G:,CCAR1:ENST00000543706:intron_variant:MODIFIER:exon1/6:c.27+858A>G:			Associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Recruited to endogenous nuclear receptor target genes in response to the appropriate hormone. Also functions as a p53 coactivator. May thus play an important role in transcriptional regulation (By similarity). May be involved in apoptosis signaling in the presence of the reinoid CD437. Apoptosis induction involves sequestration of 14-3-3 protein(s) and mediated altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A. Plays a role in cell cycle progression and/or cell proliferation				0.0000	0.0000	0.0000																					0		0.1538	26	0.0000	21
chr10	70520038	70520038	A	G	0.1250	32	0.0000	27		58	CCAR1	intron_variant	CCAR1:ENST00000265872:intron_variant:MODIFIER:exon15/24:c.1921-726A>G:,CCAR1:ENST00000535016:intron_variant:MODIFIER:exon14/23:c.1876-726A>G:,CCAR1:ENST00000543719:intron_variant:MODIFIER:exon14/23:c.1876-726A>G:,CCAR1:ENST00000541012:intron_variant:MODIFIER:exon14/16:c.*3-726A>G:,CCAR1:ENST00000543229:intron_variant:MODIFIER:exon13/15:c.*1536-726A>G:,CCAR1:ENST00000539539:intron_variant:MODIFIER:exon14/21:c.1876-726A>G:,CCAR1:ENST00000543225:intron_variant:MODIFIER:exon13/15:c.1843-726A>G:,CCAR1:ENST00000536012:intron_variant:MODIFIER:exon13/15:c.1336-726A>G:,CCAR1:ENST00000540210:intron_variant:MODIFIER:exon14/23:c.*3-726A>G:,CCAR1:ENST00000479143:intron_variant:MODIFIER:exon3/4:c.*107-726A>G:,CCAR1:ENST00000543706:intron_variant:MODIFIER:exon1/6:c.28-726A>G:			Associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Recruited to endogenous nuclear receptor target genes in response to the appropriate hormone. Also functions as a p53 coactivator. May thus play an important role in transcriptional regulation (By similarity). May be involved in apoptosis signaling in the presence of the reinoid CD437. Apoptosis induction involves sequestration of 14-3-3 protein(s) and mediated altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A. Plays a role in cell cycle progression and/or cell proliferation				0.0000	0.0000	0.0000																					0		0.1250	32	0.0000	27
chr10	70520533	70520533	A	G	0.1579	20	0.0000	21		54	CCAR1	intron_variant	CCAR1:ENST00000265872:intron_variant:MODIFIER:exon15/24:c.1921-231A>G:,CCAR1:ENST00000535016:intron_variant:MODIFIER:exon14/23:c.1876-231A>G:,CCAR1:ENST00000543719:intron_variant:MODIFIER:exon14/23:c.1876-231A>G:,CCAR1:ENST00000541012:intron_variant:MODIFIER:exon14/16:c.*3-231A>G:,CCAR1:ENST00000543229:intron_variant:MODIFIER:exon13/15:c.*1536-231A>G:,CCAR1:ENST00000539539:intron_variant:MODIFIER:exon14/21:c.1876-231A>G:,CCAR1:ENST00000543225:intron_variant:MODIFIER:exon13/15:c.1843-231A>G:,CCAR1:ENST00000536012:intron_variant:MODIFIER:exon13/15:c.1336-231A>G:,CCAR1:ENST00000540210:intron_variant:MODIFIER:exon14/23:c.*3-231A>G:,CCAR1:ENST00000479143:intron_variant:MODIFIER:exon3/4:c.*107-231A>G:,CCAR1:ENST00000543706:intron_variant:MODIFIER:exon1/6:c.28-231A>G:			Associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Recruited to endogenous nuclear receptor target genes in response to the appropriate hormone. Also functions as a p53 coactivator. May thus play an important role in transcriptional regulation (By similarity). May be involved in apoptosis signaling in the presence of the reinoid CD437. Apoptosis induction involves sequestration of 14-3-3 protein(s) and mediated altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A. Plays a role in cell cycle progression and/or cell proliferation				0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	21
chr10	75536335	75536335	A	G	0.1220	41	0.0000	34		66	FUT11	intron_variant	FUT11:ENST00000489264:intron_variant:MODIFIER:exon1/1:n.212-2251A>G:		Glycan structures - biosynthesis 1	Probable fucosyltransferase (By similarity)				0.0000	0.0000	0.0000																					0		0.1220	41	0.0000	34
chr10	77286429	77286429	A	G	0.5714	7	0.0000	16		33	RP11-399K21.10-MIR606	intergenic_region	RP11-399K21.10-MIR606:ENSG00000236842-ENSG00000207583:intergenic_region:MODIFIER::n.77286429A>G:							0.0000	0.0000	0.0000																					0		0.5714	7	0.0000	16
chr10	81484736	81484736	T	C	0.2632	20	0.0357	28		57	RP11-119F19.2	intron_variant	RP11-119F19.2:ENST00000601369:intron_variant:MODIFIER:exon1/1:n.60-32924A>G:,RP11-119F19.2:ENST00000596088:intron_variant:MODIFIER:exon1/3:n.54+41291A>G:,RP11-119F19.2:ENST00000600376:intron_variant:MODIFIER:exon1/1:n.54+41291A>G:							0.0000	0.0000	0.0000																					0		0.2500	20	0.0357	28
chr10	88968115	88968115	T	C	0.2222	18	0.0000	26		65	NUTM2A-AS1	intron_variant	NUTM2A-AS1:ENST00000451940:intron_variant:MODIFIER:exon5/5:n.601-4422A>G:							0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	25
chr10	90645899	90645899	A	G	0.1538	27	0.0000	19		57	STAMBPL1	intron_variant	STAMBPL1:ENST00000371927:intron_variant:MODIFIER:exon1/10:c.-54+5504A>G:,STAMBPL1:ENST00000371926:intron_variant:MODIFIER:exon1/10:c.-54+5504A>G:,STAMBPL1:ENST00000461650:intron_variant:MODIFIER:exon2/2:n.576+3520A>G:			Zinc metalloprotease that specifically cleaves 'Lys-63'- linked polyubiquitin chains. Does not cleave 'Lys-48'-linked polyubiquitin chains				0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	19
chr10	96372630	96372630	A	G	0.2083	24	0.0370	27		59	HELLS	3_prime_UTR_variant	HELLS:ENST00000371327:3_prime_UTR_variant:MODIFIER:exon10/10:c.*3022A>G:			Plays an essential role in normal development and survival. Involved in regulation of the expansion or survival of lymphoid cells. Required for de novo or maintenance DNA methylation. May control silencing of the imprinted CDKN1C gene through DNA methylation. May play a role in formation and organization of heterochromatin, implying a functional role in the regulation of transcription and mitosis (By similarity)				0.0000	0.0000	0.0000																					0		0.2083	24	0.0370	27
chr10	96525323	96525323	-	A	0.1282	44	0.0000	36		42	CYP2C19	intron_variant	CYP2C19:ENST00000371321:intron_variant:MODIFIER:exon1/8:c.168+2699dupA:,CYP2C19:ENST00000464755:intron_variant:MODIFIER:exon6/13:n.932-9486dupA:,CYP2C19:ENST00000480405:intron_variant:MODIFIER:exon1/2:n.193+2699dupA:		Arachidonic acid metabolism;Linoleic acid metabolism;Retinol metabolism;Monoterpenoid biosynthesis;Limonene and pinene degradation;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450	Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine			rs373561842	0.0000	0.0000	0.0000		124020 [CYP2C19 (confirmed) Mephenytoin poor metabolizer,609535|Omeprazole poor metabolizer,609535|Proguanil poor metabolizer,609535|Clopidogrel,impaired responsiveness to,609535];																			0		0.1064	47	0.0000	167
chr10	98626431	98626431	A	G	0.2857	14	0.0000	31		72	LCOR	intron_variant	LCOR:ENST00000356016:intron_variant:MODIFIER:exon2/7:c.-330+33195A>G:,LCOR:ENST00000540664:intron_variant:MODIFIER:exon2/8:c.-330+33195A>G:,LCOR:ENST00000371103:intron_variant:MODIFIER:exon2/7:c.-330+33195A>G:,LCOR:ENST00000371097:intron_variant:MODIFIER:exon2/7:c.-330+33195A>G:			May act as transcription activator that binds DNA elements with the sequence 5'-CCCTATCGATCGATCTCTACCT-3' (By similarity). Repressor of ligand-dependent transcription activation by target nuclear receptors. Repressor of ligand- dependent transcription activation by ESR1, ESR2, NR3C1, PGR, RARA, RARB, RARG, RXRA and VDR				0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	31
chr10	103550122	103550122	T	C	0.2609	24	0.0313	32		60	MGEA5	intron_variant	MGEA5:ENST00000361464:intron_variant:MODIFIER:exon14/15:c.2454+531A>G:,MGEA5:ENST00000439817:intron_variant:MODIFIER:exon13/14:c.2295+531A>G:,MGEA5:ENST00000482611:intron_variant:MODIFIER:exon5/6:n.1050+531A>G:,MGEA5:ENST00000357797:intron_variant:MODIFIER:exon13/14:c.2253+531A>G:,MGEA5:ENST00000494347:intron_variant:MODIFIER:exon1/2:n.108+2474A>G:,MGEA5:ENST00000479811:intron_variant:MODIFIER:exon5/6:n.481+531A>G:,MGEA5:ENST00000461645:intron_variant:MODIFIER:exon1/2:n.558+531A>G:			Cleaves GlcNAc but not GalNAc from glycopeptides. Can use p-nitrophenyl-beta-GlcNAc as substrate but not p-nitrophenyl- beta-GalNAc or p-nitrophenyl-alpha-GlcNAc. Possesses hyaluronidase activity. Acetylates 'Lys-8' of histone H4 and 'Lys-14' of histone H3				0.0000	0.0000	0.0000																					0		0.2917	24	0.0312	32
chr10	103570929	103570929	T	C	0.3415	41	0.0000	37		91	MGEA5	intron_variant	MGEA5:ENST00000361464:intron_variant:MODIFIER:exon3/15:c.350-858A>G:,MGEA5:ENST00000439817:intron_variant:MODIFIER:exon3/14:c.350-858A>G:,MGEA5:ENST00000357797:intron_variant:MODIFIER:exon3/14:c.350-858A>G:,MGEA5:ENST00000370094:intron_variant:MODIFIER:exon3/9:c.350-858A>G:,MGEA5:ENST00000429860:intron_variant:MODIFIER:exon3/5:c.194-858A>G:,MGEA5:ENST00000419011:intron_variant:MODIFIER:exon5/7:c.*113-956A>G:			Cleaves GlcNAc but not GalNAc from glycopeptides. Can use p-nitrophenyl-beta-GlcNAc as substrate but not p-nitrophenyl- beta-GalNAc or p-nitrophenyl-alpha-GlcNAc. Possesses hyaluronidase activity. Acetylates 'Lys-8' of histone H4 and 'Lys-14' of histone H3				0.0000	0.0000	0.0000																					0		0.3415	41	0.0263	38
chr10	121331784	121331784	T	C	0.2941	18	0.0000	22		52	RP11-179H18.8-TIAL1	intergenic_region	RP11-179H18.8-TIAL1:ENSG00000271353-ENSG00000151923:intergenic_region:MODIFIER::n.121331784T>C:							0.0000	0.0000	0.0000																					0		0.3333	18	0.0000	22
chr10	126467798	126467798	T	C	0.3125	16	0.0000	22		53	RP11-12J10.3,METTL10	intron_variant	RP11-12J10.3:ENST00000494792:intron_variant:MODIFIER:exon3/9:c.184-4447A>G:,METTL10:ENST00000368836:intron_variant:MODIFIER:exon3/6:c.292-4447A>G:,METTL10:ENST00000466270:intron_variant:MODIFIER:exon3/6:c.296-4447A>G:,METTL10:ENST00000464099:intron_variant:MODIFIER:exon3/5:c.296-4447A>G:							0.0000	0.0000	0.0000																					0		0.3125	16	0.0000	22
chr10	126761945	126761945	T	C	0.3636	11	0.0000	16		33	CTBP2	intron_variant	CTBP2:ENST00000337195:intron_variant:MODIFIER:exon2/10:c.-101-34221A>G:,CTBP2:ENST00000531469:intron_variant:MODIFIER:exon2/10:c.-101-34221A>G:,CTBP2:ENST00000494626:intron_variant:MODIFIER:exon2/10:c.-101-34221A>G:,CTBP2:ENST00000411419:intron_variant:MODIFIER:exon2/10:c.-101-34221A>G:,CTBP2:ENST00000460976:intron_variant:MODIFIER:exon1/2:n.290-34221A>G:,CTBP2:ENST00000476817:intron_variant:MODIFIER:exon2/2:n.547-34221A>G:,CTBP2:ENST00000530884:intron_variant:MODIFIER:exon3/3:c.-102+14815A>G:		Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	Corepressor targeting diverse transcription regulators. Functions in brown adipose tissue (BAT) differentiation (By similarity)				0.0000	0.0000	0.0000																					0		0.3636	11	0.0000	16
chr10	126834631	126834631	T	C	0.2105	19	0.0000	20		51	CTBP2	intron_variant	CTBP2:ENST00000337195:intron_variant:MODIFIER:exon1/10:c.-206+14257A>G:,CTBP2:ENST00000531469:intron_variant:MODIFIER:exon1/10:c.-206+12573A>G:,CTBP2:ENST00000494626:intron_variant:MODIFIER:exon1/10:c.-202-12450A>G:,CTBP2:ENST00000411419:intron_variant:MODIFIER:exon1/10:c.-206+14765A>G:,CTBP2:ENST00000460976:intron_variant:MODIFIER:exon1/2:n.289+13795A>G:,CTBP2:ENST00000476817:intron_variant:MODIFIER:exon2/2:n.546+14257A>G:,CTBP2:ENST00000530884:intron_variant:MODIFIER:exon1/3:c.-335+14765A>G:,CTBP2:ENST00000467395:intron_variant:MODIFIER:exon1/2:n.101+13795A>G:		Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	Corepressor targeting diverse transcription regulators. Functions in brown adipose tissue (BAT) differentiation (By similarity)				0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	20
chr10	135223605	135223605	A	G	0.1935	31	0.0000	18		59	RP11-108K14.8,MTG1	intron_variant	RP11-108K14.8:ENST00000468317:intron_variant:MODIFIER:exon10/11:c.767+7328A>G:,MTG1:ENST00000317502:intron_variant:MODIFIER:exon9/10:c.752+7328A>G:,MTG1:ENST00000477902:intron_variant:MODIFIER:exon9/10:c.629+7328A>G:,MTG1:ENST00000432508:intron_variant:MODIFIER:exon7/8:c.599+7328A>G:,MTG1:ENST00000460848:intron_variant:MODIFIER:exon8/9:n.1335+7328A>G:,MTG1:ENST00000473735:intron_variant:MODIFIER:exon8/9:n.1606+7328A>G:			Plays a role in the regulation of the mitochondrial ribosome assembly and of translational activity. Displays mitochondrial GTPase activity				0.0000	0.0000	0.0000																					0		0.1935	31	0.0000	18
chr11	768571	768571	T	C	0.3750	8	0.0000	16		33	PDDC1	3_prime_UTR_variant,intron_variant	PDDC1:ENST00000319863:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2326A>G:,PDDC1:ENST00000354286:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2046A>G:,PDDC1:ENST00000397472:intron_variant:MODIFIER:exon7/7:c.630-1198A>G:,PDDC1:ENST00000465313:intron_variant:MODIFIER:exon3/3:c.*31-1198A>G:,PDDC1:ENST00000528309:intron_variant:MODIFIER:exon4/4:c.359-1198A>G:,PDDC1:ENST00000526650:intron_variant:MODIFIER:exon4/4:c.317-1203A>G:,PDDC1:ENST00000526325:intron_variant:MODIFIER:exon6/6:c.*25-1198A>G:							0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	16
chr11	32997894	32997894	G	A	0.1190	43	0.0000	25		55	QSER1	synonymous_variant	QSER1:ENST00000399302:synonymous_variant:LOW:exon13/13:c.5082G>A:p.Gln1694Gln,QSER1:ENST00000527788:synonymous_variant:LOW:exon14/16:c.4365G>A:p.Gln1455Gln						rs553810685	0.0000	0.00000	0.00000																					0		0.1136	44	0.0400	25
chr11	43721431	43721431	A	G	0.1515	39	0.0000	24		63	HSD17B12	intron_variant	HSD17B12:ENST00000278353:intron_variant:MODIFIER:exon1/10:c.160+18894A>G:,HSD17B12:ENST00000532864:intron_variant:MODIFIER:exon3/9:n.282-51030A>G:,HSD17B12:ENST00000529261:intron_variant:MODIFIER:exon4/9:n.377+26742A>G:,HSD17B12:ENST00000527433:intron_variant:MODIFIER:exon1/2:n.125+19077A>G:,HSD17B12:ENST00000531185:intron_variant:MODIFIER:exon1/5:c.160+18894A>G:,HSD17B12:ENST00000395700:intron_variant:MODIFIER:exon1/3:c.160+18894A>G:		Androgen and estrogen metabolism;Biosynthesis of unsaturated fatty acids	Catalyzes the transformation of estrone (E1) into estradiol (E2), suggesting a central role in estrogen formation. Its strong expression in ovary and mammary gland suggest that it may constitute the major enzyme responsible for the conversion of E1 to E2 in women. Also has 3-ketoacyl-CoA reductase activity, reducing both long chain 3-ketoacyl-CoAs and long chain fatty acyl-CoAs, suggesting a role in long fatty acid elongation				0.0000	0.0000	0.0000																					0		0.1538	39	0.0000	24
chr11	47538291	47538291	T	C	0.3636	22	0.0385	26		43	CELF1	intron_variant	CELF1:ENST00000531165:intron_variant:MODIFIER:exon1/15:c.-153-15807A>G:,CELF1:ENST00000310513:intron_variant:MODIFIER:exon1/13:c.-10-27715A>G:,CELF1:ENST00000532048:intron_variant:MODIFIER:exon1/15:c.-154+6509A>G:,CELF1:ENST00000530151:intron_variant:MODIFIER:exon1/4:c.-50-9842A>G:,CELF1:ENST00000528434:intron_variant:MODIFIER:exon1/4:c.-154+6861A>G:,CELF1:ENST00000525841:intron_variant:MODIFIER:exon2/3:c.-10-27715A>G:,CELF1:ENST00000543178:intron_variant:MODIFIER:exon1/3:c.-83+7785A>G:,CELF1:ENST00000526419:intron_variant:MODIFIER:exon1/1:c.-10-27715A>G:,CELF1:ENST00000528538:intron_variant:MODIFIER:exon1/5:c.-388+7785A>G:,CELF1:ENST00000526277:intron_variant:MODIFIER:exon1/3:c.-154+6509A>G:			RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre- mRNAs. Activates SM exon 5 inclusion by antagonizing the repressive effect of PTB. Promotes exclusion of exon 11 of the INSR pre-mRNA. Inhibits, together with HNRNPH1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Increases translation and controls the choice of translation initiation codon of CEBPB mRNA. Increases mRNA translation of CEBPB in aging liver (By similarity). Increases translation of CDKN1A mRNA by antagonizing the repressive effect of CALR3. Mediates rapid cytoplasmic mRNA deadenylation. Recruits the deadenylase PARN to the poly(A) tail of EDEN-containing mRNAs to promote their deadenylation. Required for completion of spermatogenesis (By similarity). Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK and to Bruno response elements (BREs). Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. Binds to AU-rich sequences (AREs or EDEN-like) localized in the 3'-UTR of JUN and FOS mRNAs. Binds to the IR RNA. Binds to the 5'-region of CDKN1A and CEBPB mRNAs. Binds with the 5'-region of CEBPB mRNA in aging liver				0.0000	0.0000	0.0000																					0		0.3636	22	0.0370	27
chr11	47540851	47540851	T	C	0.2000	20	0.0000	30		62	CELF1	intron_variant	CELF1:ENST00000531165:intron_variant:MODIFIER:exon1/15:c.-153-18367A>G:,CELF1:ENST00000310513:intron_variant:MODIFIER:exon1/13:c.-10-30275A>G:,CELF1:ENST00000532048:intron_variant:MODIFIER:exon1/15:c.-154+3949A>G:,CELF1:ENST00000530151:intron_variant:MODIFIER:exon1/4:c.-50-12402A>G:,CELF1:ENST00000528434:intron_variant:MODIFIER:exon1/4:c.-154+4301A>G:,CELF1:ENST00000525841:intron_variant:MODIFIER:exon2/3:c.-10-30275A>G:,CELF1:ENST00000543178:intron_variant:MODIFIER:exon1/3:c.-83+5225A>G:,CELF1:ENST00000526419:intron_variant:MODIFIER:exon1/1:c.-10-30275A>G:,CELF1:ENST00000528538:intron_variant:MODIFIER:exon1/5:c.-388+5225A>G:,CELF1:ENST00000526277:intron_variant:MODIFIER:exon1/3:c.-154+3949A>G:			RNA-binding protein implicated in the regulation of several post-transcriptional events. Involved in pre-mRNA alternative splicing, mRNA translation and stability. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of cardiac isoforms of TNNT2 during heart remodeling at the juvenile to adult transition. Acts as both an activator and repressor of a pair of coregulated exons: promotes inclusion of the smooth muscle (SM) exon but exclusion of the non-muscle (NM) exon in actinin pre- mRNAs. Activates SM exon 5 inclusion by antagonizing the repressive effect of PTB. Promotes exclusion of exon 11 of the INSR pre-mRNA. Inhibits, together with HNRNPH1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Increases translation and controls the choice of translation initiation codon of CEBPB mRNA. Increases mRNA translation of CEBPB in aging liver (By similarity). Increases translation of CDKN1A mRNA by antagonizing the repressive effect of CALR3. Mediates rapid cytoplasmic mRNA deadenylation. Recruits the deadenylase PARN to the poly(A) tail of EDEN-containing mRNAs to promote their deadenylation. Required for completion of spermatogenesis (By similarity). Binds to (CUG)n triplet repeats in the 3'-UTR of transcripts such as DMPK and to Bruno response elements (BREs). Binds to muscle-specific splicing enhancer (MSE) intronic sites flanking the alternative exon 5 of TNNT2 pre-mRNA. Binds to AU-rich sequences (AREs or EDEN-like) localized in the 3'-UTR of JUN and FOS mRNAs. Binds to the IR RNA. Binds to the 5'-region of CDKN1A and CEBPB mRNAs. Binds with the 5'-region of CEBPB mRNA in aging liver				0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	30
chr11	57311729	57311729	T	C	0.1600	25	0.0000	26		63	SMTNL1	intron_variant	SMTNL1:ENST00000457912:intron_variant:MODIFIER:exon4/7:c.971+336T>C:,SMTNL1:ENST00000527972:intron_variant:MODIFIER:exon3/6:c.917+336T>C:,SMTNL1:ENST00000399154:intron_variant:MODIFIER:exon4/7:c.806+336T>C:			Plays a role in the regulation of contractile properties of both striated and smooth muscles. When unphosphorylated, may inhibit myosin dephosphorylation. Phosphorylation at Ser-299 reduces this inhibitory activity (By similarity)				0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	26
chr11	57548594	57548594	A	G	0.3333	12	0.0000	24		58	TMX2-CTNND1,RP11-691N7.6,CTNND1	intron_variant	TMX2-CTNND1:ENST00000528395:intron_variant:MODIFIER:exon2/3:c.251-7915A>G:,RP11-691N7.6:ENST00000531074:intron_variant:MODIFIER:exon2/3:c.*153-10263A>G:,CTNND1:ENST00000399050:intron_variant:MODIFIER:exon1/20:c.-213-7915A>G:,CTNND1:ENST00000524630:intron_variant:MODIFIER:exon1/18:c.-213-7915A>G:,CTNND1:ENST00000529919:intron_variant:MODIFIER:exon1/19:c.-213-7915A>G:,CTNND1:ENST00000399039:intron_variant:MODIFIER:exon1/20:c.-213-7915A>G:,CTNND1:ENST00000533189:intron_variant:MODIFIER:exon1/1:c.-13-20611A>G:,CTNND1:ENST00000360682:intron_variant:MODIFIER:exon1/19:c.-213-7915A>G:,CTNND1:ENST00000361796:intron_variant:MODIFIER:exon1/18:c.-213-7915A>G:,CTNND1:ENST00000358694:intron_variant:MODIFIER:exon1/18:c.-213-7915A>G:,CTNND1:ENST00000361332:intron_variant:MODIFIER:exon1/19:c.-213-7915A>G:,CTNND1:ENST00000361391:intron_variant:MODIFIER:exon1/18:c.-213-7915A>G:,CTNND1:ENST00000415361:intron_variant:MODIFIER:exon1/18:c.-108-12888A>G:,CTNND1:ENST00000426142:intron_variant:MODIFIER:exon1/16:c.-108-12888A>G:,CTNND1:ENST00000428599:intron_variant:MODIFIER:exon1/17:c.-94-10263A>G:,CTNND1:ENST00000525902:intron_variant:MODIFIER:exon1/14:c.-14+19076A>G:,CTNND1:ENST00000526357:intron_variant:MODIFIER:exon1/18:c.-147-10372A>G:,CTNND1:ENST00000526772:intron_variant:MODIFIER:exon1/13:c.-14+19076A>G:,CTNND1:ENST00000527467:intron_variant:MODIFIER:exon1/15:c.-14+19076A>G:,CTNND1:ENST00000528232:intron_variant:MODIFIER:exon1/17:c.-108-12888A>G:,CTNND1:ENST00000528621:intron_variant:MODIFIER:exon1/17:c.-147-10372A>G:,CTNND1:ENST00000529526:intron_variant:MODIFIER:exon1/18:c.-266-7915A>G:,CTNND1:ENST00000529873:intron_variant:MODIFIER:exon1/17:c.-147-10372A>G:,CTNND1:ENST00000529986:intron_variant:MODIFIER:exon1/16:c.-108-12888A>G:,CTNND1:ENST00000530094:intron_variant:MODIFIER:exon1/17:c.-108-12888A>G:,CTNND1:ENST00000530748:intron_variant:MODIFIER:exon1/18:c.-147-10372A>G:,CTNND1:ENST00000531014:intron_variant:MODIFIER:exon1/14:c.-14+19076A>G:,CTNND1:ENST00000532245:intron_variant:MODIFIER:exon1/15:c.-36-14455A>G:,CTNND1:ENST00000532463:intron_variant:MODIFIER:exon1/16:c.-108-12888A>G:,CTNND1:ENST00000532649:intron_variant:MODIFIER:exon1/18:c.-266-7915A>G:,CTNND1:ENST00000532787:intron_variant:MODIFIER:exon1/16:c.-108-12888A>G:,CTNND1:ENST00000532844:intron_variant:MODIFIER:exon1/19:c.-147-10372A>G:,CTNND1:ENST00000533667:intron_variant:MODIFIER:exon1/13:c.-14+19076A>G:,CTNND1:ENST00000534579:intron_variant:MODIFIER:exon1/18:c.-268-7915A>G:,CTNND1:ENST00000526938:intron_variant:MODIFIER:exon1/17:c.-94-10263A>G:,CTNND1:ENST00000524579:intron_variant:MODIFIER:exon1/2:c.-213-7915A>G:		Adherens junction;Leukocyte transendothelial migration	Binds to and inhibits the transcriptional repressor ZBTB33, which may lead to activation of target genes of the Wnt signaling pathway (By similarity). Associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability. Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors. Promotes GLIS2 C-terminal cleavage				0.0000	0.0000	0.0000																					0		0.3333	12	0.0000	24
chr11	57548631	57548631	A	G	0.4444	9	0.0000	25		59	TMX2-CTNND1,RP11-691N7.6,CTNND1	intron_variant	TMX2-CTNND1:ENST00000528395:intron_variant:MODIFIER:exon2/3:c.251-7878A>G:,RP11-691N7.6:ENST00000531074:intron_variant:MODIFIER:exon2/3:c.*153-10226A>G:,CTNND1:ENST00000399050:intron_variant:MODIFIER:exon1/20:c.-213-7878A>G:,CTNND1:ENST00000524630:intron_variant:MODIFIER:exon1/18:c.-213-7878A>G:,CTNND1:ENST00000529919:intron_variant:MODIFIER:exon1/19:c.-213-7878A>G:,CTNND1:ENST00000399039:intron_variant:MODIFIER:exon1/20:c.-213-7878A>G:,CTNND1:ENST00000533189:intron_variant:MODIFIER:exon1/1:c.-13-20574A>G:,CTNND1:ENST00000360682:intron_variant:MODIFIER:exon1/19:c.-213-7878A>G:,CTNND1:ENST00000361796:intron_variant:MODIFIER:exon1/18:c.-213-7878A>G:,CTNND1:ENST00000358694:intron_variant:MODIFIER:exon1/18:c.-213-7878A>G:,CTNND1:ENST00000361332:intron_variant:MODIFIER:exon1/19:c.-213-7878A>G:,CTNND1:ENST00000361391:intron_variant:MODIFIER:exon1/18:c.-213-7878A>G:,CTNND1:ENST00000415361:intron_variant:MODIFIER:exon1/18:c.-108-12851A>G:,CTNND1:ENST00000426142:intron_variant:MODIFIER:exon1/16:c.-108-12851A>G:,CTNND1:ENST00000428599:intron_variant:MODIFIER:exon1/17:c.-94-10226A>G:,CTNND1:ENST00000525902:intron_variant:MODIFIER:exon1/14:c.-14+19113A>G:,CTNND1:ENST00000526357:intron_variant:MODIFIER:exon1/18:c.-147-10335A>G:,CTNND1:ENST00000526772:intron_variant:MODIFIER:exon1/13:c.-14+19113A>G:,CTNND1:ENST00000527467:intron_variant:MODIFIER:exon1/15:c.-14+19113A>G:,CTNND1:ENST00000528232:intron_variant:MODIFIER:exon1/17:c.-108-12851A>G:,CTNND1:ENST00000528621:intron_variant:MODIFIER:exon1/17:c.-147-10335A>G:,CTNND1:ENST00000529526:intron_variant:MODIFIER:exon1/18:c.-266-7878A>G:,CTNND1:ENST00000529873:intron_variant:MODIFIER:exon1/17:c.-147-10335A>G:,CTNND1:ENST00000529986:intron_variant:MODIFIER:exon1/16:c.-108-12851A>G:,CTNND1:ENST00000530094:intron_variant:MODIFIER:exon1/17:c.-108-12851A>G:,CTNND1:ENST00000530748:intron_variant:MODIFIER:exon1/18:c.-147-10335A>G:,CTNND1:ENST00000531014:intron_variant:MODIFIER:exon1/14:c.-14+19113A>G:,CTNND1:ENST00000532245:intron_variant:MODIFIER:exon1/15:c.-36-14418A>G:,CTNND1:ENST00000532463:intron_variant:MODIFIER:exon1/16:c.-108-12851A>G:,CTNND1:ENST00000532649:intron_variant:MODIFIER:exon1/18:c.-266-7878A>G:,CTNND1:ENST00000532787:intron_variant:MODIFIER:exon1/16:c.-108-12851A>G:,CTNND1:ENST00000532844:intron_variant:MODIFIER:exon1/19:c.-147-10335A>G:,CTNND1:ENST00000533667:intron_variant:MODIFIER:exon1/13:c.-14+19113A>G:,CTNND1:ENST00000534579:intron_variant:MODIFIER:exon1/18:c.-268-7878A>G:,CTNND1:ENST00000526938:intron_variant:MODIFIER:exon1/17:c.-94-10226A>G:,CTNND1:ENST00000524579:intron_variant:MODIFIER:exon1/2:c.-213-7878A>G:		Adherens junction;Leukocyte transendothelial migration	Binds to and inhibits the transcriptional repressor ZBTB33, which may lead to activation of target genes of the Wnt signaling pathway (By similarity). Associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability. Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors. Promotes GLIS2 C-terminal cleavage				0.0000	0.0000	0.0000																					0		0.4444	9	0.0000	25
chr11	57564807	57564807	A	G	0.1087	46	0.0000	46		64	CTNND1	intron_variant	CTNND1:ENST00000399050:intron_variant:MODIFIER:exon6/20:c.956+343A>G:,CTNND1:ENST00000524630:intron_variant:MODIFIER:exon6/18:c.956+343A>G:,CTNND1:ENST00000529919:intron_variant:MODIFIER:exon6/19:c.956+343A>G:,CTNND1:ENST00000399039:intron_variant:MODIFIER:exon6/20:c.956+343A>G:,CTNND1:ENST00000533189:intron_variant:MODIFIER:exon1/1:c.-13-4398A>G:,CTNND1:ENST00000360682:intron_variant:MODIFIER:exon6/19:c.956+343A>G:,CTNND1:ENST00000361796:intron_variant:MODIFIER:exon6/18:c.956+343A>G:,CTNND1:ENST00000358694:intron_variant:MODIFIER:exon6/18:c.956+343A>G:,CTNND1:ENST00000361332:intron_variant:MODIFIER:exon6/19:c.956+343A>G:,CTNND1:ENST00000361391:intron_variant:MODIFIER:exon6/18:c.956+343A>G:,CTNND1:ENST00000415361:intron_variant:MODIFIER:exon4/18:c.653+343A>G:,CTNND1:ENST00000426142:intron_variant:MODIFIER:exon4/16:c.653+343A>G:,CTNND1:ENST00000428599:intron_variant:MODIFIER:exon5/17:c.956+343A>G:,CTNND1:ENST00000525902:intron_variant:MODIFIER:exon1/14:c.-13-4398A>G:,CTNND1:ENST00000526357:intron_variant:MODIFIER:exon5/18:c.794+343A>G:,CTNND1:ENST00000526772:intron_variant:MODIFIER:exon1/13:c.-13-4398A>G:,CTNND1:ENST00000527467:intron_variant:MODIFIER:exon1/15:c.-13-4398A>G:,CTNND1:ENST00000528232:intron_variant:MODIFIER:exon4/17:c.653+343A>G:,CTNND1:ENST00000528621:intron_variant:MODIFIER:exon5/17:c.794+343A>G:,CTNND1:ENST00000529526:intron_variant:MODIFIER:exon6/18:c.794+343A>G:,CTNND1:ENST00000529873:intron_variant:MODIFIER:exon5/17:c.794+343A>G:,CTNND1:ENST00000529986:intron_variant:MODIFIER:exon4/16:c.653+343A>G:,CTNND1:ENST00000530094:intron_variant:MODIFIER:exon4/17:c.653+343A>G:,CTNND1:ENST00000530748:intron_variant:MODIFIER:exon5/18:c.794+343A>G:,CTNND1:ENST00000531014:intron_variant:MODIFIER:exon1/14:c.-13-4398A>G:,CTNND1:ENST00000532245:intron_variant:MODIFIER:exon3/15:c.653+343A>G:,CTNND1:ENST00000532463:intron_variant:MODIFIER:exon4/16:c.653+343A>G:,CTNND1:ENST00000532649:intron_variant:MODIFIER:exon6/18:c.794+343A>G:,CTNND1:ENST00000532787:intron_variant:MODIFIER:exon4/16:c.653+343A>G:,CTNND1:ENST00000532844:intron_variant:MODIFIER:exon5/19:c.794+343A>G:,CTNND1:ENST00000533667:intron_variant:MODIFIER:exon1/13:c.-13-4398A>G:,CTNND1:ENST00000534579:intron_variant:MODIFIER:exon6/18:c.794+343A>G:,CTNND1:ENST00000526938:intron_variant:MODIFIER:exon5/17:c.956+343A>G:,CTNND1:ENST00000534647:intron_variant:MODIFIER:exon3/3:c.722+343A>G:		Adherens junction;Leukocyte transendothelial migration	Binds to and inhibits the transcriptional repressor ZBTB33, which may lead to activation of target genes of the Wnt signaling pathway (By similarity). Associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability. Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors. Promotes GLIS2 C-terminal cleavage				0.0000	0.0000	0.0000																					0		0.1087	46	0.0000	46
chr11	64075544	64075544	A	G	0.2105	19	0.0217	46		58	ESRRA	intron_variant	ESRRA:ENST00000000442:intron_variant:MODIFIER:exon2/6:c.325+568A>G:,ESRRA:ENST00000406310:intron_variant:MODIFIER:exon2/6:c.325+568A>G:,ESRRA:ENST00000539594:intron_variant:MODIFIER:exon1/4:c.-105+2336A>G:,ESRRA:ENST00000405666:intron_variant:MODIFIER:exon2/6:c.325+568A>G:			Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism	Regulation of PGC-1a			0.0000	0.0000	0.0000																					0		0.2105	19	0.0217	46
chr11	66400880	66400880	A	G	0.1892	38	0.0250	40		51	RBM14-RBM4,RBM4	intron_variant	RBM14-RBM4:ENST00000412278:intron_variant:MODIFIER:exon1/2:c.338-10041A>G:,RBM4:ENST00000514361:intron_variant:MODIFIER:exon1/2:c.338-10041A>G:,RBM14-RBM4:ENST00000511114:intron_variant:MODIFIER:exon1/1:n.429-5150A>G:,RBM14-RBM4:ENST00000421355:intron_variant:MODIFIER:exon1/2:c.338-6291A>G:,RBM4:ENST00000503028:intron_variant:MODIFIER:exon1/2:c.-12-6291A>G:,RBM14-RBM4:ENST00000500635:intron_variant:MODIFIER:exon1/1:c.338-12618A>G:			Isoform 1 may function as a nuclear receptor coactivator, enhancing transcription through other coactivators such as NCOA6 and CITED1. Isoform 2, functions as a transcriptional repressor, modulating transcriptional activities of coactivators including isoform 1, NCOA6 and CITED1.,RNA-binding factor involved in multiple aspects of cellular processes like alternative splicing of pre-mRNA and translation regulation. Modulates alternative 5'-splice site and exon selection. Acts as a muscle cell differentiation-promoting factor. Activates exon skipping of the PTB pre-mRNA during muscle cell differentiation. Antagonizes the activity of the splicing factor PTBP1 to modulate muscle cell-specific exon selection of alpha tropomyosin. Binds to intronic pyrimidine-rich sequence of the TPM1 and MAPT pre-mRNAs. Required for the translational activation of PER1 mRNA in response to circadian clock. Binds directly to the 3'-UTR of the PER1 mRNA. Exerts a suppressive activity on Cap-dependent translation via binding to CU-rich responsive elements within the 3'UTR of mRNAs, a process increased under stress conditions or during myocytes differentiation. Recruits EIF4A1 to stimulate IRES-dependent translation initiation in respons to cellular stress. Associates to internal ribosome entry segment (IRES) in target mRNA species under stress conditions. Plays a role for miRNA-guided RNA cleavage and translation suppression by promoting association of AGO2- containing miRNPs with their cognate target mRNAs. Associates with miRNAs during muscle cell differentiation. Binds preferentially to 5'-CGCGCG[GCA]-3' motif in vitro				0.0000	0.0000	0.0000																					0		0.2105	38	0.0250	40
chr11	66910586	66910586	A	G	0.5000	6	0.0000	17		36	KDM2A	intron_variant	KDM2A:ENST00000529006:intron_variant:MODIFIER:exon2/20:c.42+21757A>G:,KDM2A:ENST00000398645:intron_variant:MODIFIER:exon2/20:c.42+21757A>G:,KDM2A:ENST00000532436:intron_variant:MODIFIER:exon2/3:n.285-89A>G:,KDM2A:ENST00000527157:intron_variant:MODIFIER:exon2/2:n.199+21757A>G:			Histone demethylase that specifically demethylates 'Lys- 36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys- 36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis				0.0000	0.0000	0.0000																					0		0.5000	6	0.0000	17
chr11	66915266	66915266	A	G	0.3125	16	0.0682	44		54	KDM2A	intron_variant	KDM2A:ENST00000529006:intron_variant:MODIFIER:exon2/20:c.42+26437A>G:,KDM2A:ENST00000398645:intron_variant:MODIFIER:exon2/20:c.42+26437A>G:,KDM2A:ENST00000532436:intron_variant:MODIFIER:exon3/3:n.453-1260A>G:,KDM2A:ENST00000527157:intron_variant:MODIFIER:exon2/2:n.199+26437A>G:			Histone demethylase that specifically demethylates 'Lys- 36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys- 36'. May also recognize and bind to some phosphorylated proteins and promote their ubiquitination and degradation. Required to maintain the heterochromatic state. Associates with centromeres and represses transcription of small non-coding RNAs that are encoded by the clusters of satellite repeats at the centromere. Required to sustain centromeric integrity and genomic stability, particularly during mitosis				0.0000	0.0000	0.0000																					0		0.3125	16	0.0682	44
chr11	67860670	67860670	T	C	0.2143	28	0.0238	42		58	CHKA	intron_variant	CHKA:ENST00000265689:intron_variant:MODIFIER:exon2/11:c.462+3816A>G:,CHKA:ENST00000356135:intron_variant:MODIFIER:exon2/10:c.462+3816A>G:,CHKA:ENST00000531341:intron_variant:MODIFIER:exon2/5:c.96+3816A>G:		Glycine, serine and threonine metabolism;Glycerophospholipid metabolism	Has a key role in phospholipid biosynthesis and may contribute to tumor cell growth. Catalyzes the first step in phosphatidylcholine biosynthesis. Contributes to phosphatidylethanolamine biosynthesis. Phosphorylates choline and ethanolamine. Has higher activity with choline				0.0000	0.0000	0.0000																					0		0.2143	28	0.0238	42
chr11	69466463	69466463	-	A	0.0741	94	0.0000	109		49	CCND1	3_prime_UTR_variant	CCND1:ENST00000227507:3_prime_UTR_variant:MODIFIER:exon5/5:c.*421dupA:		Cell cycle;p53 signaling pathway;Wnt signaling pathway;Focal adhesion;Jak-STAT signaling pathway;Colorectal cancer;Pancreatic cancer;Endometrial cancer;Glioma;Prostate cancer;Thyroid cancer;Melanoma;Bladder cancer;Chronic myeloid leukemia;Acute myeloid leukemia;Small cell lung cancer;Non-small cell lung cancer	Regulatory component of the cyclin D1-CDK4 (DC) complex that phosphorylates and inhibits members of the retinoblastoma (RB) protein family including RB1 and regulates the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complex and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also substrate for SMAD3, phosphorylating SMAD3 in a cell-cycle-dependent manner and repressing its transcriptional activity. Component of the ternary complex, cyclin D1/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex	BTG family proteins and cell cycle regulation;Cell Cycle: G1/S Check Point ;Cyclins and Cell Cycle Regulation;Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages;Influence of Ras and Rho proteins on G1 to S Transition;p53 Signaling Pathway;WNT Signaling Pathway			0.0000	0.0000	0.0000		168461 [CCND1 (confirmed) Colorectal cancer,susceptibility to,114500|von Hippel-Lindau syndrome,modifier of,193300|Multiple myeloma,susceptibility to,254500];																			0		0.0568	88	0.0000	103
chr11	73408517	73408517	T	C	0.2778	18	0.0000	23		58	RAB6A	intron_variant	RAB6A:ENST00000310653:intron_variant:MODIFIER:exon6/7:c.495+9948A>G:,RAB6A:ENST00000336083:intron_variant:MODIFIER:exon6/7:c.495+9948A>G:,RAB6A:ENST00000536566:intron_variant:MODIFIER:exon6/7:c.396+9948A>G:,RAB6A:ENST00000541973:intron_variant:MODIFIER:exon6/7:c.471+9948A>G:,RAB6A:ENST00000541588:intron_variant:MODIFIER:exon3/4:c.184-17752A>G:,RAB6A:ENST00000545625:intron_variant:MODIFIER:exon5/5:c.*125+9948A>G:,RAB6A:ENST00000540771:intron_variant:MODIFIER:exon2/3:c.130-17752A>G:,RAB6A:ENST00000537446:intron_variant:MODIFIER:exon5/5:c.*125+9948A>G:			Protein transport. Regulator of membrane traffic from the Golgi apparatus towards the endoplasmic reticulum (ER). Has a low GTPase activity	Rab GTPases Mark Targets In The Endocytotic Machinery			0.0000	0.0000	0.0000																					0		0.2778	18	0.0000	23
chr11	77409558	77409558	-	T	0.1935	38	0.0000	32		44	RSF1	frameshift_variant,non_coding_transcript_exon_variant	RSF1:ENST00000308488:frameshift_variant:HIGH:exon7/16:c.2688dupA:p.Cys897fs,RSF1:ENST00000480887:frameshift_variant:HIGH:exon2/11:c.1932dupA:p.Cys645fs,RSF1:ENST00000360355:frameshift_variant:HIGH:exon6/15:c.2595dupA:p.Cys866fs,RSF1:ENST00000531026:frameshift_variant:HIGH:exon1/8:c.15dupA:p.Cys6fs,RSF1:ENST00000526324:frameshift_variant:HIGH:exon3/7:c.2091dupA:p.Cys698fs,RSF1:ENST00000532556:frameshift_variant:HIGH:exon2/3:c.447dupA:p.Cys150fs,RSF1:ENST00000531768:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.221dupA:			Required for assembly of regular nucleosome arrays by the RSF chromatin-remodeling complex. Facilitates transcription of hepatitis B virus (HBV) genes by the pX transcription activator. In case of infection by HBV, together with pX, it represses TNF- alpha induced NF-kappa-B transcription activation. Represses transcription when artificially recruited to chromatin by fusion to a heterogeneous DNA binding domain				0.0000	0.0000	0.0000																					0		0.1429	42	0.0000	36
chr11	82886650	82886650	A	G	0.1739	23	0.0000	16		51	PCF11	intron_variant	PCF11:ENST00000298281:intron_variant:MODIFIER:exon9/15:c.3758-1477A>G:,PCF11:ENST00000530906:intron_variant:MODIFIER:exon2/5:c.113-1477A>G:			Component of pre-mRNA cleavage complex II				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	16
chr11	88057431	88057431	T	C	0.1143	35	0.0000	34		57	CTSC	3_prime_UTR_variant,intron_variant	CTSC:ENST00000524463:3_prime_UTR_variant:MODIFIER:exon4/4:c.*2170A>G:,CTSC:ENST00000227266:intron_variant:MODIFIER:exon2/6:c.318+10674A>G:,CTSC:ENST00000527018:intron_variant:MODIFIER:exon2/5:c.186+10674A>G:,CTSC:ENST00000533865:intron_variant:MODIFIER:exon2/3:n.340+10674A>G:			Thiol protease. Has dipeptidylpeptidase activity. Active against a broad range of dipeptide substrates composed of both polar and hydrophobic amino acids. Proline cannot occupy the P1 position and arginine cannot occupy the P2 position of the substrate. Can act as both an exopeptidase and endopeptidase. Activates serine proteases such as elastase, cathepsin G and granzymes A and B. Can also activate neuraminidase and factor XIII				0.0000	0.0000	0.0000		602365 [CTSC (confirmed) Papillon-Lefevre syndrome,245000|Haim-Munk syndrome,245010|Periodontitis 1,juvenile,170650];																			0		0.1143	35	0.0000	34
chr11	95564341	95564341	-	A	0.2308	28	0.0000	31		49	CEP57	frameshift_variant,3_prime_UTR_variant	CEP57:ENST00000325542:frameshift_variant:HIGH:exon11/11:c.1430dupA:p.Asn477fs,CEP57:ENST00000537677:frameshift_variant:HIGH:exon11/11:c.1349dupA:p.Asn450fs,CEP57:ENST00000325486:frameshift_variant:HIGH:exon10/10:c.1352dupA:p.Asn451fs,CEP57:ENST00000541150:frameshift_variant:HIGH:exon11/11:c.1403dupA:p.Asn468fs,CEP57:ENST00000539855:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1209dupA:,CEP57:ENST00000540830:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1194dupA:			Centrosomal protein which may be required for microtubule attachment to centrosomes. May act by forming ring- like structures around microtubules. Mediates nuclear translocation and mitogenic activity of the internalized growth factor FGF2, but that of FGF1				0.0000	0.0000	0.0000		607951 [CEP57 (provisional) Mosaic variegated aneuploidy syndrome 2,614114];																			0		0.1923	26	0.0000	31
chr11	96086148	96086148	-	A	0.2500	25	0.0000	19		40	CCDC82	3_prime_UTR_variant	CCDC82:ENST00000278520:3_prime_UTR_variant:MODIFIER:exon9/9:c.*661dupT:,CCDC82:ENST00000542662:3_prime_UTR_variant:MODIFIER:exon11/11:c.*661dupT:							0.0000	0.0000	0.0000																					0		0.2174	23	0.0000	19
chr11	102042845	102042845	A	G	0.1600	25	0.0000	21		61	YAP1	sequence_feature,intron_variant	YAP1:ENST00000282441:sequence_feature:LOW::c.688+9543A>G:,YAP1:ENST00000537274:sequence_feature:LOW::c.688+9543A>G:,YAP1:ENST00000531439:sequence_feature:LOW::c.688+9543A>G:,YAP1:ENST00000282441:intron_variant:MODIFIER:exon3/8:c.688+9543A>G:,YAP1:ENST00000526343:intron_variant:MODIFIER:exon3/6:c.688+9543A>G:,YAP1:ENST00000345877:intron_variant:MODIFIER:exon3/6:c.688+9543A>G:,YAP1:ENST00000537274:intron_variant:MODIFIER:exon3/7:c.688+9543A>G:,YAP1:ENST00000531439:intron_variant:MODIFIER:exon3/7:c.688+9543A>G:,YAP1:ENST00000524575:intron_variant:MODIFIER:exon3/8:c.154+9543A>G:,YAP1:ENST00000526594:intron_variant:MODIFIER:exon1/1:n.116+9543A>G:			Transcriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Plays a key role to control cell proliferation in response to cell contact. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. The presence of TEAD transcription factors are required for it to stimulate gene expression, cell growth, anchorage-independent growth, and epithelial mesenchymal transition (EMT) induction. Isoform 2 and isoform 3 can activate the C-terminal fragment (CTF) of ERBB4 (isoform 3)				0.0000	0.0000	0.0000		606608 [YAP1 (provisional) Coloboma,ocular,with or without hearing impairment,cleft lip/palate,and/or mental retardation,120433|Coloboma,ocular,120433];																			0		0.1600	25	0.0000	21
chr11	114185304	114185304	A	G	0.0517	117	0.0000	97		62	RP11-64D24.2	intron_variant	RP11-64D24.2:ENST00000544925:intron_variant:MODIFIER:exon1/2:n.50+41940T>C:							0.0000	0.0000	0.0000																					0		0.0508	118	0.0000	97
chr11	114191209	114191209	A	G	0.2667	30	0.0392	51		67	RP11-64D24.2	intron_variant	RP11-64D24.2:ENST00000544925:intron_variant:MODIFIER:exon1/2:n.50+36035T>C:							0.0000	0.0000	0.0000																					0		0.2667	30	0.0392	51
chr11	117081569	117081569	T	C	0.2353	17	0.0000	28		67	PCSK7	intron_variant,non_coding_transcript_exon_variant	PCSK7:ENST00000320934:intron_variant:MODIFIER:exon12/16:c.1535-1800A>G:,PCSK7:ENST00000540028:intron_variant:MODIFIER:exon4/9:c.458-1800A>G:,PCSK7:ENST00000534529:intron_variant:MODIFIER:exon5/10:n.3565-1800A>G:,PCSK7:ENST00000527037:intron_variant:MODIFIER:exon1/5:n.1674-1800A>G:,PCSK7:ENST00000533135:intron_variant:MODIFIER:exon2/4:n.213-1807A>G:,PCSK7:ENST00000528973:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.7612A>G:			Likely to represent a ubiquitous endoprotease activity within constitutive secretory pathways and capable of cleavage at the RXXX[KR]R consensus motif			rs748153004	0.0000	0.0000	0.0000																					0		0.2353	17	0.0000	28
chr11	118373950	118373950	-	T	0.1020	57	0.0000	50		42	KMT2A	frameshift_variant,non_coding_transcript_exon_variant	KMT2A:ENST00000534358:frameshift_variant:HIGH:exon27/36:c.7349dupT:p.Leu2450fs,KMT2A:ENST00000389506:frameshift_variant:HIGH:exon27/36:c.7340dupT:p.Leu2447fs,KMT2A:ENST00000354520:frameshift_variant:HIGH:exon26/35:c.7226dupT:p.Leu2409fs,KMT2A:ENST00000528278:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.1476dupT:			Histone methyltransferase that plays an essential role in early development and hematopoiesis. Catalytic subunit of the MLL1/MLL complex, a multiprotein complex that mediates both methylation of 'Lys-4' of histone H3 (H3K4me) complex and acetylation of 'Lys-16' of histone H4 (H4K16ac). In the MLL1/MLL complex, it specifically mediates H3K4me, a specific tag for epigenetic transcriptional activation. Has weak methyltransferase activity by itself, and requires other component of the MLL1/MLL complex to obtain full methyltransferase activity. Has no activity toward histone H3 phosphorylated on 'Thr-3', less activity toward H3 dimethylated on 'Arg-8' or 'Lys-9', while it has higher activity toward H3 acetylated on 'Lys-9'. Required for transcriptional activation of HOXA9. Promotes PPP1R15A-induced apoptosis				0.0000	0.0000	0.0000		159555 [KMT2A (confirmed) Wiedemann-Steiner syndrome,605130|Leukemia,myeloid/lymphoid or mixed-lineage];																			0		0.0943	53	0.0000	58
chr11	118871252	118871252	A	G	0.2500	28	0.0833	48		53	CCDC84	intron_variant	CCDC84:ENST00000334418:intron_variant:MODIFIER:exon3/10:c.383+1433A>G:,CCDC84:ENST00000524670:intron_variant:MODIFIER:exon2/5:n.548+1433A>G:,CCDC84:ENST00000526463:intron_variant:MODIFIER:exon3/10:c.384-1071A>G:,CCDC84:ENST00000532132:intron_variant:MODIFIER:exon3/10:c.383+1433A>G:,CCDC84:ENST00000580556:intron_variant:MODIFIER:exon1/6:n.69+1433A>G:							0.0000	0.0000	0.0000																					0		0.2500	28	0.0638	47
chr11	118873283	118873283	A	G	0.3158	19	0.0588	34		53	CCDC84	intron_variant	CCDC84:ENST00000334418:intron_variant:MODIFIER:exon3/10:c.383+3464A>G:,CCDC84:ENST00000524670:intron_variant:MODIFIER:exon2/5:n.548+3464A>G:,CCDC84:ENST00000526463:intron_variant:MODIFIER:exon4/10:c.*149+748A>G:,CCDC84:ENST00000532132:intron_variant:MODIFIER:exon3/10:c.383+3464A>G:,CCDC84:ENST00000580556:intron_variant:MODIFIER:exon1/6:n.69+3464A>G:						rs540285942	0.000199681	0.0000	0.0000																					0		0.3158	19	0.0588	34
chr11	119109779	119109779	A	G	0.2857	14	0.0000	27		67	CBL	intron_variant	CBL:ENST00000264033:intron_variant:MODIFIER:exon2/15:c.443+6374A>G:		ErbB signaling pathway;Ubiquitin mediated proteolysis;Jak-STAT signaling pathway;T cell receptor signaling pathway;Insulin signaling pathway;Chronic myeloid leukemia	Adapter protein that functions as a negative regulator of many signaling pathways that are triggered by activation of cell surface receptors. Acts as an E3 ubiquitin-protein ligase, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8 and KDR and terminates signaling. Recognizes membrane-bound HCK and other kinases of the SRC family and mediates their ubiquitination and degradation. Participates in signal transduction in hematopoietic cells. Plays an important role in the regulation of osteoblast differentiation and apoptosis. Essential for osteoclastic bone resorption. The Tyr-731 phosphorylated form induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function	CBL mediated ligand-induced downregulation of EGF receptors;IL-2 Receptor Beta Chain in T cell Activation;Sprouty regulation of tyrosine kinase signals			0.0000	0.0000	0.0000		165360 [CBL (confirmed) Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia,613563|Juvenile myelomonocytic leukemia,607785];																			0		0.2667	15	0.0000	27
chr11	122541610	122541610	A	G	0.2105	19	0.0345	29		51	UBASH3B	intron_variant	UBASH3B:ENST00000284273:intron_variant:MODIFIER:exon1/13:c.161+14692A>G:,UBASH3B:ENST00000525711:intron_variant:MODIFIER:exon1/1:n.486+14692A>G:			Interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. Promotes accumulation of activated target receptors, such as T-cell receptors and EGFR, on the cell surface. Exhibits tyrosine phosphatase activity toward several substrates including EGFR, FAK, SYK, and ZAP70. Down-regulates proteins that are dually modified by both protein tyrosine phosphorylation and ubiquitination				0.0000	0.0000	0.0000																					0		0.2105	19	0.0345	29
chr12	1001033	1001033	A	G	0.3333	9	0.0000	22		46	WNK1	intron_variant	WNK1:ENST00000530271:intron_variant:MODIFIER:exon24/29:c.7003+1354A>G:,WNK1:ENST00000535572:intron_variant:MODIFIER:exon20/25:c.4765+1357A>G:,WNK1:ENST00000315939:intron_variant:MODIFIER:exon22/27:c.5509+1354A>G:,WNK1:ENST00000537687:intron_variant:MODIFIER:exon22/27:c.6289+1354A>G:,WNK1:ENST00000340908:intron_variant:MODIFIER:exon19/24:c.4288+1354A>G:			Serine/threonine kinase which plays an important role in the regulation of electrolyte homeostasis, cell signaling, survival, and proliferation. Acts as an activator and inhibitor of sodium-coupled chloride cotransporters and potassium-coupled chloride cotransporters respectively. Activates SCNN1A, SCNN1B, SCNN1D and SGK1. Controls sodium and chloride ion transport by inhibiting the activity of WNK4, by either phosphorylating the kinase or via an interaction between WNK4 and the autoinhibitory domain of WNK1. WNK4 regulates the activity of the thiazide- sensitive Na-Cl cotransporter, SLC12A3, by phosphorylation. WNK1 may also play a role in actin cytoskeletal reorganization. Phosphorylates NEDD4L (By similarity)				0.0000	0.0000	0.0000		605232 [WNK1 (confirmed) Pseudohypoaldosteronism,type IIC,614492|Neuropathy,hereditary sensory and autonomic,type II,201300];																			0		0.3333	9	0.0000	23
chr12	6347045	6347045	-	T	0.0882	73	0.0000	81		47	CD9	3_prime_UTR_variant,non_coding_transcript_exon_variant	CD9:ENST00000009180:3_prime_UTR_variant:MODIFIER:exon8/8:c.*57dupT:,CD9:ENST00000382518:3_prime_UTR_variant:MODIFIER:exon9/9:c.*57dupT:,CD9:ENST00000382515:3_prime_UTR_variant:MODIFIER:exon8/8:c.*57dupT:,CD9:ENST00000481267:non_coding_transcript_exon_variant:MODIFIER:exon8/8:n.906dupT:		Hematopoietic cell lineage	Involved in platelet activation and aggregation. Regulates paranodal junction formation. Involved in cell adhesion, cell motility and tumor metastasis. Required for sperm-egg fusion			rs754659137	0.0000	0.00007	0.00007																					0		0.0789	76	0.0000	80
chr12	7122114	7122114	T	C	0.2105	19	0.0000	19		52	LPCAT3,C1S	intron_variant	LPCAT3:ENST00000261407:intron_variant:MODIFIER:exon1/12:c.151+3464A>G:,LPCAT3:ENST00000535479:intron_variant:MODIFIER:exon1/10:c.151+3464A>G:,LPCAT3:ENST00000540090:intron_variant:MODIFIER:exon1/7:c.151+3464A>G:,LPCAT3:ENST00000543794:intron_variant:MODIFIER:exon1/8:c.151+3464A>G:,LPCAT3:ENST00000536797:intron_variant:MODIFIER:exon1/7:c.151+3464A>G:,LPCAT3:ENST00000536971:intron_variant:MODIFIER:exon1/1:n.201+3464A>G:,LPCAT3:ENST00000538910:intron_variant:MODIFIER:exon1/4:c.151+3464A>G:,C1S:ENST00000406697:intron_variant:MODIFIER:exon2/14:c.-400+16680T>C:		Complement and coagulation cascades;Systemic lupus erythematosus	Acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3- phosphocholine or PC) (LPCAT activity). Catalyzes also the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero- 3-phospho-L-serine or LPS) into phosphatidylserine (1,2-diacyl-sn- glycero-3-phospho-L-serine or PS) (LPSAT activity). Has also weak lysophosphatidylethanolamine acyltransferase activity (LPEAT activity). Favors polyunsaturated fatty acyl-CoAs as acyl donors compared to saturated fatty acyl-CoAs. Seems to be the major enzyme contributing to LPCAT activity in the liver. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle.,C1s B chain is a serine protease that combines with C1q and C1r to form C1, the first component of the classical pathway of the complement system. C1r activates C1s so that it can, in turn, activate C2 and C4	Classical Complement Pathway;Complement Pathway			0.0000	0.0000	0.0000		120580 [C1S (confirmed) C1s deficiency,613783|Ehlers-Danlos syndrome,periodontal type,2,617174];																			0		0.2105	19	0.0000	19
chr12	9589621	9589621	G	A	0.1212	33	0.0208	48		54	DDX12P	non_coding_transcript_exon_variant	DDX12P:ENST00000290818:non_coding_transcript_exon_variant:MODIFIER:exon5/27:n.811C>T:,DDX12P:ENST00000432996:non_coding_transcript_exon_variant:MODIFIER:exon5/27:n.620C>T:			DNA helicase involved in cellular proliferation. Probably required for maintaining the chromosome segregation (By similarity)			rs79096391	0.0000	0.00181	0.30745																					0		0.1176	34	0.0192	52
chr12	11857332	11857332	A	G	0.2000	20	0.0000	18		51	ETV6	intron_variant	ETV6:ENST00000396373:intron_variant:MODIFIER:exon1/7:c.34-48052A>G:,ETV6:ENST00000541426:intron_variant:MODIFIER:exon1/3:n.218-48052A>G:,ETV6:ENST00000544715:intron_variant:MODIFIER:exon1/2:n.151-12189A>G:			Transcriptional repressor; binds to the DNA sequence 5'- CCGGAAGT-3'				0.0000	0.0000	0.0000		600618 [ETV6 (confirmed) Leukemia,acute myeloid,somatic,601626|Thrombocytopenia 5,616216];																			0		0.2000	20	0.0000	18
chr12	12711499	12711499	T	C	0.0845	72	0.0000	75		72	DUSP16	intron_variant	DUSP16:ENST00000228862:intron_variant:MODIFIER:exon1/6:c.-366+3552A>G:,DUSP16:ENST00000539940:intron_variant:MODIFIER:exon1/1:c.-366+2435A>G:,DUSP16:ENST00000541207:intron_variant:MODIFIER:exon1/2:c.-490+2435A>G:,DUSP16:ENST00000536236:intron_variant:MODIFIER:exon1/1:n.121+2201A>G:		MAPK signaling pathway	Dual specificity protein phosphatase involved in the inactivation of MAP kinases. Dephosphorylates MAPK10 bound to ARRB2				0.0000	0.0000	0.0000																					0		0.0833	72	0.0000	75
chr12	20572887	20572887	A	G	0.0362	138	0.0000	84		56	PDE3A	intron_variant	PDE3A:ENST00000359062:intron_variant:MODIFIER:exon1/15:c.960+49709A>G:,PDE3A:ENST00000542675:intron_variant:MODIFIER:exon1/1:n.120+49709A>G:		Purine metabolism;Insulin signaling pathway	Cyclic nucleotide phosphodiesterase with a dual- specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (By similarity)	Actions of Nitric Oxide in the Heart			0.0000	0.0000	0.0000		123805 [PDE3A (confirmed) Hypertension and brachydactyly syndrome,112410];																			0		0.0432	139	0.0000	84
chr12	20604337	20604337	A	G	0.1034	60	0.0000	32		64	PDE3A	intron_variant	PDE3A:ENST00000359062:intron_variant:MODIFIER:exon1/15:c.960+81159A>G:,PDE3A:ENST00000542675:intron_variant:MODIFIER:exon1/1:n.120+81159A>G:		Purine metabolism;Insulin signaling pathway	Cyclic nucleotide phosphodiesterase with a dual- specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (By similarity)	Actions of Nitric Oxide in the Heart			0.0000	0.0000	0.0000		123805 [PDE3A (confirmed) Hypertension and brachydactyly syndrome,112410];																			0		0.1167	60	0.0000	32
chr12	21018529	21018529	-	T	0.1591	48	0.0000	46		47	LST3,SLCO1B3,SLCO1B7	intron_variant	LST3:ENST00000540229:intron_variant:MODIFIER:exon6/15:c.727+2748dupT:,SLCO1B3:ENST00000553473:intron_variant:MODIFIER:exon6/15:c.727+2748dupT:,SLCO1B7:ENST00000554957:intron_variant:MODIFIER:exon3/13:c.359+7031dupT:,SLCO1B3:ENST00000540853:intron_variant:MODIFIER:exon7/7:c.727+2748dupT:,SLCO1B3:ENST00000261196:intron_variant:MODIFIER:exon7/14:c.727+2748dupT:,SLCO1B3:ENST00000381545:intron_variant:MODIFIER:exon8/15:c.727+2748dupT:,LST3:ENST00000381541:intron_variant:MODIFIER:exon3/13:c.359+7031dupT:,SLCO1B3:ENST00000544370:intron_variant:MODIFIER:exon2/9:c.199+2748dupT:			Mediates the Na(+)-independent uptake of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotrexate and sulfobromophthalein (BSP). Involved in the clearance of bile acids and organic anions from the liver				0.0000	0.0000	0.0000		605495 [SLCO1B3 (provisional) Hyperbilirubinemia,Rotor type,digenic,237450];																			0		0.0193	311	0.0000	49
chr12	21128411	21128411	A	G	0.2222	19	0.0000	22		58	LST3,SLCO1B3,SLCO1B7	intron_variant	LST3:ENST00000540229:intron_variant:MODIFIER:exon13/15:c.1865+74010A>G:,SLCO1B3:ENST00000553473:intron_variant:MODIFIER:exon13/15:c.1865+74010A>G:,SLCO1B7:ENST00000554957:intron_variant:MODIFIER:exon3/13:c.360-45984A>G:,LST3:ENST00000381541:intron_variant:MODIFIER:exon3/13:c.360-45984A>G:			Mediates the Na(+)-independent uptake of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotrexate and sulfobromophthalein (BSP). Involved in the clearance of bile acids and organic anions from the liver				0.0000	0.0000	0.0000		605495 [SLCO1B3 (provisional) Hyperbilirubinemia,Rotor type,digenic,237450];																			0		0.2105	19	0.0000	22
chr12	22791266	22791266	A	G	0.2143	28	0.0000	35		76	ETNK1	intron_variant	ETNK1:ENST00000266517:intron_variant:MODIFIER:exon1/7:c.424-5431A>G:,ETNK1:ENST00000335148:intron_variant:MODIFIER:exon1/2:c.424-5431A>G:,ETNK1:ENST00000538218:intron_variant:MODIFIER:exon1/8:c.394-5431A>G:		Glycerophospholipid metabolism	Highly specific for ethanolamine phosphorylation. May be a rate-controlling step in phosphatidylethanolamine biosynthesis				0.0000	0.0000	0.0000																					0		0.2143	28	0.0000	36
chr12	32148592	32148592	A	G	0.5714	7	0.0000	18		39	KIAA1551-RP11-50I19.1	intergenic_region	KIAA1551-RP11-50I19.1:ENSG00000174718-ENSG00000257094:intergenic_region:MODIFIER::n.32148592A>G:							0.0000	0.0000	0.0000																					0		0.5714	7	0.0000	18
chr12	46752835	46752835	C	T	0.0347	177	0.0050	208		55	SLC38A2	3_prime_UTR_variant	SLC38A2:ENST00000256689:3_prime_UTR_variant:MODIFIER:exon16/16:c.*2059G>A:,SLC38A2:ENST00000549258:3_prime_UTR_variant:MODIFIER:exon15/15:c.*3197G>A:		Urea cycle and metabolism of amino groups	Functions as a sodium-dependent amino acid transporter. Mediates the saturable, pH-sensitive and electrogenic cotransport of neutral amino acids and sodium ions with a stoichiometry of 1:1. May function in the transport of amino acids at the blood- brain barrier and in the supply of maternal nutrients to the fetus through the placenta				0.0000	0.0000	0.0000																					0		0.0400	175	0.0051	197
chr12	49323169	49323169	T	C	0.1316	38	0.0000	38		68	RP11-302B13.5,CCDC65,AC073610.5	intron_variant	RP11-302B13.5:ENST00000398092:intron_variant:MODIFIER:exon4/4:c.384+10269A>G:,CCDC65:ENST00000266984:intron_variant:MODIFIER:exon8/8:c.1430-2027T>C:,AC073610.5:ENST00000537495:intron_variant:MODIFIER:exon2/2:c.168-7185A>G:							0.0000	0.0000	0.0000																					0		0.1316	38	0.0000	38
chr12	49747311	49747311	A	G	0.0526	96	0.0000	90		51	DNAJC22	intron_variant	DNAJC22:ENST00000551153:intron_variant:MODIFIER:exon1/1:n.327-451A>G:,DNAJC22:ENST00000552651:intron_variant:MODIFIER:exon1/1:n.60+1912A>G:			May function as a co-chaperone				0.0000	0.0000	0.0000																					0		0.0625	96	0.0000	90
chr12	49747760	49747760	A	G	0.0847	59	0.0000	48		67	DNAJC22	splice_acceptor_variant&intron_variant,intron_variant	DNAJC22:ENST00000551153:splice_acceptor_variant&intron_variant:HIGH:exon1/1:n.327-2A>G:,DNAJC22:ENST00000552651:intron_variant:MODIFIER:exon1/1:n.60+2361A>G:			May function as a co-chaperone				0.0000	0.0000	0.0000																					0		0.0847	59	0.0000	48
chr12	53838985	53838985	A	G	0.4444	9	0.0000	17		35	RP11-793H13.8,PRR13,PCBP2	intron_variant	RP11-793H13.8:ENST00000547717:intron_variant:MODIFIER:exon3/12:n.474+1428A>G:,PRR13:ENST00000547368:intron_variant:MODIFIER:exon3/3:c.445-814A>G:,PRR13:ENST00000429243:intron_variant:MODIFIER:exon3/3:c.403-814A>G:,PRR13:ENST00000549924:intron_variant:MODIFIER:exon3/3:c.403-814A>G:,PRR13:ENST00000551003:intron_variant:MODIFIER:exon3/3:c.307-814A>G:,PCBP2:ENST00000541275:intron_variant:MODIFIER:exon3/12:c.-76+1428A>G:,PRR13:ENST00000549068:intron_variant:MODIFIER:exon3/3:c.*50-814A>G:,PRR13:ENST00000546581:intron_variant:MODIFIER:exon3/3:c.115-814A>G:,PRR13:ENST00000549581:intron_variant:MODIFIER:exon3/3:c.253-814A>G:,PRR13:ENST00000379786:intron_variant:MODIFIER:exon3/3:c.253-814A>G:,PRR13:ENST00000549135:intron_variant:MODIFIER:exon3/3:c.403-814A>G:			Negatively regulates TSP1 expression at the level of transcription. This down-regulation was shown to reduce taxane- induced apoptosis.,Single-stranded nucleic acid binding protein that binds preferentially to oligo dC. Major cellular poly(rC)-binding protein. Binds also poly(rU). Negatively regulates cellular antiviral responses mediated by MAVS signaling. It acts as an adapter between MAVS and the E3 ubiquitin ligase ITCH, therefore triggering MAVS ubiquitinationa and degradation				0.0000	0.0000	0.0000																					0		0.4444	9	0.0000	16
chr12	54066209	54066209	T	C	0.3889	18	0.0000	18		39	ATP5G2	intron_variant	ATP5G2:ENST00000394349:intron_variant:MODIFIER:exon2/4:c.210+151A>G:,ATP5G2:ENST00000602871:intron_variant:MODIFIER:exon2/4:c.39+151A>G:,ATP5G2:ENST00000495596:intron_variant:MODIFIER:exon1/3:n.1446+151A>G:,ATP5G2:ENST00000552242:intron_variant:MODIFIER:exon3/5:c.*132+151A>G:,ATP5G2:ENST00000549164:intron_variant:MODIFIER:exon2/4:c.39+151A>G:,ATP5G2:ENST00000338662:intron_variant:MODIFIER:exon2/4:c.87+151A>G:,ATP5G2:ENST00000549748:intron_variant:MODIFIER:exon2/4:c.39+151A>G:		Oxidative phosphorylation	Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. A homomeric c-ring of probably 10 subunits is part of the complex rotary element				0.0000	0.0000	0.0000																					0		0.3889	18	0.0000	18
chr12	69204306	69204306	A	G	0.1739	23	0.0000	19		55	MDM2	intron_variant	MDM2:ENST00000462284:intron_variant:MODIFIER:exon2/10:c.99+1234A>G:,MDM2:ENST00000258149:intron_variant:MODIFIER:exon2/8:c.81+1234A>G:,MDM2:ENST00000356290:intron_variant:MODIFIER:exon2/5:c.81+1234A>G:,MDM2:ENST00000428863:intron_variant:MODIFIER:exon2/3:c.81+1234A>G:,MDM2:ENST00000540827:intron_variant:MODIFIER:exon2/4:c.81+1234A>G:,MDM2:ENST00000393412:intron_variant:MODIFIER:exon2/2:c.81+1234A>G:,MDM2:ENST00000311420:intron_variant:MODIFIER:exon2/9:c.99+1234A>G:,MDM2:ENST00000493419:intron_variant:MODIFIER:exon2/3:n.295+1234A>G:,MDM2:ENST00000393417:intron_variant:MODIFIER:exon2/11:c.81+1234A>G:,MDM2:ENST00000258148:intron_variant:MODIFIER:exon2/8:c.99+1234A>G:,MDM2:ENST00000539479:intron_variant:MODIFIER:exon2/8:c.81+1234A>G:,MDM2:ENST00000393415:intron_variant:MODIFIER:exon2/10:c.81+1234A>G:,MDM2:ENST00000523991:intron_variant:MODIFIER:exon2/5:c.81+1234A>G:,MDM2:ENST00000543323:intron_variant:MODIFIER:exon2/4:c.81+1234A>G:,MDM2:ENST00000393416:intron_variant:MODIFIER:exon2/8:c.81+1234A>G:,MDM2:ENST00000544561:intron_variant:MODIFIER:exon1/3:c.81+1234A>G:,MDM2:ENST00000299252:intron_variant:MODIFIER:exon1/4:c.81+1234A>G:,MDM2:ENST00000350057:intron_variant:MODIFIER:exon1/8:c.81+1234A>G:,MDM2:ENST00000360430:intron_variant:MODIFIER:exon1/3:c.81+1234A>G:,MDM2:ENST00000393410:intron_variant:MODIFIER:exon1/2:c.81+1234A>G:,MDM2:ENST00000393413:intron_variant:MODIFIER:exon1/1:c.81+1234A>G:,MDM2:ENST00000481186:intron_variant:MODIFIER:exon1/5:c.81+1234A>G:,MDM2:ENST00000496959:intron_variant:MODIFIER:exon1/4:c.81+1234A>G:,MDM2:ENST00000517852:intron_variant:MODIFIER:exon1/2:c.81+1234A>G:,MDM2:ENST00000536089:intron_variant:MODIFIER:exon1/7:c.81+1234A>G:,MDM2:ENST00000537182:intron_variant:MODIFIER:exon1/5:c.81+1234A>G:,MDM2:ENST00000540352:intron_variant:MODIFIER:exon1/8:c.81+1234A>G:,MDM2:ENST00000542502:intron_variant:MODIFIER:exon1/5:c.81+1234A>G:,MDM2:ENST00000545204:intron_variant:MODIFIER:exon1/1:c.87+1228A>G:,MDM2:ENST00000546048:intron_variant:MODIFIER:exon1/5:c.81+1234A>G:,MDM2:ENST00000348801:intron_variant:MODIFIER:exon1/2:c.66+1234A>G:,MDM2:ENST00000478070:intron_variant:MODIFIER:exon1/2:c.66+1234A>G:		Cell cycle;p53 signaling pathway;Ubiquitin mediated proteolysis;Glioma;Prostate cancer;Melanoma;Bladder cancer;Chronic myeloid leukemia	E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as an ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways. Mediates ubiquitination and subsequent proteasome degradation of DYRK2 in nucleus. Ubiquitinates IGF1R and SNAI1 and promotes them to proteasomal degradation	ATM Signaling Pathway;Cell Cycle: G2/M Checkpoint;CTCF: First Multivalent Nuclear Factor;HIV-I Nef: negative effector of Fas and TNF;Hypoxia and p53 in the Cardiovascular system;p53 Signaling Pathway;Sumoylation by RanBP2 Regulates Transcriptional Repression;Tumor Suppressor Arf Inhibits Ribosomal Biogenesis			0.0000	0.0000	0.0000		164785 [MDM2 (confirmed) Accelerated tumor formation,susceptibility to,614401];																			0		0.1739	23	0.0000	19
chr12	69242955	69242955	T	C	0.2667	15	0.0000	23		58	CPM	intron_variant	CPM:ENST00000546556:intron_variant:MODIFIER:exon1/1:c.*456+6806A>G:,CPM:ENST00000551897:intron_variant:MODIFIER:exon5/5:c.532-6846A>G:			Specifically removes C-terminal basic residues (Arg or Lys) from peptides and proteins. It is believed to play important roles in the control of peptide hormone and growth factor activity at the cell surface, and in the membrane-localized degradation of extracellular proteins				0.0000	0.0000	0.0000																					0		0.2667	15	0.0000	23
chr12	69243902	69243902	T	C	0.1290	38	0.0000	50		51	CPM	intron_variant	CPM:ENST00000546556:intron_variant:MODIFIER:exon1/1:c.*456+5859A>G:,CPM:ENST00000551897:intron_variant:MODIFIER:exon5/5:c.531+6522A>G:			Specifically removes C-terminal basic residues (Arg or Lys) from peptides and proteins. It is believed to play important roles in the control of peptide hormone and growth factor activity at the cell surface, and in the membrane-localized degradation of extracellular proteins				0.0000	0.0000	0.0000																					0		0.1053	38	0.0000	50
chr12	96685570	96685570	T	C	0.2500	16	0.0000	22		56	CDK17	intron_variant	CDK17:ENST00000261211:intron_variant:MODIFIER:exon10/16:c.998-2505A>G:,CDK17:ENST00000543119:intron_variant:MODIFIER:exon10/15:c.998-2505A>G:,CDK17:ENST00000542666:intron_variant:MODIFIER:exon9/14:c.839-2505A>G:,CDK17:ENST00000550971:intron_variant:MODIFIER:exon1/5:n.73-2505A>G:,CDK17:ENST00000551484:intron_variant:MODIFIER:exon1/2:n.406-2505A>G:,CDK17:ENST00000553042:intron_variant:MODIFIER:exon6/6:n.540-2505A>G:			May play a role in terminally differentiated neurons. Has a Ser/Thr-phosphorylating activity for histone H1 (By similarity)				0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	22
chr12	98990647	98990647	A	G	0.1481	28	0.0000	21		59	SLC25A3	intron_variant	SLC25A3:ENST00000228318:intron_variant:MODIFIER:exon3/7:c.283-987A>G:,SLC25A3:ENST00000401722:intron_variant:MODIFIER:exon3/7:c.280-987A>G:,SLC25A3:ENST00000188376:intron_variant:MODIFIER:exon2/6:c.280-987A>G:,SLC25A3:ENST00000551917:intron_variant:MODIFIER:exon3/7:c.283-987A>G:,SLC25A3:ENST00000546766:intron_variant:MODIFIER:exon2/6:n.1961-987A>G:,SLC25A3:ENST00000548046:intron_variant:MODIFIER:exon3/3:c.283-987A>G:,SLC25A3:ENST00000552981:intron_variant:MODIFIER:exon3/7:c.280-987A>G:,SLC25A3:ENST00000550695:intron_variant:MODIFIER:exon2/2:c.283-987A>G:,SLC25A3:ENST00000547534:intron_variant:MODIFIER:exon3/3:c.280-987A>G:,SLC25A3:ENST00000549338:intron_variant:MODIFIER:exon3/7:c.280-987A>G:,SLC25A3:ENST00000551123:intron_variant:MODIFIER:exon3/7:c.*72-987A>G:,SLC25A3:ENST00000548847:intron_variant:MODIFIER:exon2/5:c.280-987A>G:,SLC25A3:ENST00000547908:intron_variant:MODIFIER:exon1/1:n.186-987A>G:			Transport of phosphate groups from the cytosol to the mitochondrial matrix. Phosphate is cotransported with H(+). May play a role regulation of the mitochondrial permeability transition pore (mPTP)				0.0000	0.0000	0.0000		600370 [SLC25A3 (confirmed) Mitochondrial phosphate carrier deficiency,610773];																			0		0.1429	28	0.0000	21
chr12	104333290	104333290	-	A	0.5714	467	0.0365	593		67	HSP90B1	frameshift_variant,non_coding_transcript_exon_variant	HSP90B1:ENST00000299767:frameshift_variant:HIGH:exon8/18:c.985dupA:p.Thr329fs,HSP90B1:ENST00000548462:non_coding_transcript_exon_variant:MODIFIER:exon8/17:n.1063dupA:,HSP90B1:ENST00000550479:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.232dupA:		Prostate cancer	Molecular chaperone that functions in the processing and transport of secreted proteins. When associated with CNPY3, required for proper folding of Toll-like receptors (By similarity). Functions in endoplasmic reticulum associated degradation (ERAD). Has ATPase activity				0.0000	0.0000	0.0000																					0		0.0194	464	0.0203	590
chr12	109179021	109179021	T	C	0.0847	59	0.0000	56		67	SSH1	3_prime_UTR_variant	SSH1:ENST00000326495:3_prime_UTR_variant:MODIFIER:exon15/15:c.*2743A>G:,SSH1:ENST00000360239:3_prime_UTR_variant:MODIFIER:exon14/14:c.*2743A>G:,SSH1:ENST00000546433:3_prime_UTR_variant:MODIFIER:exon7/7:c.*4886A>G:		Regulation of actin cytoskeleton	Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein				0.0000	0.0000	0.0000																					0		0.0833	60	0.0000	56
chr12	110766156	110766156	A	G	0.1818	22	0.0000	21		59	ATP2A2	intron_variant	ATP2A2:ENST00000539276:intron_variant:MODIFIER:exon8/19:c.1095+334A>G:,ATP2A2:ENST00000308664:intron_variant:MODIFIER:exon8/20:c.1095+334A>G:,ATP2A2:ENST00000395494:intron_variant:MODIFIER:exon7/18:c.1014+334A>G:,ATP2A2:ENST00000377685:intron_variant:MODIFIER:exon7/19:c.*935+334A>G:,ATP2A2:ENST00000548169:intron_variant:MODIFIER:exon4/15:c.765+334A>G:,ATP2A2:ENST00000547050:intron_variant:MODIFIER:exon2/2:n.1140+334A>G:,ATP2A2:ENST00000549840:intron_variant:MODIFIER:exon1/1:n.331+334A>G:		Calcium signaling pathway	This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen. Isoform 2 is involved in the regulation of the contraction/relaxation cycle				0.0000	0.0000	0.0000		108740 [ATP2A2 (confirmed) Darier disease,124200|Acrokeratosis verruciformis,101900];																			0		0.1739	23	0.0000	21
chr12	110766634	110766634	A	G	0.1600	26	0.0000	47		56	ATP2A2	intron_variant	ATP2A2:ENST00000539276:intron_variant:MODIFIER:exon8/19:c.1095+812A>G:,ATP2A2:ENST00000308664:intron_variant:MODIFIER:exon8/20:c.1095+812A>G:,ATP2A2:ENST00000395494:intron_variant:MODIFIER:exon7/18:c.1014+812A>G:,ATP2A2:ENST00000377685:intron_variant:MODIFIER:exon7/19:c.*935+812A>G:,ATP2A2:ENST00000548169:intron_variant:MODIFIER:exon4/15:c.765+812A>G:,ATP2A2:ENST00000547050:intron_variant:MODIFIER:exon2/2:n.1140+812A>G:,ATP2A2:ENST00000549840:intron_variant:MODIFIER:exon1/1:n.331+812A>G:		Calcium signaling pathway	This magnesium-dependent enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen. Isoform 2 is involved in the regulation of the contraction/relaxation cycle				0.0000	0.0000	0.0000		108740 [ATP2A2 (confirmed) Darier disease,124200|Acrokeratosis verruciformis,101900];																			0		0.1538	26	0.0000	47
chr12	113696927	113696927	A	G	0.2400	26	0.0000	25		54	TPCN1	intron_variant	TPCN1:ENST00000541517:intron_variant:MODIFIER:exon2/27:c.329-1246A>G:,TPCN1:ENST00000552642:intron_variant:MODIFIER:exon1/3:c.41-1246A>G:,TPCN1:ENST00000547275:intron_variant:MODIFIER:exon2/3:c.278-1246A>G:,TPCN1:ENST00000552985:intron_variant:MODIFIER:exon3/4:c.371-1246A>G:,TPCN1:ENST00000550873:intron_variant:MODIFIER:exon2/3:c.113-1246A>G:,TPCN1:ENST00000551096:intron_variant:MODIFIER:exon3/3:c.329-1246A>G:,TPCN1:ENST00000551099:intron_variant:MODIFIER:exon3/3:c.265-1246A>G:,TPCN1:ENST00000335509:intron_variant:MODIFIER:exon2/27:c.113-1246A>G:,TPCN1:ENST00000552897:intron_variant:MODIFIER:exon1/3:c.-92-1246A>G:,TPCN1:ENST00000550785:intron_variant:MODIFIER:exon3/28:c.329-1246A>G:,TPCN1:ENST00000549279:intron_variant:MODIFIER:exon3/3:c.265-1246A>G:,TPCN1:ENST00000552077:intron_variant:MODIFIER:exon2/26:n.379-1246A>G:,TPCN1:ENST00000392569:intron_variant:MODIFIER:exon1/26:c.-92-1246A>G:,TPCN1:ENST00000552542:intron_variant:MODIFIER:exon1/4:c.-92-1246A>G:,TPCN1:ENST00000428632:intron_variant:MODIFIER:exon1/18:n.242-1246A>G:			Nicotinic acid adenine dinucleotide phosphate (NAADP) receptor that may function as one of the major voltage-gated Ca(2+) channels (VDCC) across the lysosomal and endosomal membrane				0.0000	0.0000	0.0000																					0		0.2308	26	0.0000	25
chr12	116670709	116670709	T	C	0.2500	16	0.0000	24		58	MED13L	intron_variant	MED13L:ENST00000281928:intron_variant:MODIFIER:exon2/30:c.310+4564A>G:,MED13L:ENST00000551197:intron_variant:MODIFIER:exon2/3:n.260+4564A>G:			Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. This subunit may specifically regulate transcription of targets of the Wnt signaling pathway and SHH signaling pathway				0.0000	0.0000	0.0000		608771 [MED13L (provisional) Transposition of the great arteries,dextro-looped 1,608808|Mental retardation and distinctive facial features with or without cardiac defects,616789];																			0		0.2500	16	0.0000	24
chr12	117152354	117152354	T	C	0.0833	72	0.0000	40		61	RP11-497G19.2-C12orf49	intergenic_region	RP11-497G19.2-C12orf49:ENSG00000257654-ENSG00000111412:intergenic_region:MODIFIER::n.117152354T>C:							0.0000	0.0000	0.0000																					0		0.0833	72	0.0000	40
chr12	118501774	118501774	-	A	0.2222	30	0.0000	24		45	VSIG10	3_prime_UTR_variant	VSIG10:ENST00000359236:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2669dupT:							0.0000	0.0000	0.0000																					0		0.2000	30	0.0000	27
chr12	121412046	121412046	T	C	0.2188	32	0.0357	28		52	HNF1A-AS1	intron_variant	HNF1A-AS1:ENST00000537361:intron_variant:MODIFIER:exon1/1:n.264-5235A>G:,HNF1A-AS1:ENST00000433033:intron_variant:MODIFIER:exon3/3:n.371+242A>G:							0.0000	0.0000	0.0000																					0		0.2188	32	0.0357	28
chr12	122896713	122896713	T	C	0.1739	23	0.0000	23		57	CLIP1	intron_variant	CLIP1:ENST00000361654:intron_variant:MODIFIER:exon1/23:c.-107+10355A>G:,CLIP1:ENST00000358808:intron_variant:MODIFIER:exon1/24:c.-107+10355A>G:,CLIP1:ENST00000537178:intron_variant:MODIFIER:exon1/23:c.-107+10355A>G:,CLIP1:ENST00000539080:intron_variant:MODIFIER:exon1/3:c.-219+10355A>G:			Binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton. Promotes microtubule growth and microtubule bundling. Links cytoplasmic vesicles to microtubules and thereby plays an important role in intracellular vesicle trafficking. Plays a role macropinocytosis and endosome trafficking				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	23
chr12	122998493	122998493	T	C	0.3750	16	0.0000	24		57	RSRC2	intron_variant	RSRC2:ENST00000331738:intron_variant:MODIFIER:exon6/9:c.725+1159A>G:,RSRC2:ENST00000354654:intron_variant:MODIFIER:exon6/9:c.581+1159A>G:,RSRC2:ENST00000433877:intron_variant:MODIFIER:exon7/10:c.*594+1159A>G:,RSRC2:ENST00000532695:intron_variant:MODIFIER:exon7/10:c.*572+1159A>G:,RSRC2:ENST00000527173:intron_variant:MODIFIER:exon6/9:n.1766+1159A>G:,RSRC2:ENST00000525335:intron_variant:MODIFIER:exon7/8:n.868+766A>G:,RSRC2:ENST00000344591:intron_variant:MODIFIER:exon6/7:c.548+1159A>G:,RSRC2:ENST00000528263:intron_variant:MODIFIER:exon4/6:c.*5-72A>G:,RSRC2:ENST00000527399:intron_variant:MODIFIER:exon7/7:c.*590+1159A>G:							0.0000	0.0000	0.0000																					0		0.3750	16	0.0000	24
chr12	128128247	128128247	A	G	0.3125	32	0.0811	37		51	RP11-526P6.1-RP11-749H20.1	intergenic_region	RP11-526P6.1-RP11-749H20.1:ENSG00000256022-ENSG00000256922:intergenic_region:MODIFIER::n.128128247A>G:							0.0000	0.0000	0.0000																					0		0.3125	32	0.0811	37
chr12	128129954	128129954	-	A	0.1471	37	0.0000	28		40	RP11-526P6.1-RP11-749H20.1	intergenic_region	RP11-526P6.1-RP11-749H20.1:ENSG00000256022-ENSG00000256922:intergenic_region:MODIFIER::n.128129954_128129955insA:							0.0000	0.0000	0.0000																					0		0.0980	51	0.0000	41
chr12	132422747	132422747	A	G	0.2000	31	0.0000	24		68	PUS1	intron_variant	PUS1:ENST00000376649:intron_variant:MODIFIER:exon3/5:c.442-971A>G:,PUS1:ENST00000443358:intron_variant:MODIFIER:exon3/5:c.358-971A>G:,PUS1:ENST00000322060:intron_variant:MODIFIER:exon3/4:c.358-971A>G:,PUS1:ENST00000440818:intron_variant:MODIFIER:exon3/5:c.358-971A>G:,PUS1:ENST00000542167:intron_variant:MODIFIER:exon2/4:c.283-971A>G:,PUS1:ENST00000538037:intron_variant:MODIFIER:exon4/4:c.358-971A>G:,PUS1:ENST00000535067:intron_variant:MODIFIER:exon2/2:c.358-5337A>G:,PUS1:ENST00000537484:intron_variant:MODIFIER:exon4/4:c.470-3090A>G:			Converts specific uridines to PSI in a number of tRNA substrates. Acts on positions 27/28 in the anticodon stem and also positions 34 and 36 in the anticodon of an intron containing tRNA. Involved in regulation of nuclear receptor activity possibly through pseudouridylation of SRA1 RNA (By similarity)				0.0000	0.0000	0.0000		608109 [PUS1 (provisional) Myopathy,lactic acidosis,and sideroblastic anemia 1,600462];																			0		0.2258	31	0.0000	24
chr12	133314177	133314177	T	C	0.2143	14	0.0294	34		51	ANKLE2	intron_variant,non_coding_transcript_exon_variant	ANKLE2:ENST00000357997:intron_variant:MODIFIER:exon7/12:c.1421-526A>G:,ANKLE2:ENST00000539605:intron_variant:MODIFIER:exon6/11:c.1235-526A>G:,ANKLE2:ENST00000439231:intron_variant:MODIFIER:exon1/5:n.1141-526A>G:,ANKLE2:ENST00000337516:intron_variant:MODIFIER:exon7/10:c.1421-526A>G:,ANKLE2:ENST00000538591:intron_variant:MODIFIER:exon2/3:n.169-526A>G:,ANKLE2:ENST00000535036:intron_variant:MODIFIER:exon4/5:c.110-526A>G:,ANKLE2:ENST00000545623:intron_variant:MODIFIER:exon5/5:c.731-526A>G:,ANKLE2:ENST00000505031:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.1317A>G:			Involved in mitotic nuclear envelope reassembly by promoting dephosphorylation of BAF/BANF1 during mitotic exit. Coordinates the control of BAF/BANF1 dephosphorylation by inhibiting VRK1 kinase and promoting dephosphorylation of BAF/BANF1 by protein phosphatase 2A (PP2A), thereby facilitating nuclear envelope assembly. It is unclear whether it acts as a real PP2A regulatory subunit or whether it is involved in recruitment of the PP2A complex				0.0000	0.0000	0.0000		616062 [ANKLE2 (provisional) Microcephaly 16,primary,autosomal recessive,616681];																			0		0.2143	14	0.0294	34
chr13	21595079	21595079	T	C	0.4000	12	0.0400	25		39	LATS2	intron_variant	LATS2:ENST00000382592:intron_variant:MODIFIER:exon2/7:c.342+24745A>G:,LATS2:ENST00000542899:intron_variant:MODIFIER:exon2/7:c.342+24745A>G:,LATS2:ENST00000472754:intron_variant:MODIFIER:exon1/2:n.67+2123A>G:			Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability. Negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity. Negative regulator of the androgen receptor. Phosphorylates SNAI1 in the nucleus leading to its nuclear retention and stabilization, which enhances its epithelial-mesenchymal transition and tumor cell invasion/migration activities. This tumor-promoting activity is independent of its effects upon YAP1 or WWTR1/TAZ				0.0000	0.0000	0.0000																					0		0.4167	12	0.0400	25
chr13	25015133	25015133	T	C	0.4348	23	0.0606	33		48	PARP4,TPTE2P6	intron_variant	PARP4:ENST00000381989:intron_variant:MODIFIER:exon30/33:c.3666+851A>G:,TPTE2P6:ENST00000445572:intron_variant:MODIFIER:exon3/9:n.233+31691T>C:		Base excision repair					0.0000	0.0000	0.0000																					0		0.4348	23	0.0606	33
chr13	25015148	25015148	T	C	0.6190	21	0.0303	33		63	PARP4,TPTE2P6	intron_variant	PARP4:ENST00000381989:intron_variant:MODIFIER:exon30/33:c.3666+836A>G:,TPTE2P6:ENST00000445572:intron_variant:MODIFIER:exon3/9:n.233+31706T>C:		Base excision repair					0.0000	0.0000	0.0000																					0		0.6190	21	0.0303	33
chr13	28762680	28762680	A	G	0.5000	6	0.0435	23		38	PAN3	intron_variant	PAN3:ENST00000380958:intron_variant:MODIFIER:exon4/18:c.691-8642A>G:,PAN3:ENST00000503791:intron_variant:MODIFIER:exon4/13:n.843-8642A>G:,PAN3:ENST00000399613:intron_variant:MODIFIER:exon4/17:c.252+10608A>G:			Functions in cytoplasmic mRNA decay. As part of the Pan nuclease complex, recruits polyadenylate-binding protein which in turn stimulates PAN2 nuclease activity				0.0000	0.0000	0.0000																					0		0.5000	6	0.0435	23
chr13	31037760	31037760	-	A	0.0505	100	0.0000	130		41	HMGB1	frameshift_variant,non_coding_transcript_exon_variant	HMGB1:ENST00000339872:frameshift_variant:HIGH:exon2/5:c.57dupT:p.Val20fs,HMGB1:ENST00000405805:frameshift_variant:HIGH:exon2/5:c.57dupT:p.Val20fs,HMGB1:ENST00000341423:frameshift_variant:HIGH:exon2/5:c.57dupT:p.Val20fs,HMGB1:ENST00000399489:frameshift_variant:HIGH:exon1/5:c.57dupT:p.Val20fs,HMGB1:ENST00000399494:frameshift_variant:HIGH:exon2/5:c.57dupT:p.Val20fs,HMGB1:ENST00000326004:frameshift_variant:HIGH:exon2/5:c.57dupT:p.Val20fs,HMGB1:ENST00000398908:frameshift_variant:HIGH:exon2/3:c.57dupT:p.Val20fs,HMGB1:ENST00000468384:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.190dupT:		Base excision repair	DNA binding proteins that associates with chromatin and has the ability to bend DNA. Binds preferentially single-stranded DNA. Involved in V(D)J recombination by acting as a cofactor of the RAG complex. Acts by stimulating cleavage and RAG protein binding at the 23 bp spacer of conserved recombination signal sequences (RSS). Heparin-binding protein that has a role in the extension of neurite-type cytoplasmic processes in developing cells (By similarity)	Apoptotic DNA fragmentation and tissue homeostasis;The information-processing pathway at the IFN-beta enhancer			0.0000	0.0000	0.0000																					0		0.0547	128	0.0000	176
chr13	45125808	45125808	T	C	0.5556	9	0.0000	19		42	TSC22D1	intron_variant	TSC22D1:ENST00000458659:intron_variant:MODIFIER:exon1/2:c.2912+21491A>G:,TSC22D1:ENST00000501704:intron_variant:MODIFIER:exon1/1:c.1663+22740A>G:,TSC22D1:ENST00000460842:intron_variant:MODIFIER:exon1/2:n.184-11749A>G:,TSC22D1:ENST00000486464:intron_variant:MODIFIER:exon1/2:c.360-11736A>G:			Transcriptional repressor. Acts on the C-type natriuretic peptide (CNP) promoter				0.0000	0.0000	0.0000																					0		0.5556	9	0.0000	19
chr13	49602494	49602494	A	G	0.1739	23	0.0000	29		65	FNDC3A	intron_variant	FNDC3A:ENST00000492622:intron_variant:MODIFIER:exon2/25:c.99+22069A>G:,FNDC3A:ENST00000378383:intron_variant:MODIFIER:exon2/7:n.247+22069A>G:,FNDC3A:ENST00000484074:intron_variant:MODIFIER:exon2/25:c.99+22069A>G:,FNDC3A:ENST00000541916:intron_variant:MODIFIER:exon2/25:c.99+22069A>G:		ECM-receptor interaction	Mediates spermatid-Sertoli adhesion during spermatogenesis (By similarity)				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	29
chr13	55815887	55815887	A	G	0.1667	36	0.0000	23		66	MIR5007-HNF4GP1	intergenic_region	MIR5007-HNF4GP1:ENSG00000264387-ENSG00000228611:intergenic_region:MODIFIER::n.55815887A>G:							0.0000	0.0000	0.0000																					0		0.1579	38	0.0000	24
chr13	73519546	73519546	A	G	0.4286	9	0.0000	20		41	PIBF1	intron_variant	PIBF1:ENST00000326291:intron_variant:MODIFIER:exon14/17:c.1833+14141A>G:			Mediator of progesterone that by acting on the phospholipase A2 enzyme interferes with arachidonic acid metabolism, induces a Th2 biased immune response, and by controlling NK activity exerts an anti-abortive effect				0.0000	0.0000	0.0000																					0		0.4444	9	0.0000	20
chr13	73522123	73522123	A	G	0.4286	7	0.0000	17		36	PIBF1	intron_variant	PIBF1:ENST00000326291:intron_variant:MODIFIER:exon14/17:c.1833+16718A>G:			Mediator of progesterone that by acting on the phospholipase A2 enzyme interferes with arachidonic acid metabolism, induces a Th2 biased immune response, and by controlling NK activity exerts an anti-abortive effect				0.0000	0.0000	0.0000																					0		0.4286	7	0.0000	17
chr13	79965651	79965651	T	C	0.4118	17	0.0435	23		33	RBM26	intron_variant	RBM26:ENST00000438737:intron_variant:MODIFIER:exon1/21:c.72-12609A>G:,RBM26:ENST00000267229:intron_variant:MODIFIER:exon1/20:c.72-12609A>G:,RBM26:ENST00000438724:intron_variant:MODIFIER:exon1/20:c.72-12609A>G:,RBM26:ENST00000472143:intron_variant:MODIFIER:exon1/2:n.775-12609A>G:							0.0000	0.0000	0.0000																					0		0.4118	17	0.0435	23
chr13	93970912	93970912	A	G	0.1667	36	0.0000	43		69	GPC6	intron_variant	GPC6:ENST00000377047:intron_variant:MODIFIER:exon1/8:c.160+91043A>G:			Cell surface proteoglycan that bears heparan sulfate. Putative cell surface coreceptor for growth factors, extracellular matrix proteins, proteases and anti-proteases (By similarity). Enhances migration and invasion of cancer cells through WNT5A signaling				0.0000	0.0000	0.0000		604404 [GPC6 (provisional) Omodysplasia 1,258315];																			0		0.1667	36	0.0000	43
chr14	21729260	21729260	T	C	0.2308	26	0.0204	49		63	HNRNPC	intron_variant	HNRNPC:ENST00000320084:intron_variant:MODIFIER:exon1/7:c.-59+8197A>G:,HNRNPC:ENST00000449098:intron_variant:MODIFIER:exon1/7:c.-37+8197A>G:,HNRNPC:ENST00000336053:intron_variant:MODIFIER:exon1/6:c.-37+8197A>G:,HNRNPC:ENST00000554969:intron_variant:MODIFIER:exon3/9:c.-37+2210A>G:,HNRNPC:ENST00000556142:intron_variant:MODIFIER:exon1/6:c.-37+8197A>G:,HNRNPC:ENST00000554455:intron_variant:MODIFIER:exon2/8:c.-37+2210A>G:,HNRNPC:ENST00000430246:intron_variant:MODIFIER:exon1/7:c.-37+1500A>G:,HNRNPC:ENST00000553753:intron_variant:MODIFIER:exon2/7:c.-37+2210A>G:,HNRNPC:ENST00000555914:intron_variant:MODIFIER:exon2/8:c.-37+2210A>G:,HNRNPC:ENST00000555309:intron_variant:MODIFIER:exon2/8:c.-37+2210A>G:,HNRNPC:ENST00000557442:intron_variant:MODIFIER:exon2/7:c.-37+2210A>G:,HNRNPC:ENST00000556628:intron_variant:MODIFIER:exon2/7:c.-37+2210A>G:,HNRNPC:ENST00000555883:intron_variant:MODIFIER:exon1/7:c.-37+8197A>G:,HNRNPC:ENST00000556513:intron_variant:MODIFIER:exon3/8:c.-37+2210A>G:,HNRNPC:ENST00000557201:intron_variant:MODIFIER:exon1/7:c.-37+8197A>G:,HNRNPC:ENST00000553300:intron_variant:MODIFIER:exon2/8:c.-37+2210A>G:,HNRNPC:ENST00000556897:intron_variant:MODIFIER:exon1/7:c.-37+1500A>G:,HNRNPC:ENST00000420743:intron_variant:MODIFIER:exon4/10:c.-37+1500A>G:,HNRNPC:ENST00000554539:intron_variant:MODIFIER:exon2/8:c.-35+2210A>G:,HNRNPC:ENST00000554383:intron_variant:MODIFIER:exon3/8:c.-37+2210A>G:,HNRNPC:ENST00000555215:intron_variant:MODIFIER:exon3/6:c.-37+2210A>G:,HNRNPC:ENST00000555137:intron_variant:MODIFIER:exon2/6:c.-125+2210A>G:,HNRNPC:ENST00000554891:intron_variant:MODIFIER:exon3/7:c.-100+2210A>G:,HNRNPC:ENST00000556226:intron_variant:MODIFIER:exon2/5:c.-125+2210A>G:,HNRNPC:ENST00000555176:intron_variant:MODIFIER:exon2/5:c.-125+2210A>G:,HNRNPC:ENST00000553614:intron_variant:MODIFIER:exon2/3:n.152+2210A>G:,HNRNPC:ENST00000557336:intron_variant:MODIFIER:exon3/4:c.-84+2210A>G:,HNRNPC:ENST00000557768:intron_variant:MODIFIER:exon2/2:c.-37+2210A>G:			Binds pre-mRNA and nucleates the assembly of 40S hnRNP particles. Single HNRNPC tetramers bind 230-240 nucleotides. Trimers of HNRNPC tetramers bind 700 nucleotides. May play a role in the early steps of spliceosome assembly and pre-mRNA splicing. Interacts with poly-U tracts in the 3'-UTR or 5'-UTR of mRNA and modulates the stability and the level of translation of bound mRNA molecules				0.0000	0.0000	0.0000																					0		0.2308	26	0.0204	49
chr14	23540358	23540358	-	T	0.1613	39	0.0000	53		44	ACIN1	5_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	ACIN1:ENST00000557515:5_prime_UTR_variant:MODIFIER:exon1/12:c.-3dupA:,ACIN1:ENST00000357481:5_prime_UTR_variant:MODIFIER:exon2/13:c.-3dupA:,ACIN1:ENST00000397341:5_prime_UTR_variant:MODIFIER:exon1/12:c.-3dupA:,ACIN1:ENST00000555566:5_prime_UTR_variant:MODIFIER:exon2/7:c.-3dupA:,ACIN1:ENST00000262710:intron_variant:MODIFIER:exon8/18:c.2298-1533dupA:,ACIN1:ENST00000338631:intron_variant:MODIFIER:exon1/11:c.116+277dupA:,ACIN1:ENST00000605057:intron_variant:MODIFIER:exon8/18:c.2124-1533dupA:,ACIN1:ENST00000457657:intron_variant:MODIFIER:exon7/17:c.2178-1533dupA:,ACIN1:ENST00000555053:intron_variant:MODIFIER:exon8/18:c.2298-1533dupA:,ACIN1:ENST00000553721:intron_variant:MODIFIER:exon1/2:n.129+277dupA:,ACIN1:ENST00000555352:intron_variant:MODIFIER:exon3/4:n.247-1533dupA:,ACIN1:ENST00000553501:intron_variant:MODIFIER:exon1/1:n.131+277dupA:,ACIN1:ENST00000557432:non_coding_transcript_exon_variant:MODIFIER:exon1/3:n.401dupA:,ACIN1:ENST00000554979:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.52dupA:			Component of a splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of a few core proteins and several more peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Induces apoptotic chromatin condensation after activation by CASP3. Regulates cyclin A1, but not cyclin A2, expression in leukemia cells			rs781124581	0.0000	0.00005	0.00003																					0		0.0394	127	0.0000	196
chr14	31483206	31483206	T	C	0.1429	28	0.0000	23		57	STRN3	intron_variant	STRN3:ENST00000357479:intron_variant:MODIFIER:exon1/17:c.282+11904A>G:,STRN3:ENST00000355683:intron_variant:MODIFIER:exon1/15:c.282+11904A>G:,STRN3:ENST00000555358:intron_variant:MODIFIER:exon1/14:c.282+11904A>G:			Binds calmodulin in a calcium dependent manner. May function as scaffolding or signaling protein				0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	23
chr14	58760732	58760732	T	C	0.2333	30	0.0000	23		65	RP11-349A22.5,C14orf37	intron_variant,non_coding_transcript_exon_variant	RP11-349A22.5:ENST00000554360:intron_variant:MODIFIER:exon1/4:n.176-2307A>G:,C14orf37:ENST00000554218:intron_variant:MODIFIER:exon1/2:n.186-2307A>G:,RP11-349A22.5:ENST00000556002:intron_variant:MODIFIER:exon1/3:n.149-2307A>G:,RP11-349A22.5:ENST00000555275:intron_variant:MODIFIER:exon1/3:n.169-2307A>G:,RP11-349A22.5:ENST00000554378:intron_variant:MODIFIER:exon1/4:n.181-2307A>G:,RP11-349A22.5:ENST00000555707:intron_variant:MODIFIER:exon1/2:n.176-2307A>G:,RP11-349A22.5:ENST00000556400:intron_variant:MODIFIER:exon1/2:n.162-2307A>G:,RP11-349A22.5:ENST00000553657:intron_variant:MODIFIER:exon1/3:n.131-876A>G:,RP11-349A22.5:ENST00000551597:intron_variant:MODIFIER:exon1/3:n.179-470A>G:,RP11-349A22.5:ENST00000555037:intron_variant:MODIFIER:exon1/4:n.180-876A>G:,RP11-349A22.5:ENST00000554309:intron_variant:MODIFIER:exon1/1:n.173-88A>G:,RP11-349A22.5:ENST00000557660:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.1964A>G:							0.0000	0.0000	0.0000																					0		0.2333	30	0.0000	23
chr14	73873729	73873729	T	C	0.1739	25	0.0000	29		63	NUMB	intron_variant	NUMB:ENST00000355058:intron_variant:MODIFIER:exon3/12:c.-16+2916A>G:,NUMB:ENST00000554546:intron_variant:MODIFIER:exon2/10:c.-101+2916A>G:,NUMB:ENST00000356296:intron_variant:MODIFIER:exon3/11:c.-16+2916A>G:,NUMB:ENST00000557597:intron_variant:MODIFIER:exon2/11:c.-101+2916A>G:,NUMB:ENST00000555238:intron_variant:MODIFIER:exon2/12:c.-101+2916A>G:,NUMB:ENST00000359560:intron_variant:MODIFIER:exon3/11:c.-16+2916A>G:,NUMB:ENST00000555394:intron_variant:MODIFIER:exon2/11:c.-101+2916A>G:,NUMB:ENST00000535282:intron_variant:MODIFIER:exon2/10:c.-16+2916A>G:,NUMB:ENST00000555859:intron_variant:MODIFIER:exon1/6:c.-101+2916A>G:,NUMB:ENST00000555307:intron_variant:MODIFIER:exon2/8:c.-16+2916A>G:,NUMB:ENST00000554394:intron_variant:MODIFIER:exon2/8:c.-16+2916A>G:,NUMB:ENST00000554315:intron_variant:MODIFIER:exon2/6:n.186+2916A>G:,NUMB:ENST00000555987:intron_variant:MODIFIER:exon2/5:c.-101+2916A>G:,NUMB:ENST00000556112:intron_variant:MODIFIER:exon2/5:n.217+2916A>G:,NUMB:ENST00000557774:intron_variant:MODIFIER:exon2/4:n.217+2916A>G:,NUMB:ENST00000554818:intron_variant:MODIFIER:exon2/4:c.-101+2916A>G:,NUMB:ENST00000557031:intron_variant:MODIFIER:exon2/3:n.442+2916A>G:,NUMB:ENST00000556700:intron_variant:MODIFIER:exon3/3:n.444+2916A>G:		Notch signaling pathway	Plays a role in the process of neurogenesis. Required throughout embryonic neurogenesis to maintain neural progenitor cells, also called radial glial cells (RGCs), by allowing their daughter cells to choose progenitor over neuronal cell fate. Not required for the proliferation of neural progenitor cells before the onset of neurogenesis. Also involved postnatally in the subventricular zone (SVZ) neurogenesis by regulating SVZ neuroblasts survival and ependymal wall integrity. May also mediate local repair of brain ventricular wall damage				0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	29
chr14	100831720	100831720	T	C	0.3077	13	0.0000	18		41	WARS	intron_variant	WARS:ENST00000355338:intron_variant:MODIFIER:exon2/10:c.100-3462A>G:,WARS:ENST00000392882:intron_variant:MODIFIER:exon2/10:c.100-3462A>G:,WARS:ENST00000358655:intron_variant:MODIFIER:exon1/9:c.-24-3462A>G:,WARS:ENST00000344102:intron_variant:MODIFIER:exon1/9:c.-24-3462A>G:,WARS:ENST00000557135:intron_variant:MODIFIER:exon3/11:c.100-3462A>G:,WARS:ENST00000556645:intron_variant:MODIFIER:exon2/10:c.-24-3462A>G:,WARS:ENST00000553395:intron_variant:MODIFIER:exon1/5:c.-24-3462A>G:,WARS:ENST00000556504:intron_variant:MODIFIER:exon2/6:c.-24-3462A>G:,WARS:ENST00000557722:intron_variant:MODIFIER:exon3/6:c.100-3462A>G:,WARS:ENST00000557297:intron_variant:MODIFIER:exon3/6:c.-5-3481A>G:,WARS:ENST00000556435:intron_variant:MODIFIER:exon1/4:c.-24-3462A>G:,WARS:ENST00000553808:intron_variant:MODIFIER:exon2/4:n.364-3462A>G:,WARS:ENST00000554331:intron_variant:MODIFIER:exon2/4:n.244-3462A>G:,WARS:ENST00000555063:intron_variant:MODIFIER:exon1/3:n.85-3462A>G:,WARS:ENST00000556338:intron_variant:MODIFIER:exon1/3:c.-24-3462A>G:,WARS:ENST00000556698:intron_variant:MODIFIER:exon3/5:c.100-3462A>G:,WARS:ENST00000557239:intron_variant:MODIFIER:exon2/3:n.222-3462A>G:,WARS:ENST00000553524:intron_variant:MODIFIER:exon3/5:c.100-3462A>G:,WARS:ENST00000555410:intron_variant:MODIFIER:exon3/5:c.201+92A>G:,WARS:ENST00000556579:intron_variant:MODIFIER:exon2/3:n.213-3462A>G:,WARS:ENST00000554772:intron_variant:MODIFIER:exon3/4:c.100-3462A>G:,WARS:ENST00000556660:intron_variant:MODIFIER:exon2/3:c.100-3462A>G:,WARS:ENST00000556783:intron_variant:MODIFIER:exon3/4:c.*102+571A>G:,WARS:ENST00000553413:intron_variant:MODIFIER:exon3/4:c.100-3462A>G:,WARS:ENST00000557094:intron_variant:MODIFIER:exon2/2:n.364-3462A>G:,WARS:ENST00000553769:intron_variant:MODIFIER:exon3/3:c.100-3462A>G:,WARS:ENST00000553545:intron_variant:MODIFIER:exon3/3:c.100-3462A>G:,WARS:ENST00000554820:intron_variant:MODIFIER:exon3/3:c.100-3462A>G:,WARS:ENST00000557347:intron_variant:MODIFIER:exon3/3:c.*68+2991A>G:,WARS:ENST00000554509:intron_variant:MODIFIER:exon4/4:c.201+92A>G:,WARS:ENST00000556209:intron_variant:MODIFIER:exon4/4:c.100-3462A>G:,WARS:ENST00000554605:intron_variant:MODIFIER:exon4/4:c.100-3462A>G:,WARS:ENST00000555813:intron_variant:MODIFIER:exon3/3:c.100-3462A>G:,WARS:ENST00000556695:intron_variant:MODIFIER:exon3/3:c.100-3462A>G:,WARS:ENST00000556295:intron_variant:MODIFIER:exon3/3:c.100-3462A>G:,WARS:ENST00000555031:intron_variant:MODIFIER:exon3/3:c.100-3462A>G:		Tryptophan metabolism;Aminoacyl-tRNA biosynthesis	Isoform 1, isoform 2 and T1-TrpRS have aminoacylation activity while T2-TrpRS lacks it. Isoform 2, T1-TrpRS and T2-TrpRS possess angiostatic activity whereas isoform 1 lacks it. T2-TrpRS inhibits fluid shear stress-activated responses of endothelial cells. Regulates ERK, Akt, and eNOS activation pathways that are associated with angiogenesis, cytoskeletal reorganization and shear stress-responsive gene expression				0.0000	0.0000	0.0000																					0		0.3077	13	0.0000	18
chr14	100836281	100836281	T	C	0.3182	22	0.0303	33		62	WARS	intron_variant	WARS:ENST00000355338:intron_variant:MODIFIER:exon1/10:c.-73-686A>G:,WARS:ENST00000392882:intron_variant:MODIFIER:exon1/10:c.-73-686A>G:,WARS:ENST00000358655:intron_variant:MODIFIER:exon1/9:c.-25+6316A>G:,WARS:ENST00000344102:intron_variant:MODIFIER:exon1/9:c.-25+5339A>G:,WARS:ENST00000557135:intron_variant:MODIFIER:exon2/11:c.-73-686A>G:,WARS:ENST00000556645:intron_variant:MODIFIER:exon2/10:c.-25+5339A>G:,WARS:ENST00000553395:intron_variant:MODIFIER:exon1/5:c.-25+5567A>G:,WARS:ENST00000556504:intron_variant:MODIFIER:exon2/6:c.-25+5339A>G:,WARS:ENST00000557722:intron_variant:MODIFIER:exon2/6:c.-73-686A>G:,WARS:ENST00000557297:intron_variant:MODIFIER:exon2/6:c.-177-686A>G:,WARS:ENST00000556435:intron_variant:MODIFIER:exon1/4:c.-25+6316A>G:,WARS:ENST00000553808:intron_variant:MODIFIER:exon1/4:n.192-686A>G:,WARS:ENST00000554331:intron_variant:MODIFIER:exon1/4:n.72-686A>G:,WARS:ENST00000555063:intron_variant:MODIFIER:exon1/3:n.84+6316A>G:,WARS:ENST00000556338:intron_variant:MODIFIER:exon1/3:c.-25+5567A>G:,WARS:ENST00000556698:intron_variant:MODIFIER:exon2/5:c.-73-686A>G:,WARS:ENST00000557239:intron_variant:MODIFIER:exon1/3:n.50-686A>G:,WARS:ENST00000553524:intron_variant:MODIFIER:exon2/5:c.-73-686A>G:,WARS:ENST00000555410:intron_variant:MODIFIER:exon1/5:c.-73-686A>G:,WARS:ENST00000556579:intron_variant:MODIFIER:exon1/3:n.41-686A>G:,WARS:ENST00000554772:intron_variant:MODIFIER:exon2/4:c.-73-686A>G:,WARS:ENST00000556660:intron_variant:MODIFIER:exon1/3:c.-73-686A>G:,WARS:ENST00000556783:intron_variant:MODIFIER:exon1/4:c.-73-686A>G:,WARS:ENST00000553413:intron_variant:MODIFIER:exon2/4:c.-73-686A>G:,WARS:ENST00000557094:intron_variant:MODIFIER:exon1/2:n.192-686A>G:,WARS:ENST00000553769:intron_variant:MODIFIER:exon2/3:c.-73-686A>G:,WARS:ENST00000553545:intron_variant:MODIFIER:exon2/3:c.-73-686A>G:,WARS:ENST00000554820:intron_variant:MODIFIER:exon2/3:c.-73-686A>G:,WARS:ENST00000557347:intron_variant:MODIFIER:exon1/3:c.-73-686A>G:,WARS:ENST00000554509:intron_variant:MODIFIER:exon2/4:c.-73-686A>G:,WARS:ENST00000556209:intron_variant:MODIFIER:exon3/4:c.-73-686A>G:,WARS:ENST00000554605:intron_variant:MODIFIER:exon3/4:c.-73-686A>G:,WARS:ENST00000555813:intron_variant:MODIFIER:exon2/3:c.-73-686A>G:,WARS:ENST00000556695:intron_variant:MODIFIER:exon2/3:c.-73-686A>G:,WARS:ENST00000556295:intron_variant:MODIFIER:exon2/3:c.-73-686A>G:,WARS:ENST00000555031:intron_variant:MODIFIER:exon2/3:c.-73-686A>G:,WARS:ENST00000553934:intron_variant:MODIFIER:exon2/2:c.-73-686A>G:,WARS:ENST00000553581:intron_variant:MODIFIER:exon3/3:c.-73-686A>G:		Tryptophan metabolism;Aminoacyl-tRNA biosynthesis	Isoform 1, isoform 2 and T1-TrpRS have aminoacylation activity while T2-TrpRS lacks it. Isoform 2, T1-TrpRS and T2-TrpRS possess angiostatic activity whereas isoform 1 lacks it. T2-TrpRS inhibits fluid shear stress-activated responses of endothelial cells. Regulates ERK, Akt, and eNOS activation pathways that are associated with angiogenesis, cytoskeletal reorganization and shear stress-responsive gene expression				0.0000	0.0000	0.0000																					0		0.3182	22	0.0303	33
chr14	100837996	100837996	T	C	0.2105	20	0.0323	31		53	WARS	intron_variant	WARS:ENST00000355338:intron_variant:MODIFIER:exon1/10:c.-73-2401A>G:,WARS:ENST00000392882:intron_variant:MODIFIER:exon1/10:c.-73-2401A>G:,WARS:ENST00000358655:intron_variant:MODIFIER:exon1/9:c.-25+4601A>G:,WARS:ENST00000344102:intron_variant:MODIFIER:exon1/9:c.-25+3624A>G:,WARS:ENST00000557135:intron_variant:MODIFIER:exon2/11:c.-73-2401A>G:,WARS:ENST00000556645:intron_variant:MODIFIER:exon2/10:c.-25+3624A>G:,WARS:ENST00000553395:intron_variant:MODIFIER:exon1/5:c.-25+3852A>G:,WARS:ENST00000556504:intron_variant:MODIFIER:exon2/6:c.-25+3624A>G:,WARS:ENST00000557722:intron_variant:MODIFIER:exon2/6:c.-74+2321A>G:,WARS:ENST00000557297:intron_variant:MODIFIER:exon2/6:c.-177-2401A>G:,WARS:ENST00000556435:intron_variant:MODIFIER:exon1/4:c.-25+4601A>G:,WARS:ENST00000553808:intron_variant:MODIFIER:exon1/4:n.192-2401A>G:,WARS:ENST00000554331:intron_variant:MODIFIER:exon1/4:n.72-2401A>G:,WARS:ENST00000555063:intron_variant:MODIFIER:exon1/3:n.84+4601A>G:,WARS:ENST00000556338:intron_variant:MODIFIER:exon1/3:c.-25+3852A>G:,WARS:ENST00000556698:intron_variant:MODIFIER:exon2/5:c.-73-2401A>G:,WARS:ENST00000557239:intron_variant:MODIFIER:exon1/3:n.50-2401A>G:,WARS:ENST00000553524:intron_variant:MODIFIER:exon2/5:c.-73-2401A>G:,WARS:ENST00000555410:intron_variant:MODIFIER:exon1/5:c.-73-2401A>G:,WARS:ENST00000556579:intron_variant:MODIFIER:exon1/3:n.41-2401A>G:,WARS:ENST00000554772:intron_variant:MODIFIER:exon2/4:c.-73-2401A>G:,WARS:ENST00000556660:intron_variant:MODIFIER:exon1/3:c.-73-2401A>G:,WARS:ENST00000556783:intron_variant:MODIFIER:exon1/4:c.-73-2401A>G:,WARS:ENST00000553413:intron_variant:MODIFIER:exon2/4:c.-73-2401A>G:,WARS:ENST00000557094:intron_variant:MODIFIER:exon1/2:n.192-2401A>G:,WARS:ENST00000553769:intron_variant:MODIFIER:exon2/3:c.-73-2401A>G:,WARS:ENST00000553545:intron_variant:MODIFIER:exon2/3:c.-73-2401A>G:,WARS:ENST00000554820:intron_variant:MODIFIER:exon2/3:c.-73-2401A>G:,WARS:ENST00000557347:intron_variant:MODIFIER:exon1/3:c.-73-2401A>G:,WARS:ENST00000554509:intron_variant:MODIFIER:exon2/4:c.-73-2401A>G:,WARS:ENST00000556209:intron_variant:MODIFIER:exon3/4:c.-73-2401A>G:,WARS:ENST00000554605:intron_variant:MODIFIER:exon3/4:c.-73-2401A>G:,WARS:ENST00000555813:intron_variant:MODIFIER:exon2/3:c.-73-2401A>G:,WARS:ENST00000556695:intron_variant:MODIFIER:exon2/3:c.-73-2401A>G:,WARS:ENST00000556295:intron_variant:MODIFIER:exon2/3:c.-74+2321A>G:,WARS:ENST00000555031:intron_variant:MODIFIER:exon2/3:c.-73-2401A>G:,WARS:ENST00000553934:intron_variant:MODIFIER:exon2/2:c.-73-2401A>G:,WARS:ENST00000553581:intron_variant:MODIFIER:exon3/3:c.-73-2401A>G:,WARS:ENST00000555464:intron_variant:MODIFIER:exon2/2:n.396-1132A>G:		Tryptophan metabolism;Aminoacyl-tRNA biosynthesis	Isoform 1, isoform 2 and T1-TrpRS have aminoacylation activity while T2-TrpRS lacks it. Isoform 2, T1-TrpRS and T2-TrpRS possess angiostatic activity whereas isoform 1 lacks it. T2-TrpRS inhibits fluid shear stress-activated responses of endothelial cells. Regulates ERK, Akt, and eNOS activation pathways that are associated with angiogenesis, cytoskeletal reorganization and shear stress-responsive gene expression				0.0000	0.0000	0.0000																					0		0.2500	20	0.0323	31
chr15	30032303	30032303	T	C	0.4444	18	0.0370	27		44	TJP1	intron_variant	TJP1:ENST00000356107:intron_variant:MODIFIER:exon10/27:c.1256+1232A>G:,TJP1:ENST00000346128:intron_variant:MODIFIER:exon10/27:c.1256+1232A>G:,TJP1:ENST00000400011:intron_variant:MODIFIER:exon11/27:c.1268+1232A>G:,TJP1:ENST00000545208:intron_variant:MODIFIER:exon10/26:c.1256+1232A>G:		Adherens junction;Tight junction;Gap junction;Vibrio cholerae infection;Epithelial cell signaling in Helicobacter pylori infection	The N-terminal may be involved in transducing a signal required for tight junction assembly, while the C-terminal may have specific properties of tight junctions. The alpha domain might be involved in stabilizing junctions. Plays a role in the regulation of cell migration by targeting CDC42BPB to the leading edge of migrating cells				0.0000	0.0000	0.0000																					0		0.4444	18	0.0357	28
chr15	41578609	41578609	A	G	0.4286	7	0.0345	29		43	OIP5-AS1	intron_variant,non_coding_transcript_exon_variant	OIP5-AS1:ENST00000500949:intron_variant:MODIFIER:exon3/3:n.335+311A>G:,OIP5-AS1:ENST00000558945:intron_variant:MODIFIER:exon3/3:n.528+311A>G:,OIP5-AS1:ENST00000561275:intron_variant:MODIFIER:exon3/3:n.334+311A>G:,OIP5-AS1:ENST00000559368:intron_variant:MODIFIER:exon3/3:n.332+311A>G:,OIP5-AS1:ENST00000560706:intron_variant:MODIFIER:exon3/4:n.332+311A>G:,OIP5-AS1:ENST00000557993:intron_variant:MODIFIER:exon3/3:n.309+311A>G:,OIP5-AS1:ENST00000501665:intron_variant:MODIFIER:exon3/4:n.308+311A>G:,OIP5-AS1:ENST00000558457:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.661A>G:,OIP5-AS1:ENST00000561226:non_coding_transcript_exon_variant:MODIFIER:exon3/4:n.630A>G:							0.0000	0.0000	0.0000																					0		0.4286	7	0.0303	33
chr15	41683729	41683729	T	C	0.2667	15	0.0000	21		52	NDUFAF1	intron_variant	NDUFAF1:ENST00000260361:intron_variant:MODIFIER:exon3/4:c.760-3009A>G:,NDUFAF1:ENST00000559127:intron_variant:MODIFIER:exon4/5:c.*227+2574A>G:			Chaperone protein involved in the assembly of the mitochondrial NADH:ubiquinone oxidoreductase complex (complex I) (By similarity)				0.0000	0.0000	0.0000		606934 [NDUFAF1 (provisional) Mitochondrial complex I deficiency,252010];																			0		0.2667	15	0.0000	23
chr15	44797782	44797782	A	G	0.2105	19	0.0000	30		65	CTDSPL2	intron_variant	CTDSPL2:ENST00000260327:intron_variant:MODIFIER:exon8/12:c.969+5771A>G:,CTDSPL2:ENST00000396780:intron_variant:MODIFIER:exon7/11:c.753+5771A>G:,CTDSPL2:ENST00000558966:intron_variant:MODIFIER:exon8/12:c.969+5771A>G:,CTDSPL2:ENST00000558373:intron_variant:MODIFIER:exon6/10:c.753+5771A>G:,CTDSPL2:ENST00000560620:intron_variant:MODIFIER:exon3/7:c.*27+3536A>G:			Probable phosphatase (By similarity)				0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	31
chr15	44869615	44869615	T	C	0.3333	21	0.0000	23		56	SPG11	intron_variant	SPG11:ENST00000261866:intron_variant:MODIFIER:exon30/39:c.5867-2376A>G:,SPG11:ENST00000559511:intron_variant:MODIFIER:exon1/7:c.712+6397A>G:,SPG11:ENST00000535302:intron_variant:MODIFIER:exon30/37:c.5867-4597A>G:,SPG11:ENST00000427534:intron_variant:MODIFIER:exon30/36:c.5867-2376A>G:,SPG11:ENST00000558319:intron_variant:MODIFIER:exon30/31:c.5867-2376A>G:,SPG11:ENST00000559822:intron_variant:MODIFIER:exon2/3:c.*16-2376A>G:							0.0000	0.0000	0.0000		610844 [SPG11 (confirmed) Spastic paraplegia 11,autosomal recessive,604360|Amyotrophic lateral sclerosis 5,juvenile,602099|Charcot-Marie-Tooth disease,axonal,type 2X,616668];																			0		0.3333	21	0.0000	23
chr15	50653343	50653343	A	G	0.1600	26	0.0000	18		54	GABPB1-AS1	intron_variant	GABPB1-AS1:ENST00000558593:intron_variant:MODIFIER:exon1/1:n.448+4228A>G:						rs1137993	0.0000	0.0000	0.0000																					0		0.1923	26	0.0000	18
chr15	50791778	50791778	-	T	0.2069	32	0.0000	26		43	USP8	3_prime_UTR_variant,non_coding_transcript_exon_variant	USP8:ENST00000307179:3_prime_UTR_variant:MODIFIER:exon20/20:c.*500dupT:,USP8:ENST00000433963:3_prime_UTR_variant:MODIFIER:exon21/21:c.*500dupT:,USP8:ENST00000396444:3_prime_UTR_variant:MODIFIER:exon20/20:c.*500dupT:,USP8:ENST00000419830:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.2295dupT:			Hydrolase that can remove conjugated ubiquitin from proteins and therefore plays an important regulatory role at the level of protein turnover by preventing degradation. Converts both 'Lys-48' an 'Lys-63'-linked ubiquitin chains. Catalytic activity is enhanced in the M phase. Involved in cell proliferation. Required to enter into S phase in response to serum stimulation. May regulate T-cell anergy mediated by RNF128 via the formation of a complex containing RNF128 and OTUB1. Probably regulates the stability of STAM2 and RASGRF1. Regulates endosomal ubiquitin dynamics, cargo sorting, membrane traffic at early endosomes, and maintenance of ESCRT-0 stability. The level of protein ubiquitination on endosomes is essential for maintaining the morphology of the organelle. Deubiquitinates EPS15 and controles tyrosine kinase stability. Removes conjugated ubiquitin from EGFR thus regulating EGFR degradation and downstream MAPK signaling. Involved in acrosome biogenesis through interaction with the spermatid ESCRT-0 complex and microtubules. Deubiquitinates BIRC6/bruce and KIF23/MKLP1				0.0000	0.0000	0.0000																					0		0.1515	33	0.0000	27
chr15	50997430	50997430	T	C	0.1053	38	0.0000	50		55	RN7SL354P-SPPL2A	intergenic_region	RN7SL354P-SPPL2A:ENSG00000243027-ENSG00000138600:intergenic_region:MODIFIER::n.50997430T>C:							0.0000	0.0000	0.0000																					0		0.0811	37	0.0000	50
chr15	50999484	50999484	T	C	0.1538	28	0.0000	29		59	RN7SL354P-SPPL2A	intergenic_region	RN7SL354P-SPPL2A:ENSG00000243027-ENSG00000138600:intergenic_region:MODIFIER::n.50999484T>C:							0.0000	0.0000	0.0000																					0		0.1786	28	0.0000	29
chr15	51044846	51044846	T	C	0.3000	21	0.0000	22		55	SPPL2A	intron_variant	SPPL2A:ENST00000261854:intron_variant:MODIFIER:exon1/14:c.67-2903A>G:,SPPL2A:ENST00000558414:intron_variant:MODIFIER:exon1/4:c.-60-2903A>G:,SPPL2A:ENST00000560288:intron_variant:MODIFIER:exon1/3:n.243-2903A>G:			Intramembrane-cleaving aspartic protease (I-CLiP) that cleaves type II membrane signal peptides in the hydrophobic plane of the membrane. Functions in FASLG, ITM2B and TNF processing. Catalyzes the intramembrane cleavage of the anchored fragment of shed TNF-alpha (TNF), which promotes the release of the intracellular domain (ICD) for signaling to the nucleus. Also responsible for the intramembrane cleavage of Fas antigen ligand FASLG, which promotes the release of the intracellular FasL domain (FasL ICD). May play a role in the regulation of innate and adaptive immunity				0.0000	0.0000	0.0000																					0		0.2857	21	0.0000	22
chr15	57233421	57233421	A	G	0.2105	23	0.0313	40		51	TCF12	intron_variant	TCF12:ENST00000333725:intron_variant:MODIFIER:exon3/20:c.148+20125A>G:,TCF12:ENST00000438423:intron_variant:MODIFIER:exon3/20:c.148+20125A>G:,TCF12:ENST00000267811:intron_variant:MODIFIER:exon3/19:c.148+20125A>G:,TCF12:ENST00000452095:intron_variant:MODIFIER:exon3/20:c.148+20125A>G:,TCF12:ENST00000558908:intron_variant:MODIFIER:exon3/5:n.402+20125A>G:,TCF12:ENST00000559609:intron_variant:MODIFIER:exon3/19:c.148+20125A>G:,TCF12:ENST00000560190:intron_variant:MODIFIER:exon3/5:n.402+20125A>G:,TCF12:ENST00000557843:intron_variant:MODIFIER:exon3/19:c.148+20125A>G:,TCF12:ENST00000557947:intron_variant:MODIFIER:exon3/6:c.148+20125A>G:,TCF12:ENST00000561152:intron_variant:MODIFIER:exon2/3:c.148+20125A>G:			Transcriptional regulator. Involved in the initiation of neuronal differentiation. Activates transcription by binding to the E box (5'-CANNTG-3')				0.0000	0.0000	0.0000		600480 [TCF12 (confirmed) Craniosynostosis 3,615314];																			0		0.2000	25	0.0476	42
chr15	65251859	65251859	T	C	0.2000	20	0.0333	30		52	ANKDD1A-SPG21	intergenic_region	ANKDD1A-SPG21:ENSG00000166839-ENSG00000090487:intergenic_region:MODIFIER::n.65251859T>C:							0.0000	0.0000	0.0000																					0		0.2000	20	0.0333	30
chr15	66070117	66070117	T	C	0.2222	18	0.0000	20		52	DENND4A,RAB11A	intron_variant	DENND4A:ENST00000443035:intron_variant:MODIFIER:exon1/32:c.-102+14231A>G:,DENND4A:ENST00000431932:intron_variant:MODIFIER:exon1/31:c.-95+14231A>G:,DENND4A:ENST00000564674:intron_variant:MODIFIER:exon1/21:c.-102+14231A>G:,DENND4A:ENST00000568515:intron_variant:MODIFIER:exon1/13:n.198+14231A>G:,RAB11A:ENST00000569304:intron_variant:MODIFIER:exon2/2:n.124+23844T>C:			Probable guanine nucleotide exchange factor (GEF) which may activate RAB10. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP- bound form. According to PubMed:8056341, it may bind to ISRE-like element (interferon-stimulated response element) of MYC P2 promoter.,The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. That Rab regulates endocytic recycling. Acts as a major regulator of membrane delivery during cytokinesis. Together with MYO5B and RAB8A participates in epithelial cell polarization. Together with RAB3IP, RAB8A, the exocyst complex, PARD3, PRKCI, ANXA2, CDC42 and DNMBP promotes transcytosis of PODXL to the apical membrane initiation sites (AMIS), apical surface formation and lumenogenesis. Together with MYO5B participates in CFTR trafficking to the plasma membrane and TF (Transferrin) recycling in nonpolarized cells. Required in a complex with MYO5B and RAB11FIP2 for the transport of NPC1L1 to the plasma membrane. Participates in the sorting and basolateral transport of CDH1 from the Golgi apparatus to the plasma membrane. Regulates the recycling of FCGRT (receptor of Fc region of monomeric Ig G) to basolateral membranes. May also play a role in melanosome transport and release from melanocytes	Rab GTPases Mark Targets In The Endocytotic Machinery			0.0000	0.0000	0.0000																					0		0.2222	18	0.0000	20
chr15	72773981	72773981	A	G	0.2571	35	0.0571	36		57	ARIH1	intron_variant	ARIH1:ENST00000379887:intron_variant:MODIFIER:exon1/13:c.375+6626A>G:,ARIH1:ENST00000570085:intron_variant:MODIFIER:exon1/4:c.375+6626A>G:,ARIH1:ENST00000564062:intron_variant:MODIFIER:exon1/3:c.369+6626A>G:,ARIH1:ENST00000567762:intron_variant:MODIFIER:exon1/3:n.79+6626A>G:			E3 ubiquitin-protein ligase, which catalyzes polyubiquitination of target proteins together with ubiquitin- conjugating enzyme E2 UBE2L3. May play a role in protein translation by mediating polyubiquitination of EIF4E2, leading to its subsequent degradation. Acts as the ligase involved in ISGylation of EIF4E2				0.0000	0.0000	0.0000																					0		0.2571	35	0.0556	36
chr15	93430200	93430200	-	T	0.1739	27	0.0000	31		41	AC013394.2,CHD2	intron_variant,non_coding_transcript_exon_variant	AC013394.2:ENST00000554133:intron_variant:MODIFIER:exon2/3:n.1300+722dupT:,AC013394.2:ENST00000557682:intron_variant:MODIFIER:exon3/4:n.636+722dupT:,AC013394.2:ENST00000556895:intron_variant:MODIFIER:exon3/4:n.481+722dupT:,AC013394.2:ENST00000554894:intron_variant:MODIFIER:exon5/5:n.525+722dupT:,CHD2:ENST00000556722:intron_variant:MODIFIER:exon3/8:c.-141+722dupT:,CHD2:ENST00000556930:intron_variant:MODIFIER:exon1/11:n.52+722dupT:,AC013394.2:ENST00000555227:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1069dupT:			Sequence-selective DNA-binding protein (By similarity)				0.0000	0.0000	0.0000		602119 [CHD2 (provisional) Epileptic encephalopathy,childhood-onset,615369];																			0		0.0500	80	0.0000	57
chr15	93530654	93530654	A	G	0.1765	17	0.0000	27		52	CHD2	intron_variant	CHD2:ENST00000394196:intron_variant:MODIFIER:exon26/38:c.3413+1751A>G:,CHD2:ENST00000557381:intron_variant:MODIFIER:exon26/37:c.3413+1751A>G:			Sequence-selective DNA-binding protein (By similarity)				0.0000	0.0000	0.0000		602119 [CHD2 (provisional) Epileptic encephalopathy,childhood-onset,615369];																			0		0.1765	17	0.0000	27
chr16	1410058	1410058	A	G	0.3125	16	0.0000	16		36	GNPTG,LA16c-316G12.2	intron_variant	GNPTG:ENST00000204679:intron_variant:MODIFIER:exon3/10:c.179-1686A>G:,LA16c-316G12.2:ENST00000569831:intron_variant:MODIFIER:exon1/1:n.359+990T>C:,GNPTG:ENST00000526820:intron_variant:MODIFIER:exon4/6:c.*81-1686A>G:,GNPTG:ENST00000529957:intron_variant:MODIFIER:exon2/8:n.278-1686A>G:,GNPTG:ENST00000527168:intron_variant:MODIFIER:exon2/7:n.270-1815A>G:,GNPTG:ENST00000529110:intron_variant:MODIFIER:exon2/5:c.245-1686A>G:			May recognize the substrate of GlcNAc-1- phosphotransferase but also the lysosomal proteins with mannose-6- phosphate residues				0.0000	0.0000	0.0000		607838 [GNPTG (confirmed) Mucolipidosis III gamma,252605];																			0		0.3125	16	0.0000	16
chr16	1988120	1988120	T	C	0.1163	45	0.0000	38		52	HS3ST6-MSRB1	intergenic_region	HS3ST6-MSRB1:ENSG00000162040-ENSG00000198736:intergenic_region:MODIFIER::n.1988120T>C:						rs190956514	0.000199681	0.0000	0.0000																					0		0.1111	45	0.0000	38
chr16	11022246	11022246	A	G	0.0962	52	0.0000	61		69	CIITA	3_prime_UTR_variant,intron_variant	CIITA:ENST00000324288:3_prime_UTR_variant:MODIFIER:exon20/20:c.*4534A>G:,CIITA:ENST00000571545:intron_variant:MODIFIER:exon1/1:n.169+57A>G:		Antigen processing and presentation;Primary immunodeficiency	Essential for transcriptional activity of the HLA class II promoter; activation is via the proximal promoter. No DNA binding of in vitro translated CIITA was detected. May act in a coactivator-like fashion through protein-protein interactions by contacting factors binding to the proximal MHC class II promoter, to elements of the transcription machinery, or both. Alternatively it may activate HLA class II transcription by modifying proteins that bind to the MHC class II promoter				0.0000	0.0000	0.0000																					0		0.0962	52	0.0000	63
chr16	15117429	15117429	T	C	0.2593	27	0.0357	28		53	PDXDC1	intron_variant	PDXDC1:ENST00000563679:intron_variant:MODIFIER:exon13/22:c.1194+818T>C:,PDXDC1:ENST00000325823:intron_variant:MODIFIER:exon13/22:c.1095+818T>C:,PDXDC1:ENST00000447912:intron_variant:MODIFIER:exon12/21:c.867+818T>C:,PDXDC1:ENST00000535621:intron_variant:MODIFIER:exon13/16:c.1140+818T>C:,PDXDC1:ENST00000455313:intron_variant:MODIFIER:exon12/13:c.1071+818T>C:,PDXDC1:ENST00000562119:intron_variant:MODIFIER:exon4/8:c.175-9706T>C:,PDXDC1:ENST00000396410:intron_variant:MODIFIER:exon13/22:c.1140+818T>C:,PDXDC1:ENST00000570001:intron_variant:MODIFIER:exon13/21:n.1235+818T>C:,PDXDC1:ENST00000569715:intron_variant:MODIFIER:exon12/21:c.1059+818T>C:,PDXDC1:ENST00000450288:intron_variant:MODIFIER:exon12/21:c.1056+818T>C:							0.0000	0.0000	0.0000																					0		0.2593	27	0.0357	28
chr16	19131427	19131427	A	G	0.2273	22	0.0556	36		53	CTD-2349B8.1,ITPRIPL2,RP11-626G11.3	splice_acceptor_variant&intron_variant,3_prime_UTR_variant,intron_variant,non_coding_transcript_exon_variant	CTD-2349B8.1:ENST00000564808:splice_acceptor_variant&intron_variant:HIGH:exon2/5:c.*105-2A>G:,ITPRIPL2:ENST00000381440:3_prime_UTR_variant:MODIFIER:exon1/1:c.*4036A>G:,CTD-2349B8.1:ENST00000568526:intron_variant:MODIFIER:exon2/4:c.210+5320A>G:,RP11-626G11.3:ENST00000567236:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.1008T>C:							0.0000	0.0000	0.0000																					0		0.2273	22	0.0556	36
chr16	21652025	21652025	T	C	0.2105	21	0.0323	38		52	METTL9	intron_variant	METTL9:ENST00000358154:intron_variant:MODIFIER:exon4/4:c.752-14523T>C:,METTL9:ENST00000567404:intron_variant:MODIFIER:exon4/4:c.632-14523T>C:,METTL9:ENST00000396014:intron_variant:MODIFIER:exon4/4:c.752-14526T>C:,METTL9:ENST00000568826:intron_variant:MODIFIER:exon2/2:c.320-14523T>C:							0.0000	0.0000	0.0000																					0		0.2500	24	0.0789	38
chr16	22297276	22297276	A	G	0.0492	122	0.0000	116		77	EEF2K	3_prime_UTR_variant	EEF2K:ENST00000263026:3_prime_UTR_variant:MODIFIER:exon18/18:c.*1959A>G:			Threonine kinase that regulates protein synthesis by controlling the rate of peptide chain elongation. Upon activation by a variety of upstream kinases including AMPK or TRPM7, phosphorylates the elongation factor EEF2 at a single site, renders it unable to bind ribosomes and thus inactive. In turn, the rate of protein synthesis is reduced	Eukaryotic protein translation			0.0000	0.0000	0.0000																					0		0.0492	122	0.0000	116
chr16	27327489	27327489	A	G	0.2414	30	0.0682	44		54	IL4R	intron_variant	IL4R:ENST00000566117:intron_variant:MODIFIER:exon1/3:c.-19+2351A>G:,IL4R:ENST00000395762:intron_variant:MODIFIER:exon1/10:c.-152+2148A>G:,IL4R:ENST00000562142:intron_variant:MODIFIER:exon1/2:c.-19+1937A>G:,IL4R:ENST00000561742:intron_variant:MODIFIER:exon1/3:c.-254+2148A>G:,IL4R:ENST00000563926:intron_variant:MODIFIER:exon1/4:c.-152+2148A>G:,IL4R:ENST00000543915:intron_variant:MODIFIER:exon1/9:c.-19+2148A>G:,IL4R:ENST00000449195:intron_variant:MODIFIER:exon1/7:c.-152+2148A>G:,IL4R:ENST00000380922:intron_variant:MODIFIER:exon1/10:c.-308+2148A>G:,IL4R:ENST00000568746:intron_variant:MODIFIER:exon1/10:c.-19+2148A>G:,IL4R:ENST00000566318:intron_variant:MODIFIER:exon1/5:c.-19+2148A>G:,IL4R:ENST00000563002:intron_variant:MODIFIER:exon1/4:c.-152+2148A>G:,IL4R:ENST00000561946:intron_variant:MODIFIER:exon1/4:n.29+2110A>G:,IL4R:ENST00000563787:intron_variant:MODIFIER:exon1/4:n.170+602A>G:		Cytokine-cytokine receptor interaction;Jak-STAT signaling pathway;Hematopoietic cell lineage	Receptor for both interleukin 4 and interleukin 13. Couples to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in promoting Th2 differentiation. The IL4/IL13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation. In certain cell types, can signal through activation of insulin receptor substrates, IRS1/IRS2	IL 4 signaling pathway;Selective expression of chemokine receptors during T-cell polarization;Th1/Th2 Differentiation			0.0000	0.0000	0.0000		147781 [IL4R (provisional) Atopy,susceptibility to,147050|AIDS,slow progression to,609423];																			0		0.2581	31	0.0682	44
chr16	27339738	27339738	A	G	0.1852	28	0.0000	37		73	IL4R	intron_variant	IL4R:ENST00000566117:intron_variant:MODIFIER:exon1/3:c.-18-11769A>G:,IL4R:ENST00000395762:intron_variant:MODIFIER:exon1/10:c.-151-1649A>G:,IL4R:ENST00000562142:intron_variant:MODIFIER:exon1/2:c.-18-11769A>G:,IL4R:ENST00000561742:intron_variant:MODIFIER:exon1/3:c.-253-1649A>G:,IL4R:ENST00000563926:intron_variant:MODIFIER:exon1/4:c.-151-1649A>G:,IL4R:ENST00000543915:intron_variant:MODIFIER:exon1/9:c.-18-11769A>G:,IL4R:ENST00000449195:intron_variant:MODIFIER:exon1/7:c.-151-1649A>G:,IL4R:ENST00000380922:intron_variant:MODIFIER:exon1/10:c.-307-11769A>G:,IL4R:ENST00000568746:intron_variant:MODIFIER:exon1/10:c.-18-11769A>G:,IL4R:ENST00000566318:intron_variant:MODIFIER:exon1/5:c.-18-11769A>G:,IL4R:ENST00000563002:intron_variant:MODIFIER:exon2/4:c.-19+9650A>G:,IL4R:ENST00000561946:intron_variant:MODIFIER:exon1/4:n.30-1649A>G:,IL4R:ENST00000563787:intron_variant:MODIFIER:exon1/4:n.171-1649A>G:		Cytokine-cytokine receptor interaction;Jak-STAT signaling pathway;Hematopoietic cell lineage	Receptor for both interleukin 4 and interleukin 13. Couples to the JAK1/2/3-STAT6 pathway. The IL4 response is involved in promoting Th2 differentiation. The IL4/IL13 responses are involved in regulating IgE production and, chemokine and mucus production at sites of allergic inflammation. In certain cell types, can signal through activation of insulin receptor substrates, IRS1/IRS2	IL 4 signaling pathway;Selective expression of chemokine receptors during T-cell polarization;Th1/Th2 Differentiation			0.0000	0.0000	0.0000		147781 [IL4R (provisional) Atopy,susceptibility to,147050|AIDS,slow progression to,609423];																			0		0.1786	28	0.0000	37
chr16	28968454	28968454	A	G	0.1212	33	0.0000	33		54	NFATC2IP,RP11-264B17.2	intron_variant	NFATC2IP:ENST00000320805:intron_variant:MODIFIER:exon5/7:c.846+796A>G:,RP11-264B17.2:ENST00000568057:intron_variant:MODIFIER:exon1/1:n.237-59T>C:,NFATC2IP:ENST00000564978:intron_variant:MODIFIER:exon2/4:c.10-1584A>G:,NFATC2IP:ENST00000562977:intron_variant:MODIFIER:exon2/3:n.466-1584A>G:,RP11-264B17.2:ENST00000569974:intron_variant:MODIFIER:exon1/1:n.469-371T>C:			In T-helper 2 (Th2) cells, regulates the magnitude of NFAT-driven transcription of a specific subset of cytokine genes, including IL3, IL4, IL5 and IL13, but not IL2. Recruits PRMT1 to the IL4 promoter; this leads to enhancement of histone H4 'Arg-3'- methylation and facilitates subsequent histone acetylation at the IL4 locus, thus promotes robust cytokine expression (By similarity). Down-regulates formation of poly-SUMO chains by UBE2I/UBC9 (By similarity)				0.0000	0.0000	0.0000																					0		0.1212	33	0.0000	33
chr16	29834156	29834156	A	G	0.1538	28	0.0000	32		54	MVP,PAGR1	intron_variant	MVP:ENST00000357402:intron_variant:MODIFIER:exon1/14:c.-36+2325A>G:,PAGR1:ENST00000562285:intron_variant:MODIFIER:exon2/2:c.*148+2933A>G:,MVP:ENST00000563915:intron_variant:MODIFIER:exon1/5:c.-77+2325A>G:,MVP:ENST00000566859:intron_variant:MODIFIER:exon1/4:c.-36+2325A>G:,MVP:ENST00000452209:intron_variant:MODIFIER:exon1/6:c.-85+2325A>G:,MVP:ENST00000563096:intron_variant:MODIFIER:exon1/1:n.45+2325A>G:,MVP:ENST00000395353:intron_variant:MODIFIER:exon1/14:c.-77+2325A>G:,MVP:ENST00000566066:intron_variant:MODIFIER:exon1/3:c.-228+2325A>G:,MVP:ENST00000562463:intron_variant:MODIFIER:exon1/3:c.-36+2325A>G:,MVP:ENST00000563558:intron_variant:MODIFIER:exon1/4:c.-77+2325A>G:,MVP:ENST00000565830:intron_variant:MODIFIER:exon1/3:n.34+2325A>G:,MVP:ENST00000569887:intron_variant:MODIFIER:exon1/3:c.-36+2325A>G:,MVP:ENST00000565164:intron_variant:MODIFIER:exon1/1:c.-36+1462A>G:,MVP:ENST00000570234:intron_variant:MODIFIER:exon2/4:c.-36+179A>G:			Required for normal vault structure. Vaults are multi- subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo- cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases			rs538999846	0.000199681	0.0000	0.0000		157700 [MVP (provisional) Mitral valve prolapse,myxomatous 1];																			0		0.2143	28	0.0000	32
chr16	29834711	29834711	A	G	0.1379	30	0.0000	30		60	MVP,PAGR1	intron_variant	MVP:ENST00000357402:intron_variant:MODIFIER:exon1/14:c.-36+2880A>G:,PAGR1:ENST00000562285:intron_variant:MODIFIER:exon2/2:c.*148+3488A>G:,MVP:ENST00000563915:intron_variant:MODIFIER:exon1/5:c.-77+2880A>G:,MVP:ENST00000566859:intron_variant:MODIFIER:exon1/4:c.-36+2880A>G:,MVP:ENST00000452209:intron_variant:MODIFIER:exon1/6:c.-85+2880A>G:,MVP:ENST00000563096:intron_variant:MODIFIER:exon1/1:n.45+2880A>G:,MVP:ENST00000395353:intron_variant:MODIFIER:exon1/14:c.-77+2880A>G:,MVP:ENST00000566066:intron_variant:MODIFIER:exon1/3:c.-227-2552A>G:,MVP:ENST00000562463:intron_variant:MODIFIER:exon1/3:c.-36+2880A>G:,MVP:ENST00000563558:intron_variant:MODIFIER:exon1/4:c.-77+2880A>G:,MVP:ENST00000565830:intron_variant:MODIFIER:exon1/3:n.34+2880A>G:,MVP:ENST00000569887:intron_variant:MODIFIER:exon1/3:c.-36+2880A>G:,MVP:ENST00000565164:intron_variant:MODIFIER:exon1/1:c.-36+2017A>G:,MVP:ENST00000570234:intron_variant:MODIFIER:exon2/4:c.-36+734A>G:			Required for normal vault structure. Vaults are multi- subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo- cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases				0.0000	0.0000	0.0000		157700 [MVP (provisional) Mitral valve prolapse,myxomatous 1];																			0		0.1667	30	0.0000	30
chr16	31132545	31132545	A	G	0.2667	15	0.0000	21		52	KAT8	intron_variant	KAT8:ENST00000448516:intron_variant:MODIFIER:exon3/9:c.462+710A>G:,KAT8:ENST00000543774:intron_variant:MODIFIER:exon4/11:c.462+710A>G:,KAT8:ENST00000219797:intron_variant:MODIFIER:exon3/10:c.462+710A>G:			Histone acetyltransferase which may be involved in transcriptional activation. May influence the function of ATM. As part of the MSL complex it is involved in acetylation of nucleosomal histone H4 producing specifically H4K16ac. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. That activity is less specific than the one of the MSL complex				0.0000	0.0000	0.0000																					0		0.2667	15	0.0000	21
chr16	31134055	31134055	A	G	0.2857	14	0.0000	22		54	KAT8	intron_variant	KAT8:ENST00000448516:intron_variant:MODIFIER:exon3/9:c.462+2220A>G:,KAT8:ENST00000543774:intron_variant:MODIFIER:exon4/11:c.462+2220A>G:,KAT8:ENST00000219797:intron_variant:MODIFIER:exon3/10:c.462+2220A>G:			Histone acetyltransferase which may be involved in transcriptional activation. May influence the function of ATM. As part of the MSL complex it is involved in acetylation of nucleosomal histone H4 producing specifically H4K16ac. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. That activity is less specific than the one of the MSL complex				0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	22
chr16	31377941	31377941	A	G	0.2000	25	0.0444	45		52	ITGAX	intron_variant	ITGAX:ENST00000562522:intron_variant:MODIFIER:exon14/30:c.1710+3246A>G:,ITGAX:ENST00000268296:intron_variant:MODIFIER:exon14/29:c.1710+3246A>G:,ITGAX:ENST00000571644:intron_variant:MODIFIER:exon7/21:n.1731+3246A>G:		Regulation of actin cytoskeleton	Integrin alpha-X/beta-2 is a receptor for fibrinogen. It recognizes the sequence G-P-R in fibrinogen. It mediates cell-cell interaction during inflammatory responses. It is especially important in monocyte adhesion and chemotaxis	Dendritic cells in regulating TH1 and TH2 Development			0.0000	0.0000	0.0000																					0		0.2000	25	0.0444	45
chr16	53286793	53286793	C	A	0.0769	26	0.0000	23		55	CHD9	intron_variant	CHD9:ENST00000398510:intron_variant:MODIFIER:exon16/37:c.3862-1557C>A:,CHD9:ENST00000447540:intron_variant:MODIFIER:exon17/38:c.3862-1557C>A:,CHD9:ENST00000566029:intron_variant:MODIFIER:exon17/38:c.3862-1557C>A:,CHD9:ENST00000564845:intron_variant:MODIFIER:exon17/38:c.3862-1557C>A:,CHD9:ENST00000565803:intron_variant:MODIFIER:exon16/20:c.2440-1557C>A:,CHD9:ENST00000219084:intron_variant:MODIFIER:exon7/28:n.1399-1557C>A:,CHD9:ENST00000562806:intron_variant:MODIFIER:exon1/1:n.167-1557C>A:			Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Proposed to be a ATP-dependent chromatin remodeling protein. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis (By similarity)				0.0000	0.0000	0.0000																					0		0.0769	26	0.0000	23
chr16	57795341	57795341	A	C	0.0191	157	0.0000	140		52	KIFC3	missense_variant,sequence_feature	KIFC3:ENST00000541240:missense_variant:MODERATE:exon14/20:c.1922T>G:p.Val641Gly,KIFC3:ENST00000465878:missense_variant:MODERATE:exon14/20:c.1439T>G:p.Val480Gly,KIFC3:ENST00000379655:missense_variant:MODERATE:exon14/19:c.1856T>G:p.Val619Gly,KIFC3:ENST00000445690:missense_variant:MODERATE:exon14/20:c.1856T>G:p.Val619Gly,KIFC3:ENST00000421376:missense_variant:MODERATE:exon13/19:c.1439T>G:p.Val480Gly,KIFC3:ENST00000540079:missense_variant:MODERATE:exon12/18:c.1550T>G:p.Val517Gly,KIFC3:ENST00000543930:missense_variant:MODERATE:exon12/18:c.1430T>G:p.Val477Gly,KIFC3:ENST00000562903:missense_variant:MODERATE:exon15/21:c.1439T>G:p.Val480Gly,KIFC3:ENST00000564136:missense_variant:MODERATE:exon14/19:c.1439T>G:p.Val480Gly,KIFC3:ENST00000539578:missense_variant:MODERATE:exon14/20:c.1682T>G:p.Val561Gly,KIFC3:ENST00000565270:missense_variant:MODERATE:exon3/7:c.245T>G:p.Val82Gly,KIFC3:ENST00000541240:sequence_feature:LOW:exon14/20:c.1922T>G:,KIFC3:ENST00000379655:sequence_feature:LOW:exon14/19:c.1856T>G:,KIFC3:ENST00000445690:sequence_feature:LOW:exon14/20:c.1856T>G:	Kinesin__motor_domain__4_		Minus-end microtubule-dependent motor protein. Involved in apically targeted transport (By similarity). Required for zonula adherens maintenance				0.0000	0.0000	0.0000					6.940000	T	D,D,D,D,D,D,D	P,P,B,B,B,P,P	T,T,T,T,T,T,T	26.70											0		0.0186	161	0.0000	143
chr16	57817522	57817522	T	C	0.2667	15	0.0000	26		66	KIFC3	intron_variant	KIFC3:ENST00000541240:intron_variant:MODIFIER:exon3/19:c.382-11322A>G:,KIFC3:ENST00000465878:intron_variant:MODIFIER:exon3/19:c.-103+4965A>G:,KIFC3:ENST00000379655:intron_variant:MODIFIER:exon3/18:c.316-11322A>G:,KIFC3:ENST00000445690:intron_variant:MODIFIER:exon3/19:c.316-11322A>G:,KIFC3:ENST00000421376:intron_variant:MODIFIER:exon2/18:c.-102-11322A>G:,KIFC3:ENST00000539578:intron_variant:MODIFIER:exon3/19:c.141+1854A>G:,KIFC3:ENST00000565481:intron_variant:MODIFIER:exon3/6:c.-102-11322A>G:,KIFC3:ENST00000562503:intron_variant:MODIFIER:exon3/5:c.141+1854A>G:,KIFC3:ENST00000562311:intron_variant:MODIFIER:exon4/6:c.-103+4965A>G:,KIFC3:ENST00000569112:intron_variant:MODIFIER:exon3/5:c.-102-11322A>G:,KIFC3:ENST00000562984:intron_variant:MODIFIER:exon3/5:c.-102-11322A>G:,KIFC3:ENST00000567204:intron_variant:MODIFIER:exon2/3:n.324-11322A>G:,KIFC3:ENST00000566648:intron_variant:MODIFIER:exon3/4:c.400-11322A>G:,KIFC3:ENST00000561524:intron_variant:MODIFIER:exon3/4:c.141+1854A>G:,KIFC3:ENST00000566975:intron_variant:MODIFIER:exon3/4:n.488+7320A>G:,KIFC3:ENST00000565684:intron_variant:MODIFIER:exon3/4:c.316-11322A>G:			Minus-end microtubule-dependent motor protein. Involved in apically targeted transport (By similarity). Required for zonula adherens maintenance				0.0000	0.0000	0.0000																					0		0.2667	15	0.0000	26
chr16	57823745	57823745	T	C	0.2069	29	0.0000	30		73	KIFC3	intron_variant	KIFC3:ENST00000541240:intron_variant:MODIFIER:exon3/19:c.381+5166A>G:,KIFC3:ENST00000465878:intron_variant:MODIFIER:exon2/19:c.-241-1120A>G:,KIFC3:ENST00000379655:intron_variant:MODIFIER:exon3/18:c.315+5166A>G:,KIFC3:ENST00000445690:intron_variant:MODIFIER:exon3/19:c.315+5166A>G:,KIFC3:ENST00000421376:intron_variant:MODIFIER:exon2/18:c.-103+5166A>G:,KIFC3:ENST00000539578:intron_variant:MODIFIER:exon2/19:c.-62-4167A>G:,KIFC3:ENST00000565481:intron_variant:MODIFIER:exon3/6:c.-103+5166A>G:,KIFC3:ENST00000562503:intron_variant:MODIFIER:exon2/5:c.-62-4167A>G:,KIFC3:ENST00000562311:intron_variant:MODIFIER:exon3/6:c.-241-1120A>G:,KIFC3:ENST00000569112:intron_variant:MODIFIER:exon3/5:c.-103+5166A>G:,KIFC3:ENST00000562984:intron_variant:MODIFIER:exon3/5:c.-103+5166A>G:,KIFC3:ENST00000567204:intron_variant:MODIFIER:exon2/3:n.323+8239A>G:,KIFC3:ENST00000566648:intron_variant:MODIFIER:exon3/4:c.399+5166A>G:,KIFC3:ENST00000561524:intron_variant:MODIFIER:exon2/4:c.-62-4167A>G:,KIFC3:ENST00000566975:intron_variant:MODIFIER:exon3/4:n.488+1097A>G:,KIFC3:ENST00000565684:intron_variant:MODIFIER:exon3/4:c.315+5166A>G:,KIFC3:ENST00000566914:intron_variant:MODIFIER:exon3/3:n.456-4167A>G:,KIFC3:ENST00000567059:intron_variant:MODIFIER:exon3/3:c.382-1120A>G:			Minus-end microtubule-dependent motor protein. Involved in apically targeted transport (By similarity). Required for zonula adherens maintenance				0.0000	0.0000	0.0000																					0		0.2069	29	0.0000	30
chr16	69723527	69723527	A	G	0.3462	26	0.0233	43		80	NFAT5	intron_variant	NFAT5:ENST00000432919:intron_variant:MODIFIER:exon11/14:c.1775-1316A>G:,NFAT5:ENST00000349945:intron_variant:MODIFIER:exon12/15:c.1493-1316A>G:,NFAT5:ENST00000426654:intron_variant:MODIFIER:exon12/15:c.*1537-1316A>G:,NFAT5:ENST00000354436:intron_variant:MODIFIER:exon10/13:c.1721-1316A>G:,NFAT5:ENST00000567239:intron_variant:MODIFIER:exon11/14:c.1772-1316A>G:,NFAT5:ENST00000393742:intron_variant:MODIFIER:exon11/14:c.1493-1316A>G:,NFAT5:ENST00000566899:intron_variant:MODIFIER:exon11/13:c.1493-1316A>G:,NFAT5:ENST00000565301:intron_variant:MODIFIER:exon1/3:c.37-4462A>G:,NFAT5:ENST00000562429:intron_variant:MODIFIER:exon2/2:n.526-1316A>G:		Wnt signaling pathway;Axon guidance;VEGF signaling pathway;Natural killer cell mediated cytotoxicity;T cell receptor signaling pathway;B cell receptor signaling pathway	Plays a role in the inducible expression of genes. Regulates hypertonicity-induced cellular accumulation of osmolytes				0.0000	0.0000	0.0000																					0		0.3462	26	0.0233	43
chr16	70406992	70406992	A	G	0.1429	21	0.0000	30		49	DDX19A	3_prime_UTR_variant,non_coding_transcript_exon_variant	DDX19A:ENST00000302243:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1103A>G:,DDX19A:ENST00000569771:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2276A>G:,DDX19A:ENST00000566574:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.4720A>G:		Starch and sucrose metabolism;Folate biosynthesis	ATP-dependent RNA helicase involved in mRNA export from the nucleus. Rather than unwinding RNA duplexes, DDX19 functions as a remodeler of ribonucleoprotein particles, whereby proteins bound to nuclear mRNA are dissociated and replaced by cytoplasmic mRNA binding proteins (By similarity)				0.0000	0.0000	0.0000																					0		0.1429	21	0.0000	30
chr16	79631924	79631924	C	T	0.1667	26	0.0000	33		63	MAF	3_prime_UTR_variant,intron_variant	MAF:ENST00000393350:3_prime_UTR_variant:MODIFIER:exon1/1:c.*754G>A:,MAF:ENST00000326043:intron_variant:MODIFIER:exon1/1:c.1118+758G>A:,MAF:ENST00000569649:intron_variant:MODIFIER:exon1/1:c.1118+758G>A:			Acts as a transcriptional activator or repressor. Involved in embryonic lens fiber cell development. Recruits the transcriptional coactivators CREBBP and/or EP300 to crystallin promoters leading to up-regulation of crystallin gene during lens fiber cell differentiation. Activates the expression of IL4 in T helper 2 (Th2) cells. Increases T-cell susceptibility to apoptosis by interacting with MYB and decreasing BCL2 expression. Together with PAX6, transactivates strongly the glucagon gene promoter through the G1 element. Activates transcription of the CD13 proximal promoter in endothelial cells. Represses transcription of the CD13 promoter in early stages of myelopoiesis by affecting the ETS1 and MYB cooperative interaction. Involved in the initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. Binds to the sequence 5'-[GT]G[GC]N[GT]NCTCAGNN-3' in the L7 promoter. Binds to the T-MARE (Maf response element) sites of lens-specific alpha- and beta-crystallin gene promoters. Binds element G1 on the glucagon promoter. Binds an AT-rich region adjacent to the TGC motif (atypical Maf response element) in the CD13 proximal promoter in endothelial cells (By similarity). When overexpressed, represses anti-oxidant response element (ARE)- mediated transcription. Involved either as an oncogene or as a tumor suppressor, depending on the cell context. Binds to the ARE sites of detoxifying enzyme gene promoters	GATA3 participate in activating the Th2 cytokine genes expression			0.0000	0.0000	0.0000		177075 [MAF (provisional) Cataract 21,multiple types,610202|Ayme-Gripp syndrome,601088];																			0		0.1600	25	0.0000	31
chr16	82107036	82107036	A	G	0.1282	39	0.0000	16		59	HSD17B2,RP11-510J16.5	intron_variant	HSD17B2:ENST00000199936:intron_variant:MODIFIER:exon3/4:c.664+2304A>G:,RP11-510J16.5:ENST00000567021:intron_variant:MODIFIER:exon1/3:n.44-2242T>C:,HSD17B2:ENST00000568090:intron_variant:MODIFIER:exon3/4:c.256+2304A>G:,HSD17B2:ENST00000566838:intron_variant:MODIFIER:exon2/2:c.292+2304A>G:		Androgen and estrogen metabolism	Capable of catalyzing the interconversion of testosterone and androstenedione, as well as estradiol and estrone. Also has 20-alpha-HSD activity. Uses NADH while EDH17B3 uses NADPH				0.0000	0.0000	0.0000																					0		0.1282	39	0.0000	16
chr16	89472418	89472418	T	C	0.2500	16	0.0000	26		66	ANKRD11,RP1-168P16.2	intron_variant	ANKRD11:ENST00000301030:intron_variant:MODIFIER:exon2/12:c.-60+12274A>G:,RP1-168P16.2:ENST00000562211:intron_variant:MODIFIER:exon1/1:n.115+6440A>G:,ANKRD11:ENST00000378330:intron_variant:MODIFIER:exon3/13:c.-60+12274A>G:,ANKRD11:ENST00000378332:intron_variant:MODIFIER:exon2/9:c.-60+12274A>G:,ANKRD11:ENST00000562816:intron_variant:MODIFIER:exon2/4:n.241+12274A>G:,ANKRD11:ENST00000568512:intron_variant:MODIFIER:exon2/2:n.134+12274A>G:,ANKRD11:ENST00000566973:intron_variant:MODIFIER:exon2/2:n.161+12274A>G:			May recruit HDACs to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation				0.0000	0.0000	0.0000		611192 [ANKRD11 (provisional) KBG syndrome,148050];																			0		0.2500	16	0.0000	26
chr16	89482124	89482124	T	C	0.2258	33	0.0556	55		56	ANKRD11	intron_variant	ANKRD11:ENST00000301030:intron_variant:MODIFIER:exon2/12:c.-60+2568A>G:,ANKRD11:ENST00000378330:intron_variant:MODIFIER:exon3/13:c.-60+2568A>G:,ANKRD11:ENST00000378332:intron_variant:MODIFIER:exon2/9:c.-60+2568A>G:,ANKRD11:ENST00000562816:intron_variant:MODIFIER:exon2/4:n.241+2568A>G:,ANKRD11:ENST00000568512:intron_variant:MODIFIER:exon2/2:n.134+2568A>G:,ANKRD11:ENST00000566973:intron_variant:MODIFIER:exon2/2:n.161+2568A>G:			May recruit HDACs to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation				0.0000	0.0000	0.0000		611192 [ANKRD11 (provisional) KBG syndrome,148050];																			0		0.2368	38	0.0526	57
chr17	1291747	1291747	T	C	0.1481	27	0.0000	20		59	YWHAE	intron_variant	YWHAE:ENST00000264335:intron_variant:MODIFIER:exon1/5:c.64+11594A>G:,YWHAE:ENST00000571732:intron_variant:MODIFIER:exon1/6:c.-36+11594A>G:,YWHAE:ENST00000573026:intron_variant:MODIFIER:exon1/1:c.64+11594A>G:,YWHAE:ENST00000573196:intron_variant:MODIFIER:exon1/3:c.64+11594A>G:,YWHAE:ENST00000575977:intron_variant:MODIFIER:exon1/2:c.64+11594A>G:,YWHAE:ENST00000469398:intron_variant:MODIFIER:exon1/3:n.105+11594A>G:,YWHAE:ENST00000486241:intron_variant:MODIFIER:exon1/2:n.163+11594A>G:,YWHAE:ENST00000489287:intron_variant:MODIFIER:exon1/1:n.154+11594A>G:		Cell cycle	Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner				0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	20
chr17	1941600	1941600	A	G	0.1250	32	0.0000	26		58	DPH1	intron_variant	DPH1:ENST00000263083:intron_variant:MODIFIER:exon6/12:c.695+1350A>G:,DPH1:ENST00000571418:intron_variant:MODIFIER:exon6/12:c.656+1350A>G:,DPH1:ENST00000575667:intron_variant:MODIFIER:exon5/11:c.567+1350A>G:,DPH1:ENST00000570477:intron_variant:MODIFIER:exon5/11:c.455+1350A>G:,DPH1:ENST00000570833:intron_variant:MODIFIER:exon4/4:c.*375+1350A>G:,DPH1:ENST00000572214:intron_variant:MODIFIER:exon1/6:n.62+1350A>G:			Required for the first step in the synthesis of diphthamide, a post-translational modification of histidine which occurs in translation elongation factor 2 (EEF2). When overexpressed, suppresses colony formation ability and growth rate of ovarian cancer cells. Acts also as a tumor suppressor in lung and breast cancers (By similarity). Plays a role in embryonic growth, organogenesis and postnatal survival (By similarity)				0.0000	0.0000	0.0000		603527 [DPH1 (provisional) Developmental delay with short stature,dysmorphic features,and sparse hair,616901];																			0		0.1250	32	0.0000	26
chr17	2507149	2507149	A	G	0.3750	8	0.0000	19		40	PAFAH1B1	intron_variant	PAFAH1B1:ENST00000397195:intron_variant:MODIFIER:exon1/10:c.-191+9849A>G:,PAFAH1B1:ENST00000576586:intron_variant:MODIFIER:exon1/4:c.-191+10525A>G:,PAFAH1B1:ENST00000575477:intron_variant:MODIFIER:exon1/3:n.193-9803A>G:,PAFAH1B1:ENST00000572915:intron_variant:MODIFIER:exon1/7:n.50+9849A>G:,PAFAH1B1:ENST00000570400:intron_variant:MODIFIER:exon1/4:c.-319+9849A>G:,PAFAH1B1:ENST00000571289:intron_variant:MODIFIER:exon1/1:n.39+9849A>G:		Ether lipid metabolism	Required for proper activation of Rho GTPases and actin polymerization at the leading edge of locomoting cerebellar neurons and postmigratory hippocampal neurons in response to calcium influx triggered via NMDA receptors. Non-catalytic subunit of an acetylhydrolase complex which inactivates platelet- activating factor (PAF) by removing the acetyl group at the SN-2 position (By similarity). Positively regulates the activity of the minus-end directed microtubule motor protein dynein. May enhance dynein-mediated microtubule sliding by targeting dynein to the microtubule plus end. Required for several dynein- and microtubule-dependent processes such as the maintenance of Golgi integrity, the peripheral transport of microtubule fragments and the coupling of the nucleus and centrosome. Required during brain development for the proliferation of neuronal precursors and the migration of newly formed neurons from the ventricular/subventricular zone toward the cortical plate. Neuronal migration involves a process called nucleokinesis, whereby migrating cells extend an anterior process into which the nucleus subsequently translocates. During nucleokinesis dynein at the nuclear surface may translocate the nucleus towards the centrosome by exerting force on centrosomal microtubules. May also play a role in other forms of cell locomotion including the migration of fibroblasts during wound healing				0.0000	0.0000	0.0000		601545 [PAFAH1B1 (confirmed) Lissencephaly 1,607432|Subcortical laminar heterotopia,607432];																			0		0.3750	8	0.0000	19
chr17	2547564	2547564	A	G	0.5000	6	0.0000	19		42	PAFAH1B1	intron_variant	PAFAH1B1:ENST00000397195:intron_variant:MODIFIER:exon2/10:c.32+5950A>G:,PAFAH1B1:ENST00000576586:intron_variant:MODIFIER:exon2/4:c.32+5950A>G:,PAFAH1B1:ENST00000575477:intron_variant:MODIFIER:exon3/3:n.619+5950A>G:,PAFAH1B1:ENST00000572915:intron_variant:MODIFIER:exon2/7:n.272+5950A>G:,PAFAH1B1:ENST00000570400:intron_variant:MODIFIER:exon3/4:c.32+5950A>G:,PAFAH1B1:ENST00000574816:intron_variant:MODIFIER:exon1/3:n.31-32044A>G:		Ether lipid metabolism	Required for proper activation of Rho GTPases and actin polymerization at the leading edge of locomoting cerebellar neurons and postmigratory hippocampal neurons in response to calcium influx triggered via NMDA receptors. Non-catalytic subunit of an acetylhydrolase complex which inactivates platelet- activating factor (PAF) by removing the acetyl group at the SN-2 position (By similarity). Positively regulates the activity of the minus-end directed microtubule motor protein dynein. May enhance dynein-mediated microtubule sliding by targeting dynein to the microtubule plus end. Required for several dynein- and microtubule-dependent processes such as the maintenance of Golgi integrity, the peripheral transport of microtubule fragments and the coupling of the nucleus and centrosome. Required during brain development for the proliferation of neuronal precursors and the migration of newly formed neurons from the ventricular/subventricular zone toward the cortical plate. Neuronal migration involves a process called nucleokinesis, whereby migrating cells extend an anterior process into which the nucleus subsequently translocates. During nucleokinesis dynein at the nuclear surface may translocate the nucleus towards the centrosome by exerting force on centrosomal microtubules. May also play a role in other forms of cell locomotion including the migration of fibroblasts during wound healing				0.0000	0.0000	0.0000		601545 [PAFAH1B1 (confirmed) Lissencephaly 1,607432|Subcortical laminar heterotopia,607432];																			0		0.5000	6	0.0000	19
chr17	4165629	4165629	T	C	0.3750	8	0.0000	16		33	ANKFY1	intron_variant	ANKFY1:ENST00000570535:intron_variant:MODIFIER:exon1/24:c.136+1261A>G:,ANKFY1:ENST00000341657:intron_variant:MODIFIER:exon1/24:c.10+1598A>G:,ANKFY1:ENST00000574367:intron_variant:MODIFIER:exon1/24:c.10+1598A>G:,ANKFY1:ENST00000572412:intron_variant:MODIFIER:exon1/23:c.10+1598A>G:,ANKFY1:ENST00000433651:intron_variant:MODIFIER:exon1/9:c.10+1598A>G:,ANKFY1:ENST00000575955:intron_variant:MODIFIER:exon1/3:n.34+1598A>G:							0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	16
chr17	4928430	4928430	A	G	0.1667	24	0.0000	26		61	KIF1C	3_prime_UTR_variant	KIF1C:ENST00000320785:3_prime_UTR_variant:MODIFIER:exon23/23:c.*984A>G:			Motor required for the retrograde transport of Golgi vesicles to the endoplasmic reticulum. Has a microtubule plus end- directed motility				0.0000	0.0000	0.0000		603060 [KIF1C (provisional) Spastic ataxia 2,autosomal recessive,611302];																			0		0.1667	24	0.0000	26
chr17	5196375	5196375	A	G	0.1818	22	0.0000	29		53	RABEP1	intron_variant	RABEP1:ENST00000262477:intron_variant:MODIFIER:exon1/18:c.34+10560A>G:,RABEP1:ENST00000408982:intron_variant:MODIFIER:exon1/17:c.34+10560A>G:,RABEP1:ENST00000575991:intron_variant:MODIFIER:exon2/2:c.220+9011A>G:,RABEP1:ENST00000537505:intron_variant:MODIFIER:exon1/16:c.34+10560A>G:,RABEP1:ENST00000546142:intron_variant:MODIFIER:exon1/17:c.34+10560A>G:,RABEP1:ENST00000575475:intron_variant:MODIFIER:exon1/13:n.199+10560A>G:,RABEP1:ENST00000341923:intron_variant:MODIFIER:exon1/16:c.34+10560A>G:			Rab effector protein acting as linker between gamma- adaptin, RAB4A and RAB5A. Involved in endocytic membrane fusion and membrane trafficking of recycling endosomes. Stimulates RABGEF1 mediated nucleotide exchange on RAB5A				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	29
chr17	7395766	7395766	A	G	0.4545	11	0.0000	21		47	POLR2A	intron_variant	POLR2A:ENST00000322644:intron_variant:MODIFIER:exon1/28:c.94-3494A>G:,POLR2A:ENST00000572844:intron_variant:MODIFIER:exon1/9:c.94-3494A>G:		Purine metabolism;Pyrimidine metabolism;RNA polymerase	DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Forms the polymerase active center together with the second largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol II. A bridging helix emanates from RPB1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol II by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition. During transcription elongation, Pol II moves on the template as the transcript elongates. Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II largest subunit (RPB1), which serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing. Acts as a RNA- dependent RNA polymerase when associated with small delta antigen of Hepatitis delta virus, acting both as a replicate and transcriptase for the viral RNA circular genome	Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells;Repression of Pain Sensation by the Transcriptional Regulator DREAM;Telomeres, Telomerase, Cellular Aging, and  Immortality;The information-processing pathway at the IFN-beta enhancer			0.0000	0.0000	0.0000																					0		0.4545	11	0.0000	21
chr17	15955143	15955143	T	C	0.3846	13	0.0000	18		39	NCOR1	sequence_feature,intron_variant	NCOR1:ENST00000268712:sequence_feature:MODERATE::c.6393-2841A>G:,NCOR1:ENST00000395851:sequence_feature:MODERATE::c.6084-2841A>G:,NCOR1:ENST00000268712:intron_variant:MODIFIER:exon40/45:c.6393-2841A>G:,NCOR1:ENST00000464381:intron_variant:MODIFIER:exon2/7:n.655-2841A>G:,NCOR1:ENST00000470782:intron_variant:MODIFIER:exon9/14:n.2168-2841A>G:,NCOR1:ENST00000395851:intron_variant:MODIFIER:exon39/44:c.6084-2841A>G:,NCOR1:ENST00000395849:intron_variant:MODIFIER:exon11/16:c.2283-2841A>G:,NCOR1:ENST00000395857:intron_variant:MODIFIER:exon11/16:c.2145-2841A>G:,NCOR1:ENST00000580554:intron_variant:MODIFIER:exon1/4:c.210-2841A>G:,NCOR1:ENST00000579606:intron_variant:MODIFIER:exon1/3:c.216-2844A>G:,NCOR1:ENST00000458113:intron_variant:MODIFIER:exon16/17:n.3153-2841A>G:		Huntington's disease	Mediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors	Control of Gene Expression by Vitamin D Receptor;Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)			0.0000	0.0000	0.0000																					0		0.3846	13	0.0000	18
chr17	27598472	27598472	T	C	0.2381	21	0.0000	25		61	NUFIP2	intron_variant	NUFIP2:ENST00000225388:intron_variant:MODIFIER:exon2/3:c.2003-3924A>G:,NUFIP2:ENST00000579665:intron_variant:MODIFIER:exon1/2:c.278-3924A>G:			Binds RNA				0.0000	0.0000	0.0000																					0		0.2381	21	0.0385	26
chr17	27777205	27777205	A	G	0.3750	8	0.0000	17		36	TAOK1	intron_variant	TAOK1:ENST00000261716:intron_variant:MODIFIER:exon1/19:c.-94-1268A>G:,TAOK1:ENST00000583121:intron_variant:MODIFIER:exon2/4:c.-94-1268A>G:,TAOK1:ENST00000587277:intron_variant:MODIFIER:exon1/1:n.101-1268A>G:,TAOK1:ENST00000536202:intron_variant:MODIFIER:exon1/17:c.-94-1268A>G:		MAPK signaling pathway	Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	17
chr17	28080217	28080217	T	C	0.2105	19	0.0513	39		53	SSH2	sequence_feature,intron_variant	SSH2:ENST00000269033:sequence_feature:MODERATE::c.107+40695A>G:,SSH2:ENST00000540801:intron_variant:MODIFIER:exon3/15:c.188+40695A>G:,SSH2:ENST00000269033:intron_variant:MODIFIER:exon2/14:c.107+40695A>G:,SSH2:ENST00000394848:intron_variant:MODIFIER:exon2/12:n.107+40695A>G:,SSH2:ENST00000579040:intron_variant:MODIFIER:exon2/7:c.107+40695A>G:,SSH2:ENST00000324677:intron_variant:MODIFIER:exon1/6:n.241+7951A>G:,SSH2:ENST00000577483:intron_variant:MODIFIER:exon2/6:n.214+40695A>G:,SSH2:ENST00000592397:intron_variant:MODIFIER:exon2/5:c.47+40695A>G:		Regulation of actin cytoskeleton	Protein phosphatase which regulates actin filament dynamics. Dephosphorylates and activates the actin binding/depolymerizing factor cofilin, which subsequently binds to actin filaments and stimulates their disassembly. Inhibitory phosphorylation of cofilin is mediated by LIMK1, which may also be dephosphorylated and inactivated by this protein				0.0000	0.0000	0.0000																					0		0.2105	19	0.0513	39
chr17	34874523	34874523	T	C	0.3846	13	0.0000	18		39	MYO19	intron_variant	MYO19:ENST00000431794:intron_variant:MODIFIER:exon6/25:c.415-2690A>G:,MYO19:ENST00000586908:intron_variant:MODIFIER:exon6/26:c.415-2690A>G:,MYO19:ENST00000591794:intron_variant:MODIFIER:exon6/18:c.415-2690A>G:,MYO19:ENST00000268852:intron_variant:MODIFIER:exon6/21:c.415-2690A>G:,MYO19:ENST00000586007:intron_variant:MODIFIER:exon6/10:c.415-2690A>G:,MYO19:ENST00000544606:intron_variant:MODIFIER:exon3/7:c.13-2690A>G:,MYO19:ENST00000585719:intron_variant:MODIFIER:exon6/6:c.415-2690A>G:,MYO19:ENST00000589404:intron_variant:MODIFIER:exon5/5:c.415-2690A>G:			Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. MYO19 is involved in mitochondrial motility				0.0000	0.0000	0.0000																					0		0.3846	13	0.0000	18
chr17	35974172	35974172	T	C	0.0789	39	0.0000	27		51	DDX52	3_prime_UTR_variant,non_coding_transcript_exon_variant	DDX52:ENST00000349699:3_prime_UTR_variant:MODIFIER:exon15/15:c.*169A>G:,DDX52:ENST00000591354:3_prime_UTR_variant:MODIFIER:exon5/6:c.*169A>G:,DDX52:ENST00000394367:3_prime_UTR_variant:MODIFIER:exon16/16:c.*169A>G:,DDX52:ENST00000488402:3_prime_UTR_variant:MODIFIER:exon16/16:c.*1745A>G:,DDX52:ENST00000592520:non_coding_transcript_exon_variant:MODIFIER:exon13/13:n.3178A>G:		Starch and sucrose metabolism;Folate biosynthesis					0.0000	0.0000	0.0000																					0		0.0769	39	0.0000	26
chr17	40470082	40470082	T	C	0.1591	44	0.0000	55		79	STAT3	sequence_feature,intron_variant	STAT3:ENST00000264657:sequence_feature:MODERATE::c.2102-840A>G:,STAT3:ENST00000585517:sequence_feature:MODERATE::c.2102-840A>G:,STAT3:ENST00000264657:intron_variant:MODIFIER:exon21/23:c.2102-840A>G:,STAT3:ENST00000585517:intron_variant:MODIFIER:exon21/23:c.2102-840A>G:,STAT3:ENST00000389272:intron_variant:MODIFIER:exon20/22:c.1808-840A>G:,STAT3:ENST00000588969:intron_variant:MODIFIER:exon21/23:c.2102-840A>G:,STAT3:ENST00000404395:intron_variant:MODIFIER:exon21/23:c.2099-840A>G:		Jak-STAT signaling pathway;Adipocytokine signaling pathway;Pancreatic cancer;Acute myeloid leukemia	Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF and other growth factors. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the interleukin-6 (IL-6)- responsive elements identified in the promoters of various acute- phase protein genes. Activated by IL31 through IL31RA. Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity. Plays an important role in host defense in methicillin-resistant S.aureus lung infection by regulating the expression of the antimicrobial lectin REG3G (By similarity)	Bioactive Peptide Induced Signaling Pathway;EGF Signaling Pathway;Erk1/Erk2 Mapk Signaling pathway;IL 6 signaling pathway;IL-10 Anti-inflammatory Signaling Pathway;IL22 Soluble Receptor Signaling Pathway ;PDGF Signaling Pathway;Role of ERBB2 in Signal Transduction and Oncology;Signaling of Hepatocyte Growth Factor Receptor;Stat3 Signaling Pathway;TPO Signaling Pathway			0.0000	0.0000	0.0000		102582 [STAT3 (provisional) Hyper-IgE recurrent infection syndrome,147060|Autoimmune disease,multisystem,infantile-onset,1,615952];																			0		0.1591	44	0.0000	55
chr17	40501024	40501024	T	C	0.1818	22	0.0000	24		62	STAT3	intron_variant	STAT3:ENST00000264657:intron_variant:MODIFIER:exon1/23:c.-23-467A>G:,STAT3:ENST00000585517:intron_variant:MODIFIER:exon1/23:c.-4-486A>G:,STAT3:ENST00000389272:intron_variant:MODIFIER:exon1/22:c.-166-2293A>G:,STAT3:ENST00000588969:intron_variant:MODIFIER:exon1/23:c.-1-489A>G:,STAT3:ENST00000404395:intron_variant:MODIFIER:exon1/23:c.-1-489A>G:,STAT3:ENST00000588065:intron_variant:MODIFIER:exon2/3:c.6-489A>G:		Jak-STAT signaling pathway;Adipocytokine signaling pathway;Pancreatic cancer;Acute myeloid leukemia	Signal transducer and transcription activator that mediates cellular responses to interleukins, KITLG/SCF and other growth factors. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the interleukin-6 (IL-6)- responsive elements identified in the promoters of various acute- phase protein genes. Activated by IL31 through IL31RA. Cytoplasmic STAT3 represses macroautophagy by inhibiting EIF2AK2/PKR activity. Plays an important role in host defense in methicillin-resistant S.aureus lung infection by regulating the expression of the antimicrobial lectin REG3G (By similarity)	Bioactive Peptide Induced Signaling Pathway;EGF Signaling Pathway;Erk1/Erk2 Mapk Signaling pathway;IL 6 signaling pathway;IL-10 Anti-inflammatory Signaling Pathway;IL22 Soluble Receptor Signaling Pathway ;PDGF Signaling Pathway;Role of ERBB2 in Signal Transduction and Oncology;Signaling of Hepatocyte Growth Factor Receptor;Stat3 Signaling Pathway;TPO Signaling Pathway			0.0000	0.0000	0.0000		102582 [STAT3 (provisional) Hyper-IgE recurrent infection syndrome,147060|Autoimmune disease,multisystem,infantile-onset,1,615952];																			0		0.1818	22	0.0000	24
chr17	41372229	41372229	A	G	0.2308	26	0.0000	36		78	LINC00854	intron_variant	LINC00854:ENST00000427995:intron_variant:MODIFIER:exon3/3:n.578+1230T>C:,LINC00854:ENST00000593624:intron_variant:MODIFIER:exon3/3:n.520-938T>C:,LINC00854:ENST00000595400:intron_variant:MODIFIER:exon3/3:n.569-938T>C:							0.0000	0.0000	0.0000																					0		0.2308	26	0.0000	36
chr17	42523741	42523741	T	C	0.2105	19	0.0000	25		62	GPATCH8	intron_variant	GPATCH8:ENST00000591680:intron_variant:MODIFIER:exon3/7:c.194-9828A>G:,GPATCH8:ENST00000335500:intron_variant:MODIFIER:exon1/6:n.1465-7658A>G:,GPATCH8:ENST00000434000:intron_variant:MODIFIER:exon4/8:c.-41-9828A>G:,GPATCH8:ENST00000587228:intron_variant:MODIFIER:exon4/8:c.*80-9828A>G:,GPATCH8:ENST00000585614:intron_variant:MODIFIER:exon2/6:c.119-9828A>G:,GPATCH8:ENST00000590041:intron_variant:MODIFIER:exon5/9:c.*194-9828A>G:,GPATCH8:ENST00000592746:intron_variant:MODIFIER:exon4/6:c.*88-7658A>G:,GPATCH8:ENST00000586037:intron_variant:MODIFIER:exon4/5:c.*88-7658A>G:							0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	26
chr17	42529418	42529418	T	C	0.1481	27	0.0000	25		58	GPATCH8	intron_variant	GPATCH8:ENST00000591680:intron_variant:MODIFIER:exon3/7:c.193+12422A>G:,GPATCH8:ENST00000335500:intron_variant:MODIFIER:exon1/6:n.1464+12422A>G:,GPATCH8:ENST00000434000:intron_variant:MODIFIER:exon4/8:c.-42+12422A>G:,GPATCH8:ENST00000587228:intron_variant:MODIFIER:exon4/8:c.*79+12422A>G:,GPATCH8:ENST00000585614:intron_variant:MODIFIER:exon2/6:c.118+12422A>G:,GPATCH8:ENST00000590041:intron_variant:MODIFIER:exon5/9:c.*193+12422A>G:,GPATCH8:ENST00000592746:intron_variant:MODIFIER:exon4/6:c.*87+12422A>G:,GPATCH8:ENST00000586037:intron_variant:MODIFIER:exon4/5:c.*87+12422A>G:							0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	25
chr17	43651629	43651629	T	C	0.1765	34	0.0000	24		67	RP11-798G7.6-DND1P1	intergenic_region	RP11-798G7.6-DND1P1:ENSG00000267198-ENSG00000264070:intergenic_region:MODIFIER::n.43651629T>C:							0.0000	0.0000	0.0000																					0		0.1765	34	0.0000	24
chr17	44243522	44243522	T	C	0.2500	24	0.0000	25		68	KANSL1	intron_variant	KANSL1:ENST00000262419:intron_variant:MODIFIER:exon2/14:c.1289+4699A>G:,KANSL1:ENST00000574590:intron_variant:MODIFIER:exon2/14:c.1289+4699A>G:,KANSL1:ENST00000575318:intron_variant:MODIFIER:exon1/12:c.1289+4699A>G:,KANSL1:ENST00000572904:intron_variant:MODIFIER:exon2/14:c.1289+4699A>G:,KANSL1:ENST00000432791:intron_variant:MODIFIER:exon1/13:c.1289+4699A>G:,KANSL1:ENST00000393476:intron_variant:MODIFIER:exon2/13:c.-641+4699A>G:,KANSL1:ENST00000577114:intron_variant:MODIFIER:exon1/5:n.86+4699A>G:,KANSL1:ENST00000576248:intron_variant:MODIFIER:exon1/1:n.265+4699A>G:			As part of the NSL complex it is involved in acetylation of nucleosomal histone H4 on several lysine residues and therefore may be involved in the regulation of transcription				0.0000	0.0000	0.0000		612452 [KANSL1 (provisional) Koolen-De Vries syndrome,610443];																			0		0.2500	24	0.0000	25
chr17	44580533	44580533	A	G	0.3750	16	0.0000	18		38	NSFP1-RP11-995C19.2	intergenic_region	NSFP1-RP11-995C19.2:ENSG00000260075-ENSG00000266497:intergenic_region:MODIFIER::n.44580533A>G:						rs2684556	0.482228	0.0000	0.0000																					0		0.4118	17	0.0000	18
chr17	44596608	44596608	A	G	0.1714	35	0.0000	26		65	LRRC37A2,ARL17A	intron_variant	LRRC37A2:ENST00000333412:intron_variant:MODIFIER:exon2/13:c.2682-970A>G:,ARL17A:ENST00000337845:intron_variant:MODIFIER:exon4/5:c.526-2009T>C:,LRRC37A2:ENST00000576629:intron_variant:MODIFIER:exon3/14:c.2682-970A>G:,ARL17A:ENST00000445552:intron_variant:MODIFIER:exon3/4:c.260-2009T>C:,ARL17A:ENST00000329240:intron_variant:MODIFIER:exon3/3:c.260-2009T>C:			GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP- ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus (By similarity)				0.0000	0.0000	0.0000																					0		0.1622	37	0.0345	29
chr17	44607538	44607538	T	C	0.4000	15	0.0000	19		41	LRRC37A2,ARL17A	intron_variant	LRRC37A2:ENST00000333412:intron_variant:MODIFIER:exon5/13:c.2906+6288T>C:,ARL17A:ENST00000337845:intron_variant:MODIFIER:exon4/5:c.526-12939A>G:,LRRC37A2:ENST00000576629:intron_variant:MODIFIER:exon6/14:c.2906+6288T>C:,ARL17A:ENST00000445552:intron_variant:MODIFIER:exon3/4:c.260-12939A>G:,ARL17A:ENST00000329240:intron_variant:MODIFIER:exon3/3:c.260-12939A>G:			GTP-binding protein that functions as an allosteric activator of the cholera toxin catalytic subunit, an ADP- ribosyltransferase. Involved in protein trafficking; may modulate vesicle budding and uncoating within the Golgi apparatus (By similarity)				0.0000	0.0000	0.0000																					0		0.2727	22	0.0714	28
chr17	46935821	46935821	A	G	0.4615	13	0.0000	18		38	CALCOCO2	intron_variant	CALCOCO2:ENST00000448105:intron_variant:MODIFIER:exon11/13:c.1081-1855A>G:,CALCOCO2:ENST00000258947:intron_variant:MODIFIER:exon10/12:c.1009-1855A>G:,CALCOCO2:ENST00000509507:intron_variant:MODIFIER:exon11/13:c.1072-1855A>G:,CALCOCO2:ENST00000416445:intron_variant:MODIFIER:exon9/11:c.883-1855A>G:,CALCOCO2:ENST00000508679:intron_variant:MODIFIER:exon9/11:c.793-1855A>G:,CALCOCO2:ENST00000506971:intron_variant:MODIFIER:exon3/3:n.473-1855A>G:,CALCOCO2:ENST00000507306:intron_variant:MODIFIER:exon2/3:c.147+2272A>G:,CALCOCO2:ENST00000509784:intron_variant:MODIFIER:exon2/4:c.125+1843A>G:			May play a role in ruffle formation and actin cytoskeleton organization. Seems to negatively regulate constitutive secretion				0.0000	0.0000	0.0000																					0		0.4615	13	0.0000	18
chr17	47412064	47412064	T	C	0.3750	8	0.0000	17		36	ZNF652	intron_variant	ZNF652:ENST00000362063:intron_variant:MODIFIER:exon1/5:c.-258-16719A>G:,ZNF652:ENST00000508237:intron_variant:MODIFIER:exon1/7:c.-382-12194A>G:,ZNF652:ENST00000430262:intron_variant:MODIFIER:exon1/5:c.-258-16719A>G:			Functions as a transcriptional repressor				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	17
chr17	48768915	48768915	-	T	0.0479	159	0.0000	115		51	ABCC3	3_prime_UTR_variant,non_coding_transcript_exon_variant	ABCC3:ENST00000285238:3_prime_UTR_variant:MODIFIER:exon31/31:c.*360dupT:,ABCC3:ENST00000502426:3_prime_UTR_variant:MODIFIER:exon30/30:c.*3615dupT:,ABCC3:ENST00000505699:3_prime_UTR_variant:MODIFIER:exon30/30:c.*1376dupT:,ABCC3:ENST00000503337:non_coding_transcript_exon_variant:MODIFIER:exon6/6:n.2138dupT:		ABC transporters	May act as an inducible transporter in the biliary and intestinal excretion of organic anions. Acts as an alternative route for the export of bile acids and glucuronides from cholestatic hepatocytes (By similarity)	Multi-Drug Resistance Factors;Nuclear Receptors in Lipid Metabolism and Toxicity			0.0000	0.0000	0.0000																					0		0.0455	154	0.0000	121
chr17	49077050	49077050	C	T	0.0952	64	0.0000	64		56	SPAG9	missense_variant,non_coding_transcript_exon_variant	SPAG9:ENST00000262013:missense_variant:MODERATE:exon14/30:c.1636G>A:p.Glu546Lys,SPAG9:ENST00000510283:missense_variant:MODERATE:exon10/27:c.1165G>A:p.Glu389Lys,SPAG9:ENST00000505279:missense_variant:MODERATE:exon13/30:c.1594G>A:p.Glu532Lys,SPAG9:ENST00000357122:missense_variant:MODERATE:exon13/29:c.1594G>A:p.Glu532Lys,SPAG9:ENST00000514613:non_coding_transcript_exon_variant:MODIFIER:exon12/19:n.1209G>A:,SPAG9:ENST00000505173:non_coding_transcript_exon_variant:MODIFIER:exon12/19:n.1154G>A:,SPAG9:ENST00000513827:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.60G>A:,SPAG9:ENST00000515685:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.59G>A:			The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Isoform 5 may play a role in spermatozoa-egg- interaction				0.0000	0.0000	0.00000					6.984000	T	T,T,T,T,T,T,T	B,P,B,B,B,B	T,T,T,T	24.30											0		0.0952	63	0.0000	62
chr17	57921604	57921604	A	G	0.1667	30	0.0000	29		68	VMP1-RNU6-450P	intergenic_region	VMP1-RNU6-450P:ENSG00000062716-ENSG00000201524:intergenic_region:MODIFIER::n.57921604A>G:							0.0000	0.0000	0.0000																					0		0.1667	30	0.0000	29
chr17	57952539	57952539	A	G	0.3846	13	0.0000	16		33	TUBD1	intron_variant	TUBD1:ENST00000325752:intron_variant:MODIFIER:exon5/8:c.770-475T>C:,TUBD1:ENST00000346141:intron_variant:MODIFIER:exon2/4:c.173-8429T>C:,TUBD1:ENST00000340993:intron_variant:MODIFIER:exon5/7:c.769+2925T>C:,TUBD1:ENST00000394239:intron_variant:MODIFIER:exon5/7:c.770-475T>C:,TUBD1:ENST00000376094:intron_variant:MODIFIER:exon4/5:c.769+2925T>C:,TUBD1:ENST00000592426:intron_variant:MODIFIER:exon4/7:c.770-475T>C:,TUBD1:ENST00000539018:intron_variant:MODIFIER:exon2/5:c.122-475T>C:,TUBD1:ENST00000591548:intron_variant:MODIFIER:exon6/8:c.*487+2925T>C:,TUBD1:ENST00000588009:intron_variant:MODIFIER:exon2/3:n.487+2925T>C:,TUBD1:ENST00000593110:intron_variant:MODIFIER:exon2/3:c.120-8429T>C:,TUBD1:ENST00000587476:intron_variant:MODIFIER:exon1/1:n.661-475T>C:			In the elongating spermatid it is associated with the manchette, a specialized microtubule system present during reshaping of the sperm head (By similarity)				0.0000	0.0000	0.0000																					0		0.3846	13	0.0000	16
chr17	58295605	58295605	T	C	0.1724	29	0.0000	17		58	USP32	intron_variant	USP32:ENST00000300896:intron_variant:MODIFIER:exon16/33:c.1867+1426A>G:,USP32:ENST00000592339:intron_variant:MODIFIER:exon8/25:c.877+1426A>G:,USP32:ENST00000590133:intron_variant:MODIFIER:exon16/21:c.1858+1426A>G:,USP32:ENST00000591768:intron_variant:MODIFIER:exon4/5:c.502+1384A>G:							0.0000	0.0000	0.0000																					0		0.1724	29	0.0000	17
chr17	58296127	58296127	T	C	0.2857	14	0.0000	23		57	USP32	intron_variant	USP32:ENST00000300896:intron_variant:MODIFIER:exon16/33:c.1867+904A>G:,USP32:ENST00000592339:intron_variant:MODIFIER:exon8/25:c.877+904A>G:,USP32:ENST00000590133:intron_variant:MODIFIER:exon16/21:c.1858+904A>G:,USP32:ENST00000591768:intron_variant:MODIFIER:exon4/5:c.502+862A>G:							0.0000	0.0000	0.0000																					0		0.2857	14	0.0000	23
chr17	60099417	60099417	T	C	0.5000	8	0.0000	16		33	MED13	intron_variant	MED13:ENST00000397786:intron_variant:MODIFIER:exon8/29:c.1283+7485A>G:,MED13:ENST00000583958:intron_variant:MODIFIER:exon2/2:c.260+7485A>G:			Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors				0.0000	0.0000	0.0000																					0		0.5000	8	0.0000	16
chr17	62779276	62779276	T	C	0.2632	20	0.0000	32		76	PLEKHM1P	intron_variant,non_coding_transcript_exon_variant	PLEKHM1P:ENST00000578036:intron_variant:MODIFIER:exon12/17:n.2745-539A>G:,PLEKHM1P:ENST00000582986:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.4575A>G:							0.0000	0.0000	0.0000																					0		0.2500	20	0.0000	32
chr17	64324858	64324858	A	G	0.1163	43	0.0000	26		62	PRKCA	intron_variant	PRKCA:ENST00000413366:intron_variant:MODIFIER:exon2/16:c.205+22613A>G:,PRKCA:ENST00000578063:intron_variant:MODIFIER:exon2/9:c.205+22613A>G:,PRKCA:ENST00000583361:intron_variant:MODIFIER:exon2/2:n.250-11051A>G:,PRKCA:ENST00000284384:intron_variant:MODIFIER:exon2/14:c.196+22613A>G:		MAPK signaling pathway;ErbB signaling pathway;Calcium signaling pathway;Phosphatidylinositol signaling system;Wnt signaling pathway;VEGF signaling pathway;Focal adhesion;Tight junction;Gap junction;Natural killer cell mediated cytotoxicity;Fc epsilon RI signaling pathway;Leukocyte transendothelial migration;Long-term potentiation;Long-term depression;GnRH signaling pathway;Melanogenesis;Vibrio cholerae infection;Pathogenic Escherichia coli infection;EPEC;Glioma;Non-small cell lung cancer	Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)- dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B- ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF- kappa-B-induced genes, through IL1A-dependent induction of NF- kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O- tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity	Activation of PKC through G protein coupled receptor;Activation of Src by Protein-tyrosine phosphatase alpha;Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling;Apoptotic Signaling in Response to DNA Damage;Aspirin Blocks Signaling Pathway Involved in Platelet Activation;Attenuation of GPCR Signaling;BCR Signaling Pathway;Bioactive Peptide Induced Signaling Pathway;Cadmium induces DNA synthesis and proliferation in macrophages;CBL mediated ligand-induced downregulation of EGF receptors;CCR3 signaling in Eosinophils;CXCR4 Signaling Pathway;Effects of calcineurin in Keratinocyte Differentiation;EGF Signaling Pathway;Growth Hormone Signaling Pathway;g-Secretase mediated ErbB4 Signaling Pathway ;Ion Channel and Phorbal Esters Signaling Pathway;Keratinocyte Differentiation;Links between Pyk2 and Map Kinases;Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha);Oxidative Stress Induced Gene Expression Via Nrf2;PDGF Signaling Pathway;Pertussis toxin-insensitive CCR5 Signaling in Macrophage;Phospholipase C d1 in phospholipid associated cell signaling;Phospholipase C Signaling Pathway;Phospholipids as signalling intermediaries;PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;Regulation of eIF4e and p70 S6 Kinase;Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy;Role of MEF2D in T-cell Apoptosis;Signaling Pathway from G-Protein Families;T Cell Receptor Signaling Pathway;Telomeres, Telomerase, Cellular Aging, and  Immortality;Thrombin signaling and protease-activated receptors;TPO Signaling Pathway;Transcription factor CREB and its extracellular signals;Trka Receptor Signaling Pathway;VEGF, Hypoxia, and Angiogenesis			0.0000	0.0000	0.0000		176960 [PRKCA (confirmed) Pituitary tumor,invasive];																			0		0.1163	43	0.0000	26
chr17	64342400	64342400	A	G	0.2500	26	0.0000	20		52	PRKCA	intron_variant	PRKCA:ENST00000413366:intron_variant:MODIFIER:exon2/16:c.205+40155A>G:,PRKCA:ENST00000578063:intron_variant:MODIFIER:exon2/9:c.205+40155A>G:,PRKCA:ENST00000284384:intron_variant:MODIFIER:exon2/14:c.196+40155A>G:		MAPK signaling pathway;ErbB signaling pathway;Calcium signaling pathway;Phosphatidylinositol signaling system;Wnt signaling pathway;VEGF signaling pathway;Focal adhesion;Tight junction;Gap junction;Natural killer cell mediated cytotoxicity;Fc epsilon RI signaling pathway;Leukocyte transendothelial migration;Long-term potentiation;Long-term depression;GnRH signaling pathway;Melanogenesis;Vibrio cholerae infection;Pathogenic Escherichia coli infection;EPEC;Glioma;Non-small cell lung cancer	Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)- dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B- ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF- kappa-B-induced genes, through IL1A-dependent induction of NF- kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O- tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity	Activation of PKC through G protein coupled receptor;Activation of Src by Protein-tyrosine phosphatase alpha;Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling;Apoptotic Signaling in Response to DNA Damage;Aspirin Blocks Signaling Pathway Involved in Platelet Activation;Attenuation of GPCR Signaling;BCR Signaling Pathway;Bioactive Peptide Induced Signaling Pathway;Cadmium induces DNA synthesis and proliferation in macrophages;CBL mediated ligand-induced downregulation of EGF receptors;CCR3 signaling in Eosinophils;CXCR4 Signaling Pathway;Effects of calcineurin in Keratinocyte Differentiation;EGF Signaling Pathway;Growth Hormone Signaling Pathway;g-Secretase mediated ErbB4 Signaling Pathway ;Ion Channel and Phorbal Esters Signaling Pathway;Keratinocyte Differentiation;Links between Pyk2 and Map Kinases;Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha);Oxidative Stress Induced Gene Expression Via Nrf2;PDGF Signaling Pathway;Pertussis toxin-insensitive CCR5 Signaling in Macrophage;Phospholipase C d1 in phospholipid associated cell signaling;Phospholipase C Signaling Pathway;Phospholipids as signalling intermediaries;PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;Regulation of eIF4e and p70 S6 Kinase;Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy;Role of MEF2D in T-cell Apoptosis;Signaling Pathway from G-Protein Families;T Cell Receptor Signaling Pathway;Telomeres, Telomerase, Cellular Aging, and  Immortality;Thrombin signaling and protease-activated receptors;TPO Signaling Pathway;Transcription factor CREB and its extracellular signals;Trka Receptor Signaling Pathway;VEGF, Hypoxia, and Angiogenesis			0.0000	0.0000	0.0000		176960 [PRKCA (confirmed) Pituitary tumor,invasive];																			0		0.3077	26	0.0000	21
chr17	66420939	66420939	A	G	0.2143	28	0.0000	32		73	RP11-120M18.2,WIPI1	intron_variant	RP11-120M18.2:ENST00000592030:intron_variant:MODIFIER:exon3/3:n.647-3839A>G:,WIPI1:ENST00000262139:intron_variant:MODIFIER:exon12/12:c.1293+1277T>C:,RP11-120M18.2:ENST00000590353:intron_variant:MODIFIER:exon1/5:n.173+11003A>G:,RP11-120M18.2:ENST00000591567:intron_variant:MODIFIER:exon1/1:n.154+11003A>G:,RP11-120M18.2:ENST00000586515:intron_variant:MODIFIER:exon3/3:n.540+4292A>G:,WIPI1:ENST00000592645:intron_variant:MODIFIER:exon2/3:c.198+1277T>C:,WIPI1:ENST00000589459:intron_variant:MODIFIER:exon11/11:n.1292+1277T>C:,WIPI1:ENST00000589316:intron_variant:MODIFIER:exon12/12:c.*187+1277T>C:,WIPI1:ENST00000585393:intron_variant:MODIFIER:exon2/2:c.158+1260T>C:,WIPI1:ENST00000546360:intron_variant:MODIFIER:exon11/11:c.1047+1277T>C:			Plays an important role in autophagy and in particular starvation- and calcium-mediated autophagy, as well as in mitophagy. Functions upstream of the ATG12-ATG5-ATG16L1 complex and LC3, and downstream of the ULK1 and PI3-kinase complexes. Involved in xenophagy of Staphylococcus aureus. Invading S.aureus cells become entrapped in autophagosome-like WIPI1 positive vesicles targeted for lysosomal degradation. Plays also a distinct role in controlling the transcription of melanogenic enzymes and melanosome maturation, a process that is distinct from starvation- induced autophagy. May also regulate the trafficking of proteins involved in the mannose-6-phosphate receptor (MPR) recycling pathway				0.0000	0.0000	0.0000																					0		0.2143	28	0.0000	32
chr17	70488013	70488013	T	C	0.1429	28	0.0000	21		54	LINC00511	intron_variant	LINC00511:ENST00000581801:intron_variant:MODIFIER:exon1/2:n.154-63574A>G:,LINC00511:ENST00000453722:intron_variant:MODIFIER:exon1/4:n.603-60648A>G:,LINC00511:ENST00000457958:intron_variant:MODIFIER:exon1/2:n.139-63574A>G:,LINC00511:ENST00000580861:intron_variant:MODIFIER:exon1/1:n.407-60648A>G:							0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	21
chr17	70580873	70580873	C	A	0.0909	22	0.0000	20		58	LINC00511	intron_variant	LINC00511:ENST00000581801:intron_variant:MODIFIER:exon1/2:n.153+7469G>T:,LINC00511:ENST00000453722:intron_variant:MODIFIER:exon1/4:n.602+7469G>T:,LINC00511:ENST00000457958:intron_variant:MODIFIER:exon1/2:n.138+7469G>T:,LINC00511:ENST00000580861:intron_variant:MODIFIER:exon1/1:n.406+18369G>T:							0.0000	0.0000	0.0000																					0		0.0909	22	0.0000	20
chr17	73792642	73792642	A	G	0.2667	15	0.0000	23		58	UNK	intron_variant	UNK:ENST00000293218:intron_variant:MODIFIER:exon2/16:c.332+11577A>G:,UNK:ENST00000589666:intron_variant:MODIFIER:exon1/15:c.104+11577A>G:,UNK:ENST00000592629:intron_variant:MODIFIER:exon1/3:c.104+11577A>G:							0.0000	0.0000	0.0000																					0		0.2667	15	0.0000	23
chr17	73938267	73938267	T	C	0.1667	30	0.0000	25		65	ACOX1	3_prime_UTR_variant	ACOX1:ENST00000293217:3_prime_UTR_variant:MODIFIER:exon14/14:c.*4562A>G:,ACOX1:ENST00000537812:3_prime_UTR_variant:MODIFIER:exon14/14:c.*4562A>G:		Fatty acid metabolism;alpha-Linolenic acid metabolism;Biosynthesis of unsaturated fatty acids;PPAR signaling pathway	Catalyzes the desaturation of acyl-CoAs to 2-trans- enoyl-CoAs. Isoform 1 shows highest activity against medium-chain fatty acyl-CoAs and activity decreases with increasing chain length. Isoform 2 is active against a much broader range of substrates and shows activity towards very long-chain acyl-CoAs. Isoform 2 is twice as active as isoform 1 against 16-hydroxy- palmitoyl-CoA and is 25% more active against 1,16-hexadecanodioyl- CoA	Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)			0.0000	0.0000	0.0000		609751 [ACOX1 (confirmed) Peroxisomal acyl-CoA oxidase deficiency,264470];																			0		0.1667	30	0.0000	25
chr17	74484536	74484536	T	C	0.4167	12	0.0000	19		41	RHBDF2	intron_variant	RHBDF2:ENST00000313080:intron_variant:MODIFIER:exon1/18:c.-219-545A>G:,RHBDF2:ENST00000389760:intron_variant:MODIFIER:exon1/18:c.-219-545A>G:,RHBDF2:ENST00000591885:intron_variant:MODIFIER:exon1/18:c.-219-545A>G:,RHBDF2:ENST00000592123:intron_variant:MODIFIER:exon1/5:c.-320-322A>G:,RHBDF2:ENST00000592378:intron_variant:MODIFIER:exon1/3:n.33-545A>G:,RHBDF2:ENST00000585989:intron_variant:MODIFIER:exon1/4:c.-161-603A>G:,RHBDF2:ENST00000589526:intron_variant:MODIFIER:exon1/3:c.-219-545A>G:,RHBDF2:ENST00000591697:intron_variant:MODIFIER:exon1/4:c.-320-322A>G:,RHBDF2:ENST00000585701:intron_variant:MODIFIER:exon1/3:c.-337-322A>G:,RHBDF2:ENST00000591192:intron_variant:MODIFIER:exon1/3:c.-320-322A>G:,RHBDF2:ENST00000590288:intron_variant:MODIFIER:exon1/2:c.-219-545A>G:,RHBDF2:ENST00000591255:intron_variant:MODIFIER:exon1/2:c.-442-322A>G:,RHBDF2:ENST00000593103:intron_variant:MODIFIER:exon1/1:n.64-545A>G:			Rhomboid protease-like protein which has no protease activity but regulates the secretion of several ligands of the epidermal growth factor receptor. Indirectly activates the epidermal growth factor receptor signaling pathway and may thereby regulate sleep, cell survival, proliferation and migration (By similarity)				0.0000	0.0000	0.0000		614404 [RHBDF2 (provisional) Tylosis with esophageal cancer,148500];																			0		0.4167	12	0.0000	19
chr17	75408091	75408091	A	G	0.4286	7	0.0000	20		45	SEPT9	intron_variant	SEPT9:ENST00000427177:intron_variant:MODIFIER:exon3/11:c.721+9306A>G:,SEPT9:ENST00000591198:intron_variant:MODIFIER:exon2/10:c.664+9306A>G:,SEPT9:ENST00000449803:intron_variant:MODIFIER:exon3/11:c.229+9306A>G:,SEPT9:ENST00000431235:intron_variant:MODIFIER:exon3/11:c.229+9306A>G:,SEPT9:ENST00000329047:intron_variant:MODIFIER:exon2/10:c.667+9306A>G:,SEPT9:ENST00000590294:intron_variant:MODIFIER:exon2/11:c.667+9306A>G:,SEPT9:ENST00000588575:intron_variant:MODIFIER:exon2/4:c.195+9514A>G:,SEPT9:ENST00000588690:intron_variant:MODIFIER:exon2/11:c.229+9306A>G:,SEPT9:ENST00000423034:intron_variant:MODIFIER:exon2/10:c.700+9306A>G:,SEPT9:ENST00000590059:intron_variant:MODIFIER:exon2/3:c.172+9306A>G:,SEPT9:ENST00000427674:intron_variant:MODIFIER:exon2/10:c.229+9306A>G:,SEPT9:ENST00000592420:intron_variant:MODIFIER:exon1/1:c.148+9306A>G:,SEPT9:ENST00000585930:intron_variant:MODIFIER:exon1/9:c.49+6869A>G:			Filament-forming cytoskeletal GTPase (By similarity). May play a role in cytokinesis (Potential). May play a role in the internalization of 2 intracellular microbial pathogens, Listeria monocytogenes and Shigella flexneri				0.0000	0.0000	0.0000		604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];																			0		0.4286	7	0.0000	20
chr17	76197101	76197101	A	G	0.4286	7	0.0000	16		33	AFMID	intron_variant	AFMID:ENST00000327898:intron_variant:MODIFIER:exon2/10:c.155-1479A>G:,AFMID:ENST00000409257:intron_variant:MODIFIER:exon2/10:c.155-1479A>G:,AFMID:ENST00000591256:intron_variant:MODIFIER:exon2/5:c.155-1479A>G:,AFMID:ENST00000592988:intron_variant:MODIFIER:exon2/3:n.164-1479A>G:,AFMID:ENST00000589107:intron_variant:MODIFIER:exon3/6:c.*121-1479A>G:,AFMID:ENST00000588199:intron_variant:MODIFIER:exon2/6:c.155-1479A>G:,AFMID:ENST00000588800:intron_variant:MODIFIER:exon2/4:c.155-1683A>G:,AFMID:ENST00000591952:intron_variant:MODIFIER:exon2/2:c.155-5891A>G:,AFMID:ENST00000586542:intron_variant:MODIFIER:exon2/4:c.155-1479A>G:,AFMID:ENST00000591538:intron_variant:MODIFIER:exon1/2:n.351-1479A>G:		Tryptophan metabolism;Glyoxylate and dicarboxylate metabolism	Catalyzes the hydrolysis of N-formyl-L-kynurenine to L- kynurenine, the second step in the kynurenine pathway of tryptophan degradation. Kynurenine may be further oxidized to nicotinic acid, NAD(H) and NADP(H). Required for elimination of toxic metabolites (By similarity)				0.0000	0.0000	0.0000																					0		0.4286	7	0.0000	16
chr17	78154642	78154642	A	G	0.1351	37	0.0000	19		63	CARD14	intron_variant	CARD14:ENST00000344227:intron_variant:MODIFIER:exon1/20:c.-20-576A>G:,CARD14:ENST00000576785:intron_variant:MODIFIER:exon3/3:c.-20-576A>G:,CARD14:ENST00000573882:intron_variant:MODIFIER:exon3/22:c.-20-576A>G:,CARD14:ENST00000575465:intron_variant:MODIFIER:exon3/3:c.-20-576A>G:,CARD14:ENST00000575500:intron_variant:MODIFIER:exon2/21:c.-20-576A>G:,CARD14:ENST00000570421:intron_variant:MODIFIER:exon1/14:c.-20-576A>G:			Plays a role in signaling mediated by TRAF2, TRAF3 and TRAF6 and protects cells against apoptosis. Activates NF-kappa-B via BCL10 and IKK. Stimulates the phosphorylation of BCL10				0.0000	0.0000	0.0000		607211 [CARD14 (confirmed) Psoriasis 2,602723|Pityriasis rubra pilaris,173200];																			0		0.1351	37	0.0000	19
chr17	78285781	78285781	A	G	0.1739	23	0.0000	29		64	RNF213	intron_variant	RNF213:ENST00000508628:intron_variant:MODIFIER:exon15/68:c.2803-1031A>G:,RNF213:ENST00000456466:intron_variant:MODIFIER:exon14/22:c.2656-1031A>G:,RNF213:ENST00000582970:intron_variant:MODIFIER:exon14/67:c.2656-1031A>G:,RNF213:ENST00000319921:intron_variant:MODIFIER:exon14/16:c.2656-1031A>G:,RNF213:ENST00000559070:intron_variant:MODIFIER:exon11/19:n.2251-1031A>G:			Probable E3 ubiquitin-protein ligase that may play a role in angiogenesis. May also have an ATPase activity				0.0000	0.0000	0.0000		613768 [RNF213 (provisional) Moyamoya disease 2,susceptibility to,607151];																			0		0.1739	23	0.0000	29
chr18	704204	704204	T	C	0.2917	24	0.0313	32		61	ENOSF1	intron_variant	ENOSF1:ENST00000340116:intron_variant:MODIFIER:exon2/14:c.256+2266A>G:,ENOSF1:ENST00000383578:intron_variant:MODIFIER:exon2/15:c.63+2266A>G:,ENOSF1:ENST00000251101:intron_variant:MODIFIER:exon2/15:c.193+2266A>G:,ENOSF1:ENST00000581475:intron_variant:MODIFIER:exon2/13:c.193+2266A>G:,ENOSF1:ENST00000580982:intron_variant:MODIFIER:exon2/12:c.193+2266A>G:,ENOSF1:ENST00000585128:intron_variant:MODIFIER:exon2/14:c.127+2266A>G:,ENOSF1:ENST00000584453:intron_variant:MODIFIER:exon2/14:c.193+2266A>G:,ENOSF1:ENST00000578651:intron_variant:MODIFIER:exon2/10:n.217+2266A>G:,ENOSF1:ENST00000585004:intron_variant:MODIFIER:exon2/7:n.256+2266A>G:,ENOSF1:ENST00000579053:intron_variant:MODIFIER:exon1/5:n.320+2266A>G:,ENOSF1:ENST00000583771:intron_variant:MODIFIER:exon1/5:c.3+8300A>G:,ENOSF1:ENST00000539164:intron_variant:MODIFIER:exon2/6:c.193+2266A>G:,ENOSF1:ENST00000580605:intron_variant:MODIFIER:exon2/5:n.216+2266A>G:,ENOSF1:ENST00000581332:intron_variant:MODIFIER:exon2/2:n.362+2266A>G:			May regulate thymidylate synthase activity				0.0000	0.0000	0.0000																					0		0.2917	24	0.0312	32
chr18	708428	708428	T	C	0.1613	31	0.0000	28		67	ENOSF1	intron_variant	ENOSF1:ENST00000340116:intron_variant:MODIFIER:exon1/14:c.148-1850A>G:,ENOSF1:ENST00000383578:intron_variant:MODIFIER:exon1/15:c.-46-1850A>G:,ENOSF1:ENST00000251101:intron_variant:MODIFIER:exon1/15:c.85-1850A>G:,ENOSF1:ENST00000581475:intron_variant:MODIFIER:exon1/13:c.85-1850A>G:,ENOSF1:ENST00000580982:intron_variant:MODIFIER:exon1/12:c.85-1850A>G:,ENOSF1:ENST00000585128:intron_variant:MODIFIER:exon1/14:c.19-1850A>G:,ENOSF1:ENST00000584453:intron_variant:MODIFIER:exon1/14:c.85-1850A>G:,ENOSF1:ENST00000578651:intron_variant:MODIFIER:exon1/10:n.109-1850A>G:,ENOSF1:ENST00000585004:intron_variant:MODIFIER:exon1/7:n.148-1850A>G:,ENOSF1:ENST00000583771:intron_variant:MODIFIER:exon1/5:c.3+4076A>G:,ENOSF1:ENST00000539164:intron_variant:MODIFIER:exon1/6:c.85-1850A>G:,ENOSF1:ENST00000580605:intron_variant:MODIFIER:exon1/5:n.108-1850A>G:,ENOSF1:ENST00000581332:intron_variant:MODIFIER:exon1/2:n.254-1850A>G:			May regulate thymidylate synthase activity				0.0000	0.0000	0.0000																					0		0.1613	31	0.0000	28
chr18	7573863	7573863	A	G	0.1739	46	0.0270	37		64	PTPRM	intron_variant	PTPRM:ENST00000400060:intron_variant:MODIFIER:exon1/32:c.73+5974A>G:,PTPRM:ENST00000580170:intron_variant:MODIFIER:exon1/32:c.73+5974A>G:,PTPRM:ENST00000332175:intron_variant:MODIFIER:exon1/30:c.73+5974A>G:		Cell adhesion molecules (CAMs);Adherens junction	Involved in cell-cell adhesion through homophilic interactions. May play a key role in signal transduction and growth control				0.0000	0.0000	0.0000																					0		0.1739	46	0.0270	37
chr18	9255444	9255444	G	A	0.1212	33	0.0000	29		57	ANKRD12	missense_variant,3_prime_UTR_variant	ANKRD12:ENST00000262126:missense_variant:MODERATE:exon9/13:c.2179G>A:p.Glu727Lys,ANKRD12:ENST00000383440:missense_variant:MODERATE:exon8/12:c.2110G>A:p.Glu704Lys,ANKRD12:ENST00000400020:missense_variant:MODERATE:exon8/12:c.2110G>A:p.Glu704Lys,ANKRD12:ENST00000359158:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1293G>A:			May recruit HDACs to the p160 coactivators/nuclear receptor complex to inhibit ligand-dependent transactivation			rs768063081	0.0000	0.00001	0.00000					6.210000,6.210000	T,T	D,D,D,T	D,D,D,	D,D,	23.50											0		0.1212	33	0.0000	29
chr18	18683558	18683558	T	C	0.3333	9	0.0000	25		50	ROCK1	intron_variant	ROCK1:ENST00000399799:intron_variant:MODIFIER:exon1/32:c.93+7221A>G:		Wnt signaling pathway;TGF-beta signaling pathway;Axon guidance;Focal adhesion;Leukocyte transendothelial migration;Regulation of actin cytoskeleton;Pathogenic Escherichia coli infection;EPEC	Protein kinase which is a key regulator of actin cytoskeleton and cell polarity. Involved in regulation of smooth muscle contraction, actin cytoskeleton organization, stress fiber and focal adhesion formation, neurite retraction, cell adhesion and motility via phosphorylation of DAPK3, GFAP, LIMK1, LIMK2, MYL9/MLC2, PFN1 and PPP1R12A. Phosphorylates FHOD1 and acts synergistically with it to promote SRC-dependent non-apoptotic plasma membrane blebbing. Phosphorylates JIP3 and regulates the recruitment of JNK to JIP3 upon UVB-induced stress. Acts as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. Acts as a negative regulator of VEGF-induced angiogenic endothelial cell activation. Required for centrosome positioning and centrosome-dependent exit from mitosis. Plays a role in terminal erythroid differentiation. May regulate closure of the eyelids and ventral body wall by inducing the assembly of actomyosin bundles. Promotes keratinocyte terminal differentiation. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process, essential for osteoblast mineralization	Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia;Integrin Signaling Pathway;PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase;Rho cell motility signaling pathway;Role of MAL in Rho-Mediated Activation of SRF;Thrombin signaling and protease-activated receptors			0.0000	0.0000	0.0000																					0		0.3333	9	0.0000	25
chr18	21637973	21637973	A	G	0.3636	11	0.0000	18		39	TTC39C	intron_variant	TTC39C:ENST00000317571:intron_variant:MODIFIER:exon1/13:c.168-6131A>G:,TTC39C:ENST00000304621:intron_variant:MODIFIER:exon1/13:c.-16-6131A>G:,TTC39C:ENST00000578150:intron_variant:MODIFIER:exon1/3:n.127-6131A>G:							0.0000	0.0000	0.0000																					0		0.3636	11	0.0000	18
chr18	32116443	32116443	A	G	0.2727	23	0.0732	41		56	DTNA	intron_variant	DTNA:ENST00000283365:intron_variant:MODIFIER:exon1/21:c.-127+42965A>G:,DTNA:ENST00000596745:intron_variant:MODIFIER:exon1/10:c.-127+42965A>G:,DTNA:ENST00000315456:intron_variant:MODIFIER:exon1/12:c.-127+42965A>G:,DTNA:ENST00000590412:intron_variant:MODIFIER:exon1/4:c.-127+42458A>G:			May be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors				0.0000	0.0000	0.0000		601239 [DTNA (provisional) Left ventricular noncompaction 1,with or without congenital heart defects,604169];																			0		0.3043	23	0.0732	41
chr18	32119051	32119051	A	G	0.1081	37	0.0000	45		52	DTNA	intron_variant	DTNA:ENST00000283365:intron_variant:MODIFIER:exon1/21:c.-127+45573A>G:,DTNA:ENST00000596745:intron_variant:MODIFIER:exon1/10:c.-127+45573A>G:,DTNA:ENST00000315456:intron_variant:MODIFIER:exon1/12:c.-127+45573A>G:,DTNA:ENST00000590412:intron_variant:MODIFIER:exon1/4:c.-127+45066A>G:			May be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors				0.0000	0.0000	0.0000		601239 [DTNA (provisional) Left ventricular noncompaction 1,with or without congenital heart defects,604169];																			0		0.1081	37	0.0000	45
chr18	32119085	32119085	A	G	0.2500	30	0.0541	38		53	DTNA	intron_variant	DTNA:ENST00000283365:intron_variant:MODIFIER:exon1/21:c.-127+45607A>G:,DTNA:ENST00000596745:intron_variant:MODIFIER:exon1/10:c.-127+45607A>G:,DTNA:ENST00000315456:intron_variant:MODIFIER:exon1/12:c.-127+45607A>G:,DTNA:ENST00000590412:intron_variant:MODIFIER:exon1/4:c.-127+45100A>G:			May be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors				0.0000	0.0000	0.0000		601239 [DTNA (provisional) Left ventricular noncompaction 1,with or without congenital heart defects,604169];																			0		0.3000	30	0.0789	38
chr18	33289746	33289746	-	A	0.1163	45	0.0000	46		42	GALNT1	3_prime_UTR_variant	GALNT1:ENST00000269195:3_prime_UTR_variant:MODIFIER:exon11/11:c.*19dupA:,GALNT1:ENST00000589189:3_prime_UTR_variant:MODIFIER:exon11/11:c.*520dupA:		O-Glycan biosynthesis;Glycan structures - biosynthesis 1	Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D- galactosamine residue to a serine or threonine residue on the protein receptor. Has a broad spectrum of substrates for peptides such as EA2, Muc5AC, Muc1a, Muc1b and Muc7			rs745418426	0.0000	0.00003	0.00002																					0		0.0952	42	0.0000	44
chr18	42351334	42351334	A	G	0.1818	22	0.0000	20		59	SETBP1	intron_variant	SETBP1:ENST00000282030:intron_variant:MODIFIER:exon2/5:c.486+69537A>G:,SETBP1:ENST00000426838:intron_variant:MODIFIER:exon2/3:c.486+69537A>G:							0.0000	0.0000	0.0000		611060 [SETBP1 (confirmed) Schinzel-Giedion midface retraction syndrome,269150|Mental retardation,autosomal dominant 29,616078];																			0		0.1818	22	0.0000	20
chr18	43599667	43599667	T	C	0.3636	11	0.0000	20		45	PSTPIP2	intron_variant	PSTPIP2:ENST00000409746:intron_variant:MODIFIER:exon3/14:c.213-3764A>G:,PSTPIP2:ENST00000589328:intron_variant:MODIFIER:exon3/13:c.213-3764A>G:,PSTPIP2:ENST00000588801:intron_variant:MODIFIER:exon3/8:n.308-3764A>G:,PSTPIP2:ENST00000587042:intron_variant:MODIFIER:exon3/4:n.297-3764A>G:			Binds to F-actin. May be involved in regulation of the actin cytoskeleton (By similarity)				0.0000	0.0000	0.0000																					0		0.3636	11	0.0000	20
chr18	66803371	66803371	A	G	0.4000	11	0.0385	26		42	CCDC102B-RP11-674P19.2	intergenic_region	CCDC102B-RP11-674P19.2:ENSG00000150636-ENSG00000264705:intergenic_region:MODIFIER::n.66803371A>G:							0.0000	0.0000	0.0000																					0		0.3636	11	0.0385	26
chr18	66870005	66870005	A	G	0.2222	18	0.0000	23		61	CCDC102B-RP11-674P19.2	intergenic_region	CCDC102B-RP11-674P19.2:ENSG00000150636-ENSG00000264705:intergenic_region:MODIFIER::n.66870005A>G:							0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	24
chr19	4050033	4050033	T	C	0.1481	27	0.0000	22		54	ZBTB7A	intron_variant	ZBTB7A:ENST00000322357:intron_variant:MODIFIER:exon2/2:c.1263-1791A>G:,ZBTB7A:ENST00000601588:intron_variant:MODIFIER:exon2/2:c.1263-1791A>G:			Plays a key role in the instruction of early lymphoid progenitors to develop into B lineage by repressing T-cell instructive Notch signals (By similarity). Specifically represses the transcription of the CDKN2A gene. Efficiently abrogates E2F1- dependent CDKN2A transactivation/de-repression. Binds to the consensus sequence 5'-[GA][CA]GACCCCCCCCC-3' (By similarity)				0.0000	0.0000	0.0000																					0		0.1429	28	0.0000	23
chr19	4654458	4654458	T	C	0.0952	42	0.0000	56		49	TNFAIP8L1,C19orf10	3_prime_UTR_variant,intron_variant	TNFAIP8L1:ENST00000327473:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016T>C:,TNFAIP8L1:ENST00000536716:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2016T>C:,C19orf10:ENST00000599761:intron_variant:MODIFIER:exon3/3:c.184+5485A>G:		Cytokine-cytokine receptor interaction				rs768504363	0.0000	0.0000	0.0000																					0		0.0952	42	0.0000	56
chr19	6671456	6671456	T	C	0.0732	83	0.0000	89		49	TNFSF14-C3	intergenic_region	TNFSF14-C3:ENSG00000125735-ENSG00000125730:intergenic_region:MODIFIER::n.6671456T>C:							0.0000	0.0000	0.0000																					0		0.0814	86	0.0100	100
chr19	6698633	6698633	T	C	0.0490	102	0.0000	91		58	C3	sequence_feature,intron_variant	C3:ENST00000245907:sequence_feature:LOW::c.2441-828A>G:,C3:ENST00000245907:intron_variant:MODIFIER:exon19/40:c.2441-828A>G:,C3:ENST00000602053:intron_variant:MODIFIER:exon2/2:n.489-828A>G:		Complement and coagulation cascades;Systemic lupus erythematosus	Acylation stimulating protein (ASP): adipogenic hormone that stimulates triglyceride (TG) synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial TG clearance. Appears to stimulate TG synthesis via activation of the PLC, MAPK and AKT signaling pathways. Ligand for C5AR2. Promotes the phosphorylation, ARRB2-mediated internalization and recycling of C5AR2	Alternative Complement Pathway;Cells and Molecules involved in local acute inflammatory response;Classical Complement Pathway;Complement Pathway;Lectin Induced Complement Pathway			0.0000	0.0000	0.0000		120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];																			0		0.0490	102	0.0000	91
chr19	6698638	6698638	T	C	0.0463	108	0.0000	95		56	C3	sequence_feature,intron_variant	C3:ENST00000245907:sequence_feature:LOW::c.2441-833A>G:,C3:ENST00000245907:intron_variant:MODIFIER:exon19/40:c.2441-833A>G:,C3:ENST00000602053:intron_variant:MODIFIER:exon2/2:n.489-833A>G:		Complement and coagulation cascades;Systemic lupus erythematosus	Acylation stimulating protein (ASP): adipogenic hormone that stimulates triglyceride (TG) synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial TG clearance. Appears to stimulate TG synthesis via activation of the PLC, MAPK and AKT signaling pathways. Ligand for C5AR2. Promotes the phosphorylation, ARRB2-mediated internalization and recycling of C5AR2	Alternative Complement Pathway;Cells and Molecules involved in local acute inflammatory response;Classical Complement Pathway;Complement Pathway;Lectin Induced Complement Pathway			0.0000	0.0000	0.0000		120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];																			0		0.0463	108	0.0000	95
chr19	6709459	6709459	A	C	0.0379	133	0.0000	117		53	C3	intron_variant	C3:ENST00000245907:intron_variant:MODIFIER:exon14/40:c.1845+236T>G:		Complement and coagulation cascades;Systemic lupus erythematosus	Acylation stimulating protein (ASP): adipogenic hormone that stimulates triglyceride (TG) synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial TG clearance. Appears to stimulate TG synthesis via activation of the PLC, MAPK and AKT signaling pathways. Ligand for C5AR2. Promotes the phosphorylation, ARRB2-mediated internalization and recycling of C5AR2	Alternative Complement Pathway;Cells and Molecules involved in local acute inflammatory response;Classical Complement Pathway;Complement Pathway;Lectin Induced Complement Pathway			0.0000	0.0000	0.0000		120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];																			0		0.0000	119	0.0000	114
chr19	6709486	6709486	G	A	0.0493	144	0.0000	130		78	C3	intron_variant	C3:ENST00000245907:intron_variant:MODIFIER:exon14/40:c.1845+209C>T:		Complement and coagulation cascades;Systemic lupus erythematosus	Acylation stimulating protein (ASP): adipogenic hormone that stimulates triglyceride (TG) synthesis and glucose transport in adipocytes, regulating fat storage and playing a role in postprandial TG clearance. Appears to stimulate TG synthesis via activation of the PLC, MAPK and AKT signaling pathways. Ligand for C5AR2. Promotes the phosphorylation, ARRB2-mediated internalization and recycling of C5AR2	Alternative Complement Pathway;Cells and Molecules involved in local acute inflammatory response;Classical Complement Pathway;Complement Pathway;Lectin Induced Complement Pathway			0.0000	0.0000	0.0000		120700 [C3 (confirmed) C3 deficiency,613779|Hemolytic uremic syndrome,atypical,susceptibility to,5,612925|Macular degeneration,age-related,9,611378];																			0		0.0519	135	0.0000	123
chr19	6747273	6747273	T	C	0.1429	29	0.0000	25		60	TRIP10	intron_variant	TRIP10:ENST00000313244:intron_variant:MODIFIER:exon11/14:c.1262+701T>C:,TRIP10:ENST00000600428:intron_variant:MODIFIER:exon10/13:c.770+701T>C:,TRIP10:ENST00000313285:intron_variant:MODIFIER:exon10/13:c.1094+701T>C:,TRIP10:ENST00000600677:intron_variant:MODIFIER:exon11/14:c.*100+701T>C:,TRIP10:ENST00000595305:intron_variant:MODIFIER:exon10/12:n.1129+701T>C:,TRIP10:ENST00000596758:intron_variant:MODIFIER:exon10/13:c.1094+701T>C:,TRIP10:ENST00000598843:intron_variant:MODIFIER:exon1/2:n.254+701T>C:		Insulin signaling pathway	Required for translocation of GLUT4 to the plasma membrane in response to insulin signaling (By similarity). Required to coordinate membrane tubulation with reorganization of the actin cytoskeleton during endocytosis. Binds to lipids such as phosphatidylinositol 4,5-bisphosphate and phosphatidylserine and promotes membrane invagination and the formation of tubules. Also promotes CDC42-induced actin polymerization by recruiting WASL/N- WASP which in turn activates the Arp2/3 complex. Actin polymerization may promote the fission of membrane tubules to form endocytic vesicles. Required for the formation of podosomes, actin-rich adhesion structures specific to monocyte-derived cells. May be required for the lysosomal retention of FASLG/FASL				0.0000	0.0000	0.0000																					0		0.1379	29	0.0000	25
chr19	7086172	7086172	A	G	0.7500	4	0.0000	18		41	ZNF557	3_prime_UTR_variant	ZNF557:ENST00000414706:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2417A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.7500	4	0.0000	18
chr19	10385084	10385084	A	G	0.2593	27	0.0323	31		59	CTD-2369P2.5,ICAM1	intron_variant	CTD-2369P2.5:ENST00000592893:intron_variant:MODIFIER:exon1/2:n.141+10560T>C:,ICAM1:ENST00000264832:intron_variant:MODIFIER:exon1/6:c.68-357A>G:,ICAM1:ENST00000423829:intron_variant:MODIFIER:exon1/4:c.67+3182A>G:,ICAM1:ENST00000588645:intron_variant:MODIFIER:exon1/3:c.68-357A>G:		Cell adhesion molecules (CAMs);Natural killer cell mediated cytotoxicity;Leukocyte transendothelial migration	ICAM proteins are ligands for the leukocyte adhesion protein LFA-1 (integrin alpha-L/beta-2). During leukocyte trans- endothelial migration, ICAM1 engagement promotes the assembly of endothelial apical cups through ARHGEF26/SGEF and RHOG activation. In case of rhinovirus infection acts as a cellular receptor for the virus	Adhesion and Diapedesis of Granulocytes;Adhesion and Diapedesis of Lymphocytes;Adhesion Molecules on Lymphocyte;B Lymphocyte Cell Surface Molecules;Cells and Molecules involved in local acute inflammatory response;CTL mediated immune response against target cells ;Monocyte and its Surface Molecules;Neutrophil and Its Surface Molecules;T Cytotoxic Cell Surface Molecules;T Helper Cell Surface Molecules			0.0000	0.0000	0.0000		147840 [ICAM1 (confirmed) Malaria,cerebral,susceptibility to,611162];																			0		0.2593	27	0.0323	31
chr19	12394716	12394716	T	C	0.1739	23	0.0000	23		63	ZNF44	intron_variant	ZNF44:ENST00000356109:intron_variant:MODIFIER:exon2/4:c.148-7819A>G:,ZNF44:ENST00000600003:intron_variant:MODIFIER:exon2/11:c.148-7819A>G:,ZNF44:ENST00000393337:intron_variant:MODIFIER:exon2/7:c.148-7819A>G:,ZNF44:ENST00000397742:intron_variant:MODIFIER:exon1/6:c.4-7819A>G:,ZNF44:ENST00000355684:intron_variant:MODIFIER:exon1/3:c.4-7819A>G:,ZNF44:ENST00000354656:intron_variant:MODIFIER:exon3/4:c.178+7319A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	23
chr19	12394756	12394756	T	C	0.2381	21	0.0000	21		57	ZNF44	intron_variant	ZNF44:ENST00000356109:intron_variant:MODIFIER:exon2/4:c.148-7859A>G:,ZNF44:ENST00000600003:intron_variant:MODIFIER:exon2/11:c.148-7859A>G:,ZNF44:ENST00000393337:intron_variant:MODIFIER:exon2/7:c.148-7859A>G:,ZNF44:ENST00000397742:intron_variant:MODIFIER:exon1/6:c.4-7859A>G:,ZNF44:ENST00000355684:intron_variant:MODIFIER:exon1/3:c.4-7859A>G:,ZNF44:ENST00000354656:intron_variant:MODIFIER:exon3/4:c.178+7279A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.2381	21	0.0000	21
chr19	12396583	12396583	T	C	0.4167	12	0.0000	22		50	ZNF44	intron_variant	ZNF44:ENST00000356109:intron_variant:MODIFIER:exon2/4:c.147+7464A>G:,ZNF44:ENST00000600003:intron_variant:MODIFIER:exon2/11:c.147+7464A>G:,ZNF44:ENST00000393337:intron_variant:MODIFIER:exon2/7:c.147+7464A>G:,ZNF44:ENST00000397742:intron_variant:MODIFIER:exon1/6:c.3+8924A>G:,ZNF44:ENST00000355684:intron_variant:MODIFIER:exon1/3:c.3+8924A>G:,ZNF44:ENST00000354656:intron_variant:MODIFIER:exon3/4:c.178+5452A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.4167	12	0.0000	22
chr19	12783383	12783383	T	C	0.3571	14	0.0000	17		36	WDR83	splice_region_variant&intron_variant,intron_variant,non_coding_transcript_exon_variant	WDR83:ENST00000547797:splice_region_variant&intron_variant:LOW:exon4/7:c.299+20T>C:,WDR83:ENST00000242796:intron_variant:MODIFIER:exon5/8:c.507-278T>C:,WDR83:ENST00000418543:intron_variant:MODIFIER:exon7/10:c.507-278T>C:,WDR83:ENST00000546754:intron_variant:MODIFIER:exon6/9:n.920-278T>C:,WDR83:ENST00000548381:intron_variant:MODIFIER:exon7/10:c.*274-278T>C:,WDR83:ENST00000553179:intron_variant:MODIFIER:exon7/9:c.*318-278T>C:,WDR83:ENST00000547255:intron_variant:MODIFIER:exon2/4:n.635-278T>C:,WDR83:ENST00000547481:intron_variant:MODIFIER:exon5/7:c.*29-278T>C:,WDR83:ENST00000551329:intron_variant:MODIFIER:exon4/4:n.612-278T>C:,WDR83:ENST00000425834:intron_variant:MODIFIER:exon2/5:c.196-278T>C:,WDR83:ENST00000552700:non_coding_transcript_exon_variant:MODIFIER:exon1/4:n.297T>C:			Molecular scaffold protein for various multimeric protein complexes. Acts as a module in the assembly of a multicomponent scaffold for the ERK pathway, linking ERK responses to specific agonists. At low concentrations it enhances ERK activation, whereas high concentrations lead to the inhibition of ERK activation. Also involved in response to hypoxia by acting as a negative regulator of HIF1A/HIF-1-alpha via its interaction with EGLN3/PHD3. May promote degradation of HIF1A. May act by recruiting signaling complexes to a specific upstream activator (By similarity). May also be involved in pre-mRNA splicing				0.0000	0.0000	0.0000																					0		0.3571	14	0.0000	17
chr19	13878328	13878328	A	G	0.2500	12	0.0000	17		35	MRI1	intron_variant	MRI1:ENST00000040663:intron_variant:MODIFIER:exon3/5:c.548-1047A>G:,MRI1:ENST00000588526:intron_variant:MODIFIER:exon3/3:n.541-845A>G:,MRI1:ENST00000319545:intron_variant:MODIFIER:exon2/5:c.372-845A>G:,MRI1:ENST00000593245:intron_variant:MODIFIER:exon3/3:c.548-845A>G:,MRI1:ENST00000591688:intron_variant:MODIFIER:exon3/3:n.588-1047A>G:,MRI1:ENST00000589290:intron_variant:MODIFIER:exon2/2:n.380-845A>G:			Catalyzes the interconversion of methylthioribose-1- phosphate (MTR-1-P) into methylthioribulose-1-phosphate (MTRu-1- P). Independently from catalytic activity, promotes cell invasion in response to constitutive RhoA activation by promoting FAK tyrosine phosphorylation and stress fiber turnover				0.0000	0.0000	0.0000																					0		0.2500	12	0.0000	17
chr19	13883492	13883492	A	G	0.2353	25	0.0323	40		55	MRI1,CTB-5E10.3	3_prime_UTR_variant,intron_variant	MRI1:ENST00000040663:3_prime_UTR_variant:MODIFIER:exon6/6:c.*397A>G:,MRI1:ENST00000319545:3_prime_UTR_variant:MODIFIER:exon6/6:c.*397A>G:,CTB-5E10.3:ENST00000586894:intron_variant:MODIFIER:exon1/1:n.378-373T>C:,CTB-5E10.3:ENST00000586297:intron_variant:MODIFIER:exon1/1:n.376-220T>C:,CTB-5E10.3:ENST00000591826:intron_variant:MODIFIER:exon1/1:n.303-45T>C:			Catalyzes the interconversion of methylthioribose-1- phosphate (MTR-1-P) into methylthioribulose-1-phosphate (MTRu-1- P). Independently from catalytic activity, promotes cell invasion in response to constitutive RhoA activation by promoting FAK tyrosine phosphorylation and stress fiber turnover				0.0000	0.0000	0.0000																					0		0.3043	23	0.0263	38
chr19	14599028	14599028	T	C	0.3750	9	0.0000	19		41	GIPC1	intron_variant	GIPC1:ENST00000345425:intron_variant:MODIFIER:exon1/6:c.-30-5210A>G:,GIPC1:ENST00000393028:intron_variant:MODIFIER:exon1/5:c.-3-7438A>G:,GIPC1:ENST00000393029:intron_variant:MODIFIER:exon3/7:c.-4+3440A>G:,GIPC1:ENST00000393033:intron_variant:MODIFIER:exon3/8:c.-31+3440A>G:,GIPC1:ENST00000586027:intron_variant:MODIFIER:exon2/7:c.-31+3440A>G:,GIPC1:ENST00000591349:intron_variant:MODIFIER:exon2/6:c.-4+3440A>G:,GIPC1:ENST00000589497:intron_variant:MODIFIER:exon3/6:c.-4+3440A>G:,GIPC1:ENST00000587210:intron_variant:MODIFIER:exon1/3:c.-3-7438A>G:,GIPC1:ENST00000587934:intron_variant:MODIFIER:exon1/2:c.-122+3440A>G:			May be involved in G protein-linked signaling				0.0000	0.0000	0.0000																					0		0.4444	9	0.0000	19
chr19	16322481	16322481	A	G	0.2222	18	0.0000	29		69	AP1M1	intron_variant	AP1M1:ENST00000444449:intron_variant:MODIFIER:exon6/12:c.582+1275A>G:,AP1M1:ENST00000291439:intron_variant:MODIFIER:exon5/11:c.546+2493A>G:,AP1M1:ENST00000541844:intron_variant:MODIFIER:exon4/10:c.330+2493A>G:,AP1M1:ENST00000590756:intron_variant:MODIFIER:exon3/9:c.330+2493A>G:,AP1M1:ENST00000429941:intron_variant:MODIFIER:exon5/10:c.546+2493A>G:,AP1M1:ENST00000591966:intron_variant:MODIFIER:exon1/2:n.328+2493A>G:,AP1M1:ENST00000586461:intron_variant:MODIFIER:exon1/1:n.219+2493A>G:			Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the trans-Golgi network (TGN) and endosomes. The AP complexes mediate the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules				0.0000	0.0000	0.0000																					0		0.2222	18	0.0000	29
chr19	16749220	16749220	T	C	0.3750	8	0.0000	17		36	CTC-429P9.4,CTC-429P9.1,SMIM7	intron_variant	CTC-429P9.4:ENST00000593991:intron_variant:MODIFIER:exon5/7:c.*127-7850A>G:,CTC-429P9.1:ENST00000601687:intron_variant:MODIFIER:exon1/1:n.367-455T>C:,CTC-429P9.4:ENST00000593962:intron_variant:MODIFIER:exon5/6:n.352+8711A>G:,CTC-429P9.4:ENST00000601636:intron_variant:MODIFIER:exon4/5:c.*126+8711A>G:,CTC-429P9.4:ENST00000595505:intron_variant:MODIFIER:exon4/5:c.*137+8687A>G:,CTC-429P9.4:ENST00000593459:intron_variant:MODIFIER:exon3/4:c.115+20986A>G:,CTC-429P9.4:ENST00000594509:intron_variant:MODIFIER:exon5/6:c.*150+8687A>G:,CTC-429P9.4:ENST00000600705:intron_variant:MODIFIER:exon4/4:c.*137+8687A>G:,SMIM7:ENST00000465250:intron_variant:MODIFIER:exon4/4:c.*138-6685A>G:,CTC-429P9.1:ENST00000601040:intron_variant:MODIFIER:exon1/1:n.403-5499T>C:,SMIM7:ENST00000481671:intron_variant:MODIFIER:exon5/5:c.*151-6685A>G:,SMIM7:ENST00000594662:intron_variant:MODIFIER:exon4/4:c.*127-6685A>G:,SMIM7:ENST00000597781:intron_variant:MODIFIER:exon5/5:c.*127-6685A>G:,SMIM7:ENST00000598278:intron_variant:MODIFIER:exon4/4:c.*138-6745A>G:							0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	17
chr19	18477420	18477420	A	G	0.2195	41	0.0000	28		74	PGPEP1	3_prime_UTR_variant,intron_variant	PGPEP1:ENST00000269919:3_prime_UTR_variant:MODIFIER:exon5/5:c.*3027A>G:,PGPEP1:ENST00000597663:intron_variant:MODIFIER:exon1/1:c.138-3096A>G:,PGPEP1:ENST00000595552:intron_variant:MODIFIER:exon2/2:c.176-3096A>G:		Glyoxylate and dicarboxylate metabolism	Removes 5-oxoproline from various penultimate amino acid residues except L-proline				0.0000	0.0000	0.0000																					0		0.2143	42	0.0000	30
chr19	19286824	19286824	T	C	0.2500	16	0.0000	22		54	MEF2BNB-MEF2B,MEF2B	intron_variant	MEF2BNB-MEF2B:ENST00000514819:intron_variant:MODIFIER:exon2/8:c.22+6558A>G:,MEF2BNB-MEF2B:ENST00000444486:intron_variant:MODIFIER:exon3/9:c.-30+4671A>G:,MEF2BNB-MEF2B:ENST00000354191:intron_variant:MODIFIER:exon5/11:c.*42+4671A>G:,MEF2B:ENST00000602424:intron_variant:MODIFIER:exon3/9:c.-30+4671A>G:,MEF2BNB-MEF2B:ENST00000602804:intron_variant:MODIFIER:exon5/12:c.*42+4671A>G:,MEF2B:ENST00000162023:intron_variant:MODIFIER:exon5/12:c.-30+4671A>G:,MEF2BNB-MEF2B:ENST00000602276:intron_variant:MODIFIER:exon2/6:n.130+4671A>G:,MEF2BNB-MEF2B:ENST00000602438:intron_variant:MODIFIER:exon4/5:n.356+6558A>G:,MEF2BNB-MEF2B:ENST00000602689:intron_variant:MODIFIER:exon5/6:c.*42+4671A>G:			Transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle- specific genes. Activates transcription via this element. May be involved in muscle-specific and/or growth factor-related transcription	Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling;Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK);MAPKinase Signaling Pathway;p38 MAPK Signaling Pathway ;Regulation of PGC-1a;Role of Erk5 in Neuronal Survival;Signal Dependent Regulation of Myogenesis by Corepressor MITR			0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	22
chr19	34810967	34810967	G	T	0.1667	43	0.0000	28		69	KIAA0355	missense_variant,intron_variant	KIAA0355:ENST00000299505:missense_variant:MODERATE:exon3/14:c.651G>T:p.Met217Ile,KIAA0355:ENST00000588338:intron_variant:MODIFIER:exon2/4:c.-205+20139G>T:							0.0000	0.0000	0.0000					0.413000	T	T	B		13.02											1	eMed-HCC,	0.1591	44	0.0000	28
chr19	34810968	34810968	G	T	0.1667	43	0.0000	27		68	KIAA0355	missense_variant,intron_variant	KIAA0355:ENST00000299505:missense_variant:MODERATE:exon3/14:c.652G>T:p.Gly218Cys,KIAA0355:ENST00000588338:intron_variant:MODIFIER:exon2/4:c.-205+20140G>T:							0.0000	0.0000	0.0000					2.333000	T	D	P		23.40											1	eMed-HCC,	0.1591	44	0.0000	27
chr19	36718942	36718942	A	G	0.2353	17	0.0000	24		61	ZNF565,ZNF146	intron_variant	ZNF565:ENST00000355114:intron_variant:MODIFIER:exon1/4:c.55+17436T>C:,ZNF146:ENST00000443387:intron_variant:MODIFIER:exon2/3:c.-854-708A>G:,ZNF146:ENST00000456324:intron_variant:MODIFIER:exon1/2:c.-854-708A>G:,ZNF146:ENST00000591063:intron_variant:MODIFIER:exon1/2:n.61-708A>G:,ZNF146:ENST00000586094:intron_variant:MODIFIER:exon1/2:n.92-708A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.2353	17	0.0000	24
chr19	45165662	45165662	A	G	0.2927	41	0.0714	43		55	CEACAM19,PVR,CTB-171A8.1	5_prime_UTR_premature_start_codon_gain_variant,5_prime_UTR_variant,3_prime_UTR_variant,intron_variant	CEACAM19:ENST00000592472:5_prime_UTR_premature_start_codon_gain_variant:LOW:exon1/4:c.-553A>G:,CEACAM19:ENST00000585657:5_prime_UTR_premature_start_codon_gain_variant:LOW:exon1/5:c.-542A>G:,CEACAM19:ENST00000587729:5_prime_UTR_premature_start_codon_gain_variant:LOW:exon1/5:c.-686A>G:,CEACAM19:ENST00000591979:5_prime_UTR_premature_start_codon_gain_variant:LOW:exon1/4:c.-323A>G:,CEACAM19:ENST00000592789:5_prime_UTR_premature_start_codon_gain_variant:LOW:exon1/3:c.-190A>G:,CEACAM19:ENST00000592472:5_prime_UTR_variant:MODIFIER:exon1/4:c.-553A>G:,CEACAM19:ENST00000585657:5_prime_UTR_variant:MODIFIER:exon1/5:c.-542A>G:,CEACAM19:ENST00000587729:5_prime_UTR_variant:MODIFIER:exon1/5:c.-686A>G:,CEACAM19:ENST00000591979:5_prime_UTR_variant:MODIFIER:exon1/4:c.-323A>G:,CEACAM19:ENST00000592789:5_prime_UTR_variant:MODIFIER:exon1/3:c.-190A>G:,PVR:ENST00000425690:3_prime_UTR_variant:MODIFIER:exon8/8:c.*584A>G:,PVR:ENST00000344956:3_prime_UTR_variant:MODIFIER:exon7/7:c.*584A>G:,PVR:ENST00000403059:3_prime_UTR_variant:MODIFIER:exon8/8:c.*584A>G:,PVR:ENST00000187830:3_prime_UTR_variant:MODIFIER:exon8/8:c.*1626A>G:,CTB-171A8.1:ENST00000590796:intron_variant:MODIFIER:exon3/3:n.409-29742T>C:		Cell adhesion molecules (CAMs)	Mediates NK cell adhesion and triggers NK cell effector functions. Binds two different NK cell receptors: CD96 and CD226. These interactions accumulates at the cell-cell contact site, leading to the formation of a mature immunological synapse between NK cell and target cell. This may trigger adhesion and secretion of lytic granules and IFN-gamma and activate cytoxicity of activated NK cells. May also promote NK cell-target cell modular exchange, and PVR transfer to the NK cell. This transfer is more important in some tumor cells expressing a lot of PVR, and may trigger fratricide NK cell activation, providing tumors with a mechanism of immunoevasion. Plays a role in mediating tumor cell invasion and migration. Serves as a receptor for poliovirus attachment to target cells. May play a role in axonal transport of poliovirus, by targeting virion-PVR-containing endocytic vesicles to the microtubular network through interaction with DYNLT1. This interaction would drive the virus-containing vesicle to the axonal retrograde transport				0.0000	0.0000	0.0000																					0		0.2927	41	0.0930	43
chr19	45246646	45246646	A	G	0.1212	33	0.0000	22		57	snoZ6-BCL3	intergenic_region	snoZ6-BCL3:ENSG00000252200-ENSG00000069399:intergenic_region:MODIFIER::n.45246646A>G:							0.0000	0.0000	0.0000																					0		0.1212	33	0.0000	22
chr19	45253990	45253990	A	G	0.2143	29	0.0000	22		65	BCL3	intron_variant	BCL3:ENST00000164227:intron_variant:MODIFIER:exon1/8:c.257-494A>G:,BCL3:ENST00000403534:intron_variant:MODIFIER:exon1/7:n.425-494A>G:			Contributes to the regulation of transcriptional activation of NF-kappa-B target genes. In the cytoplasm, inhibits the nuclear translocation of the NF-kappa-B p50 subunit. In the nucleus, acts as transcriptional activator that promotes transcription of NF-kappa-B target genes. Contributes to the regulation of cell proliferation (By similarity)				0.0000	0.0000	0.0000		109560 [BCL3 (confirmed) Leukemia/lymphoma,B-cell,3];																			0		0.2069	29	0.0000	24
chr19	53067155	53067155	A	G	0.1818	24	0.0000	21		57	ZNF808,ZNF701	3_prime_UTR_variant,intron_variant	ZNF808:ENST00000487863:3_prime_UTR_variant:MODIFIER:exon4/4:c.*1007A>G:,ZNF701:ENST00000478039:intron_variant:MODIFIER:exon1/2:n.230-6138A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.2500	24	0.0000	21
chr19	53155447	53155447	T	C	0.3750	8	0.0000	16		33	ZNF83,CTD-3099C6.9	intron_variant,non_coding_transcript_exon_variant	ZNF83:ENST00000600714:intron_variant:MODIFIER:exon2/5:c.-74+3367A>G:,ZNF83:ENST00000601257:intron_variant:MODIFIER:exon4/6:c.-74+3367A>G:,ZNF83:ENST00000594682:intron_variant:MODIFIER:exon3/5:c.-74+3367A>G:,ZNF83:ENST00000598536:intron_variant:MODIFIER:exon4/5:c.-74+3367A>G:,ZNF83:ENST00000595171:intron_variant:MODIFIER:exon3/5:n.263+3367A>G:,ZNF83:ENST00000596440:intron_variant:MODIFIER:exon3/5:n.255+3367A>G:,ZNF83:ENST00000602232:intron_variant:MODIFIER:exon2/3:n.136+8568A>G:,CTD-3099C6.9:ENST00000598322:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1091A>G:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	16
chr19	54957804	54957804	T	C	0.3333	15	0.0000	23		55	LENG8-AS1	intron_variant	LENG8-AS1:ENST00000429922:intron_variant:MODIFIER:exon2/2:n.505-1447A>G:,LENG8-AS1:ENST00000416022:intron_variant:MODIFIER:exon1/1:n.439-1447A>G:							0.0000	0.0000	0.0000																					0		0.3125	16	0.0000	24
chr19	54957859	54957859	T	C	0.2381	21	0.0303	33		55	LENG8-AS1	intron_variant	LENG8-AS1:ENST00000429922:intron_variant:MODIFIER:exon2/2:n.504+1484A>G:,LENG8-AS1:ENST00000416022:intron_variant:MODIFIER:exon1/1:n.438+1484A>G:							0.0000	0.0000	0.0000																					0		0.2083	24	0.0286	35
chr19	58317623	58317623	A	G	0.3750	8	0.0000	20		45	ZNF586,ZNF552	intron_variant	ZNF586:ENST00000598885:intron_variant:MODIFIER:exon2/2:c.164-8171A>G:,ZNF586:ENST00000599802:intron_variant:MODIFIER:exon1/1:c.37-13313A>G:,ZNF552:ENST00000594473:intron_variant:MODIFIER:exon1/1:c.110-2191T>C:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	21
chr19	58358169	58358169	A	G	0.1786	28	0.0000	31		70	CTD-2583A14.10,ZNF587B	intron_variant	CTD-2583A14.10:ENST00000598031:intron_variant:MODIFIER:exon1/2:c.34-9303A>G:,CTD-2583A14.10:ENST00000597134:intron_variant:MODIFIER:exon3/4:c.-97+7652A>G:,CTD-2583A14.10:ENST00000593873:intron_variant:MODIFIER:exon1/1:c.-122-11775A>G:,CTD-2583A14.10:ENST00000596498:intron_variant:MODIFIER:exon2/3:c.-93-9306A>G:,ZNF587B:ENST00000316462:intron_variant:MODIFIER:exon3/4:c.478+5646A>G:,CTD-2583A14.10:ENST00000603271:intron_variant:MODIFIER:exon1/2:c.34-9306A>G:,CTD-2583A14.10:ENST00000604231:intron_variant:MODIFIER:exon2/3:c.163+7652A>G:			May be involved in transcriptional regulation (Probable)				0.0000	0.0000	0.0000																					0		0.1786	28	0.0000	31
chr19	58358195	58358195	A	G	0.2174	23	0.0000	22		57	CTD-2583A14.10,ZNF587B	intron_variant	CTD-2583A14.10:ENST00000598031:intron_variant:MODIFIER:exon1/2:c.34-9277A>G:,CTD-2583A14.10:ENST00000597134:intron_variant:MODIFIER:exon3/4:c.-97+7678A>G:,CTD-2583A14.10:ENST00000593873:intron_variant:MODIFIER:exon1/1:c.-122-11749A>G:,CTD-2583A14.10:ENST00000596498:intron_variant:MODIFIER:exon2/3:c.-93-9280A>G:,ZNF587B:ENST00000316462:intron_variant:MODIFIER:exon3/4:c.478+5672A>G:,CTD-2583A14.10:ENST00000603271:intron_variant:MODIFIER:exon1/2:c.34-9280A>G:,CTD-2583A14.10:ENST00000604231:intron_variant:MODIFIER:exon2/3:c.163+7678A>G:			May be involved in transcriptional regulation (Probable)				0.0000	0.0000	0.0000																					0		0.2174	23	0.0000	22
chr19	58365263	58365263	A	G	0.3636	11	0.0000	25		60	CTD-2583A14.10,ZNF587,ZNF587B,ZNF814	intron_variant,non_coding_transcript_exon_variant	CTD-2583A14.10:ENST00000598031:intron_variant:MODIFIER:exon1/2:c.34-2209A>G:,ZNF587:ENST00000339656:intron_variant:MODIFIER:exon1/2:c.34-2209A>G:,CTD-2583A14.10:ENST00000597134:intron_variant:MODIFIER:exon3/4:c.-96-2209A>G:,CTD-2583A14.10:ENST00000593873:intron_variant:MODIFIER:exon1/1:c.-122-4681A>G:,CTD-2583A14.10:ENST00000596498:intron_variant:MODIFIER:exon2/3:c.-93-2212A>G:,ZNF587B:ENST00000316462:intron_variant:MODIFIER:exon3/4:c.479-2209A>G:,CTD-2583A14.10:ENST00000603271:intron_variant:MODIFIER:exon1/2:c.34-2212A>G:,CTD-2583A14.10:ENST00000604231:intron_variant:MODIFIER:exon2/3:c.164-2209A>G:,ZNF814:ENST00000597652:intron_variant:MODIFIER:exon1/1:n.273+3122T>C:,ZNF587:ENST00000423137:intron_variant:MODIFIER:exon1/2:c.34-2212A>G:,ZNF814:ENST00000596604:intron_variant:MODIFIER:exon2/2:c.164-3334T>C:,ZNF814:ENST00000597342:intron_variant:MODIFIER:exon3/3:c.251-3334T>C:,ZNF814:ENST00000597832:intron_variant:MODIFIER:exon2/2:c.164-1507T>C:,ZNF814:ENST00000595894:intron_variant:MODIFIER:exon4/5:c.*179-1507T>C:,ZNF587:ENST00000484707:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.332A>G:			May be involved in transcriptional regulation.,May be involved in transcriptional regulation (Probable)				0.0000	0.0000	0.0000																					0		0.3333	12	0.0000	25
chr19	58375201	58375201	A	G	0.1622	40	0.0233	44		65	ZNF587,ZNF814	3_prime_UTR_variant,intron_variant	ZNF587:ENST00000339656:3_prime_UTR_variant:MODIFIER:exon3/3:c.*3693A>G:,ZNF587:ENST00000419854:3_prime_UTR_variant:MODIFIER:exon2/2:c.*3693A>G:,ZNF814:ENST00000596604:intron_variant:MODIFIER:exon2/2:c.163+13083T>C:,ZNF814:ENST00000597342:intron_variant:MODIFIER:exon3/3:c.250+13083T>C:,ZNF814:ENST00000597832:intron_variant:MODIFIER:exon2/2:c.164-11445T>C:,ZNF814:ENST00000595894:intron_variant:MODIFIER:exon3/5:c.*9+4625T>C:,ZNF814:ENST00000595295:intron_variant:MODIFIER:exon1/1:c.37-4850T>C:			May be involved in transcriptional regulation				0.0000	0.0000	0.0000																					0		0.1500	40	0.0222	45
chr19	58821716	58821716	G	A	0.1667	30	0.0000	20		59	AC010642.1,ERVK3-1	intron_variant,non_coding_transcript_exon_variant	AC010642.1:ENST00000591325:intron_variant:MODIFIER:exon5/6:c.*2951-1816G>A:,ERVK3-1:ENST00000413518:intron_variant:MODIFIER:exon2/3:n.227-1816G>A:,ERVK3-1:ENST00000427361:intron_variant:MODIFIER:exon2/3:n.202-1847G>A:,ERVK3-1:ENST00000610038:intron_variant:MODIFIER:exon2/3:n.201-1678G>A:,ERVK3-1:ENST00000608070:intron_variant:MODIFIER:exon2/2:n.199-1671G>A:,ERVK3-1:ENST00000609864:intron_variant:MODIFIER:exon2/3:n.199-1671G>A:,ERVK3-1:ENST00000608004:intron_variant:MODIFIER:exon1/3:n.130-849G>A:,ERVK3-1:ENST00000590505:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.1321G>A:						rs200867520	0.0000	0.0000	0.0000																					0		0.1667	30	0.0476	21
chr19	58821718	58821718	A	C	0.1667	30	0.0000	20		59	AC010642.1,ERVK3-1	intron_variant,non_coding_transcript_exon_variant	AC010642.1:ENST00000591325:intron_variant:MODIFIER:exon5/6:c.*2951-1814A>C:,ERVK3-1:ENST00000413518:intron_variant:MODIFIER:exon2/3:n.227-1814A>C:,ERVK3-1:ENST00000427361:intron_variant:MODIFIER:exon2/3:n.202-1845A>C:,ERVK3-1:ENST00000610038:intron_variant:MODIFIER:exon2/3:n.201-1676A>C:,ERVK3-1:ENST00000608070:intron_variant:MODIFIER:exon2/2:n.199-1669A>C:,ERVK3-1:ENST00000609864:intron_variant:MODIFIER:exon2/3:n.199-1669A>C:,ERVK3-1:ENST00000608004:intron_variant:MODIFIER:exon1/3:n.130-847A>C:,ERVK3-1:ENST00000590505:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.1323A>C:						rs201531315	0.0000	0.0000	0.0000																					0		0.1667	30	0.0476	21
chr19	58821719	58821719	G	C	0.1667	30	0.0000	20		59	AC010642.1,ERVK3-1	intron_variant,non_coding_transcript_exon_variant	AC010642.1:ENST00000591325:intron_variant:MODIFIER:exon5/6:c.*2951-1813G>C:,ERVK3-1:ENST00000413518:intron_variant:MODIFIER:exon2/3:n.227-1813G>C:,ERVK3-1:ENST00000427361:intron_variant:MODIFIER:exon2/3:n.202-1844G>C:,ERVK3-1:ENST00000610038:intron_variant:MODIFIER:exon2/3:n.201-1675G>C:,ERVK3-1:ENST00000608070:intron_variant:MODIFIER:exon2/2:n.199-1668G>C:,ERVK3-1:ENST00000609864:intron_variant:MODIFIER:exon2/3:n.199-1668G>C:,ERVK3-1:ENST00000608004:intron_variant:MODIFIER:exon1/3:n.130-846G>C:,ERVK3-1:ENST00000590505:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.1324G>C:						rs200118369	0.0000	0.0000	0.0000																					0		0.1667	30	0.0476	21
chr19	59078086	59078086	A	G	0.2000	15	0.0303	33		51	AC016629.8,MZF1	intron_variant	AC016629.8:ENST00000600534:intron_variant:MODIFIER:exon1/5:n.186-2194A>G:,MZF1:ENST00000215057:intron_variant:MODIFIER:exon5/5:c.772+2558T>C:,AC016629.8:ENST00000593642:intron_variant:MODIFIER:exon1/2:n.282-2194A>G:,AC016629.8:ENST00000600726:intron_variant:MODIFIER:exon1/3:n.225-2194A>G:,MZF1:ENST00000594234:intron_variant:MODIFIER:exon5/5:c.772+2558T>C:,MZF1:ENST00000599369:intron_variant:MODIFIER:exon5/5:c.772+2558T>C:			Binds to target promoter DNA and functions as trancription regulator. Regulates transcription from the PADI1 and CDH2 promoter. May be one regulator of transcriptional events during hemopoietic development	Overview of telomerase protein component gene hTert Transcriptional Regulation 			0.0000	0.0000	0.0000																					0		0.2000	15	0.0303	33
chr20	5998700	5998700	A	G	0.1600	25	0.0000	32		63	CRLS1	intron_variant	CRLS1:ENST00000378863:intron_variant:MODIFIER:exon3/6:c.574+2564A>G:,CRLS1:ENST00000452938:intron_variant:MODIFIER:exon3/5:c.574+2564A>G:,CRLS1:ENST00000378868:intron_variant:MODIFIER:exon3/6:c.277+2564A>G:,CRLS1:ENST00000489345:intron_variant:MODIFIER:exon2/7:n.264+2564A>G:		Glycerophospholipid metabolism	Catalyzes the reversible phosphatidyl group transfer from one phosphatidylglycerol molecule to another to form cardiolipin (CL) (diphosphatidylglycerol) and glycerol				0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	32
chr20	19999032	19999032	A	G	0.4211	19	0.0645	31		42	NAA20	intron_variant,non_coding_transcript_exon_variant	NAA20:ENST00000334982:intron_variant:MODIFIER:exon1/5:c.53+939A>G:,NAA20:ENST00000310450:intron_variant:MODIFIER:exon1/4:c.53+939A>G:,NAA20:ENST00000463154:intron_variant:MODIFIER:exon1/5:n.102+939A>G:,NAA20:ENST00000480550:intron_variant:MODIFIER:exon1/4:n.91+939A>G:,NAA20:ENST00000398602:intron_variant:MODIFIER:exon1/5:c.17+347A>G:,NAA20:ENST00000481837:intron_variant:MODIFIER:exon1/1:n.400+188A>G:,NAA20:ENST00000484480:non_coding_transcript_exon_variant:MODIFIER:exon2/7:n.167A>G:		Tyrosine metabolism;Phenylalanine metabolism;Glycerophospholipid metabolism;1- and 2-Methylnaphthalene degradation;Benzoate degradation via CoA ligation;Limonene and pinene degradation;Alkaloid biosynthesis II	Catalytic subunit of the NatB complex which catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Asp, Met-Glu, Met-Asn and Met-Gln. Proteins with cell cycle functions are overrepresented in the pool of NatB substrates. Required for maintaining the structure and function of actomyosin fibers and for proper cellular migration				0.0000	0.0000	0.0000																					0		0.4211	19	0.0645	31
chr20	30284737	30284737	T	C	0.2083	24	0.0435	46		53	BCL2L1,RP11-243J16.7	intron_variant	BCL2L1:ENST00000307677:intron_variant:MODIFIER:exon2/2:c.564+24721A>G:,RP11-243J16.7:ENST00000412972:intron_variant:MODIFIER:exon1/1:n.169+10550T>C:,BCL2L1:ENST00000376062:intron_variant:MODIFIER:exon1/1:c.564+24721A>G:,BCL2L1:ENST00000376055:intron_variant:MODIFIER:exon2/2:c.375+24910A>G:,BCL2L1:ENST00000420653:intron_variant:MODIFIER:exon2/2:c.564+24721A>G:,BCL2L1:ENST00000450273:intron_variant:MODIFIER:exon2/2:c.564+24721A>G:		Neurodegenerative Diseases;Apoptosis;Jak-STAT signaling pathway;Amyotrophic lateral sclerosis (ALS);Pancreatic cancer;Chronic myeloid leukemia;Small cell lung cancer	Potent inhibitor of cell death. Inhibits activation of caspases (By similarity). Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis	Apoptotic Signaling in Response to DNA Damage;IL-2 Receptor Beta Chain in T cell Activation;Opposing roles of AIF in Apoptosis and Cell Survival;Ras Signaling Pathway;Regulation of BAD phosphorylation;Role of Mitochondria in Apoptotic Signaling			0.0000	0.0000	0.0000																					0		0.2083	24	0.0612	49
chr20	32097555	32097555	A	G	0.2105	19	0.0000	20		52	CBFA2T2	intron_variant	CBFA2T2:ENST00000471007:intron_variant:MODIFIER:exon1/3:n.227+19448A>G:,CBFA2T2:ENST00000342704:intron_variant:MODIFIER:exon1/10:c.34+19448A>G:,CBFA2T2:ENST00000375279:intron_variant:MODIFIER:exon1/11:c.-228+19448A>G:			May function as a complex with the chimeric protein RUNX1/AML1-CBFA2T1/MTG8 which is produced in acute myeloid leukemia with the chromosomal translocation t(8;21). May thus be involved in the repression of AML1-dependent transcription and the induction of G-CSF/CSF3-dependent cell growth. May be a tumor suppressor gene candidate involved in myeloid tumors with the deletion of the 20q11 region				0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	20
chr20	32117398	32117398	A	G	0.3750	8	0.0000	17		36	CBFA2T2	intron_variant	CBFA2T2:ENST00000471007:intron_variant:MODIFIER:exon1/3:n.227+39291A>G:,CBFA2T2:ENST00000342704:intron_variant:MODIFIER:exon1/10:c.34+39291A>G:,CBFA2T2:ENST00000375279:intron_variant:MODIFIER:exon1/11:c.-228+39291A>G:			May function as a complex with the chimeric protein RUNX1/AML1-CBFA2T1/MTG8 which is produced in acute myeloid leukemia with the chromosomal translocation t(8;21). May thus be involved in the repression of AML1-dependent transcription and the induction of G-CSF/CSF3-dependent cell growth. May be a tumor suppressor gene candidate involved in myeloid tumors with the deletion of the 20q11 region				0.0000	0.0000	0.0000																					0		0.3750	8	0.0000	17
chr20	32673970	32673970	A	G	0.3077	13	0.0000	26		53	RALY	intron_variant	RALY:ENST00000489384:intron_variant:MODIFIER:exon2/2:n.82+7611A>G:			Probable-RNA binding protein. Could be a heterogeneous nuclear ribonucleoprotein (hnRNP). May be involved in pre-mRNA splicing (By similarity)				0.0000	0.0000	0.0000																					0		0.3077	13	0.0370	27
chr20	35411013	35411013	T	C	0.1786	28	0.0000	18		59	SOGA1	3_prime_UTR_variant,intron_variant	SOGA1:ENST00000237536:3_prime_UTR_variant:MODIFIER:exon15/15:c.*3875A>G:,SOGA1:ENST00000279034:intron_variant:MODIFIER:exon14/14:c.2994-4779A>G:			Regulates autophagy by playing a role in the reduction of glucose production in an adiponectin- and insulin-dependent manner (By similarity)				0.0000	0.0000	0.0000																					0		0.1786	28	0.0000	18
chr20	42215754	42215754	A	G	0.1818	22	0.0000	31		73	SGK2	intron_variant	SGK2:ENST00000496343:intron_variant:MODIFIER:exon13/13:c.*804-531A>G:			Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, survival and proliferation. Up- regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase				0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	31
chr20	42215768	42215768	A	G	0.1600	25	0.0000	28		63	SGK2	intron_variant	SGK2:ENST00000496343:intron_variant:MODIFIER:exon13/13:c.*804-517A>G:			Serine/threonine-protein kinase which is involved in the regulation of a wide variety of ion channels, membrane transporters, cell growth, survival and proliferation. Up- regulates Na(+) channels: SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger: SLC9A3/NHE3, and the Na(+)/K(+) ATPase				0.0000	0.0000	0.0000																					0		0.1600	25	0.0000	28
chr20	45961371	45961371	T	C	0.1333	30	0.0000	22		58	ZMYND8	intron_variant	ZMYND8:ENST00000536340:intron_variant:MODIFIER:exon2/22:c.106+15229A>G:,ZMYND8:ENST00000311275:intron_variant:MODIFIER:exon2/21:c.25+15229A>G:,ZMYND8:ENST00000360911:intron_variant:MODIFIER:exon2/21:c.85+15229A>G:,ZMYND8:ENST00000458360:intron_variant:MODIFIER:exon2/20:c.85+15229A>G:,ZMYND8:ENST00000262975:intron_variant:MODIFIER:exon3/23:c.25+15229A>G:,ZMYND8:ENST00000471951:intron_variant:MODIFIER:exon2/22:c.85+15229A>G:,ZMYND8:ENST00000352431:intron_variant:MODIFIER:exon2/21:c.85+15229A>G:,ZMYND8:ENST00000396281:intron_variant:MODIFIER:exon4/23:c.100+15229A>G:,ZMYND8:ENST00000446994:intron_variant:MODIFIER:exon2/21:c.25+15229A>G:,ZMYND8:ENST00000355972:intron_variant:MODIFIER:exon3/23:c.25+15229A>G:,ZMYND8:ENST00000372023:intron_variant:MODIFIER:exon2/21:c.85+15229A>G:,ZMYND8:ENST00000461685:intron_variant:MODIFIER:exon2/22:c.85+15229A>G:,ZMYND8:ENST00000540497:intron_variant:MODIFIER:exon2/20:c.85+15229A>G:,ZMYND8:ENST00000435836:intron_variant:MODIFIER:exon3/6:c.25+15229A>G:,ZMYND8:ENST00000446894:intron_variant:MODIFIER:exon2/2:c.25+15229A>G:,ZMYND8:ENST00000441977:intron_variant:MODIFIER:exon2/2:c.25+15229A>G:						rs745857955	0.0000	0.0000	0.0000																					0		0.1333	30	0.0000	22
chr20	48123007	48123007	T	C	0.2727	23	0.0541	37		59	PTGIS	3_prime_UTR_variant	PTGIS:ENST00000244043:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1450A>G:		Arachidonic acid metabolism	Catalyzes the isomerization of prostaglandin H2 to prostacyclin (= prostaglandin I2)				0.0000	0.0000	0.0000		601699 [PTGIS (provisional) Hypertension,essential,145500];																			0		0.3043	23	0.0541	37
chr20	49529596	49529596	T	C	0.2941	17	0.0588	34		52	ADNP	intron_variant	ADNP:ENST00000396029:intron_variant:MODIFIER:exon2/4:c.-5-9058A>G:,ADNP:ENST00000396032:intron_variant:MODIFIER:exon1/3:c.-5-9058A>G:,ADNP:ENST00000534467:intron_variant:MODIFIER:exon1/4:c.-89-8210A>G:			Potential transcription factor. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation				0.0000	0.0000	0.0000		611386 [ADNP (provisional) Helsmoortel-van der Aa syndrome,615873];																			0		0.2941	17	0.0588	34
chr20	49535895	49535895	T	C	0.1667	24	0.0000	27		61	ADNP	intron_variant	ADNP:ENST00000396029:intron_variant:MODIFIER:exon2/4:c.-6+9293A>G:,ADNP:ENST00000396032:intron_variant:MODIFIER:exon1/3:c.-6+11468A>G:,ADNP:ENST00000534467:intron_variant:MODIFIER:exon1/4:c.-90+9293A>G:			Potential transcription factor. May mediate some of the neuroprotective peptide VIP-associated effects involving normal growth and cancer proliferation				0.0000	0.0000	0.0000		611386 [ADNP (provisional) Helsmoortel-van der Aa syndrome,615873];																			0		0.1667	24	0.0000	26
chr20	51603106	51603106	A	G	0.1667	25	0.0000	24		60	TSHZ2	intron_variant	TSHZ2:ENST00000371497:intron_variant:MODIFIER:exon1/2:c.40+13234A>G:			Probable transcriptional regulator involved in developmental processes. May act as a transcriptional repressor (Potential)				0.0000	0.0000	0.0000																					0		0.2000	25	0.0000	24
chr20	51625639	51625639	A	G	0.1379	29	0.0000	15		54	TSHZ2	intron_variant	TSHZ2:ENST00000371497:intron_variant:MODIFIER:exon1/2:c.40+35767A>G:			Probable transcriptional regulator involved in developmental processes. May act as a transcriptional repressor (Potential)				0.0000	0.0000	0.0000																					0		0.1379	29	0.0000	15
chr20	51666258	51666258	G	A	0.1290	32	0.0000	18		54	TSHZ2	intron_variant	TSHZ2:ENST00000371497:intron_variant:MODIFIER:exon1/2:c.40+76386G>A:			Probable transcriptional regulator involved in developmental processes. May act as a transcriptional repressor (Potential)				0.0000	0.0000	0.0000																					0		0.1250	32	0.0000	18
chr20	51709496	51709496	A	G	0.1042	48	0.0000	26		61	TSHZ2	intron_variant	TSHZ2:ENST00000371497:intron_variant:MODIFIER:exon1/2:c.40+119624A>G:			Probable transcriptional regulator involved in developmental processes. May act as a transcriptional repressor (Potential)				0.0000	0.0000	0.0000																					0		0.1042	48	0.0000	26
chr20	52055489	52055489	A	G	0.3636	11	0.0000	16		33	TSHZ2,RP4-678D15.1	intron_variant	TSHZ2:ENST00000371497:intron_variant:MODIFIER:exon2/2:c.*9-48194A>G:,RP4-678D15.1:ENST00000606932:intron_variant:MODIFIER:exon1/2:n.133+48192T>C:,TSHZ2:ENST00000603338:intron_variant:MODIFIER:exon2/2:c.*9-48194A>G:,TSHZ2:ENST00000605656:intron_variant:MODIFIER:exon1/2:c.*9-48194A>G:			Probable transcriptional regulator involved in developmental processes. May act as a transcriptional repressor (Potential)				0.0000	0.0000	0.0000																					0		0.3636	11	0.0000	16
chr20	52190523	52190523	T	C	0.1538	26	0.0000	20		54	RP4-724E16.2,ZNF217	intron_variant	RP4-724E16.2:ENST00000424252:intron_variant:MODIFIER:exon5/5:n.997-374T>C:,ZNF217:ENST00000302342:intron_variant:MODIFIER:exon3/4:c.3037+1743A>G:,ZNF217:ENST00000371471:intron_variant:MODIFIER:exon4/5:c.3037+1743A>G:,ZNF217:ENST00000437222:intron_variant:MODIFIER:exon1/1:c.301+1743A>G:			Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at 'Ser-473'				0.0000	0.0000	0.0000																					0		0.1538	26	0.0000	20
chr21	9825855	9825855	G	T	0.1935	31	0.0000	20		62	MIR3648	non_coding_transcript_exon_variant	MIR3648:ENST00000581792:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.24G>T:							0.0000	0.0000	0.00121																					0		0.1475	61	0.0200	50
chr21	9827000	9827000	-	T	0.3514	216	0.0330	108		83	MIR3687-TEKT4P2	intergenic_region	MIR3687-TEKT4P2:ENSG00000264063-ENSG00000188681:intergenic_region:MODIFIER::n.9827000_9827001insT:						rs371427877	0.0299521	0.0000	0.0000																					0		0.0763	236	0.0270	111
chr21	11083894	11083894	T	A	0.1667	24	0.0000	16		52	BAGE2	intron_variant	BAGE2:ENST00000470054:intron_variant:MODIFIER:exon2/9:n.324+13652A>T:,BAGE2:ENST00000474011:intron_variant:MODIFIER:exon2/2:n.379+13652A>T:			Unknown. Candidate gene encoding tumor antigens			rs8134560	0.0000	0.0000	0.0000																					0		0.1379	29	0.0000	24
chr21	11094909	11094909	C	G	0.3333	29	0.0556	36		58	BAGE2	intron_variant	BAGE2:ENST00000470054:intron_variant:MODIFIER:exon2/9:n.324+2637G>C:,BAGE2:ENST00000474011:intron_variant:MODIFIER:exon2/2:n.379+2637G>C:			Unknown. Candidate gene encoding tumor antigens			rs2747622	0.0000	0.0000	0.0000																					1	eMed-HCC,	0.3793	29	0.0541	37
chr21	11174019	11174019	C	T	0.2927	41	0.0526	38		65	AP003900.6	splice_region_variant&intron_variant,intron_variant	AP003900.6:ENST00000603265:splice_region_variant&intron_variant:LOW:exon3/3:n.231+17C>T:,AP003900.6:ENST00000604142:intron_variant:MODIFIER:exon1/1:n.122+4178C>T:						rs4518054	0.0000	0.0000	0.0000																					0		0.2927	41	0.0526	38
chr21	11178644	11178644	A	T	0.2059	34	0.0000	18		60	AP003900.6	intron_variant	AP003900.6:ENST00000603265:intron_variant:MODIFIER:exon3/3:n.231+4642A>T:,AP003900.6:ENST00000604142:intron_variant:MODIFIER:exon1/1:n.123-4775A>T:						rs4410373	0.0000	0.0000	0.0000																					0		0.2000	35	0.0000	20
chr21	11180717	11180717	C	T	0.2778	36	0.0345	30		57	AP003900.6	intron_variant	AP003900.6:ENST00000603265:intron_variant:MODIFIER:exon3/3:n.232-2702C>T:,AP003900.6:ENST00000604142:intron_variant:MODIFIER:exon1/1:n.123-2702C>T:						rs1015554	0.0000	0.0000	0.0000																					0		0.2778	36	0.0606	33
chr21	16336342	16336342	-	T	0.2593	36	0.0000	31		49	NRIP1,AF127577.10	3_prime_UTR_variant,intron_variant	NRIP1:ENST00000318948:3_prime_UTR_variant:MODIFIER:exon4/4:c.*694dupA:,NRIP1:ENST00000400199:3_prime_UTR_variant:MODIFIER:exon3/3:c.*694dupA:,NRIP1:ENST00000400202:3_prime_UTR_variant:MODIFIER:exon3/3:c.*694dupA:,AF127577.10:ENST00000446301:intron_variant:MODIFIER:exon1/1:n.414-56dupT:			Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors	Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)		rs776463156	0.0000	0.0000	0.0000																					0		0.1471	34	0.0000	34
chr21	16413368	16413368	-	A	0.2632	23	0.0000	41		55	NRIP1	intron_variant	NRIP1:ENST00000318948:intron_variant:MODIFIER:exon2/3:c.-458+2447dupT:,NRIP1:ENST00000400199:intron_variant:MODIFIER:exon2/2:c.-335+2447dupT:,NRIP1:ENST00000400202:intron_variant:MODIFIER:exon1/2:c.-458+23697dupT:			Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors	Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)			0.0000	0.0000	0.0000																					0		0.0656	61	0.0000	37
chr21	17190118	17190118	A	G	0.2222	18	0.0000	22		59	USP25	intron_variant	USP25:ENST00000400183:intron_variant:MODIFIER:exon9/25:c.932-899A>G:,USP25:ENST00000285679:intron_variant:MODIFIER:exon9/23:c.932-899A>G:,USP25:ENST00000351097:intron_variant:MODIFIER:exon7/10:c.780+12541A>G:,USP25:ENST00000285681:intron_variant:MODIFIER:exon9/24:c.932-899A>G:,USP25:ENST00000547201:intron_variant:MODIFIER:exon7/7:n.726-899A>G:,USP25:ENST00000549362:intron_variant:MODIFIER:exon5/5:n.575-899A>G:			Deubiquitinating enzyme that hydrolyzes ubiquitin moieties conjugated to substrates and thus, functions to process newly synthesized Ubiquitin, to recycle ubiquitin molecules or to edit polyubiquitin chains and prevents proteasomal degradation of substrates. Hydrolyzes both 'Lys-48'- and 'Lys-63'-linked tetraubiquitin chains				0.0000	0.0000	0.0000																					0		0.2222	18	0.0000	22
chr21	20100572	20100572	T	C	0.1818	22	0.0000	22		61	AL109763.2	intron_variant	AL109763.2:ENST00000437492:intron_variant:MODIFIER:exon2/3:n.332+9670A>G:,AL109763.2:ENST00000355189:intron_variant:MODIFIER:exon3/4:n.502+9670A>G:,AL109763.2:ENST00000414582:intron_variant:MODIFIER:exon2/2:n.383+9670A>G:							0.0000	0.0000	0.0000																					0		0.1818	22	0.0000	22
chr21	20130758	20130758	C	T	0.1481	27	0.0000	15		54	AL109763.2	intron_variant	AL109763.2:ENST00000437492:intron_variant:MODIFIER:exon1/3:n.230+1334G>A:,AL109763.2:ENST00000355189:intron_variant:MODIFIER:exon1/4:n.31+1334G>A:							0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	15
chr21	33801900	33801900	A	G	0.1613	31	0.0000	25		65	EVA1C	intron_variant	EVA1C:ENST00000300255:intron_variant:MODIFIER:exon1/7:c.160+16579A>G:,EVA1C:ENST00000469079:intron_variant:MODIFIER:exon1/3:n.1008+16579A>G:,EVA1C:ENST00000459833:intron_variant:MODIFIER:exon1/4:n.152+17399A>G:,EVA1C:ENST00000435323:intron_variant:MODIFIER:exon1/5:c.160+16579A>G:,EVA1C:ENST00000437338:intron_variant:MODIFIER:exon1/6:c.160+16579A>G:,EVA1C:ENST00000457807:intron_variant:MODIFIER:exon1/5:c.160+16579A>G:,EVA1C:ENST00000401402:intron_variant:MODIFIER:exon1/6:c.160+16579A>G:,EVA1C:ENST00000382699:intron_variant:MODIFIER:exon1/7:c.160+16579A>G:,EVA1C:ENST00000481638:intron_variant:MODIFIER:exon1/1:n.251-3559A>G:,EVA1C:ENST00000412833:intron_variant:MODIFIER:exon1/4:c.-126+908A>G:			Binds heparin				0.0000	0.0000	0.0000																					0		0.1613	31	0.0000	25
chr21	35043988	35043988	A	G	0.1923	26	0.0286	35		52	AP000304.12,ITSN1	intron_variant	AP000304.12:ENST00000429238:intron_variant:MODIFIER:exon3/4:c.286-85501T>C:,ITSN1:ENST00000381285:intron_variant:MODIFIER:exon1/39:c.-33+28969A>G:,ITSN1:ENST00000399353:intron_variant:MODIFIER:exon1/28:c.-33+28969A>G:,ITSN1:ENST00000444491:intron_variant:MODIFIER:exon1/6:c.-219-17639A>G:,ITSN1:ENST00000470742:intron_variant:MODIFIER:exon1/3:n.261+28969A>G:,ITSN1:ENST00000381318:intron_variant:MODIFIER:exon1/39:c.-33+28969A>G:,ITSN1:ENST00000381291:intron_variant:MODIFIER:exon1/29:c.-33+28969A>G:,ITSN1:ENST00000399367:intron_variant:MODIFIER:exon1/38:c.-33+28969A>G:,ITSN1:ENST00000399352:intron_variant:MODIFIER:exon1/28:c.-33+28969A>G:,ITSN1:ENST00000399355:intron_variant:MODIFIER:exon1/27:c.-33+28969A>G:,ITSN1:ENST00000399349:intron_variant:MODIFIER:exon1/26:c.-33+28969A>G:,ITSN1:ENST00000451686:intron_variant:MODIFIER:exon1/5:c.-94-17639A>G:			Adapter protein that may provide indirect link between the endocytic membrane traffic and the actin assembly machinery. May regulate the formation of clathrin-coated vesicles. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR may involve association with DAB2. Isoform 1 could be involved in brain-specific synaptic vesicle recycling. Inhibits ARHGAP31 activity toward RAC1				0.0000	0.0000	0.0000																					0		0.1923	26	0.0286	35
chr21	38244049	38244049	T	C	0.1818	33	0.0000	18		61	HLCS	intron_variant	HLCS:ENST00000336648:intron_variant:MODIFIER:exon7/11:c.1451+25111A>G:,HLCS:ENST00000399120:intron_variant:MODIFIER:exon7/11:c.1451+25111A>G:		Biotin metabolism	Post-translational modification of specific protein by attachment of biotin. Acts on various carboxylases such as acetyl- CoA-carboxylase, pyruvate carboxylase, propionyl CoA carboxylase, and 3-methylcrotonyl CoA carboxylase				0.0000	0.0000	0.0000		609018 [HLCS (confirmed) Holocarboxylase synthetase deficiency,253270];																			0		0.1818	33	0.0000	18
chr21	47418065	47418065	G	A	0.0263	152	0.0046	216		58	COL6A1	missense_variant	COL6A1:ENST00000361866:missense_variant:MODERATE:exon23/35:c.1555G>A:p.Glu519Lys		Cell Communication;Focal adhesion;ECM-receptor interaction	Collagen VI acts as a cell-binding protein			rs754384963	0.0000	0.00007	0.00006	COSM3551642	120220 [COL6A1 (confirmed) Bethlem myopathy 1,158810|Ullrich congenital muscular dystrophy 1,254090];	RCV000330732.1 [uncertain significance]; RCV000368419.1 [uncertain significance]; 		1.522000	D	T,T	B	D	22.70											0		0.0263	152	0.0046	217
chr22	16154554	16154554	T	A	0.2188	32	0.0000	18		57	AP000525.9,LL22NC03-N14H11.1	intron_variant,non_coding_transcript_exon_variant	AP000525.9:ENST00000447898:intron_variant:MODIFIER:exon3/3:n.294-2733A>T:,AP000525.9:ENST00000437781:intron_variant:MODIFIER:exon7/7:n.832-2733A>T:,AP000525.9:ENST00000413768:intron_variant:MODIFIER:exon7/7:n.810-2733A>T:,LL22NC03-N14H11.1:ENST00000608286:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.213A>T:						rs879772142	0.0000	0.0000	0.0000																					0		0.2188	32	0.0000	18
chr22	16164263	16164263	G	A	0.1905	21	0.0000	18		53	AP000525.9,AP000525.10	intron_variant	AP000525.9:ENST00000447898:intron_variant:MODIFIER:exon2/3:n.203-1776C>T:,AP000525.10:ENST00000440946:intron_variant:MODIFIER:exon1/2:n.324-219G>A:,AP000525.9:ENST00000437781:intron_variant:MODIFIER:exon6/7:n.741-1776C>T:,AP000525.9:ENST00000413768:intron_variant:MODIFIER:exon6/7:n.719-1776C>T:,AP000525.10:ENST00000609679:intron_variant:MODIFIER:exon1/2:n.265-219G>A:,AP000525.9:ENST00000383038:intron_variant:MODIFIER:exon6/7:n.712-1776C>T:						rs2298424	0.0000	0.0000	0.0000																					0		0.1481	27	0.0000	24
chr22	24259754	24259754	T	C	0.1538	27	0.0000	26		53	AP000350.5-AP000350.6	intergenic_region	AP000350.5-AP000350.6:ENSG00000273295-ENSG00000225282:intergenic_region:MODIFIER::n.24259754T>C:							0.0000	0.0000	0.0000																					0		0.1333	30	0.0000	26
chr22	24265045	24265045	T	C	0.1739	24	0.0000	29		54	AP000350.5-AP000350.6	intergenic_region	AP000350.5-AP000350.6:ENSG00000273295-ENSG00000225282:intergenic_region:MODIFIER::n.24265045T>C:							0.0000	0.0000	0.0000																					0		0.2083	24	0.0345	29
chr22	24505987	24505987	A	G	0.2609	23	0.0789	38		51	CABIN1	intron_variant	CABIN1:ENST00000263119:intron_variant:MODIFIER:exon26/36:c.4118-3546A>G:,CABIN1:ENST00000405822:intron_variant:MODIFIER:exon25/35:c.3881-3546A>G:,CABIN1:ENST00000398319:intron_variant:MODIFIER:exon26/36:c.4118-3546A>G:,CABIN1:ENST00000467937:intron_variant:MODIFIER:exon1/2:n.171-3546A>G:			May be required for replication-independent chromatin assembly. May serve as a negative regulator of T-cell receptor (TCR) signaling via inhibition of calcineurin. Inhibition of activated calcineurin is dependent on both PKC and calcium signals	Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK);Role of MEF2D in T-cell Apoptosis			0.0000	0.0000	0.0000																					0		0.2609	23	0.0789	38
chr22	24968608	24968608	A	G	0.1282	40	0.0000	32		66	SNRPD3	3_prime_UTR_variant,intron_variant	SNRPD3:ENST00000215829:3_prime_UTR_variant:MODIFIER:exon4/4:c.*663A>G:,SNRPD3:ENST00000402849:intron_variant:MODIFIER:exon4/4:c.363+579A>G:,SNRPD3:ENST00000404603:intron_variant:MODIFIER:exon4/6:c.*40+623A>G:,SNRPD3:ENST00000439775:intron_variant:MODIFIER:exon4/6:c.*35+579A>G:		Systemic lupus erythematosus	Appears to function in the U7 snRNP complex that is involved in histone 3'-end processing. Binds to the downstream cleavage product (DCP) of histone pre-mRNA in a U7 snRNP dependent manner				0.0000	0.0000	0.0000																					0		0.1500	40	0.0000	32
chr22	30883584	30883584	T	C	0.2000	20	0.0000	18		51	RP4-539M6.14	intron_variant	RP4-539M6.14:ENST00000610156:intron_variant:MODIFIER:exon1/2:n.486+3758T>C:							0.0000	0.0000	0.0000																					0		0.2000	20	0.0000	18
chr22	36548922	36548922	T	C	0.1842	38	0.0238	42		51	APOL3	intron_variant	APOL3:ENST00000349314:intron_variant:MODIFIER:exon1/2:c.224-7275A>G:,APOL3:ENST00000397293:intron_variant:MODIFIER:exon1/3:c.-87-3732A>G:,APOL3:ENST00000424878:intron_variant:MODIFIER:exon2/3:c.-377-7275A>G:,APOL3:ENST00000397289:intron_variant:MODIFIER:exon1/3:c.224-3732A>G:,APOL3:ENST00000422426:intron_variant:MODIFIER:exon1/4:c.224-3503A>G:,APOL3:ENST00000432700:intron_variant:MODIFIER:exon1/3:c.224-3503A>G:,APOL3:ENST00000361710:intron_variant:MODIFIER:exon2/3:c.-377-7275A>G:,APOL3:ENST00000397287:intron_variant:MODIFIER:exon3/4:c.-377-7275A>G:,APOL3:ENST00000487355:intron_variant:MODIFIER:exon2/4:c.*150-3732A>G:,APOL3:ENST00000487423:intron_variant:MODIFIER:exon1/2:n.93+3970A>G:,APOL3:ENST00000426939:intron_variant:MODIFIER:exon1/4:c.86-3732A>G:,APOL3:ENST00000534251:intron_variant:MODIFIER:exon1/3:n.107-3689A>G:,APOL3:ENST00000531195:intron_variant:MODIFIER:exon1/3:c.86-3732A>G:,APOL3:ENST00000487783:intron_variant:MODIFIER:exon2/4:c.*107+411A>G:,APOL3:ENST00000525184:intron_variant:MODIFIER:exon1/2:n.138-3732A>G:,APOL3:ENST00000485453:intron_variant:MODIFIER:exon1/2:n.96-3503A>G:,APOL3:ENST00000530895:intron_variant:MODIFIER:exon1/2:c.86-3503A>G:,APOL3:ENST00000472303:intron_variant:MODIFIER:exon1/3:c.86-2910A>G:			May affect the movement of lipids in the cytoplasm or allow the binding of lipids to organelles				0.0000	0.0000	0.0000																					0		0.1842	38	0.0238	42
chr22	38343683	38343683	A	G	0.2500	16	0.0000	20		51	C22orf23	intron_variant	C22orf23:ENST00000249079:intron_variant:MODIFIER:exon3/6:c.167-213T>C:,C22orf23:ENST00000403305:intron_variant:MODIFIER:exon3/6:c.167-213T>C:,C22orf23:ENST00000403026:intron_variant:MODIFIER:exon3/6:c.167-213T>C:,C22orf23:ENST00000418863:intron_variant:MODIFIER:exon3/5:c.167-213T>C:,C22orf23:ENST00000422191:intron_variant:MODIFIER:exon2/3:c.167-213T>C:							0.0000	0.0000	0.0000																					0		0.2500	16	0.0000	20
chr22	39414772	39414772	A	G	0.2381	21	0.0588	34		52	APOBEC3C,APOBEC3D	3_prime_UTR_variant,intron_variant	APOBEC3C:ENST00000361441:3_prime_UTR_variant:MODIFIER:exon4/4:c.*380A>G:,APOBEC3C:ENST00000428892:3_prime_UTR_variant:MODIFIER:exon3/3:c.*610A>G:,APOBEC3D:ENST00000381568:intron_variant:MODIFIER:exon1/6:c.18-4055A>G:		Atrazine degradation	DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination- independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double- stranded RNA. Exhibits antiviral activity against simian immunodeficiency virus (SIV), hepatitis B virus (HBV), herpes simplex virus 1 (HHV-1) and Epstein-Barr virus (EBV) and may inhibit the mobility of LTR and non-LTR retrotransposons. May also play a role in the epigenetic regulation of gene expression through the process of active DNA demethylation.,DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination- independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double- stranded RNA. May inhibit the mobility of LTR and non-LTR retrotransposons				0.0000	0.0000	0.0000																					0		0.2381	21	0.0588	34
chr22	43385034	43385034	T	C	0.1379	29	0.0000	18		53	PACSIN2	intron_variant	PACSIN2:ENST00000263246:intron_variant:MODIFIER:exon1/10:c.-78+25993A>G:,PACSIN2:ENST00000337959:intron_variant:MODIFIER:exon1/9:c.-78+25993A>G:,PACSIN2:ENST00000453643:intron_variant:MODIFIER:exon2/4:c.-78+4592A>G:,PACSIN2:ENST00000422336:intron_variant:MODIFIER:exon1/3:c.-78+13282A>G:,PACSIN2:ENST00000445706:intron_variant:MODIFIER:exon1/3:c.-78+25993A>G:			Plays a role in the formation of normal, flask-shaped caveolae at the cell membrane. Recruits DNM2 to caveolae, and thereby plays a role in caveola-mediated endocytosis. Plays a role in intracellular vesicle-mediated transport. Binds to membranes via its F-BAR domain and promotes membrane tubulation. Plays a role in the internalization of cell-surface receptors. Is not required for internalization of EGFR after EGF stimulus, but contributes to the internalization of EGFR in the absence of EGF stimulus				0.0000	0.0000	0.0000																					0		0.1379	29	0.0000	18
chr22	43408075	43408075	T	C	0.2105	19	0.0000	22		56	PACSIN2	intron_variant	PACSIN2:ENST00000263246:intron_variant:MODIFIER:exon1/10:c.-78+2952A>G:,PACSIN2:ENST00000337959:intron_variant:MODIFIER:exon1/9:c.-78+2952A>G:,PACSIN2:ENST00000453643:intron_variant:MODIFIER:exon1/4:c.-239+2952A>G:,PACSIN2:ENST00000445706:intron_variant:MODIFIER:exon1/3:c.-78+2952A>G:			Plays a role in the formation of normal, flask-shaped caveolae at the cell membrane. Recruits DNM2 to caveolae, and thereby plays a role in caveola-mediated endocytosis. Plays a role in intracellular vesicle-mediated transport. Binds to membranes via its F-BAR domain and promotes membrane tubulation. Plays a role in the internalization of cell-surface receptors. Is not required for internalization of EGFR after EGF stimulus, but contributes to the internalization of EGFR in the absence of EGF stimulus				0.0000	0.0000	0.0000																					0		0.2105	19	0.0000	22
chr22	45736849	45736849	A	G	0.1613	32	0.0000	21		63	FAM118A	3_prime_UTR_variant	FAM118A:ENST00000216214:3_prime_UTR_variant:MODIFIER:exon10/10:c.*563A>G:							0.0000	0.0000	0.0000																					0		0.1562	32	0.0000	21
chrX	46464502	46464502	T	C	0.1818	23	0.0000	30		58	CHST7-SLC9A7	intergenic_region	CHST7-SLC9A7:ENSG00000147119-ENSG00000065923:intergenic_region:MODIFIER::n.46464502T>C:							0.0000	0.0000	0.0000																					0		0.1739	23	0.0000	30
chrX	64914252	64914252	A	G	0.3000	10	0.0000	21		45	MSN	intron_variant	MSN:ENST00000360270:intron_variant:MODIFIER:exon1/12:c.13-22428A>G:,MSN:ENST00000609672:intron_variant:MODIFIER:exon1/3:c.-21-22428A>G:		Leukocyte transendothelial migration;Regulation of actin cytoskeleton	Probably involved in connections of major cytoskeletal structures to the plasma membrane. May inhibit herpes simplex virus 1 infection at an early stage				0.0000	0.0000	0.0000		309845 [MSN (provisional) Immunodeficiency 50,300988];																			0		0.3000	10	0.0000	21
chrX	73177259	73177259	A	G	0.3333	18	0.0000	22		53	JPX	intron_variant	JPX:ENST00000414209:intron_variant:MODIFIER:exon3/4:n.579+10050A>G:,JPX:ENST00000602938:intron_variant:MODIFIER:exon2/4:n.221+12762A>G:,JPX:ENST00000602294:intron_variant:MODIFIER:exon2/4:n.221+12762A>G:,JPX:ENST00000602920:intron_variant:MODIFIER:exon2/3:n.221+12762A>G:,JPX:ENST00000602772:intron_variant:MODIFIER:exon2/4:n.217+12762A>G:,JPX:ENST00000602895:intron_variant:MODIFIER:exon2/3:n.202+12762A>G:,JPX:ENST00000602546:intron_variant:MODIFIER:exon2/4:n.148+12762A>G:,JPX:ENST00000602985:intron_variant:MODIFIER:exon2/2:n.194+12762A>G:							0.0000	0.0000	0.0000																					0		0.3333	18	0.0000	22
chrX	73419965	73419965	T	C	0.1053	38	0.0000	40		68	FTX	intron_variant	FTX:ENST00000603672:intron_variant:MODIFIER:exon5/5:n.489+74212A>G:,FTX:ENST00000602812:intron_variant:MODIFIER:exon5/6:n.695+74212A>G:,FTX:ENST00000602420:intron_variant:MODIFIER:exon4/4:n.524+80264A>G:							0.0000	0.0000	0.0000																					0		0.1053	38	0.0000	40
chrX	73445383	73445383	T	C	0.0649	78	0.0000	89		64	RP3-368A4.5,FTX	intron_variant	RP3-368A4.5:ENST00000603037:intron_variant:MODIFIER:exon1/1:n.216+16385A>G:,FTX:ENST00000603672:intron_variant:MODIFIER:exon5/5:n.489+48794A>G:,FTX:ENST00000602812:intron_variant:MODIFIER:exon5/6:n.695+48794A>G:,FTX:ENST00000602420:intron_variant:MODIFIER:exon4/4:n.524+54846A>G:							0.0000	0.0000	0.0000																					0		0.0641	78	0.0000	89
chrX	73485863	73485863	T	C	0.0800	50	0.0000	56		49	FTX	intron_variant	FTX:ENST00000603672:intron_variant:MODIFIER:exon5/5:n.489+8314A>G:,FTX:ENST00000602812:intron_variant:MODIFIER:exon5/6:n.695+8314A>G:,FTX:ENST00000602420:intron_variant:MODIFIER:exon4/4:n.524+14366A>G:,FTX:ENST00000430772:intron_variant:MODIFIER:exon5/5:n.648+8314A>G:							0.0000	0.0000	0.0000																					0		0.0800	50	0.0000	56
chrX	73495808	73495808	T	C	0.0685	73	0.0000	90		69	FTX	intron_variant	FTX:ENST00000603672:intron_variant:MODIFIER:exon4/5:n.421-1563A>G:,FTX:ENST00000602812:intron_variant:MODIFIER:exon4/6:n.627-1563A>G:,FTX:ENST00000602420:intron_variant:MODIFIER:exon4/4:n.524+4421A>G:,FTX:ENST00000430772:intron_variant:MODIFIER:exon4/5:n.580-1563A>G:,FTX:ENST00000602576:intron_variant:MODIFIER:exon4/4:n.506-1563A>G:,FTX:ENST00000602776:intron_variant:MODIFIER:exon4/4:n.507-1563A>G:							0.0000	0.0000	0.0000																					0		0.0685	73	0.0000	90
chrX	108890930	108890930	-	A	0.1282	41	0.0000	30		40	ACSL4	intron_variant	ACSL4:ENST00000340800:intron_variant:MODIFIER:exon16/16:c.1979-3516dupT:,ACSL4:ENST00000505075:intron_variant:MODIFIER:exon1/1:n.160+11652dupT:,ACSL4:ENST00000469796:intron_variant:MODIFIER:exon15/15:c.1979-3516dupT:,ACSL4:ENST00000348502:intron_variant:MODIFIER:exon15/15:c.1856-3516dupT:,ACSL4:ENST00000514500:intron_variant:MODIFIER:exon5/5:c.*66-3516dupT:		Fatty acid metabolism;PPAR signaling pathway;Adipocytokine signaling pathway	Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates				0.0000	0.0000	0.0000		300157 [ACSL4 (confirmed) Mental retardation,X-linked 63,300387];																			0		0.0107	374	0.0000	29
chrX	108947004	108947004	T	C	0.1111	64	0.0000	26		62	ACSL4	intron_variant	ACSL4:ENST00000340800:intron_variant:MODIFIER:exon1/16:c.-251-7579A>G:,ACSL4:ENST00000469796:intron_variant:MODIFIER:exon1/15:c.-233-7579A>G:,ACSL4:ENST00000348502:intron_variant:MODIFIER:exon1/15:c.-62-7579A>G:,ACSL4:ENST00000502391:intron_variant:MODIFIER:exon1/2:c.-180-20109A>G:,ACSL4:ENST00000508092:intron_variant:MODIFIER:exon1/2:c.-66-20223A>G:,ACSL4:ENST00000504980:intron_variant:MODIFIER:exon1/3:c.-119-7579A>G:,ACSL4:ENST00000469857:intron_variant:MODIFIER:exon1/3:c.-251-7579A>G:,ACSL4:ENST00000504383:intron_variant:MODIFIER:exon1/1:n.138-7579A>G:		Fatty acid metabolism;PPAR signaling pathway;Adipocytokine signaling pathway	Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates				0.0000	0.0000	0.0000		300157 [ACSL4 (confirmed) Mental retardation,X-linked 63,300387];																			0		0.1094	64	0.0000	26
chrX	108954056	108954056	T	C	0.1233	74	0.0000	31		66	ACSL4	intron_variant	ACSL4:ENST00000340800:intron_variant:MODIFIER:exon1/16:c.-251-14631A>G:,ACSL4:ENST00000469796:intron_variant:MODIFIER:exon1/15:c.-233-14631A>G:,ACSL4:ENST00000348502:intron_variant:MODIFIER:exon1/15:c.-62-14631A>G:,ACSL4:ENST00000502391:intron_variant:MODIFIER:exon1/2:c.-181+22312A>G:,ACSL4:ENST00000508092:intron_variant:MODIFIER:exon1/2:c.-67+22312A>G:,ACSL4:ENST00000504980:intron_variant:MODIFIER:exon1/3:c.-119-14631A>G:,ACSL4:ENST00000469857:intron_variant:MODIFIER:exon1/3:c.-251-14631A>G:,ACSL4:ENST00000504383:intron_variant:MODIFIER:exon1/1:n.138-14631A>G:		Fatty acid metabolism;PPAR signaling pathway;Adipocytokine signaling pathway	Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates				0.0000	0.0000	0.0000		300157 [ACSL4 (confirmed) Mental retardation,X-linked 63,300387];																			0		0.1216	74	0.0000	31
chrX	108967936	108967936	T	C	0.0909	56	0.0000	39		63	ACSL4	intron_variant	ACSL4:ENST00000340800:intron_variant:MODIFIER:exon1/16:c.-252+8432A>G:,ACSL4:ENST00000469796:intron_variant:MODIFIER:exon1/15:c.-234+8432A>G:,ACSL4:ENST00000348502:intron_variant:MODIFIER:exon1/15:c.-63+8432A>G:,ACSL4:ENST00000502391:intron_variant:MODIFIER:exon1/2:c.-181+8432A>G:,ACSL4:ENST00000508092:intron_variant:MODIFIER:exon1/2:c.-67+8432A>G:,ACSL4:ENST00000504980:intron_variant:MODIFIER:exon1/3:c.-120+8432A>G:,ACSL4:ENST00000469857:intron_variant:MODIFIER:exon1/3:c.-252+8432A>G:,ACSL4:ENST00000504383:intron_variant:MODIFIER:exon1/1:n.137+8432A>G:		Fatty acid metabolism;PPAR signaling pathway;Adipocytokine signaling pathway	Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates				0.0000	0.0000	0.0000		300157 [ACSL4 (confirmed) Mental retardation,X-linked 63,300387];																			0		0.0893	56	0.0000	39
chrX	110947630	110947630	A	G	0.1905	21	0.0000	24		64	ALG13	intron_variant	ALG13:ENST00000394780:intron_variant:MODIFIER:exon3/26:c.384-3625A>G:,ALG13:ENST00000487141:intron_variant:MODIFIER:exon4/6:n.571-7273A>G:,ALG13:ENST00000251943:intron_variant:MODIFIER:exon3/25:c.72-3625A>G:,ALG13:ENST00000486353:intron_variant:MODIFIER:exon3/3:c.384-3625A>G:,ALG13:ENST00000495283:intron_variant:MODIFIER:exon3/13:c.72-3625A>G:,ALG13:ENST00000471924:intron_variant:MODIFIER:exon3/3:n.492-3625A>G:,ALG13:ENST00000470704:intron_variant:MODIFIER:exon1/1:n.472-4563A>G:		N-Glycan biosynthesis;Glycan structures - biosynthesis 1	Isoform 2 may be involved in protein N-glycosylation, second step of the dolichol-linked oligosaccharide pathway				0.0000	0.0000	0.0000		300776 [ALG13 (provisional) Epileptic encephalopathy,early infantile,36,300884|Congenital disorder of glycosylation,type Is,300884];																			0		0.1905	21	0.0000	24
chrX	115041510	115041510	T	C	0.2391	46	0.0606	33		53	RP11-761E20.1	intron_variant	RP11-761E20.1:ENST00000430756:intron_variant:MODIFIER:exon2/2:n.201-6028A>G:							0.0000	0.0000	0.0000																					0		0.2391	46	0.0606	33
chrX	115045908	115045908	T	C	0.2778	36	0.0000	34		85	RP11-761E20.1	intron_variant	RP11-761E20.1:ENST00000430756:intron_variant:MODIFIER:exon2/2:n.201-10426A>G:							0.0000	0.0000	0.0000																					0		0.2424	33	0.0000	34
chrX	115045909	115045909	T	C	0.2500	36	0.0000	33		80	RP11-761E20.1	intron_variant	RP11-761E20.1:ENST00000430756:intron_variant:MODIFIER:exon2/2:n.201-10427A>G:							0.0000	0.0000	0.0000																					0		0.2059	34	0.0000	33
chrX	115045919	115045919	T	C	0.1389	36	0.0000	31		70	RP11-761E20.1	intron_variant	RP11-761E20.1:ENST00000430756:intron_variant:MODIFIER:exon2/2:n.201-10437A>G:							0.0000	0.0000	0.0000																					0		0.1429	35	0.0000	31
chrX	115046070	115046070	T	C	0.2250	41	0.0385	26		52	RP11-761E20.1	intron_variant	RP11-761E20.1:ENST00000430756:intron_variant:MODIFIER:exon2/2:n.201-10588A>G:							0.0000	0.0000	0.0000																					0		0.2195	41	0.0385	26
chrX	115046229	115046229	C	T	0.0909	44	0.0000	41		52	RP11-761E20.1	intron_variant	RP11-761E20.1:ENST00000430756:intron_variant:MODIFIER:exon2/2:n.201-10747G>A:							0.0000	0.0000	0.0000																					0		0.0909	44	0.0000	41
chrX	123042978	123042978	A	G	0.2647	68	0.0824	86		58	XIAP	3_prime_UTR_variant	XIAP:ENST00000355640:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1947A>G:,XIAP:ENST00000371199:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1947A>G:		Ubiquitin mediated proteolysis;Apoptosis;Focal adhesion;Small cell lung cancer	Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, copper homeostasis, mitogenic kinase signaling, cell proliferation, as well as cell invasion and metastasis. Acts as a direct caspase inhibitor. Directly bind to the active site pocket of CASP3 and CASP7 and obstructs substrate entry. Inactivates CASP9 by keeping it in a monomeric, inactive state. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and the target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, CASP3, CASP7, CASP8, CASP9, MAP3K2/MEKK2, DIABLO/SMAC, AIFM1, CCS and BIRC5/survivin. Ubiquitinion of CCS leads to enhancement of its chaperone activity toward its physiologic target, SOD1, rather than proteasomal degradation. Ubiquitinion of MAP3K2/MEKK2 and AIFM1 does not lead to proteasomal degradation. Plays a role in copper homeostasis by ubiquitinationg COMMD1 and promoting its proteasomal degradation. Can also function as E3 ubiquitin-protein ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Regulates the BMP signaling pathway and the SMAD and MAP3K7/TAK1 dependent pathways leading to NF-kappa-B and JNK activation. Acts as an important regulator of innate immune signaling via regulation of Nodlike receptors (NLRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. Acts as a positive regulator of Wnt signaling and ubiquitinates TLE1, TLE2, TLE3, TLE4 and AES. Ubiquitination of TLE3 results in inhibition of its interaction with TCF7L2/TCF4 thereby allowing efficient recruitment and binding of the transcriptional coactivator beta- catenin to TCF7L2/TCF4 that is required to initiate a Wnt-specific transcriptional program	Caspase Cascade in Apoptosis;HIV-I Nef: negative effector of Fas and TNF;Induction of apoptosis through DR3 and DR4/5 Death Receptors ;Role of Mitochondria in Apoptotic Signaling			0.0000	0.0000	0.0000		300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];																			0		0.2647	68	0.1023	88
chrX	123046590	123046590	A	G	0.3214	33	0.0909	48		53	XIAP	3_prime_UTR_variant	XIAP:ENST00000355640:3_prime_UTR_variant:MODIFIER:exon7/7:c.*5559A>G:,XIAP:ENST00000371199:3_prime_UTR_variant:MODIFIER:exon7/7:c.*5559A>G:		Ubiquitin mediated proteolysis;Apoptosis;Focal adhesion;Small cell lung cancer	Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, copper homeostasis, mitogenic kinase signaling, cell proliferation, as well as cell invasion and metastasis. Acts as a direct caspase inhibitor. Directly bind to the active site pocket of CASP3 and CASP7 and obstructs substrate entry. Inactivates CASP9 by keeping it in a monomeric, inactive state. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and the target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, CASP3, CASP7, CASP8, CASP9, MAP3K2/MEKK2, DIABLO/SMAC, AIFM1, CCS and BIRC5/survivin. Ubiquitinion of CCS leads to enhancement of its chaperone activity toward its physiologic target, SOD1, rather than proteasomal degradation. Ubiquitinion of MAP3K2/MEKK2 and AIFM1 does not lead to proteasomal degradation. Plays a role in copper homeostasis by ubiquitinationg COMMD1 and promoting its proteasomal degradation. Can also function as E3 ubiquitin-protein ligase of the NEDD8 conjugation pathway, targeting effector caspases for neddylation and inactivation. Regulates the BMP signaling pathway and the SMAD and MAP3K7/TAK1 dependent pathways leading to NF-kappa-B and JNK activation. Acts as an important regulator of innate immune signaling via regulation of Nodlike receptors (NLRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8. Acts as a positive regulator of Wnt signaling and ubiquitinates TLE1, TLE2, TLE3, TLE4 and AES. Ubiquitination of TLE3 results in inhibition of its interaction with TCF7L2/TCF4 thereby allowing efficient recruitment and binding of the transcriptional coactivator beta- catenin to TCF7L2/TCF4 that is required to initiate a Wnt-specific transcriptional program	Caspase Cascade in Apoptosis;HIV-I Nef: negative effector of Fas and TNF;Induction of apoptosis through DR3 and DR4/5 Death Receptors ;Role of Mitochondria in Apoptotic Signaling			0.0000	0.0000	0.00001		300079 [XIAP (confirmed) Lymphoproliferative syndrome,X-linked,2,300635];																			0		0.3939	33	0.1042	48
chrX	135959718	135959718	T	C	0.2727	22	0.0000	23		60	RBMX	intron_variant	RBMX:ENST00000320676:intron_variant:MODIFIER:exon4/8:c.388+356A>G:,RBMX:ENST00000431446:intron_variant:MODIFIER:exon3/7:c.216+1458A>G:,RBMX:ENST00000568578:intron_variant:MODIFIER:exon3/7:c.217-904A>G:,RBMX:ENST00000419968:intron_variant:MODIFIER:exon3/7:c.391+356A>G:,RBMX:ENST00000464781:intron_variant:MODIFIER:exon3/7:c.217-904A>G:,RBMX:ENST00000570135:intron_variant:MODIFIER:exon3/7:c.-17-904A>G:,RBMX:ENST00000562646:intron_variant:MODIFIER:exon4/7:c.388+356A>G:,RBMX:ENST00000565438:intron_variant:MODIFIER:exon2/6:c.4+356A>G:,RBMX:ENST00000567262:intron_variant:MODIFIER:exon4/4:n.421+356A>G:			RNA-binding protein that plays several role in the regulation of pre- and post-transcriptional processes. Implicated in tissue-specific regulation of gene transcription and alternative splicing of several pre-mRNAs. Binds to and stimulates transcription from the tumor suppressor TXNIP gene promoter; may thus be involved in tumor suppression. When associated with SAFB, binds to and stimulates transcription from the SREBF1 promoter. Associates with nascent mRNAs transcribed by RNA polymerase II. Component of the supraspliceosome complex that regulates pre-mRNA alternative splice site selection. Can either activate or suppress exon inclusion; acts additively with TRA2B to promote exon 7 inclusion of the survival motor neuron SMN2. Represses the splicing of MAPT/Tau exon 10. Binds preferentially to single- stranded 5'-CC[A/C]-rich RNA sequence motifs localized in a single-stranded conformation; probably binds RNA as a homodimer. Binds non-specifically to pre-mRNAs. Plays also a role in the cytoplasmic TNFR1 trafficking pathways; promotes both the IL-1- beta-mediated inducible proteolytic cleavage of TNFR1 ectodomains and the release of TNFR1 exosome-like vesicles to the extracellular compartment				0.0000	0.0000	0.0000		300199 [RBMX (confirmed) Mental retardation,X-linked,syndromic 11,Shashi type,300238];																			0		0.2727	22	0.0000	23
chrY	15354867	15354867	T	C	0.3636	11	0.0000	19		42	DPPA2P1-UTY	intergenic_region	DPPA2P1-UTY:ENSG00000223915-ENSG00000183878:intergenic_region:MODIFIER::n.15354867T>C:							0.0000	0.0000	0.0000																					0		0.3636	11	0.0000	19
chrY	15496480	15496480	T	C	0.2000	21	0.0000	30		61	UTY	intron_variant	UTY:ENST00000382896:intron_variant:MODIFIER:exon8/28:c.645+9259A>G:,UTY:ENST00000331397:intron_variant:MODIFIER:exon8/27:c.645+9259A>G:,UTY:ENST00000537580:intron_variant:MODIFIER:exon8/27:c.645+9259A>G:,UTY:ENST00000362096:intron_variant:MODIFIER:exon8/24:c.645+9259A>G:,UTY:ENST00000329134:intron_variant:MODIFIER:exon8/19:c.645+9259A>G:,UTY:ENST00000538878:intron_variant:MODIFIER:exon8/18:c.645+9259A>G:,UTY:ENST00000540140:intron_variant:MODIFIER:exon8/19:c.645+9259A>G:,UTY:ENST00000545955:intron_variant:MODIFIER:exon8/20:c.645+9259A>G:,UTY:ENST00000478900:intron_variant:MODIFIER:exon7/9:n.485+12318A>G:			Histone demethylase (By similarity)				0.0000	0.0000	0.0000																					0		0.2381	21	0.0000	30
chrMT	723	723	A	G	0.0242	2362	0.0076	1586		110	MT-RNR1	non_coding_transcript_exon_variant	MT-RNR1:ENST00000389680:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.76A>G:						rs386828878	0.0000	0.0000	0.0000																					1	TEST_SomaticAndTreatment,	0.0241	2367	0.0082	1590
chrMT	955	955	-	C	0.0209	3159	0.0027	2644		385	MT-RNR1	non_coding_transcript_exon_variant	MT-RNR1:ENST00000389680:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.313dupC:						rs111033185;rs879161658	0.0000	0.0000	0.0000			RCV000035059.2 [likely benign]; 																		0		0.0138	2689	0.0018	2238
chrMT	1822	1822	T	C	0.0255	5582	0.0009	4346		778	MT-RNR2	non_coding_transcript_exon_variant	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.152T>C:			Plays a role as a neuroprotective factor. Protects against death induced by multiple different familial Alzheimer disease genes and beta amyloid proteins in Alzheimer disease. Suppresses apoptosis by binding to BAX and preventing the translocation of BAX from the cytosol to mitochondria. Binds to IGFBP3 and specifically blocks IGFBP3-induced cell death Induces chemotaxis of mononuclear phagocytes via FPR2. Reduces the aggregation and fibrillary formation by suppressing the effect of APP on mononuclear phagocytes and acts by competitively inhibiting the access of FPRL1 to APP				0.0000	0.0000	0.0000																					0		0.0251	5614	0.0009	4353
chrMT	2141	2141	T	C	0.0246	10189	0.0022	8771		1269	MT-RNR2	non_coding_transcript_exon_variant	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.471T>C:			Plays a role as a neuroprotective factor. Protects against death induced by multiple different familial Alzheimer disease genes and beta amyloid proteins in Alzheimer disease. Suppresses apoptosis by binding to BAX and preventing the translocation of BAX from the cytosol to mitochondria. Binds to IGFBP3 and specifically blocks IGFBP3-induced cell death Induces chemotaxis of mononuclear phagocytes via FPR2. Reduces the aggregation and fibrillary formation by suppressing the effect of APP on mononuclear phagocytes and acts by competitively inhibiting the access of FPRL1 to APP				0.0000	0.0000	0.0000																					0		0.0223	10200	0.0017	8758
chrMT	2416	2416	T	C	0.0281	6621	0.0020	4602		806	MT-RNR2	non_coding_transcript_exon_variant	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.746T>C:			Plays a role as a neuroprotective factor. Protects against death induced by multiple different familial Alzheimer disease genes and beta amyloid proteins in Alzheimer disease. Suppresses apoptosis by binding to BAX and preventing the translocation of BAX from the cytosol to mitochondria. Binds to IGFBP3 and specifically blocks IGFBP3-induced cell death Induces chemotaxis of mononuclear phagocytes via FPR2. Reduces the aggregation and fibrillary formation by suppressing the effect of APP on mononuclear phagocytes and acts by competitively inhibiting the access of FPRL1 to APP			rs28358580	0.0000	0.0000	0.0000																					0		0.0205	6571	0.0015	4601
chrMT	2501	2501	C	A	0.0261	8547	0.0033	6386		943	MT-RNR2	non_coding_transcript_exon_variant	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.831C>A:			Plays a role as a neuroprotective factor. Protects against death induced by multiple different familial Alzheimer disease genes and beta amyloid proteins in Alzheimer disease. Suppresses apoptosis by binding to BAX and preventing the translocation of BAX from the cytosol to mitochondria. Binds to IGFBP3 and specifically blocks IGFBP3-induced cell death Induces chemotaxis of mononuclear phagocytes via FPR2. Reduces the aggregation and fibrillary formation by suppressing the effect of APP on mononuclear phagocytes and acts by competitively inhibiting the access of FPRL1 to APP				0.0000	0.0000	0.0000																					0		0.0259	8534	0.0036	6377
chrMT	2789	2789	C	T	0.0148	8053	0.0009	6865		1283	MT-RNR2	non_coding_transcript_exon_variant	MT-RNR2:ENST00000387347:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1119C>T:			Plays a role as a neuroprotective factor. Protects against death induced by multiple different familial Alzheimer disease genes and beta amyloid proteins in Alzheimer disease. Suppresses apoptosis by binding to BAX and preventing the translocation of BAX from the cytosol to mitochondria. Binds to IGFBP3 and specifically blocks IGFBP3-induced cell death Induces chemotaxis of mononuclear phagocytes via FPR2. Reduces the aggregation and fibrillary formation by suppressing the effect of APP on mononuclear phagocytes and acts by competitively inhibiting the access of FPRL1 to APP			rs28358581	0.0000	0.0000	0.0000																					0		0.0143	8055	0.0009	6863
chrMT	4175	4175	G	A	0.0159	568	0.0019	521		57	MT-ND1	stop_gained	MT-ND1:ENST00000361390:stop_gained:HIGH:exon1/1:c.869G>A:p.Trp290*		Ubiquinone biosynthesis;Oxidative phosphorylation	Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (By similarity)				0.0000	0.0000	0.0000																					0		0.0137	656	0.0033	606
chrMT	8496	8496	-	A	0.0125	1202	0.0064	1035		48	MT-ATP8	frameshift_variant	MT-ATP8:ENST00000361851:frameshift_variant:HIGH:exon1/1:c.137dupA:p.Asn46fs		Oxidative phosphorylation	Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain. Minor subunit located with subunit a in the membrane (By similarity)				0.0000	0.0000	0.0000																					0		0.0106	1129	0.0042	959
